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Summary of thesis  
Urinary tract infections (UTI) in young children have been associated with serious long-term 
complications such as renal scarring, hypertension and renal failure. The presenting 
symptoms of UTI in children are non-specific. If UTI is not suspected, a urine sample is not 
obtained, and without this, UTI cannot be diagnosed. There is evidence that the diagnosis is 
often missed.  
 
Most published studies have not systematically sampled urine, and those that have are largely 
based in US emergency departments and only include highly selected groups of children. The 
true prevalence of UTI in acutely ill children presenting in UK general practice is therefore 
unknown. 
 
My thesis consists of a literature review discussing the association of childhood UTI with 
long-term complications, the challenges of diagnosis and the evidence that UTIs are being 
missed; a systematic review of papers reporting UTI prevalence in children which highlights 
the need for a study in UK general practice; a pilot study to determine the feasibility of 
recruiting children and obtaining urine samples in UK general practice; and a prospective 
cohort study to determine the point prevalence of UTI in 597 presenting children, determine 
the predictive value of presenting symptoms, signs and risk factors, and describe the clinical 
outcomes for children with UTI.  
 
I found that the prevalence of UTI was 5.9% (95% confidence interval: 4.3-8.0%). This may 
be sufficiently high to justify increased urine sampling in general practice. 
 
 A multi-variable logistic regression model identified younger age range, pain on passing 
urine (dysuria) and urinary frequency as being associated with UTI. I propose a urine 
sampling strategy for GPs assessing acutely ill children and compare this to suspicion-led 
sampling and current guidelines. In my discussion I discuss the limitations, generalisability 
and implications of these findings. 
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Glossary of terms and abbreviations  
A&E  Accident and Emergency department 
ASB  Asymptomatic bacteriuria 
cfu/ml  colony forming units per millilitre of urine 
CLED agar Cystine-Lactose-Electrolyte-Deficient agar 
CRF  Case report form 
DMSA  Technetium
99m
 dimercaptosuccinic acid 
E.coli  Escherichia coli 
ED  Emergency department 
EURICA The epidemiology of urinary tract infections in children with acute illness 
presenting in primary care 
GP  General Practitioner 
HPA  Health Protection Agency 
LRTI  Lower respiratory tract infection 
MCUG Micturating cystourethrogram 
MSU  Mid-stream urine sample 
NHS  National Health Service 
NICE  National Institute for Health and Clinical Excellence 
PCR  Polymerase chain reaction 
R&D  Research and Development 
SOP  Standard operating procedures 
SPA  Supra-pubic aspiration 
SPARC Streamlined NHS permissions approach to research Cymru 
SSI  Site specific information 
URTI  Upper respiratory tract infection 
USS  Ultrasound scan 
UTI   Urinary tract infection 
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VUR  Vesico-ureteric reflux 
WBC  White blood cells 
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Chapter 1: Background  
 
 
Introduction  Research aim 
 
The main aim of this thesis is to determine the prevalence of urinary tract infection (UTI) in 
young children presenting with an acute illness in primary care. 
 
In this chapter I will discuss why this is an important question, the difficulties of diagnosing 
UTI and some of the challenges for research studies attempting to address these issues. For 
each of these questions I conducted a thorough review of the literature. A systematic review 
of the existing literature concerning the prevalence of UTI in children is presented in chapter 
two. 
 
Importance of the research question 
 
Importance of UTI in children 
The diagnosis and treatment of UTI in children has been considered to be particularly 
important due to both short term and long term sequelae.
1 2
  UTI is one of the causes of 
serious bacterial illness in infants requiring hospital admission and has been associated with 
significant morbidity.
3
 It has also been thought to cause, or contribute to, the development of 
renal scarring and later to renal failure, hypertension and pre-eclampsia. In this section I will 
discuss the evidence for the link with long-term complications.  
 
Long term complications 
Renal scarring following UTI 
There is evidence that UTI leads to renal scarring in some cases.
1 4
 Renal scarring is the term 
used to describe radiological evidence of persistent kidney damage.
5
 Renal scarring is 
thought to occur as a result of pyelonephritis (infection involving the kidneys). Pyelonephritis 
causes acute damage to the kidneys which can be detected by Technetium
99m
   
dimercaptosuccinic acid (DMSA) scans performed during or soon after a UTI.
6 7
 The acute 
damage seen with pyelonephritis usually resolves. However, some children with 
abnormalities on an early scan will have persistent abnormalities on later scans. Persistent 
abnormalities are known as renal scarring. Renal scarring has been associated with long-term 
complications including renal failure, hypertension and pre-eclampsia.
1 8-10
 
 2 
 
 
Shaikh et al. (2010) conducted a systematic review of the risk of renal scarring following a 
first UTI in childhood.
11
 They included 33 studies with a total of 4891 children. Papers were 
only included if results of acute (<15 days) or follow-up (>5 months) DMSA scans were 
presented and when the studies were based on a cohort of children with UTI all of whom 
were referred for DMSA scans. They found that 57% children had evidence of acute 
pyelonephritis on early scans. This was based on 29 studies and they commented that there 
was considerable variation across studies, with significant heterogeneity (p<0.001).  Most 
children (85%) did not develop renal scars after UTI. The overall prevalence of renal scarring 
(i.e. abnormalities at the follow-up scan which are likely to be persistent) was 18% (95% CI 
14-23). This was based on 14 studies and there was significant heterogeneity (test for 
heterogeneity p<0.001) in these studies.   
 
Age and renal scarring 
It has been generally believed that younger children are more at risk of renal scarring, 
although a review in the National Institute for Health and Clinical Excellence (NICE) 
guidelines concludes that the situation on new and progressive renal scarring is not clear. In 
general, as children get older their risk of developing new renal scars reduces.
1 12
 Berg and 
Johansson found that renal scarring was more likely in children with a first UTI under 3 years 
old, although they did not use DMSA scanning which is now considered the gold standard.
13 
14
 Coulthard et al found that the scarring rate following referral for a first febrile UTI was 
similar regardless of the childs age, even for children older than five years old (n=324 
children).
4
 They suggest that this was probably due to previous but unrecognised UTI when 
the child was younger. The same authors followed up children with a normal DMSA scan 
following initial UTI to determine the risk of subsequent scar formation depending on the age 
of the child.
12
 They found that the risk of developing a new renal scar over the age of four 
was extremely low.  
 
Culture results and scarring 
Evidence of acute pyelonephritis and renal scarring has been found in children with equivocal 
or negative urine cultures.
15
 Kanellopoulos et al (2005) showed that low count UTI was more 
common in infants and young children and that children with low count UTI had a similar 
prevalence of pyelonephritis, urogenital malformations, and clinical and laboratory 
 3 
 
findings.
16
  Some studies have found that renal scarring is more common in children with 
non-E.coli UTIs.
17 18
 
 
The role of vesico-ureteric reflux (VUR)  
The risk of renal scarring with UTI has been strongly associated with VUR. VUR is the 
reflux of urine from the bladder into the ureters and/or the kidneys. It was previously thought 
that renal scarring only occurs in the presence of VUR, but it is now recognised that renal 
scarring can occur following UTI without VUR.
1 11 19
 
 
VUR can be caused by a congenital abnormality of the ureterovesical junction (primary 
VUR) or can be caused by increased pressure in the bladder due to bladder dysfunction or 
outlet obstruction (secondary VUR). VUR is found in 30-40% children investigated for 
UTI.
20 21
 The incidence of primary VUR in the general population is reported to be about 1-
3% 
1 22 although a more recent paper suggests that this is vastly underestimating the likely 
prevalence of VUR and that VUR is fairly common even in healthy children.
21
  
 
Coulthard (2008) reviewed the evidence for the association between VUR, UTI and renal 
scarring and stated that a strong association between childhood UTI, VUR and kidney 
scarring has been recognised for many years, but their relationship is inconsistent.
19
 The 
NICE guidelines include a review of the association between VUR and renal scarring and 
conclude that renal scarring is much more common in children with VUR, and almost 
universal in the most severe grades.
1
 The most recent review, by Shaikh et al., found that 
children with VUR were 1.5 times more likely to have acute changes on DMSA scan, and 2.6 
times more likely to have renal scarring than those without VUR.
11
 However, Coulthard, 
NICE and Shaikh have all recognised that renal scarring can occur without VUR.
1 11 19
 
 
Venhola et al (2010) questioned the association between VUR and UTI and VUR and renal 
scarring, suggesting that VUR is a lot more prevalent than previously thought, and less 
important in the development of renal scarring.
21
 They stated that diagnosing and treating 
VUR has not been shown to reduce UTI recurrences or renal scarring and that a focus on 
prompt and correct diagnosis of UTI could result in better prevention of renal damage.
21
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Can antibiotics reduce renal scarring? 
Guidelines emphasise the importance of prompt antibiotic treatment of UTI.
1
 This is mainly 
because it is believed that prompt treatment with antibiotics will reduce or prevent renal 
scarring.  
 
There is evidence that a delay in treatment of an acute UTI is more likely to result in renal 
scarring.
23-28
 However, in 2008, Hewitt et al found that early antibiotic treatment did not 
reduce subsequent scarring.
29
 
  
A recent paper (2012) found that delay in treatment was associated with renal scarring in both 
the presence and absence of VUR but that renal scars occurred with shorter delays in 
treatment if VUR was present.
7
 
 
Renal failure, pre-eclampsia, hypertension 
Renal scarring has been associated with long-term complications including renal failure, 
hypertension and pre-eclampsia.
1 8-10
 If renal scarring can be prevented by prompt treatment 
of childhood UTI, it is hoped that the serious long-term complications will also be prevented.  
 
The evidence for the association between UTI, renal scarring and long term complications is 
weak.
1
 In part, this is due to the long time between childhood UTI and the complications 
occurring; in part due to the low prevalence of the complications, and also due to the 
necessary design of studies which cannot show causation and are subject to bias, particularly 
attrition bias. Some researchers are now questioning these associations.
30 31
  
 
Renal failure 
Certainly, it is not clear how many children with UTI go on to develop end stage renal failure 
(ESRF) or other complications.
1 32
 One estimate is that ESRF occurs in 0.01% of those with 
childhood UTI.
33
 A more recent paper criticises this estimate, finding the risk of ESRF based 
on current data to be uncertain but at least between 0.03 and 0.1%, and probably significantly 
higher.
32
  
 
Hypertension 
NICE review the evidence for an association between UTI and hypertension.
1
 They conclude 
that there may be a small risk of hypertension from UTI but that it is most likely if renal 
 5 
 
scarring is severe. They comment that it is difficult to draw conclusions, largely because of 
the high prevalence of essential hypertension in the adult population. 
 
Pre-eclampsia 
There is very little evidence that UTI in childhood leads to pre-eclampsia in pregnancy. NICE 
found limited evidence that hypertension in pregnancy and pre-eclampsia were more likely if 
there was a history of childhood UTI and VUR.
1
 
   
The NICE guidelines provide a comprehensive review of the risk of long term complications 
following UTI in childhood, and conclude that there are no appropriate studies that 
accurately estimate the risks of long term complications as a result of childhood UTI.
1
 They 
comment that a well designed cohort study investigating long-term outcomes including renal 
scarring and renal function of infants and children who have had UTI should be conducted in 
the UK.   
 
In the absence of such studies, the guidelines continue to advocate the early diagnosis and 
treatment of UTI in order to reduce the risk of any complications.
1
  
 
Other complications 
Recurrent UTI is common, and the risk seems to be highest for children presenting with UTI 
at younger ages, and is more common in girls than boys.
1 34
 Merrick et al (1995) found that 
78% of girls and 71% of boys presenting with UTI in the first year of life in the UK, 
experienced recurrence and 45% of girls and 39% of boys presenting aged over1 years 
experienced recurrence.
35
 
 
Recurrence rates increase in girls as they get older, but not in boys.
1
 A Dutch study in 
primary care found that 34% of children had at least one further episode of UTI in a 3 year 
period following an initial UTI.
36
 There is also some evidence that children with UTI are 
more likely to have UTI as adults.
37
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Importance of knowing the prevalence 
 
The importance of a condition not only depends on how serious it is, how ill the patient is 
likely to be or the possibility that it will cause complications in the future, but also on how 
common the condition is and the likelihood of it being the cause of a particular illness 
episode. 
 
Children with UTI are difficult to diagnose as they often present with non-specific symptoms 
and signs which are also seen in many common childhood conditions.
2
 General practitioners 
(GPs) frequently see ill children in their surgeries, most of whom have other more common 
conditions like upper respiratory tract infections. The majority of children are managed in the 
community by the GP. Infectious diseases account for about 40% consultations with ill 
children in the UK.
38
 Non-specific symptoms are the main presentation in about 10% of 
consultations with children less than five years old.
39
  
 
In order to identify the children who may have UTI and obtain a urine sample to diagnose the 
condition, GPs need to have a reasonably high degree of suspicion. If the prevalence of UTI 
among presenting ill children is sufficiently low, the level of suspicion will be low. If the 
prevalence of UTI is sufficiently high, then GPs should have a corresponding high level of 
suspicion, resulting in a higher chance of obtaining a urine sample, even without specific 
urinary symptom features.  
 
The prevalence of UTI in the population of acutely ill presenting children corresponds to the 
pre-test probability, which is the probability that the child has a UTI before any further 
assessment of symptoms, signs or diagnostic testing is completed.  
 
Current guidelines (published in 2007) recommend a high level of suspicion of UTI in young 
children and promote urine sampling in many more children than was previously 
recommended.
1
 Without knowing the pre-test probability of UTI among presenting children, 
it will be difficult to convince GPs that it is appropriate to consider the diagnosis and change 
their current practice and request urine samples from many more children. In fact, if the 
prevalence is very low, this may not be an appropriate, cost effective strategy. If the 
prevalence is sufficiently high, there may be a case for obtaining and testing urine samples 
from all acutely ill children.   
 7 
 
 
A study in 1983 questioned 200 paediatricians (academics and practitioners) in order to reach 
a consensus on the prevalence of UTI (yield) which would warrant sampling urine in all 
febrile infants.
40
 All of the respondents agreed that a prevalence of 5% would warrant urine 
sampling in all febrile infants; and more than 80% felt that a prevalence of more than 3% 
would warrant urine sampling in all febrile infants. Approximately half felt that a prevalence 
of between 1 and 3% would warrant sampling urine from all febrile children. Table 1.1 is 
copied directly from their paper.  
 
Table 1.1: Results table copied from Roberts et al 40 
Questionnaire responses 
What yield is required to warrant urine culture in febrile infants? 
Yield (%) Academicians (%) Practitioners (%) 
<1 10.4 11.7 
1 to 3 67.5
* 
45.7
*
 
3 to 5 92.2
*
 80
*
 
>5 100
*
 100
*
 
*
 Cumulative percentage 
 
Missed diagnoses 
 
The NICE guidelines published in 2007, note the difficulty of diagnosing UTI due to non-
specific presenting symptoms and signs and because of the difficulty of urine collection.
1
 The 
guidelines emphasise the importance of increasing urine sampling from ill children, 
particularly in primary care. Although the evidence that UTIs are being missed is not clearly 
stated, the guideline assumes that there is an under-diagnosis of UTI, with a paragraph 
entitled Back to first steps: dealing with underdiagnosis of UTIs. In this short section they 
comment that, there has been little evidence that the diagnosis of UTI in primary care in the 
UK has improved in pre-toilet-trained infants and children [since the 1991 RCP guideline 
was published], referencing the three papers discussed below.
41-43
 They note that Coulthards 
study with increased education about UTI and urine sampling led to increases in the diagnosis 
of UTI.
1 43
 
 
 8 
 
Coulthard et al report the results of a randomised controlled trial in UK general practice 
(n=88 practices).
43
 Intervention practices had training on UTI in children, and were given 
management guidelines and direct access to a nurse practitioner who organised imaging and 
follow up with a nephrologist for children found to have positive culture. Direct access was 
only accepted if a urine sample was collected. They found that intervention practices referred 
twice as many children with confirmed UTI as control (normal practice) practices (6.42 vs. 
3.45/1000 children/year). In infants under 1years old in intervention practices, there were 
four times more UTIs diagnosed and in children without specific urinary symptoms there 
were six times more UTIs diagnosed. This implies strongly that many UTIs are missed in 
primary care with standard practice. The authors felt that the education element of the 
intervention was of key importance.  
 
This research was carried out in 2003 and since then, with the publication of the NICE 
guideline, there may be better awareness of the problem and possibly increased urine 
sampling behaviour amongst GPs. 
 
A survey of 82 GPs in the UK concerning diagnosis and management of UTI in children (<2 
years) found that only 14% stated that they would regularly send urine from febrile infants 
and toddlers.
41
 Sixty three percent said that they sent urine in less than 10% of presenting 
children and 26% said that they never sent urine samples from children under two. The 
reasons given for these low figures for urine sampling were not that UTI was not suspected, 
but related to practical difficulties with urine collection and concerns of costs of investigation 
as well as a lack of awareness of the importance of UTI. Overall general difficulty or inability 
to obtain a urine sample was the most common reason given for being unable to exclude UTI.  
 
Although this survey was carried out 15 years ago, many of the reasons given for low levels 
of urine sampling are still likely to apply. Certainly, the NICE guidelines published in 2007, 
still highlight these same issues as ongoing problems. This paper also highlights the point that 
even when guidelines have been published concerning UTI in children (the 1991 Royal 
College of Physicians guidelines had been published recommending all children with a fever 
of more than 38.5
o
C without an obvious cause should have their urine sampled), this will not 
necessarily lead to a change in practice if it is still practically difficult.  
 
 9 
 
Jadresic et al (1993) surveyed urine samples from children less than 15 years old from 53 
general practices in the UK and found a ten-fold variation between general practices in the 
rate of urine sampling and rate of UTI in children.
42
 They found that the number of urine 
specimens sent from a practice correlated very well with the number of samples with positive 
culture results; the more urine samples which were sent, the more UTIs were diagnosed. This 
could simply derive from increased numbers of coincidental asymptomatic bacteriuria being 
found, or false positive results due to contamination. However, these always could be the 
explanation for any positive culture results. It seems likely that if increased urine sampling 
detects more UTIs, then less urine sampling is probably leading to some cases being missed.  
 
How often do GPs obtain urine samples? 
Jadresic found that 2 urine samples were sent per 100 registered children aged less than two 
years old, per year.
42
 We know that children under the age of five consult on average 6 times 
per year in primary care and approximately 87% of these consultations are for acute illness.
38 
44 45 The results from Jadresics study equate to urine being sampled in approximately 0.4% 
of illness consultations with children under age two.
42
  
 
Based on these findings it seems likely that if a practice has a low rate of urine sampling, 
some UTIs will be missed.  
 
Another study of young children (aged under two) in Wales measured urine sampling rates 
from six general practices before and after an intervention designed to increase urine 
sampling and compared this with data from the remaining 47 (control) practices in the same 
area.
46
 This showed a urine culture rate of approximately 30 per 1000 children per year in 
routine practice (control practices). This suggests that urine is sampled and sent for culture in 
approximately 0.6% of consultations in acutely unwell children (prior to the publication of 
the NICE guideline).  
 
We do not know with adequate precision how many UTIs are being missed as we do not 
know the prevalence of UTI in presenting acutely ill children, and we do not know the 
prevalence because studies have not systematically sampled urine from all presenting ill 
children. 
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If urine is sampled in less than 1% consultations with acutely ill children, and if the 
prevalence of UTI among ill children is greater than 1%, then UTIs will be missed even if all 
of the urine samples sent are positive. For example, in 100 consultations with ill children, if 
the prevalence of UTI in this group is 1%, then one of these illness consultations would be a 
child with UTI. If urine is sampled in 1% of consultations with ill children, then the one urine 
sample taken in these 100 illness consultations would need to be aimed perfectly at the one 
child with UTI to identify it. Given that it is very difficult to predict UTI in young children 
from symptoms and signs, then such accurate targeting of testing would be unlikely. 
Increasing the proportion of urine sampling among ill children will increase the chance that 
that one UTI is correctly detected.  
 
Figure 1.1 shows some possible urine sampling and positive culture scenarios. Figure 1.1.b 
represents low levels of urine sampling, with similar low levels of UTI prevalence (e.g. both 
1%) with nearly all the UTIs being picked up by the urine sampling. Figure 1.1.a shows the 
more likely scenario where some UTIs are missed but with similarly low levels of both urine 
sampling and UTI. Of course, almost all of the UTIs could be missed with this sampling 
strategy. Figure 1.1.c represents low urine sampling (e.g. 1%) and higher levels of UTI 
prevalence (e.g. 3% -5%) and figure 1.1.d represents higher levels of urine sampling with low 
prevalence of UTI.  
 
Figure 1.1: Possible urine sampling and positive culture scenarios 
Urine sampled
Presenting acutely ill children
Positive culture
Urine sampled
Presenting acutely ill children
Positive culture
Urine sampled
Presenting acutely ill children
Positive culture
Urine sampled
Presenting acutely ill children
Positive culture
Figure 1.1.a. Figure 1.1.b.
Figure 1.1.c. Figure 1.1.d.
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It is difficult to quantify how many are being missed as we do not know the prevalence of 
UTI in presenting ill children.  
 
Jadesic found that in the under 2 year olds, 11% of the urine samples sent had positive culture 
results.
42
 With such a small proportion of urine sampled, one would hope that or expect that 
the detection rate of UTI among those who did have their urine sampled would be much 
higher, and if nearing 100%, indicating that clinicians were correctly predicting the 1% of 
children with UTI with their sampling strategy. A prevalence of UTI of 11% detected in urine 
samples sent in less than 1% of illness consultations, would equate to a true prevalence of 
0.1%.  
 
From the studies in emergency departments which have designed studies with systematic 
sampling, the prevalence is much higher than 0.1%. So, despite not knowing the true 
prevalence of UTI in ill children presenting in primary care we can be fairly confident that 
there is a significant number of cases of UTI being missed.  
 
If the true prevalence is 3% yet current practice is finding it to be 0.1% this implies that more 
than 90% of UTIs are being missed.  
  
What can be done? 
If symptoms or signs could be identified which were reliably predictive of UTI, the 
diagnostic process would be easier. Many papers have described the symptoms and signs of 
UTI in children and some of these are discussed below. 
 
The most obvious solution would seem to be to increase urine sampling from acutely ill 
children in primary care. Coulthard and Jadresic both found that increased urine sampling 
was associated with increased numbers of UTIs detected.
42 43
 However, Cunningham et al did 
not find that increasing urine sampling increased UTI detection at all.
46
  
 
The NICE guidelines encourage a substantial increase in urine sampling, particularly from 
primary care. Although this is not explicitly stated, the guidelines (and table) advising when 
to obtain a urine sample in presenting ill children are very inclusive.
1
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Review of presenting symptoms and signs  
The main problem with many of the papers describing presenting symptoms and signs of UTI 
is that urine is not systematically sampled from ill children. Therefore, the test to diagnose 
UTI is not performed in the majority of ill children and UTI is only diagnosed in those in 
whom the clinician suspected a UTI or chose to obtain and test a urine sample. Therefore, in 
these papers, the presenting symptoms and signs are only presenting symptoms and signs of 
clinician suspected UTI. For example, one recently published paper reports a large 
prospective cohort study of children under the age of five presenting to the ED in Australia 
(15 781 illness episodes).
47
 Presenting symptoms and signs associated with serious bacterial 
illness including UTI are described. Unfortunately urine culture was only performed in 21% 
of children and so the prevalence of confirmed UTI of 3.2% is based only on those in whom 
UTI was suspected, therefore missing the presenting symptoms and signs of children with 
UTI who were not suspected of having UTI and who were unidentified.  
 
Since we  know that many UTIs are being missed in children in primary care 
43
 it is important 
to identify symptoms and signs in the group of children with UTI who are currently not 
suspected of having UTI, the very group these sort of studies would have missed.  
 
We need to consider symptoms and signs of children from prospective studies which 
systematically sampled urine from all children. The problem with many of the studies which 
have systematically sampled urine is that the numbers with UTI are low or the symptoms and 
signs are not described. Many only include children with fever (see Chapter 2). 
 
The NICE guidelines base their table of presenting symptoms and signs on thirteen studies.
1
  
Only one of these studies systematically sampled urine and this was only in febrile infants 
less than 2 months old with a rectal temperature of >38.3
o
C. 
48
  I have summarised these 
studies in table 1.2 below.  
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Table 1.2: Characteristics of 13 studies described in NICE for presenting symptoms and 
signs  
Study  
first 
author & 
year 
Setting Number and age of 
participants 
Diagnostic 
criteria of 
UTI 
Systematic 
sampling? 
Symptoms and signs 
Winberg 
1974 
28
 
Childrens 
hospital 
Sweden 
Age under 16 
596 cases of UTI 
Case series 
Not stated No Fever (88%); failure to thrive 
uncommon.[Other symptoms 
reported in 5 separate papers] 
Hallett 
1976 
49
 
GP 
UK 
 
2-12 years 
49 boys with definite 
infection. 51 controls 
Case control 
MSU + 
dipslide 
culture by 
parents 
No 2-5 yr old: Enuresis (50%), 
Dysuria/frequency (81%), 
haematuria (2%), Fever (8%), 
abdominal pain (6%), balanitis 
(4%). 6-12 yr olds: fever (29%), 
dysuria/frequency (82%), 
haematuria (29%), fever (18%), 
abdominal pain (39%), balanitis 
(21%) 
Brooks 
1977 
50
 
 
GP UK 
 
Age <15 years. 
38 confirmed UTI, 
unknown denominator 
(not told how many 
presented/had urine 
cultured); 1632 children 
under 15 on GP list at 
the time and data 
collection for 4 years 
Case series 
>100,000 
orgs/ml 
from a 
dipslide 
culture of a 
clean catch 
specimen 
No Dysuria (71%), loin pain (8%), 
loin tenderness (5%), abdominal 
pain (32%), fever (21%), 
offensive urine (18%), night 
time wetting when previously 
dry (24%), daytime incontinence 
(5%), haematuria (3%) 
 
Dickinson 
1979 
51
 
 
GP UK 
 
Age under 15 
156 children in who 
clinicians suspected 
UTI. 14 with UTI.  
Case series  
 
>100,000 
org/ml in 3 
consecutive 
samples 
No 
 
Dysuria & frequency (43%), 
abdominal pain (21%), enuresis 
(14%), loin pain (7%), 
haematuria (7%), failure to 
thrive (7%) 
Smellie  
1981
52
 
Hospital 
UK 
744 children aged 0-12 
years with confirmed 
UTI. Compared 
children with and 
without VUR 
Case control 
Not stated No Fever (42%), abdominal or loin 
pain (31%), enuresis aged 5 or 
over (38%). 
Fever was more common in 
children with reflux. 
Ginsburg 
1982 
53
 
Pediatric 
dept  
USA 
Age 5 days- 8 months 
100 cases UTI  
Case series 
SPA in all.  
96% 
>100,000 
org/ml; 4% 
40,000-
80,000 
org/ml 
No Fever (63%), irritable (55%), 
refused 1 or more feeds (38%), 
vomiting (36%), diarrhoea 
(31%), abdominal distension 
(8%), jaundice (7%),  
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Study  
first 
author & 
year 
Setting Number and age of 
participants 
Diagnostic 
criteria of 
UTI 
Systematic 
sampling? 
Symptoms and signs 
Burbige 
1984 
54
 
 
Hospital 
USA 
Age 2 weeks to 14 
years 
83 boys with UTI 
Case series 
 No Fever (45%), Enuresis (8%), 
Haematuria (7%) 
Smellie 
1985 
55
 
Hospital  
UK 
120 children 2 weeks  
12 years who had had 
confirmed UTI and IVU 
Case series 
Not stated No Fever (48%)* abdominal or loin 
pain (28%), chronic constipation 
(13%), uncoordinated voiding 
with residual urine (7%) 
Messi 
1989 
56
 
 
Hospital  
Italy 
Age under 14 
223 with UTI 
Case series 
 No Fever (65%) Dysuria and 
frequency (41%), Haematuria 
(11%), Failure to thrive (6%) 
Hoberman  
1993 
48
 
ED 
Hospital  
USA 
Febrile infants <1 year 
old 
Nested case control but 
systematically sampled 
20 with UTI and 396 
without UTI.  
>10,000 
cfu/ml from 
a catheter 
specimen 
Infants < 
2months- 
yes; infants 
>2 months 
No 
Study only included febrile 
infants (temp >=38.3
o
C) 
No statistical differences 
between the 2 groups. Those 
with UTI had vomiting (40%), 
diarrhoea (30%), irritability 
(80%), poor feeding (65%) 
Craig 
1998 
57
 
ED at 
childrens 
hospital 
Australia 
Age under 5 
304 cases UTI 
Case series 
>10
6
 cfu/L 
on SPA or 
catheter or 
>10
7 
cfu/L 
from MSU 
or 
>10
8
cfu/L + 
WBC>100 
from bag 
No History of fever (80%), measure 
temp >37.5 (60%), irritable 
(52%), anorexia (49%), 
malaise/lethargy (44%), 
vomiting (42%), diarrhoea 
(21%), dysuria (15%), offensive 
urine (13%), abdominal pain 
(13%), 1
st
 degree relative with 
PH UTI (11%), previous 
unexplained febrile episodes 
(11%), frequency (10%), 
increase in daytime wetting 
(7%), haematuria (7%), febrile 
convulsion (5%) 
Honkinen 
1999 
58
 
 
Finland 
Hospital 
 
1 week to 9.5 years  
134 with bacteremic 
UTI. Compared to 
blood culture negative 
UTI so  
Case control  
 No Fever (92%)**, irritablility 
(60%), vomiting (15%), Dysuria 
(1%), abdominal pain(7%), 
malaise (26%), poor feeding 
(20%) 
Nayir 
2001 
59
 
Hospital  
Turkey 
100 boys from 3 months 
 10 years 
Case series 
Urine 
culture but 
diagnostic 
value not 
stated 
No Fever <38.5
o
C (48%), fever 
>38.5
o
C (24%), vomiting and/or 
diarrhoea (22%), 
dysuria/frequency (34%), 
enuresis (7%), suprapubic 
discomfort (11%), abdominal 
pain (18%), flank pain (5%), 
malodorous urine (2%) 
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*  there seems to be an error in the NICE guideline table which states that fever was present 
in 77% children in the Smellie 1985 study. On p1958 it states that the most common 
presenting symptoms were fever (57 children) and abdominal pain or loin pain (34).57/120 
=48%.  
 
** NB these are children with positive culture AND positive blood cultures which may 
explain such a high proportion with fever. 
 
For some reason, in the summary table presented in the NICE guideline, they have left out the 
studies by Winberg et al
28
 and Hoberman et al.
48
 Hobermans study is the only one out of all 
of those discussed in the NICE guidelines which has attempted to systematically sample 
urine. 
 
The following table (1.3) shows the presenting symptoms and signs from studies in which 
UTI was detected following systematic sampling of groups of presenting ill children. 
Unfortunately the majority of these studies do not give presenting symptoms and signs.  
 16 
 
Table 1.3 Presenting symptoms and signs (if given) from papers describing studies 
which have used systematic urine sampling. 
 
Lead author 
and date 
Setting  Age and sample size  Diagnostic 
criteria of 
UTI 
Symptoms and signs 
North  
1963 
60
 
ED or O/P 
USA 
82 febrile children 
(>38
o
C) aged under 13 
years. 3 UTI. 
Catheter or 
clean catch 
Symptoms and signs not 
clearly presented. States 
only 1 had signs and 
symptoms of acute 
pyelonephritis. The others 
did not develop clinical 
evidence of infection 
Krober 1985 
61
 
Hawaii 
Army 
centre 
182 infants <3 months 
old with fever 
>=38.0
o
C. UTI in 20. 
Catheter 
urine 
>10
4
cfu/m 
No symptoms or signs 
given. Only that non-
circumcised males were 
more likely to have UTI. 
Grundy-
Wheeler 
1987 
62
 
GP UK 104 children. 17 with 
UTI. Aged under 12 
years 
Culture 
MSU. 
>10
5
cfu/ml 
All those with UTI either 
had an illness clinically 
suggestive of this diagnosis 
or had some degree of 
abdominal pain or 
tenderness as a feature of 
their illness.  
Crain  
1990 
63
 
Pediatric 
ED 
USA 
442 febrile infants 
(>38.1
o
C) 
Aged less than 8 weeks. 
33 with UTI 
Dipslide 
culture. 
Catheter 
>=10
4
cfu/ml; 
SPA 
>=10
2
cfu/ml; 
bag specimen 
>=10
4
cfu/ml 
Found that impression of 
sepsis, WBC count and ESR 
were not useful for 
identifying UTIs.  
Fallahzadeh 
2006 
64
 
Iran 
Hospital 
120 Aged between 4 
weeks and 5 years with 
diarrhoea. 120 controls 
healthy children from 
nurseries. 
8 patients with UTI 
 
MSU or bag. 
2 positive 
cultures with 
>10
5
cfu/ml 
with similar 
sensitivity 
patterns 
88% fever, 63% vomiting 
Baker 
1993  
ED  
USA 
 
Rectal temp >38.2
o
C 
747 infants age 1-2 
months old 
 
Catheter 
sample 
>1000 cfu/ml 
of a single 
organism. 
No symptoms or signs 
given. 
Bonadio 
1993 
65
 
 
ED 
USA 
233 febrile infants aged 
0-8 weeks. Fever 
>38.0
o
C 
Urine culture 
from catheter 
specimen 
>=10
5
 cfu/ml 
single 
species. 
No symptoms or signs 
given. Reports the use of a 
scale for assessing serious 
bacterial illness. 
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Lead author 
and date 
Setting  Age and sample size  Diagnostic 
criteria of 
UTI 
Symptoms and signs 
Bonadio 
1993 
66
 
ED 
USA 
447 febrile infants aged 
0-8 weeks. 36 with 
confirmed UTI 
>= 10
4
 cfu/ml 
from catheter 
spec or >=10
3
 
from SPA 
No symptoms or signs 
given. 
Hoberman 
(see above 
table) 
    
Bonadio 
1994 
67
 
ED 
USA 
 
356 febrile infants aged 
8-12 weeks. 17 with 
confirmed UTI. 
Rectal temp >38.0
o
C 
>= 10
4
 cfu/ml 
from catheter 
spec 
No symptoms or signs 
given. 
Shaw 
1998 
68
 
ED 
USA 
2411 febrile children 
(>38.5
o
C); Boys <1 
year and girls <2 years 
old. 
Catheter UTI more common in girls, 
white race, no potential 
source of fever, Ill 
appearance, not 
circumcised, fever >39, PH 
of UTI, abdominal 
tenderness, and presence of 
urinary symptoms. They do 
not present % or RR of 
symptoms, only prevalence 
of UTI in the various sub-
groups. 
 
Gorelick 2000 
69
 
Pediatric 
ED 
USA 
1469 girls younger than 
2 years with fever 
(>=38.3
o
C) and no 
unequivocal source of 
fever. 63 with UTI 
>10
4
cfu/ml 
catheter urine 
Found that UTI was 
associated with age less that 
12 months old, white race, 
temp of 39.0
o
C or higher, 
fever for 2 days or more and 
absence of another source of 
infection on examination.  
Herr 2001 
70
 ED  
USA 
434 infants <60 days 
with fever (>=38.0
o
C). 
25 with UTI 
>50 000 
cfu/ml 
catheter 
specimen 
No symptoms or signs 
given. 
Maniaci 
2008 
71
 
ED 
USA 
234 febrile (>=38.0
o
C) 
infants <90 days. 
Excluded infants with 
focal bacterial infection 
(other than otitis 
media). 24 with UTI 
Catheter 
urine >= 
50,000 
cfu/ml or 
10,000-
49,000 with 
positive 
urinalysis.  
No symptoms or signs 
given. The focus of the 
study was procalcitonin 
levels. 
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Shaw et al found that infants without a potential source of fever were more likely to have a 
UTI (5.9% of 474 with no potential source of fever had UTI vs. 2.7% of 1858 with a potential 
source of fever; p<0.001). However, given the large number of presenting infants with a 
potential alternative source of fever, this feature is less helpful when trying to rule out UTI, 
and ensuring that no UTI is missed. Using the numbers provided by the authors, this equates 
to only 36% of children with UTI presenting without an alternative potential source of fever.   
 
Shaikh et al published a systematic review of the diagnostic accuracy of symptoms and signs 
for the diagnosis of UTI in infants and children.
72 The authors reviewed 12 articles which met 
their inclusion criteria. Eight of the studies included children only aged under 24 months old. 
Nine studies only included children if they had a fever of >=38.0
o
C. The prevalence of UTI 
found in studies ranged from 3.3  13.8% suggesting variation in sampling or population. 
Seven of the studies were conducted in ED departments. The others were in office setting 
which may indicate primary care or secondary care outpatient clinics. Eight studies describe 
urine collected with catheters or SPA. All but two studies were considered by the authors to 
have sampled urine from consecutive children. However, they were interested in consecutive 
patients suspected of having a UTI, therefore studies could be included if children had urine 
sampled based only on level of clinical suspicion for UTI or specific urinary symptoms.  
 
For example, one of the papers (Dickinson (1979) conducted in general practice in the UK, 
included children aged under 15 if the GP suspected them of having a UTI, but in the quality 
rating was considered to have included consecutive children.
51
 However, eight of the 12 
included studies did appear to have systematic urine sampling from febrile children which 
was independent of clinician suspicion of UTI.
48 61 67 68 73-76
 In addition to Dickinsons study, 
Newman, Heale and Chens studies reported results where urine samples were obtained based 
on clinician suspicion of UTI.
51 77-79
 Struthers describes children in a paediatric acute 
admissions unit, so children had already been selected for admission by GPs or ED staff, but 
once admitted they did have urine sampled systematically.
75
  
 
The systematic review reported by Shaikh et al found that in febrile infants up to 2 years old, 
a history of previous UTI, non-black race (which was not fully explained by circumcision 
status), a temperature of higher than 40
o
C, prolonged fever for >24 hours, suprapubic 
tenderness and lack of circumcision increased the probability of UTI.
72
 They found that the 
presence of another source for fever (e.g. otitis media, URTI, gastroenteritis) reduced the 
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probability of UTI only to a small extent. They found that in verbal children (>2 years old) 
that abdominal pain, back pain, dysuria, frequency, and new onset urinary incontinence 
increased the probability of UTI.  
 
The authors comment that because the negative Likelihood Ratios (LRs) for all studied 
symptoms were more than 0.60 and often approached 1.00, the absence of individual 
symptoms does not substantially reduce the likelihood of a UTI. However, they conclude 
that the absence of several key signs and symptoms in combination can be used to identify 
infants at low risk for UTI.
72
  
 
The issue of fever 
Most of the studies described only include febrile children. There are several problems with 
this. The first is the definition of fever. Some authors define what they mean by fever and 
some do not. The definition of fever can vary widely
80
, temperature fluctuates during an 
illness and can be affected by medications. In most of these studies discussed here it is 
defined as >38.0
o
 C. The NICE guideline (UTI) table considers any description of fever 
together, both temperatures >38.5 and <38.5
o
C.
1
 Temperature can also vary widely 
depending on the instrument used and where the temperature is taken from. Manufacturers of 
commonly used infra red ear thermometers give wide normal ranges of temperatures 
making interpretation difficult. Many studies do not describe methods in detail. Therefore 
populations of febrile children may be quite heterogeneous. 
 
Secondly, there is evidence that renal scarring and complications from UTI can occur in the 
absence of fever.
81
 The systematic review by Shaikh et al found that neither the rate of 
pyelonephritic abnormalities nor the rate of renal scarring on DMSA were associated with 
presence or absence of fever.
11
 However, as the majority of studies concerning UTI and renal 
scarring exclude children without fever, the association of fever with renal scarring and 
complications will continue to be unclear.
81
 
 
Presence or absence of an alternative source of infection 
Current, and previous guidelines, state that UTI is unlikely if there is evidence of a potential 
alternative source of infection, and do not require urine sampling (at least initially) in these 
children.
1
 This belief is also held by practice nurses who are often involved in triage.
82
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However, there is evidence that UTI occurs in children with other sources of infection. In 
addition, the presentation of findings in studies can lead to different interpretations and 
different emphasis. 
 
Shaw, Hoberman and NICE conclude that UTI is more likely if there is no potential 
alternative source of infection.
1 48 68
 However, if you look at the numbers, Shaw found only 
36% of those with UTIs had no alternative potential source of infection.
68
 The vast majority 
of UTIs would be missed if a strategy of not suspecting/not sampling urine from children 
with an alternative potential source of infection. 
  
Hoberman found that UTI was twice as common in febrile infants with no identified source 
of fever as those with an identified source (7.5% vs. 3.5%; p=0.02).
48
 Put another way, 34/50 
(68%) with UTI had no potential alternative source of infection. Thirty-two percent of UTIs 
would have been missed if urine was not sampled in those with a potential alternative source 
of infection. 
 
Of course, it depends what is included as a possible source of fever, who is assessing this 
and inclusion criteria of the study (Shaw and other studies exclude those with an 
unequivocal source of fever). Hoberman describes unequivocal sources of fever to include 
meningitis, pneumonia, septic arthritis, varicella and possible sources of fever to include 
URTI, gastroenteritis, otitis media, croup, bronchiolitis, and viral syndrome.
48
 
 
Torrijos et al found that 16% of children with otitis media also had UTIs.
83
 Other studies 
have found that the prevalence of UTI in children with URTI is as high as 30% .
84
 Bauchner 
et al found that all their cases of UTI in infants had originally been diagnosed with alternative 
infections (n=11/11 out of 664).
85
  
 
Gorelick et al found that risk of UTI was greater if there was no other potential source of 
infection (RR 1.9; p=0.01).
69
 The number of children overall with UTI was 63 (4.3%). 
Overall, 77% had a potential source of fever on examination, with only 23% having no 
alternative source of fever. Unfortunately they did not give the numbers of children with UTI 
with and without an alternative source of infection, so I cannot work out the proportion of 
those with UTI without an alternative source of infection. However, given the low percentage 
of presenting children without a potential source of infection, I suspect they will not have 
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found it to be effective at ruling out UTI either. Shaikh et als systematic review concludes 
that, the presence of another source for fever (e.g. otitis media, URTI, gastroenteritis) 
reduced the probability of UTI only to a small extent.
72
 
 
Unfortunately, the findings that UTI is more likely in a child with no alternative source of 
infection, even if the majority of children with UTI may have an alternative site of infection, 
has led to current guidelines suggesting that children with an alternative source of infection 
do not need to have their urine sampled (at least on initial consultation).
1
 
 
Urine sampling 
For current diagnosis of UTI, a urine sample needs to be obtained and sent to the laboratory 
for culture. 
 
There are five main methods of obtaining urine samples from children: suprapubic aspiration, 
catheter insertion, clean catch, nappy pad, and bag collection. Suprapubic aspiration (SPA) is 
considered to be the gold standard method, as it is aseptic and (supposedly) avoids the issue 
of contamination. However, it is an invasive test, requires training and is only feasible for 
hospital environments. Using a catheter is also invasive and distressing for children and not 
feasible for use in primary care. The three remaining methods are non-invasive and have been 
used in primary care. However the clean catch method can be time-consuming for parents, 
and the urine collection bags have been found to be unpleasant for the child. All three 
methods have a risk of contamination, but the clean catch method has been found to be 
associated with the lowest levels of contamination.
1
 The NICE guidelines published in 2007 
recommend clean catch to be first choice, and a nappy pad as second choice if clean catch is 
not possible or acceptable.
1
  
 
Once the urine sample is obtained, it needs to be placed in a suitable container to be sent to 
the laboratory. Urine samples collected in primary care can rarely be cultured immediately. 
There is a delay between the sample being collected from the child and collection from the 
surgery and transported to the laboratory. There is further delay once the sample is received 
by the laboratory but before it is cultured. Bacteria present in the urine sample at the time of 
voiding, do not stay in the same state, but multiply. The growth is exponential and numbers 
depend on the time between when the sample was voided and the time at which the culture 
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and count is measured. The growth rate of the bacteria also depends on the temperature and 
can be affected by the presence of other substances (e.g. boric acid).  
 
Contamination 
If a urine specimen comes into contact with bacteria from the skin or bowel, these bacteria 
can be taken up into the urine, grow during the culture process, and may be found in 
significant numbers. These growths do not represent a UTI but are just due to the 
contamination of the urine sample. It can be difficult to differentiate between growths of 
contaminating bacteria and growths of bacteria representing a true UTI. 
 
If there is a mixed growth, with several different species of bacteria present, this is 
considered more likely to be a contaminated sample. Sometimes the type of bacteria found is 
used to determine whether it is likely to be a contaminant. For example, bacteria known to be 
skin commensals which are not usually thought to cause UTIs, are likely to be considered as 
contaminants. Sometimes there are large numbers of epithelial cells present in the sample 
which indicates that the urine is likely to be contaminated with skin bacteria. The difficulty 
with these approaches is that just because there is contamination of the specimen with other 
bacteria, does not exclude a true UTI as well but which is hidden or disregarded due to the 
contaminants; some bacteria can act both as non-pathogens and pathogens in some case (e.g. 
coagulase negative staphylococcus aureus); bacteria found in the bowel which are likely to 
contaminate urine samples, especially those from nappy pad samples, are those which are 
often the cause of UTI. This is particularly difficult in the presence of diarrhoea, which will 
increase the likelihood of contamination but is also a potential risk factor for developing UTI.  
 
Giddens (1998) describes a contamination rate of 66% in children under 2 years old.
86
  
But the problem is largely one of definition of contamination, and this varies between 
laboratories and researchers.  
 
Diagnosis of UTI  
 
UTI is usually defined as a pure or predominant growth of bacteria of more than 100,000 
organisms per millilitre (>10
5
 org/ml) on urinary culture.
1
 However, different cut off points 
have been used and proposed.
16 87 88
 What constitutes pure or predominant growth is not 
clearly defined. Whether this is simply the most common organism found, the growth of any 
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organism over a certain threshold or whether it is the most common organism when there are 
only two organisms present and the other is in very low quantities, is not clear. The NICE 
guideline does not define predominant growth.
1
 Neither does the UK Standards for 
Microbiology Investigation of Urine, although this document includes in the appendix a 
complex table for interpretation of urine culture. 
89
 The local laboratory SOPs do not define 
what is meant by pure, predominant or mixed growths.  
 
The Quandary 
It is difficult to know if finding bacteria in the urine represents a true UTI. It is also difficult 
to be sure that absence of bacteria in the urine means there is not a UTI.  Contamination of 
the urine sample with other bacteria from skin, vagina or rectum can cause false positive or 
false negative results.
90
 A true UTI may be present but there may be only low counts of 
bacteria found on culture for various reasons (discussed later). True bacteriuria can be found 
in the absence of any evidence of inflammation in the patient, this is known as asymptomatic 
bacteriuria and the significance of this is disputed. 
 
As with other infections, there are cases where there is a definite infection, cases where there 
is clearly no infection, and a range of cases where it is less clear whether infection is present 
or not. There may be clinical (visible) features of the infection and there are the results of 
tests used to diagnose or quantify the infection in a more objective manner. The clinical 
features are subjective, both to the patient and the clinician; the diagnostic tests are not 100% 
accurate, depending both on the inherent validity of the test and the way in which it is used 
and read by the clinician. All of this introduces uncertainty into the accuracy of the diagnosis 
for infections in general. However, in the case of UTI in children, the uncertainty is even 
greater due to a number of factors, many of which have already been discussed: 
 
· The clinical symptoms are often not apparent. Infections of other parts of the body are 
usually obvious, for example skin infections or tonsillitis, where the tissue is red and 
hot and there is pus present, or infection in the intestines where there is diarrhoea and 
vomiting. UTI in adults also causes typical symptoms, namely urinary frequency, 
dysuria and abdominal pain (often localised to the suprapubic or loin regions). 
Unfortunately UTI in children does not usually cause these localised symptoms.
1
 The 
symptoms and signs associated with UTI in children are non-specific, similar to those 
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found in many other common childhood illnesses. The most commonly documented 
are fever, irritability, malaise and lethargy.
1
  
o Fever, often an important or essential component to the diagnosis in the 
literature, is defined variably and sometimes not at all.
1 80
  
o The method for measuring temperature is also often not clearly described or 
specified, and different instruments and measurement in different areas of the 
body result in large differences in the temperature found.
80
  
· The GP or nurse needs to consider the possibility of UTI and request a urine sample.  
· Obtaining a urine sample from the child can be difficult, particularly in primary care, 
where there is often no spare room (other than the toilet) for the child and parent to go 
to obtain the urine, and practices may not have the necessary paediatric equipment 
(large sterile bowl for clean catch or nappy pads for non-toilet trained babies). Time 
may also be a problem. 
· Once the urine sample has been obtained, the urine has to be sent to the laboratory for 
the diagnostic test (culture). The sample may be affected during this process 
depending on the type of storage (e.g. whether boric acid has been added), how the 
sample is stored whilst waiting for transport (e.g. kept in freezer or by warm radiator 
in the surgery), how long it takes to be collected and transported to the laboratory and 
how long it is between reaching the laboratory and being tested.  
· The test itself (urine culture) is designed to detect the presence of bacteria in the urine 
sample. It involves spreading a known volume of urine onto a culture medium and 
leaving this in an incubator for 18-24 hours. The number of bacterial colonies are then 
counted (by eye).   
o The number of bacteria secreted from the urinary tract into the urine will 
depend on the type of bacteria (e.g. some with fimbriae may be more firmly 
attached to the bladder wall and be secreted less), factors specific to the 
individual infected (some people may be better than others at clearing the 
bacteria from the urinary tract, variation in inflammatory response and cell 
shedding), the concentration of the urine (fluid intake), presence of other 
substances ingested (antibiotics, cranberry juice, others), and the stage of 
infection (perhaps fewer bacteria are secreted in the early stages and more 
when bacterial load is greater). 
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o The number of bacteria in the urine at the time of testing is dependent on the 
number of bacteria secreted from the urinary tract into the urine, 
contamination of the urine sample with bacteria from places other than the 
urinary tract (skin, nappy, GI tract etc), the growth rate of the bacteria in the 
urine, the time taken to reach the lab, the conditions it is kept in during 
transport (temperature, boric acid), and time taken from reaching the lab to 
starting the processing.   
o The detection of bacteria in urine is dependent on the numbers of bacteria in 
the urine at the time of testing, the culture medium used, the type of bacteria 
(some may not grow at all outside of the body; some may grow better outside 
of the body than in the bladder), growth rate of the bacteria in that medium, 
the temperature during the culture period, and the time at which it is read.  
 
Therefore even ignoring those cases in which the possibility of UTI was not raised and a 
urine sample was not requested, or those cases where a urine sample was requested but not 
obtained, there is still a significant degree of uncertainty surrounding any urine culture result.  
 
Causative organisms 
Most UTI are caused by uropathogenic Escherichia coli (E.coli; UPEC).
91
 A retrospective 
UK study of 547 UTI cases (337 children aged <16 years) conducted in 2002-2008 found that 
92% of UTIs were caused by E.coli.
92
 A prospective study in Brussels of 209 children (aged 
<17 years) with their first febrile UTI conducted in 2006-2008 found that the causative 
organism was E. coli in 91%.
93
 A retrospective study of 533 children (aged 6 months-6 years) 
conducted in 2001-2006 in the USA, found that the causative organism was E. coli in 80%.
94
 
A Canadian study of 173 children (<18 years old) in 2004-2005 found a pure growth of E. 
coli in 74% of UTIs.
95
  A study of 141 hospitalised infants less than 2 months old found that 
the most commonly identified bacterium was coagulase-negative staphylococcus (found in 
28%).
96
 The problem with these studies (except for the study of infants <2 months old) is that 
the urine sampling was not systematic. In addition, most included children were aged up to 
16 or more.  
 
Furthermore, the laboratory culture methods have been established to detect E.coli UTIs with 
counts of more than 10
5 
bacteria/ml.
97
 Even if a greater proportion of UTIs is caused by 
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organisms other than E. coli, they may not be detected, and could be reported as culture 
negative UTI or not classified as UTI at all. 
 
There seems to be a trend towards a greater proportion of non-E.coli UTIs in younger 
children.
94 96
  Friedman et al found that children with non-E.coli UTIs were younger.
98
 They 
also found that non-E.coli UTI was more likely to be associated with VUR, as have other 
studies.
99
 Honkinen et al (1999) found that VUR was nearly twice as common in children 
with non-E.coli UTIs.
99
 
 
Kanellopoulos et al (2005) found that low count UTIs are often due to non-E.coli bacteria.
16
 
They showed that these types of UTI were more likely to affect infants and young children 
and were associated with the same clinical findings and outcomes as higher count UTIs.  
 
Many studies reporting UTI define UTI as >10
5
cfu/ml of a uropathogen.
68 100-103
 However, 
there are no agreed lists of which organisms are uropathogens and which are not. The Cardiff 
and Vale Laboratory Standard Operating Procedure (SOP) includes a list of potential 
isolates which includes Enterococci, Lancefield Streptococcus group B, Coagulase negative 
staphylococci, Staphylococcus aureus, staphylococcus saprophyticus, Enterocbacteriaceae 
(including E.coli), Pseudomonads and Yeasts (Appendix 1.1).
104
  
 
As mentioned before, organisms can sometimes be uropathogenic and sometimes not. 
Coagulase negative staphylococcus is often not considered a pathogen but sometimes is 
considered to be an important uropathogen.
90 96
 Table 1.4 shows the proportion of E.coli and 
non-E.coli UTIs. 
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Table 1.4: Proportion of UTI caused by various bacteria in different studies 
Lead author 
and date 
Number of 
UTI cases and 
age range 
Proportion 
of UTI 
caused by 
E.coli 
Proportion of 
UTI caused by 
other gram 
negative 
pathogens * 
Proportion of 
UTI caused by 
gram positive 
pathogens ** 
Proportion of 
UTI caused by 
other/unknown 
pathogens 
Honkinen 1999 
99
  1237 children 
(age not given) 
79% 13% 4% 4% 
Friedman 2006 
98
  139 <16 yrs 77% 23%   
Chakupurakal 
2010 
92
 
547 <16 yrs 92% 5% 1% 2% 
Nowell 2010 
96
 141 <2 months Most common bacteria (28%)  coagulase negative staphylococcus 
Paschke 2010 
94
 533 6 months-
6 yrs 
80% 15% Gram positive or unknown 
5% 
Weisz 2010 
95
 173 <18 yrs 74% 13% 6%  
Ismaili 2011 
93
 209 <17 yrs 91.0% 8.5% 0.5% 0% 
* includes most commonly Pseudomonas, Klebsiella, Proteus, Enterobacter, Citrobacter, 
Haemophilus 
** includes most commonly Streptococcus, Staphylococcus 
 
Definition and threshold 
Kass established the threshold value of 10
5
 bacteria/ml more than 50 years ago.
105
 This level 
was based on studies of adult women with acute pyelonephritis and asymptomatic women 
found to have bacteriuria on repeated urine samples. He found that 95% of those with acute 
pyelonephritis had bacteriuria with more than 10
5
 bacteria/ml, and that using this threshold 
seemed reliably to distinguish between bacteriuria and contamination.
97 105 106
 
 
Stamm (1984) points out that this threshold may not be appropriate for patient population 
different from the ones Kass studied.
107
 
 
Studies of adult women with lower UTI (i.e. not pyelonephritis and not asymptomatic 
bacteriuria) have found that up to 50% have counts of less than10
5
 bacteria/ml on culture.
106
  
Stamm et al examined the urine of 187 women with acute urinary symptoms obtained by 
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SPA or catheterisation and compared this to mid-stream urine specimens obtained at the same 
time. Forty-nine percent of women with coliforms in the bladder urine specimens had less 
than10
5
 coliforms/ml on MSU.
106
 They found that the the traditional criterion of >10
5
 per 
millilitre provided a specificity of 0.99 but a sensitivity of only 0.51. They propose a 
threshold of more than 10
2
 per ml with a sensitivity of 0.95 and a specificity of 0.85 (for 
coliform UTI in adult women).  
 
Kass acknowledged that using his threshold of more than10
5
 bacteria/ml would miss some 
women with an infection. He also suggested that recent use of antibiotics, drinking lots of 
water and urine with low pH or high urea concentration would make a low count more likely 
despite an infection being present. 
108
 
 
Stamm et al also found that presence of more than one organism should not necessarily be 
regarded as a contaminated sample and could represent a true UTI.
106
 Lau et al (2007) 
comment that samples with mixed growth are generally assumed to be contaminated but, 
infants with low count UTI may yield mixed growth when the true causative organism was 
masked by contaminating flora. They also point out that genuine mixed infections may 
have occurred.
90
 
 
Many of these studies included only adult women and may not necessarily be generalisable to 
children. In fact, it may be that the cut-off developed by Kass for adult women should not 
have been established as the standard for the diagnosis of UTI in children and may need to be 
revisited. Given that infection can be present at lower counts and in the presence of more than 
one organism in adult women, perhaps the same is true of children.  
 
Pryles (1960) describes a small study of children (n=17) where 3(18%) children had clinical 
evidence of UTI but colony counts between 10
3
 and 10
5
 cfu/ml. These patients were all found 
to have colony counts of more than10
5
 cfu/ml on subsequent urine specimens.
109
 Pryles 
suggests that urines containing bacterial growths of less than10
3
 cfu/ml imply contamination; 
counts of more than10
5
 cfu/ml imply infection and counts in between are to be suspected of 
infection and repeated. 
109
 Hellerstein (1982) used a threshold of 10
4
 cfu/ml in catheter 
specimens.
110
 Hoberman et al (1994) describe a study of 2184 (catheter) urine samples from 
children less than 24 months old.
111
 They found that bacterial counts of less than10
5
 cfu/ml of 
a single pathogen were uncommon and that specimens with counts between 10
3
 and 5x10
4
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were more likely to be caused by gram-positive or mixed organisms. They suggest using a 
threshold of 5x10
4
 cfu/ml.
111
 
 
Hansson et al (1998) found that 20% of infants had less than10
5
cfu/ml of bacteria on culture 
of urine obtained by SPA.
88
 Kanellopoulos et al (2005) showed that UTI could be present 
despite low urinary bacterial counts (from catheter or SPA specimens), and found that low 
count infections were more common in infants and young children (<24 months old) and 
were often caused by non-E.coli species. There was the same risk of scarring and other 
findings in the low count group as in higher count infections.
16
 
 
Lau et al (2007) compared bacterial cultures obtained from clean void urine samples with 
catheter samples (n=98).
90
 They found that there was no difference between catheter urine 
specimens and clean voided specimens in terms of false positive results for lower threshold 
values of 10
3
 or 10
4
 cfu/ml if mixed growth results were considered contaminants. 
  
NICE points out that low counts of bacteria (<10
5
cfu/ml) and mixed growth results can 
indicate a UTI, but that the chance of bacteria representing contamination increases as the 
threshold value is lowered. They comment that, the results from urine culture can therefore 
not be interpreted in isolation, but should be done in relation to the clinical setting, symptoms 
and findings.
1
 However, there have been more recent suggestions that a lower threshold 
should be used in children even when urine samples are obtained with non-invasive methods. 
It has also been suggested that a higher cut-off point should be used in order to reduce false 
positive results.
87
 Coulthard et al advocated increasing the cut-off value for diagnosing UTI 
from a single urine sample to more than10
6
 cfu/ml.
87
 
 
Multiple urine samples 
Some studies have required two consecutive urine samples that culture more than 10
5
 cfu/ml 
of the same bacteria to define a UTI.
56 87
 These are secondary care studies. Kass required two 
samples to grow the same bacteria for a diagnosis of (asymptomatic) bacteriuria in adult 
women. Some advocate that two samples should be required in primary care paediatric 
samples as this should reduce the risk of false positive results.
87
 The NICE guidelines require 
one sample with more than10
5
 cfu/ml.
1
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Coulthard el al (2008) used two consecutive urine samples to determine true UTI.
87
 They 
argued that if the first sample is positive, but the second sample is negative or grows a 
different bacteria, that the first sample was contaminated and indicated a false positive result. 
This is one explanation for finding that the two samples were different. However, it could 
also be that for some of the reasons already mentioned, one of the results was falsely 
negative.  
 
The problem of whether two samples are needed for diagnosis is related to the problem of 
where the cut-off value should be for bacterial count. The problem is that in reducing the 
chance of false positive results (improving the specificity), we are likely to increase the 
chance of false negative results (reduced sensitivity). It is a balance and trade-off. The risk to 
patients is of unnecessary antibiotics and investigations if they are given a falsely positive 
result, and an untreated UTI, longer duration of illness and possibly long term complications 
if they are given a falsely negative result. The cost to the NHS is of unnecessary antibiotics 
and threat of antimicrobial resistance and costly investigations for false positive results and of 
possible repeat consultations or hospital admission for an untreated infection and the potential 
risk of extremely high costs related to long term and chronic complications in some children 
with a false negative result.  
 
Near patient tests 
Dipsticks in primary care 
A systematic review by Whiting and other studies led NICE to conclude that urinary dipstick 
tests should not be used in children under two years old as they are unreliable.
1 112
 For 
children older than two years, a positive leukocyte esterase and nitrite can reliably be used to 
diagnose a UTI, and if both of these tests are negative, a UTI can be ruled out with adequate 
confidence.
1
 
 
Microscopy as a near patient test  
Following a comprehensive review of studies, NICE concluded that it was difficult to be 
clear about the diagnostic accuracy of microscopy. However, they found that microscopy was 
better than dipsticks.
1
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Self-limiting UTI 
It is difficult to know if UTIs in children are self-limiting, as any identified UTI is usually 
treated promptly with antibiotics. There are no randomised controlled trials of antibiotics 
compared with placebo in the treatment of UTI in children or observational studies of the 
outcomes of those with confirmed UTI not treated with antibiotics. Therefore, I could not 
find any direct evidence that UTIs in children are self-limiting. However, it is likely that 
some UTIs in children are self-limiting. There is evidence that UTIs in adults are often self-
limiting.
113 114
 In addition, if there are many UTIs being missed, as suspected, it seems likely 
that some of these children must have resolved spontaneously, or else they would have re-
presented. Some patients recover from all types of bacterial infection and childhood UTI is 
probably no exception. Some children with UTI would probably have been given antibiotic 
treatment if they were suspected of having different diagnoses by their doctor but it seems 
unlikely that this would have happened with all childhood UTI not detected.  
 
One prospective study of feverish illness in children under five presenting to the ED found 
that one third of children with serious bacterial infection appeared to recover spontaneously 
without antibiotics.
47
 Some of these may have had UTI.  
 
The important question is, if a child has a self-limiting UTI, and they recover clinically, are 
they still at risk of renal scarring and long-term complications?   
 
In half of adult women, bacteriuria persists following a symptomatic UTI if this is left 
untreated, even if their clinical symptoms have improved.
91
 An experimental study of pigs 
found that renal scarring could occur even when clinical, symptomatic recovery had 
occurred.
115
  
 
To be able to describe the natural history of untreated UTI in children would require 
identification and confirmation of UTI with culture and then observation of symptoms and 
signs without antibiotic treatment and long term follow up to identify any scarring and 
complications. To confirm the benefit of antibiotic treatment both in the acute illness and in 
the prevention of complications would require a randomised placebo controlled trial. Studies 
which involved non-treatment or placebo treatment in children with confirmed UTI would 
not be ethical to do given the current widespread belief that UTI may lead to long term 
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complications and some indirect evidence that antibiotics are likely to help the acute illness, 
relieve suffering associated with this and possibly reduce the risk of serious complications.  
 
Asymptomatic bacteriuria (ASB) 
Definition 
Asymptomatic bacteriuria (ASB) is the growth of bacteria of more than10
5
 orgs/ml on culture 
of urine in a patient with no symptoms. Guidelines recommend that ASB is not treated with 
antibiotics in infants and children.
1
  The population of children that are the focus of my thesis 
are all acutely unwell, and therefore are not, by definition, asymptomatic. However, ASB 
may still be relevant because an acutely unwell child could have an underlying ASB with a 
coincidental acute illness unrelated to the bacteriuria. 
 
 Although the definition of ASB appears to be clear, in practice there are various possible 
explanations for a finding of significant bacteriuria in an asymptomatic patient: 
 
· It could represent true ASB, that is, bacteria present in the urine in numbers usually 
associated with symptomatic UTI but without symptoms.  
o It could be due to the presence of bacteria but which are harmless to that 
person, perhaps part of the normal flora.  
o It could be due to a problem with the persons immune response, perhaps for 
some reason they do not mount an inflammatory response to the invading 
bacteria and so there are no clinical signs of an infection.  
o It could also be the early stages of a UTI  there are enough bacteria to be 
found on culture but not quite enough time for an immune response to have 
been mounted and cause symptoms.  
o There may be an immune response occurring but the symptoms have gone 
unnoticed or unreported.  
o It could represent the end of a UTI. Perhaps the clinical symptoms have 
cleared but there is still evidence of bacteria.  
 
· The bacterial count may not represent the true levels of bacteria in the urinary tract 
o Bacteria from elsewhere could have contaminated the sample, grown in the 
urine during transport and storage and then grown on culture.  
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The diagnosis of ASB is even more difficult in an acutely ill child. In addition to the 
difficulties of diagnosing ASB in an asymptomatic child, it is impossible to distinguish 
between a child who has a symptomatic UTI and a child who has an ASB with a coincidental 
other illness, because the presenting symptoms of UTI are non-specific. 
 
Prevalence of ASB 
Several studies, most from the 1970s, have reported the prevalence of ASB. Some of these 
are summarised in Table 1.5, although this is not a comprehensive review of ASB prevalence.  
 
Table 1.5: Prevalence of ASB in children 
 
Author & year of 
publication 
Age of 
children 
Number 
screened 
Prevalence of ASB 
Female  Male 
Savage 1973 
116
 5 years  5217 1.6% - 
Davies 1974 
117
 1 month-5 
years 
507 
528 
0.8%  
0.2% 
McLachlan 1975 
118
 4-12 years 16800 1.7% -  
NABR* 1975 
119
 4-6 years 2398 1.4% - 
7-11 years 5372 2.5% - 
12-18 years 5694 1.6% - 
5-18 years 1595 - 0.2% 
Saxena 1975 
120
 Pre-school 1000 0.5% 
Silverberg 1976 
121
 2-5 years 2197 1.3% - 
Siegel 1980 
122
 0-1 years 1617 1.8% 0.5% 
Pre-school 1711 0.8% 0% 
Goosens 1985 
123
 3-36 months 441 0.4% 2.5% 
Wettergren 1985 
124
 0-2 months 3198 0.2% 1.6% 
2-8 months 3089 0.2% 0.8% 
8-15 months 2546 0.5% 0.2% 
* Newcastle Asymptomatic Bacteriuria Research Group 
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Studies varied in the techniques used to sample urines (SPA, catheter and bag urines) and in 
the number of consecutive samples showing significant bacteriuria required for a diagnosis of 
ASB.  
 
Those with ASB are a heterogeneous group as described above. NICE point out that children 
found to have ASB during screening will include those with no discernable history of UTI, 
some with a previous history of UTI, and some who have had symptomatic UTIs but have not 
been diagnosed.
1
 The authors of a Cochrane review of interventions for covert bacteriuria in 
children comment, In some previous studies, children identified with bacteriuria and no 
apparent accompanying symptoms later described mild urinary symptoms at the time of 
testing.
125
  
 
Current opinion
126
  and current guidelines
1
 suggest that antimicrobial treatment and follow-up 
is not indicated for asymptomatic children found to have significant covert bacteriuria. 
Comprehensive reviews of the prevalence and risk of long-term complications for ASB are 
not presented in the NICE guideline document, and only one of the four studies concerning 
ASB prevalence discussed in the NICE guideline includes children less than four years old.
124
 
NICE reviewed four studies of antibiotic prophylaxis for children with asymptomatic 
bacteriuria, and found that antibiotic prophylaxis reduced bacteriuria but did not reduce 
recurrence of symptomatic UTI.
127-130
 However, none of these studies included children aged 
less than four years old.  
 
A recent Cochrane review concludes that, studies do not provide sufficient detail about the 
harms and benefits of treating covert bacteriuria to enable forming reliable conclusions.
125
 
However, they also point out that there is no evidence of harm in schoolgirls with ASB not 
treated with antibiotics. The studies included in this review were girls aged 5-12 years with 4 
year follow-up, n=208;
131
 girls aged 4-18 years with 5 year follow-up, n=199;
129
 and girls 5 
years with 2 year follow-up, n=42.
130
 These results may not be generalisable to children 
(boys and girls) less than 5 years old.  
 
I could not find any recent reviews of treatment of ASB which included studies of children 
less than 4 years old. A review in 1990 concluded that neonates and preschool children with 
ASB should be treated.
132
  I found one study which followed up infants with ASB for 6 years. 
None of the 9 girls and 27 boys had renal damage on follow up urography, although some 
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developed pyelonephritis.
133
 Numbers were small and some of the infants had received 
antibiotics for RTI.  
 
For children less than five years old, the prevalence of ASB is likely to be less than 1.5% (see 
Table 1.5). It is unclear whether ASB in infants and young children is beneficial or not. 
Screening is no longer recommended or practiced, and the issue of whether to treat ASB or 
not is only relevant in a clinical context where children are generally unwell and where the 
distinction between ASB and UTI is difficult. 
 
For an acutely ill child presenting to their GP, who is found to have significant bacteriuria, 
the possibilities are: 
 
1) a true UTI 
2) a different illness + a contaminated urine sample causing significant bacteriuria 
3) a different illness + coincidental ASB 
 
In practice, and according to current guidelines, an acutely ill child with a growth of >10
5
 
cfu/ml bacteria in their urine would be considered to have a UTI and would be treated with 
antibiotics.  
 
Laboratory tests 
 Current recommendations  
The definition of UTI is the growth of >10
5
 colony forming units (cfu)/ml of urine following 
culture. The process of how the urine is cultured, what medium it is grown on, the 
temperature it is incubated at and the time for which it is left to grow will affect the number 
of bacterial colonies found. It is therefore essential that standard methods for culture and 
reporting are used. Laboratories have standard operating procedures (SOPs) detailing exactly 
how these processes should be carried out. There are different methods used for different 
types of urine specimens (suprapubic catheter specimens, bag specimens, urostomy urines 
etc). There are sometimes different procedures depending on the clinical information given. 
Different laboratories have different SOPs, and some vary in their methods.  
 
In the Cardiff and Vale SOP (Appendix 1.1)
104
. Method 1 (in this document) would be used 
for MSU or pad urine. This consists of using a dip strip which is dipped into urine up to a 
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mark. This is then pressed flat against the agar for a few seconds. Ten samples are 
inoculated on to one CLED plate. For neonatal urine samples and SPA samples, a different 
method is used as lower bacterial counts are expected. A 10 microlitre loop is used and 
spread in zigzags across a whole CLED plate. However, if any of these samples 
(MSU/pad/SPA or neonatal) had positive microscopy counts (i.e. 10 or more WBCs per high 
power field), a 1 microlitre loop is used and spread in zigzags across a whole agar plate. 
 
A CLED (Cystine-Lactose-Electrolyte-Deficient) agar is the standard agar plate used. This 
has a selective growing medium. It supports the growth of urinary pathogens and 
contaminants but prevents undue swarming of proteus species due to its lack of 
electrolytes.
134
 No single medium is likely to be able to support the growth of (and therefore 
detection of) all significant organisms. Some organisms may not grow at all or at a sufficient 
rate to be picked up on certain culture mediums (e.g. haemophilus influenza, pneumococcus, 
staphylococcus saprophyticus
135
). Other factors can also reduce the number of colonies found 
on culture:
134
 
· increased urine output due to high fluid intake (also high urine flow) 
· Urine pH of <5 
· Specific gravity of <1.003.  
 
Blood agar is used to identify fastidious organisms (those needing specific conditions to 
grow, perhaps particular media, longer culture, anaerobic conditions) but is not routinely used 
for urinary culture. 
 
Plates are then incubated at 35
o
C for 18-24 hours. An additional six hours is perhaps 
unlikely to make much difference to fast growing E.coli, but could foreseeably make a 
significant difference in the resulting culture count for infections with other organisms. 
Potentially significant isolates are listed as Enterococci, Lancefield Streptococcus group B, 
Coagulase negative staphylococci, staphylococcus aureus, staphylococcus saprophyticus, 
Enterobacteriaceae (including E.coli), Pseudomonads and yeasts.  
 
Colonies are then counted. For the dipstick method, 1 colony is equivalent to 5,000 
organisms/ml; 2 colonies equivalent to 10,000  up to 20 colonies equivalent to 100,000 
organisms/ml and more than 20 colonies equivalent to more than 100,000 organisms/ml. For 
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the 1 microlitre loop method, 1 colony is equivalent to 1,000 orgs/ml; 10-100 colonies is 
10,000-100,000 orgs/ml and >100 colonies  are equivalent to >100,000 orgs/ml. For the 10 
microlitre loop, 1 colony is equivalent to 10,000 orgs/ml.  
 
Reporting varies depending on clinical information given on the form, for example if there is 
a growth of 100,000 orgs/ml but the WBC count <10, antimicrobial susceptibility testing may 
not be performed or reported unless the clinical information suggests UTI or the patient is 
compromised. Pure or predominant growth is not strictly defined. Mixed growths are reported 
as contaminants. 
 
Could there be a better diagnostic method? 
The standard diagnostic method (culture of urine) is far from perfect. If a suprapubic aspirate 
is used and examined immediately with methods which grow fastidious organisms (different 
growth media), and a low threshold for diagnosis, it is likely to be an accurate test for 
identifying bacteriuria with a low chance of false negative and false positive results. This 
could be considered the gold standard.  
 
The reality, particularly in primary care with young children, is that the standard method falls 
short of a gold standard, with a high chance of false negative and false positive results. Even 
with the gold standard, there will be some cases where a true bacteriuria is identified but does 
not equate to a UTI, with no host reaction, no symptoms or inflammation.  
 
With the standard method, there are likely to be contaminants which may hide a true positive 
result or lead to a false positive result. Urine sampling method, storage and transport will 
exacerbate the effect of any contaminants present in the urine sample.  
 
Detecting host response or true infection rather than simply presence of bacteria is also 
flawed with the current method. Symptoms and signs are unreliable in children. Dipsticks for 
presence of white blood cells is unreliable in young children and so is microscopy for 
presence of white blood cells particularly if it is not done immediately.  
 
Ideally a method is needed which detects bacteria accurately at the point of care. If bacteria 
are found in significant numbers in the urine immediately, it is less likely that contamination 
is the cause as they will have not had the chance to grow. PCR methods can detect any/all 
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bacteria present, but will also detect bacteria present in tiny numbers (e.g. contaminants). 
However, quantitative PCR methods may be possible. Currently these methods are not 
available at the point of care or cheaply, but this may be a possibility for the future. 
 
Another possibility is to detect a host inflammatory response rather than detect the presence 
of bacteria. Microscopy or dipstick tests for white blood cells currently attempt to do this. 
This may also be achieved by detecting particular cytokines (chemicals released in an 
immune response) in the urine. This could potentially lead to a near patient test similar to a 
dipstick test. Again, there is nothing currently available but this may be a possibility in the 
future. 
 
Another alternative is to improve the accuracy of the current test. Some possible options may 
include: 
· Reducing the chance of contamination (perhaps by increasing use of SPA (unlikely in 
primary care) or improving cleaning prior to obtaining a specimen). 
· Reducing the impact of contamination by reducing time from voiding to testing 
(perhaps by improved transport methods or within practice mini-labs).  
· By stopping the growth of bacteria after voiding (by using preservatives like boric 
acid, refrigeration of samples in the practice and in the van until they reach the lab).  
 
It is important to consider that the problems with the current method, particularly the impact 
of contamination, not only increases the likelihood of false positive results, but also of false 
negative results, as specimens containing mixed growths of bacteria are classified as 
negative. This is of particular concern in young children where false negative results could 
lead to a delay in treatment of a true UTI with possible long term complications.  
 
Epidemiology of infections 
 
What is an infection? 
From the discussion above, it can be seen that it is not always clear when a UTI is present or 
not. In fact, the concept of an infection, although commonly used and understood by 
healthcare workers and lay public alike, is not necessarily that clear. The difficulties with 
finding the causative organisms responsible for disease and distinguishing pathogenic from 
non-pathogenic bacteria has been a problem ever since micro-organisms were discovered. 
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The germ theory of disease became established in the 19
th
 century. Researchers in the 17
th
 
century were questioning whether an illness could be caused by micro-organisms.  Antoni 
Van Leeuwenhoek (1632-1723) is considered to be the founder of microbiology.
136
 He was 
the first person to observe and draw bacteria.
137 Further work by Andry (1658-1742), Bassi 
(1773-1856), Henle (1809-1885), Snow (1813-1894), Semmelweiss (1818-1865), Pasteur 
(1822-1895), Billroth (1829-1894), Klebs (1834-1913), Koch (1843-1910),  and others led to 
the widespread acceptance that micro-organisms caused diseases.
137-139
  
 
However, how can you determine if a particular illness is caused by a particular bug? Is it 
enough to find the presence of the bug at the same time as presence of illness? How unwell 
does the patient have to be and can there still be an infection if they are not unwell at all? 
 
The difficulty of distinguishing between pathogens and organisms which were present but not 
harmful (commensal organisms) was a problem in the 19
th
 century, and continues to be a 
problem in the 21
st
 century.
140
  
 
Koch developed a framework to help to determine whether a disease is caused by a particular 
micro-organism.  
 
Kochs postulates 
Kochs postulates (as stated in Fredrisks & Relman)
140
 are: 
1) The parasite occurs in every case of the disease in question and under circumstances 
which can account for the pathological changes and clinical course of the disease. 
2) The parasite occurs in no other disease as a fortuitous and non-pathogenic parasite 
3) After being fully isolated from the body and repeatedly grown in pure culture, the 
parasite can induce the disease anew.  
A fourth postulate was added later: 
4) The micro-organism must be re-isolated from the inoculated, diseased host. 
 
Kochs postulates are still useful, but they have limitations which have become increasingly 
evident with the development of molecular microbiological techniques and understanding of 
the complex relationship between micro-organisms and human (host-pathogen 
interaction).
140 Some organisms cannot be grown in the laboratory or are difficult to grow 
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requiring special culture methods; an organism can be pathogenic in some circumstances and 
non-pathogenic in others; some organisms need another organism present to cause disease.
140
 
It can also be difficult to determine whether an organism is causing any harm or disease 
(subclinical infections or asymptomatic states). Whether an organism causes disease or not 
may depend on host factors including immune function, genetics and the organisms present in 
the normal flora. 
 
Although molecular differences have been found between pathogenic and non-pathogenic 
organisms, the distinction is no longer clear, with organisms previously thought to be non-
pathogenic causing diseases in some cases and pathogenic organisms not causing disease in 
some individuals despite being present in significant numbers on culture.
141
 The issue of 
whether the presence of bacteria represents colonization or invasion is still a problem.
142
  
 
Increased understanding of the complexities involved in the interaction between a human host 
and an organism, and the wide range of possible outcomes including sub-clinical immune 
response, full-blown inflammatory response and obvious clinical infection, non-symptomatic 
co-existence (asymptomatic carriage, commensalism, colonization or carrier state) and 
eradication of the organism, has made it increasingly difficult to be clear about definitions of 
previously widely understood terms like infection and pathogen.
141 The immune reaction to 
infection may be more (or as) important in the development of disease than the organism.
142
  
 
These difficulties all apply to UTI and make definitions and diagnosis from a clinical or 
research point of view challenging.  
 
Prevalence & incidence 
The main aim of my thesis is to determine the prevalence of UTI among ill children 
presenting in primary care. Most of the studies which I have reviewed for my thesis consider 
the incidence or cumulative incidence of UTI. Whilst these terms are clearly related, there are 
differences which affect the calculation and interpretation of the data.  
 
The incidence rate is the number of times a condition occurs in a given population and time 
frame. It is stated by Hennekens and Buring as the number of new cases of a disease during 
a given time period divided by the total person-time of observation.
143
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For example, the number of new cases of UTI diagnosed among a population of 1000 
children in a surgery over a year would represent the incidence rate. It is usually expressed as 
number of cases per 1000 person years which means the number of cases which would have 
occurred in 1000 people over a year.  
 
Prevalence is the number of cases of the condition which are found when a cross-section of a 
particular population is considered. Prevalence quantifies the proportion of individuals in a 
population who have the disease at a specific instant and provides an estimate of the 
probability (risk) that an individual will be ill at a point in time.
143
 In this case the 
prevalence is the proportion of children found to have bacteriuria when they present with an 
acute illness to their GP. These cases of bacteriuria are presumed to be incident (new) cases 
of UTI by GPs and researchers, however they could be cases of longstanding asymptomatic 
bacteriuria coinciding with another acute illness.  
 
As a GP, I want to know what the likelihood is of UTI in an acutely ill child presenting in my 
surgery. Of course, I really want to know how likely it is that UTI is the cause of the current 
illness. However, it is impossible, with current standard practice, to be sure that bacteriuria in 
the presence of an acute illness represents a UTI rather than a different illness with 
coincidental asymptomatic bacteriuria. But it is the prevalence of bacteriuria in presenting ill 
children which will give me the most useful information in determining what the chance of 
UTI is in a particular child. The prevalence of a condition is also known as the pre-test 
probability.  
 
Minimising bias in epidemiological studies 
All research is subject to bias. Research concerning the determination of the prevalence of a 
condition and research concerning the risk factors or symptoms and signs associated with a 
disease are prone to particular types of bias. This has been a consideration when reviewing 
papers for the background section of my thesis, in the development of the study protocol and 
method, and during the analysis and interpretation of my data.  
 
Grimes (2006) describes three main types of bias. 
138
 
1) Selection bias. 
2) Information (observation) bias. 
3) Confounding. 
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Selection bias 
For many of the papers concerning incidence and prevalence, and in the design and 
interpretation of my research study, selection bias is one of the biggest concerns.  
 
In most of the studies describing incidence, UTI is only detected in children who have had 
urine sampled following a decision by the clinician to obtain a urine sample because they 
already suspect a UTI. This could result in an erroneously high estimation because only those 
in whom the likelihood of UTI is high are selected to be the population in whom the 
incidence of UTI is calculated. Or it could result in an erroneously low estimation if the 
clinical suspicion is a poor indicator of UTI and so many children with UTI are unselected 
and their UTIs go undetected. Systematic sampling, obtaining urine from all children who 
present with all symptoms should avoid this particular type of selection bias. Unfortunately, 
even if a urine sample is requested on all children, it is not always possible to obtain one. If 
there is a reason for urine not being obtained which is associated with having (or not having) 
UTI, then there will still be selection bias. For example, if a child is more likely to be 
dehydrated if they have a UTI, and if it is more difficult to obtain a urine sample if a child has 
a UTI, then not obtaining a urine sample, because it is difficult, will result in UTI being 
missed as a result of selecting children in whom it is easy to obtain urine samples.  
 
Selection bias could also result from including children (or not including them) with a certain 
feature, if this is related to UTI. For example if only febrile children are recruited into a 
prevalence study of UTI, if fever and UTI are associated, this would result in selection bias, if 
the population being studied is all children (with and without fever). On the other hand it is 
acceptable to only recruit febrile children if the study is about the prevalence of UTI in febrile 
children. However, the findings of such a study could not be generalised to non-febrile 
children.  
 
Generally, a prospective cohort design will reduce the risk of selection bias because the 
exposures/risk factors are ascertained before the outcome of interest has developed. In the 
case of UTI, in a cross-sectional study, as the diagnosis of UTI takes time, the outcome is not 
known at the time of recruitment into the study.  
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Information (reporting) bias 
Information bias can occur if there is systematic error in the way exposure or outcome is 
measured in the study groups. This can be caused by the instruments or diagnostic 
measurements or from the researcher or observer involved in the research. Bias occurs if 
errors affect one group more than the other. 
Recall bias is a problem in retrospective studies, and less of a problem in the studies I have 
considered here.  
Interviewer bias can occur if there is a systematic difference in the recording of or 
interpretation of data. This could be relevant in the studies I have considered, particularly 
during the assessment of outcome in prospective studies (for example if the person 
determining whether there is a UTI or not is aware of whether the child had had UTI in the 
past) or in the recording of exposures or symptoms in the case of retrospective studies if the 
person recording symptoms knew the UTI status. This type of bias can be reduced by 
blinding the researcher to outcome or exposure status.  
 
In the studies concerning the long-term complications in which there is a long follow-up, loss 
to follow-up is an important issue and large potential source of bias. 
 
An important consideration is mis-classification, which if systematic and associated with the 
outcome or risk factor, can cause bias. In the case of childhood UTI, given the problems with 
diagnosis, contamination, mixed cultures, ASB, a UTI could easily be mis-classified as non-
UTI or non-UTI as UTI. Exposure or risk factor status could also be mis-classified, for 
example fever, with the large variation in definition and use of different instruments with 
varying levels of accuracy. The key question is whether the mis-classification is likely to be 
associated with the outcome (UTI) or exposure (symptom or risk factor) as this will cause 
bias. Random misclassification can dilute a true association between an exposure and an 
outcome.  
 
Confounding 
This is when an association between an exposure and an outcome is in fact due to a third 
factor which is associated with both the exposure and outcome.  
This is less of a consideration in the interpretation of incidence and prevalence studies. 
However, it is important when considering whether particular symptoms and signs are 
predictive of or associated with UTI. For example, if it was found that diarrhoea was 
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predictive of UTI, this could be due to the confounding effect of contamination. Diarrhoea 
may make contamination of the urine sample more likely and contamination of the urine 
sample might make the diagnosis of UTI (positive culture) more likely.  
 
Background summary  
 
UTI in children is important because it causes acute suffering and it has been linked with 
long-term complications including renal scarring, hypertension and renal failure. Although 
there remains some doubt about the strength of the associations with hypertension and renal 
failure, there is significant evidence for the association of UTI with renal scarring. This 
association has been seen in children with and without VUR. There is limited evidence that 
prompt treatment of UTI with antibiotics reduces the risk of renal scarring. There has been a 
recent change in the emphasis of treating children with UTI away from invasive 
investigations and prophylactic antibiotics towards the prompt diagnosis and treatment of 
UTI. This is likely to be both more effective and less costly for the NHS.
144
 
 
There is evidence that UTI in children is under-diagnosed with many cases missed, 
particularly in primary care. This appears to be largely due to insufficient urine sampling, 
presumably due to low levels of suspicion by clinicians and the non-specific nature of 
presenting symptoms and signs. The widespread belief and emphasis in current guidelines 
that UTI is unlikely if fever is not present or if there is evidence of an alternative source of 
infection may be contributing to the problem. Practical problems associated with obtaining 
urine samples in young children are also likely to compound the low levels of urine sampling. 
 
We do not know how significant the problem is as we do not know the true prevalence of 
UTI in presenting ill children. This is because published studies generally have not 
systematically sampled urine from children. Those that have were rarely in the UK, usually in 
emergency departments, and often had highly selective inclusion criteria, for example fever 
>38
o
C and only very young infants. Without knowing the prevalence of UTI, it is also 
difficult to advise on levels of urine sampling in primary care.  
 
There are no clear symptoms and signs which predict UTI in children, the diagnostic test 
(urine culture) is far from perfect and it takes 2-3 days for the treating primary care clinician 
to get the results. Studies reporting the symptoms and signs of UTI in children tend to be 
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secondary care studies and very few have systematic sampling of ill children. Almost all 
studies exclude children without fever.  
 
Research questions 
My main research question is: What is the prevalence of UTI in acutely ill children under five 
years old presenting in primary care? 
 
 My other research questions are: 
- What clinical features (symptoms, signs and risk factors) predict UTIs in children? 
- Which children should have their urine sampled?  
- What are the clinical outcomes for children diagnosed with UTI in primary care? 
 
Aims of research 
 Primary aim  
· To determine the prevalence of UTI in young children (under five) presenting with an 
acute illness (<28 days) in primary care.  
 
 Secondary aims  
· Identify the sensitivity, specificity and predictive values of clinical features and point-
of-care dipstick urine tests in predicting UTIs in children in primary care. 
· Identify clinical outcomes for children diagnosed with UTI in primary care. 
 
 Research objectives 
1. Conduct a systematic review of the literature concerning the prevalence and incidence of 
UTI in children in primary care. 
2. Conduct a pilot study to determine the feasibility of recruiting and obtaining urine 
samples from ill children in primary care. 
3. Conduct a study to determine the prevalence of UTI (defined as >105 organisms/ml of 
urine) in children aged before their fifth birthday presenting to primary care with an acute 
illness of less than or equal to 28 days duration. 
4. Determine the predictive values of symptoms, signs, risk factors and point of care 
dipstick tests in predicting positive urine culture (UTI) in urine samples systematically 
obtained from acutely ill children in primary care. 
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5. Develop a decision support system and sampling strategy for use in primary care for the 
diagnosis of UTI in children. 
6. Describe hospital referral, hospital investigation, re-consultation in primary care, and 
further UTI rates at 6 months for children found to have UTI at initial consultation 
compared with those without UTI. 
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Chapter 2: Systematic review and meta-analysis 
The prevalence of UTI in acutely ill children less than five years old 
presenting in primary care 
 
Headline: This systematic review was of studies reporting the prevalence of UTI in 
children consulting in primary care (including A&E) when urine was systematically 
sampled. Twenty-one studies were finally included in the review and meta-analysis. The 
pooled estimate for prevalence in febrile children less than three month old was 7.0%. The 
pooled prevalence for older children (up to five years old) was 8.0%. There was a high level 
of heterogeneity in the included studies. Most of the studies were set in Emergency 
Departments (ED) in the USA; and most only included febrile children. This pooled 
prevalence may not be representative of acutely ill children (not necessarily febrile) 
consulting in UK general practice.   
 
Background 
 
In chapter one, I discussed the difficulties of diagnosing UTI in children, and the evidence 
which suggests that many UTIs are missed, particularly in primary care. As a GP, I want to 
know what the likelihood of UTI is in an acutely ill child consulting at my surgery, i.e. the 
prevalence of UTI in this population of children. In this chapter I am going to present the 
results of a systematic review of the literature which I carried out to try to determine this.  
 
There are wide variations in the reported rates of UTI in children. Most studies report the 
incidence of UTI as determined from laboratory samples which have been requested by 
clinicians who suspect UTI to be present. As I discussed in chapter one, we cannot rely on 
urine sampling based on clinician suspicion to determine an accurate prevalence of UTI as 
children with non-specific symptoms will be excluded from urine sampling. The main aim of 
this systematic review was to identify the prevalence of UTI in acutely ill children less than 
five years old presenting in primary care. To do that the objectives included searching for and 
only including studies which had aimed to systematically sample urine from the study 
population rather than sampling urine according to clinician suspicion of UTI.  
 
There are a number of published reports from settings where urine sampling is more 
systematic, for example in neonatal and paediatric hospital wards where children have been 
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admitted for serious illness. However, children admitted to hospital are likely to be different 
from acutely ill children presenting to their GP and the results are unlikely to be generalisable 
to routine primary care. Children in hospital are usually much more seriously ill and the 
proportion of these children who have UTI may not be the same as the proportion with UTI 
in a primary care setting. On an initial search, there seemed to be very few studies conducted 
in general practice, but several studies in A&E departments. Although the children who 
present to A&E may be different from children who attend a GP surgery, this is a primary 
care setting where any patient can consult with an illness, unlike children admitted to hospital 
who have already been assessed by a doctor. I decided to conduct a systematic search for 
studies which had systematically sampled urine from children in a primary care setting, 
including A&E departments.  
I found two previous systematic reviews of prevalence of UTI in children, one by Downs 
(1999) and another by Shaikh and colleagues in 2008.
145 146
 Although it was used as part of a 
quality rating of primary studies in Shaikh et als review, neither of these systematic reviews 
excluded studies which had not systematically sampled urine. Ten of the eighteen studies in 
Shaikhs review had not attempted to systematically sample urine, including two of the 
largest studies. 
77 147
 
 
Aim 
The aim of this chapter was to conduct a systematic review of the literature to determine the 
reported prevalence of UTI in children under the age of five presenting in primary care with 
an acute illness when the goal was to systematically sample urine (rather than sample 
according to symptoms and signs or clinician suspicion), and to calculate a pooled prevalence 
of UTI if this was possible. 
 
Method 
 
I developed a search strategy using text words and MeSH terms (Figure 2.1). The MeSH 
terms were used to search each of the databases with this function and terms exploded when 
relevant. Text searches for words were searched using the .mp term which is the widest 
search option for text. These searches were then combined. I discussed the search strategy 
with supervisors and with one of the librarians specialising in systematic reviews. I 
performed pilot searches and checked important papers were being picked up by the search 
strategy. All the important papers which were known to me at the time were picked up by the 
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initial search. The databases searched were Medline, Medline-in-process, EMBASE, 
Cochrane Database for Systematic Reviews (DARE), HMIC, British Nursing Index, 
CINAHL and Web of Science. The original search was performed in July 2009 and updated 
in October 2012 (15/10/12). Reference lists of review articles and guideline documents were 
also searched for potentially relevant papers. 
 
Figure 2.1: Search strategy 
 
Methods of review 
Selection of studies 
I assessed the titles and abstracts of all of the papers found with this search, against the 
inclusion and exclusion criteria (figure 2.2). Abstracts of identified studies were stored in 
Endnote and duplicates removed. A sample of 10% of the titles and abstracts were also 
assessed by one of my supervisors (Professor Edwards). We marked each abstract as a 
definite inclusion, probable inclusion, probable exclusion or definite exclusion according to 
the above inclusion and exclusion criteria. The full text article was obtained for all of those 
which were not definitely excluded on the review of abstracts.  We had near complete 
agreement at this stage. On the few where we disagreed the full paper was obtained. As we 
had nearly complete agreement on this first stage, I assessed the remaining 90% of abstracts 
and titles myself. Both my supervisor and I assessed all of the full papers which were 
(urinary tract infection* or UTI or cystitis or pyelonephritis).mp text words and MeSH terms  
 
AND 
 
(child* or paediatric* or pediatric* or infant* or newborn* or baby or babies or neonat* or 
toddler*).mp. text words and MeSH terms 
 
AND  
 
(primary care or primary health care or general practice* or family * or (accident and 
emergency) or emergency medicine or community health centre* or family medicine or 
family physician or ambulatory or unscheduled or paediatric assessment unit* or walk in 
centre* or prevalence).mp. text words and MeSH terms. 
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indentified from the first stage and marked them as definite inclusion, definite exclusion, 
possible inclusion or possible exclusion. Where we had disagreement and for the possible 
inclusion and possible exclusion categories, we discussed the papers in more detail to reach a 
consensus decision. There were five papers identified from the first stage as possibly eligible 
for review of the full article which were subsequently excluded due to the full article being 
written in a language which was not English. 
 
Figure 2.2: Inclusion and exclusion criteria 
Criteria for including studies 
1) Studies must include children under five years old 
· Studies of children over the age of five included if prevalence is reported 
separately for under fives.  
2) Children should be presenting in primary care (include general practices, A&E, Out of 
hours co-operatives and walk-in centres).  
3) UTI must be determined by microbiological culture. Studies using a definition of UTI 
of >10
5
 organisms/ml for clean catch or bag or pad samples and >10
4 
organisms/ml 
for catheter samples and >10
2
organisms/ml or >10
3
 organisms/ml for suprapubic 
(SPA) samples will be included. 
4) Must involve systematic sampling (sampling urine from all children in the study 
population rather than only sampling urine from those children that the clinician 
suspects of having UTI). 
 
Studies reporting prevalence, point prevalence, cross-sectional prevalence and incidence are 
all included.  
Exclusion criteria 
1) Papers in languages other than English 
2) Studies from developing countries 
3) Studies of asymptomatic children 
4) Studies in secondary care 
5) Case series, case reports and case-control studies except where nested as part of a 
cohort study  
6) Studies which only include very specific groups of children e.g. with spina bifida, 
diabetes, long-term catheters, structural abnormalities of the urinary tract. 
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Data extraction 
From studies which met the inclusion criteria I extracted the data for the age range of children 
in the study, the sample size of the population under five years old, the country, the setting 
(e.g. general practice/A&E), the inclusion criteria for the study (particularly the temperature), 
the proportion of the study population whose urine was sampled, the method of urine 
sampling, the definition of UTI used and the prevalence of UTI. 
 
Statistical analysis 
Data were entered into EXCEL (version 2007). Confidence intervals given by individual 
studies were not used. Confidence intervals were calculated using raw data given in papers 
and using a method appropriate for proportions close to zero.
148
 A pooled UTI prevalence 
was estimated and Forest plots drawn using the calculations and spreadsheets provided by 
Neyeloff et al.
149
 However, they calculated confidence intervals using the standard method 
which is less suitable for proportions close to zero, so I calculated confidence intervals using 
a more appropriate method instead of using those given by the spreadsheet (as above).
148
 
Neyeloffs spreadsheet was also used to calculate the Q and I
2
 statistics to assess 
heterogeneity of papers. Due to significant heterogeneity, a random-effects model was used 
to calculate the pooled estimate of prevalence and associated confidence intervals.
149
 
Sensitivity analyses were performed excluding one study with an outlying prevalence and 
excluding studies with less clear or lower diagnostic thresholds for UTI.  
 
Results 
 
From the initial search, 4713 articles were found and 148 full text articles were reviewed. 
Nineteen articles met all the inclusion criteria. From the updated search, a further 55 articles 
were identified and a further four full text articles reviewed. Two were subsequently 
included, one of which was the paper reporting my pilot study.
150
 Twenty-one studies were 
included. The included studies are shown in Tables 2.6 and 2.7.  I considered the studies in 
two groups. Fifteen studies were of children aged three months old or under (Group A; table 
2.6) and six studies included children up to the age of five years old (Group B; Table 2.7). 
Tables 2.8 and 2.9 give further details including inclusion criteria, urine sampling method, 
the definition of UTI used, the sample number and the prevalence of UTI for included 
studies. Tables of summaries of studies which were considered more closely due to the 
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possibility of overlapping datasets or where only some of the data were used are presented in 
Appendix 2.1.  
Table 2.6: Included studies: Group A: Studies of children < 3 months old 
Lead author Year Country  Setting Study design Age of 
children 
Baker
151
 1993 USA Paediatric ED Prospective 29-56 days 
Bonadio
152
 1991 USA Paediatric ED Prosepective 30-60 days 
Bonadio (i)
65
 1993 USA Paediatric ED Prosepective 0-8 weeks 
Bonadio (ii)
66
 1993 USA Paediatric ED Retrospective 0-8 weeks 
Bonadio
67
  1994 USA Paediatric ED Retrospective 8-12 weeks 
Crain
63
 1990 USA Paediatric ED Prospective 0-8 weeks 
Dayan
100
 2002 USA Paediatric ED Prospective 1-60 days 
Herr
70
 2001 USA Paediatric ED Retrospective 0-60 days 
Hoberman
48
 1993 USA Paedatric ED Prospective 0-2 months 
Krober
61
 1985 USA Army medical centre Prospective 0-3 months 
Levine
101
 2004 USA Paediatric ED Prospective 0-60 days 
Lin
102
 2000 Taiwan ED or outpatient clinic Prospective 0-8 weeks 
Maniaci
71
 2008 USA Paediatric ED Prospective 0-90 days 
Schwartz
103
 2009 Israel Paediatric ED Retrospective 0-28 days 
Stanley
153
 2005 USA Paediatric ED Retrospective 0-3 months 
 
Table 2.7: Included studies: Group B: Studies of children up to 5 years old 
 
Lead 
author 
Year Country  Setting Study design Age of children 
Hsiao
73
 2006 USA Paediatric ED Prospective 57-180 days 
Manzano
154
 2010 Canada Paediatric ED Prospective 1-36 months 
North
60
  1963 USA ED or outpatient clinic Prospective <13 years* 
OBrien
150
 2011 UK General practice Prospective <5 years 
Shaw (i)
68
 1998 USA Paediatric ED Prospective Boys <1 year 
Girls <2 years 
Torrijos
83
 1989 USA ED or outpatient clinic Prospective Unclear. Mean age UTI 
group= 22.6 months and 
non-UTI group= 28 
months 
* Data for <5 year olds presented 
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There was variation between studies in both groups A and B. Although most studies required 
fever to be present, this varied from >37.4
 o
C axillary to >40.0
 o
C rectal temperature. Some 
studies allowed a fever recorded by a care-giver rather than at the time of recruitment.
48 61 65 66 
100
 All but two of the studies were conducted in the USA. The others were conducted in 
Taiwan and Israel.
102 103
 The studies conducted in the USA and Israel had high levels of 
circumcision. Some studies excluded children with a clear source of infection.
60 68 71 103
 One 
study only included children with otitis media.
83
 Most excluded children who had received 
antibiotic treatment recently,
48 65 67 68 71 100 101 153 154
 and one excluded children who had 
received antipyretic medication recently.
67
 Urine samples were usually taken using a catheter 
or SPA and the diagnosis of UTI was usually >10
4
cfu/ml pure predominant growth from a 
catheter sample or >10
3
cfu/ml pure or predominant growth from a SPA sample, although 
there was some variation in the definitions used (Baker >10
3
cfu/ml from a catheter sample
151
; 
Bonadio 1991 did not clearly state the counts used
152
; Crain & Lin >10
2
cfu/ml for SPA 
samples
63 102
; Herr >5x10
4
cfu/ml
70
; Maniaci & Levine >5x10
4
cfu/ml or >1x10
4
cfu/ml & 
positive urinalysis
71 101
). Clearly, different definitions of UTI will result in different 
prevalence rates. 
 
Most studies specified that urine was systematically sampled from all children as an inherent 
part of the study method. Some did not specifically state this as part of the research study 
method, but stated that it was the protocol or clinical guideline for the paediatric 
department.
68 70 71
 In one case, 93% urine retrieval was achieved;
70
 in another, 97%
71
; and in 
another 83%.
68
  
 
Some studies describe 100% urine retrieval. Although this may be possible, especially in 
paediatric emergency departments where obtaining urine samples, often using a catheter or 
SPA may be standard, it does raise suspicion that the study population was selected on the 
basis of a urine sample being provided as it seems unlikely that a urine sample will be 
obtained in every case in which it is requested or attempted.  
 
I calculated a pooled prevalence estimate for the fifteen studies of children aged three months 
or less as the methods and inclusion criteria of these studies seemed to be similar enough to 
justify this (Figure 2.3). They were all of children within a narrow age range; both male and 
female children were included; all but one
61
 were recruited from Paediatric Emergency 
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Departments; all were included only if they had fever, in most cases approximately 38
o
C. A 
Forest plot with the pooled estimate is shown on Figure 2.3.  
 
Figure 2.3: UTI prevalence (squares), 95% confidence intervals (lines) and pooled 
prevalence (diamond) in Group A studies  
 
 
NB. Size of squares is not proportional to the sample size of the study  
Q=124.31; I2=88.74 
X2 test with 14 df p<0.001 
 
Sensitivity analysis 
The prevalence found by Stanley was much higher than those found in the other studies in 
group A (see Figure 2.3).
153
 The data included from this study was only part of the complete 
dataset as for the majority of the sample the urine sampling did not appear to be systematic 
with only 6% of the total dataset (316/5273) having their urine sampled. The papers focus 
was hyperpyrexia, and those infants with a temperature of >40
o
C all had their urine sampled. 
However, the sample was small (n=92) and required a higher inclusion temperature than the 
other included studies. Therefore I calculated a pooled prevalence and Forest plot excluding 
the study by Stanley (Figure 2.4).
153
 Excluding this study gave a pooled prevalence of 6.6%. I 
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also calculated a pooled prevalence excluding the five studies where the definition of UTI 
was less clear
103 151 152
 or used the lower threshold (>10
2 
cfu/ml or less) for SPA samples.
63 102
 
This resulted in a pooled prevalence of 5.9.  
 
Figure 2.4: UTI prevalence (squares), 95% confidence intervals (lines) and pooled 
prevalence (diamond) for Group A studies (included children <3 months with fever) 
excluding the study by Stanley. 
 
 
NB. Size of squares is not proportional to the sample size of the study 
Q=107.28; I2=87.88 
X2 test with 13 df p<0.001 
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Figure 2.5: UTI prevalence of Group A studies with pooled estimate excluding the study 
by Stanley and the five studies with variation in UTI definition 
 
 
 
Q=61.8 
I2=87.1  
 
I calculated a pooled prevalence estimate for the six studies of older children (aged between 
three months and five years old). However, these studies had greater variation in methods. 
Figure 2.6 shows the associated Forest plot and pooled estimate. 
 
Figure 2.6: UTI prevalence (squares) and 95% confidence intervals (lines) for Group B 
studies (included children up to five years old) 
 
 
NB. Size of squares is not proportional to the sample size of the study 
Q=56.3; I2=91.1 
X2 test with 5 df p<0.001 
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The Q and I
2
 statistics are measures of heterogeneity. Both were high (124.3 and 88.7 
respectively) for the fifteen studies for children aged 3 months or less (Group A; figure 2.3); 
and remained high when the outlying study was excluded (Q=107.3; I
2
=87.9; figure 2.4). 
These statistics were high for the six studies for older children (Group B; Q=56.3; I
2
=91.1; 
figure 2.6). Group B studies seemed to vary more methodologically than Group A, with 
greater variation in age, temperature, inclusion and exclusion criteria. The Q statistic for 
Group B studies was lower than for the Group A studies, but the I
2
 was 91.1 indicating that 
91.1% of the variation in prevalence was due to the heterogeneity of studies.  
 
It is debatable whether the studies are too heterogeneous to present a pooled estimate, but it is 
not clear at what point the heterogeneity is thought to be too high. It is most important to 
understand the cause of the heterogeneity.
155 156
 The I
2
 value represents the percentage of the 
total variation across studies which is due to the heterogeneity of studies rather than chance 
alone.
155
 Therefore, an I
2
 of 88.7 (for Group A) suggests that 88.7% of the variation in my 
meta-analysis is due to the heterogeneity of the studies rather than chance. The pooled 
estimate is therefore more like an average of the prevalence found in the studies rather than 
the best estimate of the true population prevalence. 
 
Shaikh et al do not give their values for Q or I
2
, although they do give the p-value for the chi-
squared test using the Q statistic.
145
 They found it to be highly significant (p<0.01), indicating 
significant heterogeneity. I calculated the Q and I
2
 statistics for their analysis using the 
Neyeloff spreadsheet and found them to be 162.2 and 92.0 respectively.
149
  
 
Discussion 
 
Summary of results 
A total of 4768 articles were found using the search strategy and 152 full text articles were 
reviewed. Twenty-one studies met all the inclusion criteria. 
 
The pooled estimate for the prevalence of UTI in febrile children less than three months old 
was approximately 7.0%. Excluding studies with less stringent definition criteria resulted in a 
pooled prevalence of 5.9% for febrile children less than three months old. The pooled 
estimate for the prevalence of UTI in children up to the age of five years old was 8.0%. Chi
2
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tests for heterogeneity were strongly significant with p-values of <0.01 and high I
2
 values for 
both groups of studies, signifying high levels of heterogeneity. 
 
Strengths and weaknesses 
Strengths 
This was a systematic review of the literature involving two researchers selecting studies 
according to pre-determined inclusion and exclusion criteria. This method reduces the chance 
of selection bias in the meta-analysis. Systematic urine sampling rather than clinician-
suspicion led urine sampling was one of the key inclusion criteria. This ensures that the UTI 
prevalence is a true representation of the prevalence in the study populations, and therefore a 
more accurate estimate of the population prevalence, rather than the prevalence of UTI 
among a clinician selected sub-set of the study population. 
 
Weaknesses 
Non-English articles were not included in the review. The effect of publication bias was not 
assessed. Although it is possible that journals may find a higher prevalence more attractive, I 
felt that publication bias was unlikely to be a significant factor, where, unlike an intervention 
study, there are no positive or negative findings. 
 
The main weakness of the meta-analysis is the heterogeneity of studies. The high level of 
heterogeneity calls into question the validity of the pooled estimates, which are therefore 
more like an average of the findings of a variety of studies rather than a more accurate 
representation of the true population prevalence. 
 
Context/other studies 
My findings are very similar to the findings of Shaikh et al, despite different inclusion and 
exclusion criteria and subsequently different studies included in my meta-analysis compared 
with theirs.  
 
Even if the pooled prevalence estimate is representative of the true population prevalence, the 
populations in these studies are quite different from the population of presenting ill children 
in UK primary care and the estimate is unlikely to be generalisable to the UK population.  
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Nearly all the studies were from the USA. The ethnic makeup of the USA is different from 
the UK, with approximately 72% of the population White and approximately 13% Black in 
the USA compared with 91% White and 2% Black in the UK.
157
  Some of the studies which 
gave a description of the race of participants had even greater differences in ethnicity from 
the UK, for example Shaw et al described 84% of their study population as African 
American.
68
 Ethnicity has been found to be associated with UTI, with most studies finding 
that UTI is more common in White children than African American children. A high 
proportion of African American children in the studies included in the meta-analysis may 
underestimate the prevalence for a predominantly white UK population.  
 
There are much higher levels of circumcision in the USA compared with the UK 
(approximately 80% in USA; 3% in UK).
158
  Being circumcised has been associated with a 
lower risk of UTI compared with uncircumcised boys (odds ratio of 0.1).
159
 Some of the 
studies included in my systematic review stated the proportion of boys who were 
circumcised. Hoberman et al found 98% of boys in their study population were 
circumcised
48
; Shaw found 87%
68
; Hsiao 72% and Schwartz (Israel) found 97%.
103
 A high 
proportion of circumcised boys in these studies may underestimate the prevalence for a 
predominantly uncircumcised UK population. 
 
All of the studies but two included only children who were febrile.
83 150
 In most cases, a 
temperature of at least 38
o
C was required. In addition to the problem of defining fever and 
different methods of measurement, as I discussed in chapter one, fever is not always present 
in a UTI and excluding non-febrile children may miss some cases of UTI. This could result in 
studies including only febrile children to underestimate UTI prevalence. However, if UTI is 
more common in children with fever, then excluding those without fever may cause an 
overestimation of UTI prevalence as a proportion of the study population. 
 
Implications for policy, practice and further research 
My pilot study was the only UK based primary care study of UTI prevalence using 
systematic urine sampling identified by my systematic review.
150
 It was also the only study 
using urine sampling methods suitable in general practice and including all acutely ill 
children irrespective of potential alternative sources of infection or temperature. However, 
the sample size was very small and confidence intervals were wide.  
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Given the high proportion of Whites and un-circumcised boys in the UK compared with the 
populations studied in the majority of papers included in this review, the prevalence of UTI in 
acutely ill children in the UK may be higher than that found in the studies presented here. On 
the other hand, with selective inclusion criteria such as high temperature or absence of 
alternative sources of infection, and recruitment predominantly from paediatric emergency 
departments, the prevalences reported in the studies in this review may be higher than that in 
the population of acutely ill children presenting in UK general practice.  
 
If the true prevalence in acutely ill children less than five years old is 7-8% (or higher), this 
has significant implications for clinical practice. Substantial increases in urine sampling from 
ill children may be indicated, perhaps in all acutely ill children. Evaluation of the cost-
effectiveness of such approaches would need to be established.  
 
Given the heterogeneity of included studies and the differences between the populations 
included in these studies and my target population, I am not confident that the pooled 
prevalence found in this systematic review is representative of children less than five years 
old with an acute illness presenting in UK primary care. Further research is needed to identify 
the prevalence in this population. 
 
Conclusion 
 
This systematic review and meta-analysis highlights the need for a large prospective study of 
UTI prevalence, with systematic urine sampling, in acutely ill children presenting in UK 
general practice.  
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Chapter 3: Pilot Study 
 
Headline: The pilot study showed that it was feasible to recruit children less than five years 
old from general practices and obtain urine samples from them. A total of 99 children were 
recruited from four general practices, with full laboratory results in 72%. The prevalence 
of UTI was 4% (95% CI: 1%-18%). The pilot study helped to secure funding and informed 
the study design of the main study. 
 
Background 
 
Aims and objectives 
Before undertaking a large cohort study, a pilot study was needed to determine whether it 
would be possible to recruit young children and obtain urine samples in GP surgeries.  
 
Need for the pilot study 
Before a grant was awarded by WORD for the study, I had applied to several fellowship 
schemes for funding for a PhD based on this study. Reviewers of the fellowship applications 
gave positive feedback but expressed concerns about recruiting young children from primary 
care. Other studies had apparently had significant difficulties in recruiting febrile children 
from GP practices. One study in Bristol struggled to recruit children from general practice.
160
 
The initial target sample for this study was 747. Following recruitment problems, this was 
revised to 180, with a final sample of 156 achieved. However, this study involved 
randomisation and required a fever at the time of recruitment of at least 37.8
o
C. Although the 
inclusion criteria for my study were broad, including not only febrile children but any acutely 
ill child, and was only observational, reviewers remained doubtful about the feasibility of 
recruitment. 
 
It was also unclear how easy it would be for practices to obtain urine samples from all 
attending ill children. No previous studies had attempted to do this in UK GP surgeries.  
 
I did not know how often urine would normally be sampled in children consulting with an 
acute illness in general practice. I tried to answer this question in Chapter 1 (page 20). I 
estimated that GPs probably sample urine from acutely ill children in less than 1% of 
consultations. Although these figures are only an approximation, even allowing for a large 
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degree of error, these figures do suggest that it is unusual for GPs to obtain a urine sample 
from an ill child. This suggested that we could face difficulties obtaining urine samples from 
all acutely ill children in primary care. 
 
Van der Voort et al (1997) sent a questionnaire to GPs concerning UTI in children under two, 
awareness of guidelines and barriers to diagnosis.
41
 They found that GPs reported practical 
difficulties in obtaining urine samples from young children. These included problems 
engaging the co-operation of parents, time constraints and availability of equipment.   
 
A pilot study was therefore needed to see if it would be possible to recruit and obtain urine 
samples from ill children in GP practices. We needed to be sure that it was feasible to do a 
small study before investing large amounts of time and money for a large study. We also 
needed to obtain funding to carry out the large study and needed to be able to demonstrate 
feasibility to potential funders.  
 
Aim 
The aim of the pilot study was to determine whether it was feasible to recruit children less 
than five years old in primary care and obtain urine samples from them. 
 
Objectives 
· Recruit 100 children aged under five from GP practices into the study 
· Obtain urine samples from all children recruited 
 
Method 
 
Approvals 
Ethical approval for the pilot study was obtained from the South East Wales Local Research 
Ethics Committee (ref no.06/WSE03/117). I submitted an application including both the pilot 
study and subsequent planned large study, but the Ethics committee only approved the pilot 
study and requested a further application for the full study once the results of the pilot study 
were known. Site specific assessment for each of the practices was also carried out by this 
Ethics Committee. Approval was obtained from Cardiff Local Health Board (LHB) and The 
Vale of Glamorgan LHB for the practices taking part in the study.  
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Practice recruitment 
Four practices were asked to recruit for the pilot study. These practices were chosen as they 
were part of a network of research practices, known to have a practice nurse who had 
previously been involved in research studies. One practice had a nurse employed solely for 
research purposes who was also able to play a co-ordinating role with the other practices. One 
of the practices was located in Ely, and the other three in Barry. These practices were chosen 
for convenience. They had the resources to start the pilot study straight away and with their 
research experience would be able to give feedback and advice to improve procedures when 
(if) we progressed to a large study. These practices were not randomly selected and were not 
representative of all practices in Wales, but the purpose of the pilot study was to see whether 
it was feasible to recruit children and collect urine samples in selected practices, and 
hopefully to determine study processes which could then be rolled out to less research-
experienced practices for the larger study.  
 
Practices were paid £50 per participant recruited into the study. This was funded by the 
Department of Primary Care & Public Health. Study equipment was provided to surgeries, 
including a digital tympanic thermometer which practices could keep following completion 
of the pilot study. The amount of reimbursement for practices was decided upon after 
discussion with Professors Butler, Edwards and Hood as well as the research nurses at the 
practices. The amount of reimbursement was similar to those in other primary care research 
studies in the Department of Primary Care and Public Health, and reflected the time that it 
was estimated to take the research nurse and GP to complete the CRF and obtain the urine 
sample.  
 
Training 
Practice nurses and GPs from each of the four practices were invited for training at one of the 
surgeries. The practice nurse who would be the research lead from each site attended, along 
with two of the GPs from one of the practices and a healthcare assistant from one of the 
practices. A further training session was carried out at each of the practices at the start of the 
study. In three of the practices this was with the practice nurse; in the fourth, this was with 
the practice nurse and one of the GPs.  
 
In the first training session, I explained the rationale for both the main study and the pilot 
study; described study procedures in detail and invited comments and discussion on these; 
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provided study documents which needed to be completed; consent procedures, processes for 
obtaining urine samples, procedures for data collection and follow-up. Everyone attending 
was encouraged to participate in discussions and consider how the study would best be run 
within their own practice environments.  
 
The second training sessions were one-to-one sessions with practice nurses (and a GP in one 
case). The aim of these sessions was to provide equipment and study documents, to go 
through the study protocol and documents in detail and how this would be implemented in 
their practice and to answer any questions. 
 
Participant recruitment 
Practices started recruitment in February 2007. Each practice was asked to recruit 25 
children, and was encouraged to recruit these as soon as possible, preferably within one 
month. Each practice was asked to recruit children under the age of five (aged before their 
fifth birthday), who presented with an acute illness of less than or equal to 28 days duration. 
Practices were asked to recruit sequential eligible children during times of recruitment. 
Practices were also asked to keep a log of all eligible children who were approached but did 
not participate in the study and their reasons for non-participation, and where possible those 
who were not approached with reasons.  
 
Exclusion criteria 
Exclusion criteria were agreed upon after consideration of the main focus of the research, 
exclusion criteria used in other studies, and following discussion with supervisors. Table 3.2 
shows the exclusion criteria. The main aim of the pilot study was to determine feasibility of 
recruiting young children and obtaining urine samples from them. However, all study 
procedures, including the inclusion and exclusion criteria, needed to be as similar as possible 
to those of the intended large study.  
 
Table 3.2: Exclusion criteria 
 
· Previously included in this study 
· Past history of urinary tract abnormalities diagnosed with radiological 
examination (including antenatal ultrasound scan (USS)) 
· Taking regular, long term antibiotics (for > 28 days) 
· Taking immunosuppressant medication (chemotherapy for cancer or regular 
oral steroids (> 10mg per day of prednisolone or equivalent for > 2 weeks.)) 
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The aim of the research was to determine the prevalence of UTI in ill children seen routinely 
in general practice, in order to give the treating clinician more information about how likely 
UTI is, and which symptoms and signs may indicate UTI. I wanted to capture the kind of 
acutely ill child routinely presenting in primary care, in whom a urine sample would not 
routinely be taken, and find out the prevalence of UTI in this group, rather than studying 
groups already known to be at high risk or groups who would already be treated differently, 
for example immunosuppressed children or those known to have urological abnormalities. At 
the same time we wanted to be as inclusive as possible to represent the broad spectrum of 
children seen in GP surgeries.  
 
The inclusion of only children with illnesses of less than 28 days duration was intended to 
pick up those with an acute illness. We wanted to include typical ill children presenting in 
GP surgeries, often with only a few days of illness, and also to pick up those who were either 
not brought to the surgery straight away (perhaps thought to have a self limiting illness by the 
parents) and those with lingering symptoms. Children with acute illnesses can have 
symptoms lasting two or three weeks and we did not want to exclude these children.
161
 It was 
difficult to find a clear definition of what constituted an acute illness, and 28 days was 
decided upon to include most of those with the short term illnesses commonly seen in general 
practice but exclude those attending for follow-up with chronic illnesses. Twenty eight days 
has also been used to define the duration for acute illnesses in other published studies.
162
  
 
Data collection 
Following consent (Appendix 3.1), clinical history and examination details were recorded on 
the case record form (CRF) which was completed by practice nurses and clinicians 
(Appendix 3.2). A urine sample was obtained from each child and the child was managed as 
normal by the treating clinician. A telephone follow up interview was conducted at three 
weeks.  
 
Once completed, consent forms and CRFs were returned by fax to a confidential fax machine 
in a locked room. Alternative methods were considered, including Royal Mail, special 
delivery or collection by hand. I needed to receive the information straight away so that I 
could conduct the telephone interviews at three weeks and as the CRFs contained personal 
and identifiable data we thought that the confidential fax was the best method. 
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A urine sample was obtained from children either by the clean-catch method or using a urine 
collection pad inserted in the nappy (Newcastle collection pack). These methods of urine 
collection were chosen after a review of published studies and current guidelines. Collection 
of urine by suprapubic aspiration or transurethral catheterisation methods are the most 
accurate and least likely to give false positive results due to contamination but are invasive 
and associated with discomfort and distress to children. Both techniques are normally used on 
seriously ill children and are unsuitable for routine use in primary care. The clean-catch 
method is the most accurate, non-invasive method in children, and has been found to have 
reasonably good agreement with urine samples obtained by suprapubic aspiration.
112
 Liaw et 
al (2000) found that pads and bags had similar contamination rates but that parents preferred 
nappy pads and these were also cheaper.
163
 Therefore we decided to use the clean catch 
method as first choice, and where this was not possible or not acceptable to parents, to use 
nappy pads.  
 
The urine sample was tested with a urine dipstick (Bayer Multistix GP) by the nurse or 
healthcare assistant and then sent to the laboratory using the practices usual transport 
process. I wanted to include dipstick testing in the large study and so therefore wanted to 
include it in the pilot study. Using dipsticks as a diagnostic tool, whilst well established in 
adults, has been controversial in young children. There is a lack of studies using these 
methods in primary care for young children, and most studies only include children already 
suspected of having UTI. A systematic review in 2005 concluded that dipsticks may be used 
to rule out UTI if both Leucocyte esterase (LE) and nitrite were negative, however this was 
based on an estimated pre-test probability (i.e. prevalence) of UTI of 20%, and would result 
in a 4% false negative rate.
112
 Dipstick testing has not been adequately assessed as a 
diagnostic test in urine collected systematically from acutely ill children in primary care and 
the accuracy of the dipstick testing may be different in the population we were planning to 
study. We do not know the prevalence of UTI in this population but we expected it to be 
significantly lower than 20%.  
 
Standard microscopy and culture was performed on urine samples and the result sent to the 
practice in the normal way. Copies of urine results were faxed to the University by practices. 
All four practices used the same NHS laboratory for processing specimens. It was important 
to keep the transport, processing, and reporting of urine samples as close as possible to what 
would normally occur in practices, allowing clinicians to act on results in the normal way. I 
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wanted this to be primarily an observational study and did not want to influence the 
management of patients further than we already were by requesting that they obtain a urine 
sample from all recruited children.  
  
All children were followed up at three weeks with a telephone interview (Appendix 3.3). The 
aim of this was to determine outcomes of the illness including duration, impact on the family, 
method of urine sampling and how easy this was, and risk factors for UTI. Three weeks was 
chosen in the hope that most of the children would have recovered from their illness and so I 
could collect data on symptom duration but not so long after the event that the parents would 
have forgotten the details of the illness. If the child had not fully recovered at the time of 
telephone interview, the continuing symptoms could be recorded using the same table of 
symptoms used in the CRF at recruitment.  
 
Impact of the illness was also assessed in terms of hospital admissions and other NHS 
contacts and re-consultations, and parental time off work. Possible risk factors for UTI, and 
for resistant UTI, were included. It was difficult to decide which potential risk factors and 
demographics should be collected. As no previous studies had studied UTI diagnosed in this 
way, I did not know if the risk factors and symptoms would be similar for those with UTI 
diagnosed in this study. I therefore wanted to include those highlighted as possible factors in 
the literature, but also include others that may potentially play a part. This decision process 
took place over time reviewing published studies and following discussions with my 
supervisors and researchers in the immunology and microbiology fields.  
  
Methods of analysis 
Data were entered into SPSS for analysis. The data were cleaned and variables were checked. 
The main outcome measure was the prevalence of positive culture, with associated 
confidence intervals. Standard methods for calculating confidence intervals for the population 
prevalence from a sample prevalence are not accurate when the prevalence (proportion) is 
low. Therefore I used a method for calculating confidence intervals which is accepted to be 
more appropriate for proportions close to zero.
148
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Results 
 
Description of sample  
Practices recruited children between February and April 2007. The first child was recruited 
on 5/2/2007 and the last on 20/04/2007, giving a total time to recruit the target of 100 
children of nearly 3 months. 
 
Parents of 116 children under the age of five were invited to participate. The parents of seven 
did not provide consent, three were excluded and the treating GP felt that six were unsuitable. 
A total of 100 (86.2%) children were both eligible and parents provided consent. In one case, 
the CRF and consent form subsequently went missing, leaving 99 included in the analysis.  
 
Half (50.5%) of all the children were recruited by the largest practice (EB). Twenty five were 
recruited by FP, 22 by HS and two by PH. PH dropped out of the study shortly after starting 
recruitment, having only recruited two children. 
 
The carer consenting for the child to participate in the study was the mother in 86 (86.9%), 
the father in eight (8.1%) another family member in one (1.0%). In four cases this 
information was missing.  
 
Overall, 48 (48.5%) participating children were male and 51 were female. The median age 
was 20 months (IQR 8-32 months). The median age of non-participants was 17 months (IQR 
12-35 months). Table 3.3 shows the age and gender of children. 
 
Table 3.3: Age and gender of participating children 
 
Age  Male Female Total 
0-1 years 18 15 33 
1-2 years 9 15 24 
2-3 years 12 11 23 
3-4  years 4 7 11 
4-5 years 5 3 8 
All ages 48 51 99 
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Symptoms and signs 
Figure 3.1 shows the number of children with each symptom listed on the CRF. Nasal 
congestion was the most common presenting symptom with 76% children presenting with 
this symptom.  
 
Figure 3.1: Frequency of presenting symptoms 
 
 
Twenty six (26.3%) carers reported that they had measured the temperature at home. The 
median highest reported temperature was 38
o
C (IQR 36.9-39.0).  
 
Temperature was recorded in the surgery in 98 (99.0%), pulse rate in 68 (68.7%) and 
respiratory rate in 61 (61.6%). Temperature was normally distributed with a mean 
temperature of 36.7
o
C and a standard deviation of 0.95. Pulse rate and respiratory rate were 
not normally distributed. The median pulse rate was 119 beats per minute (IQR 100-120). 
The median respiratory rate was 30 per minute (IQR 20-40).  
 
Parents were asked how sick they thought their child was and how concerned they were about 
the illness. GPs were asked to give an overall impression of how ill they thought the child 
was (see CRF, Appendix 3.2). In 41 cases, the parents gave the same score for both 
questions, and different scores in 58. GPs tended to give lower scores, giving a score lower 
than both of the parental scores in 61cases. 
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Laboratory results 
Urine samples were obtained in 75 (75.8%). There was a full laboratory result in 71 (71.7%). 
Urine samples leaked in transit in three (4.0% of urine samples) and were lost in transit in one 
(1.3%).  
 
A laboratory definition of UTI was met in 3/71 (4.2%; 95% CI 1% - 18%) cases.  
A borderline, low count (between 10,000 and 100,000 cfu/ml of a single uropathogen) was 
found in one further (1.4%) case.  
 
Management  
One child was admitted to hospital on the same day and two were referred to the hospital (but 
not admitted on the same day). Sixty eight children were prescribed a medication. This 
included an oral antibiotic in 28 (41.2%), an antipyretic/analgesic in 23 (33.8%), a topical 
antibiotic in 8 (11.8%), an antifungal in 4 (5.9%), an antiviral in 2 (2.9%) and other 
medications (including emollients, steroids, cough medicine) in 26 (38.2%).  
 
In seven (7.1%) children, the working diagnosis recorded by GPs was either UTI, pyrexia 
of unknown origin (PUO) or unknown. None of these turned out to have a UTI. The 
diagnosis of UTI was not suspected in any of the three children found to have a UTI. In two 
of the cases found to have a UTI, the GPs working diagnosis was otitis media. In the other 
case, the working diagnosis was tonsillitis. All three were prescribed amoxicillin.  
 
Telephone follow-up at 3 weeks 
Follow-up telephone interviews were completed for 61 (61.6%).  The parents reported that 
the child had completely recovered by the time of interview in 50 (50.5%). The median 
number of days until recovery in those fully recovered at the time of interview was 7 (IQR 5-
14). 
 
Five (5.1%) children had been admitted to hospital. One had been admitted on the same day 
as the consultation and four were admitted subsequently.   
 
Fourteen (23.0%) were born at full term; 22 (36.1%) were premature and 24 (39.3%) were 
born postdates. Twenty five (41.0%) were breast fed. Nine (14.8%) mothers had antibiotics 
during the pregnancy. Twenty four (39.3%) had a family history of UTI.  
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When asked about urine sampling, 18 (29.5%) reported using the clean catch method and 40 
(65.6%) reported using the nappy pad technique. Generally parents found both methods 
straight forward. Parents were asked to give a score from 0-5 with 0= very difficult and 5= 
very easy for how easy it was to use whichever method they used to obtain the urine sample. 
For the clean catch method, the median score was 4 (IQR 3-5), with 14/17 giving a score of > 
3. For the nappy pad method, the median score was 5 (IQR 3-5), with 35/40 giving a score of 
> 3.  
 
Feedback from practice nurses & telephone follow-up experience 
One of the surgeries (PH) dropped out of the study shortly after starting recruitment. The 
practice nurse leading the study was a nurse practitioner. She was attempting to recruit 
children and complete all study procedures in addition to consulting with them as their 
clinician. There was little support or interest from the other clinicians and she was not 
allocated any extra time for the study. In the other three surgeries, the practice nurses leading 
study procedures were not the treating clinician that the child was booked in to see. This 
automatically built in some extra time during which a urine sample was more likely to be 
obtained. It also meant that there was a break in the study procedures for catching up on 
normal workload.  
 
Practice nurses reported that the case report forms (CRFs) took less than five minutes to 
complete, and they became faster once they were more familiar with the questions and the 
study procedures. Urine collection was also easier than they expected, especially using the 
nappy pads. The main challenge was getting parents to return urine specimens if they were 
not obtained in the surgery. All the remaining pilot practices altered their procedures so that 
potential participants were seen by the practice nurse prior to their booked appointment. After 
obtaining consent, the urine sampling procedure could be explained and started straight away. 
Starting the urine sampling as soon as possible increased the likelihood of obtaining a urine 
sample prior to participants leaving the surgery. Thus urine sampling could be underway 
whilst the CRF was completed and whilst participants waited for their booked appointment 
with the clinician. Following their appointment with the clinician, participants would return 
to the practice nurse for retrieval of the urine sample.  
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CRFs and consent forms were returned to the University by fax. A number of problems 
occurred relating to the fax, resulting in changing the procedure part of the way through the 
pilot study. The front page of the CRF (with patient contact details on for telephone follow-
up) and the consent form were faxed and the rest of the CRF was sent by Royal Mail (marked 
private and confidential).  
 
The telephone follow-up interview usually took less than five minutes to complete. All the 
parents contacted were happy to answer all the questions. The main challenge was 
successfully contacting carers. Carers also had some difficulty recalling the duration of 
symptoms.  
 
Discussion 
 
Discussion of main findings 
The pilot study
150
 has shown that it is feasible to recruit children under the age of five from 
primary care and obtain urine samples from them. Parents were generally happy to participate 
and very few were excluded due to study criteria or by the consulting clinician, with 86% of 
those approached ultimately participating in the study.  
 
The practice withdrawing from the study resulted in the pilot study taking longer to recruit 
the children than we had anticipated, however there seemed to be clear reasons for the 
difficulties, and other practices did not struggle to recruit.  
 
There were equal numbers of male and female children in the study. There were more 
participants in the younger age groups than in the older (3-5years) groups. The median age of 
non-participants was similar to that of participants. The numbers of younger children 
participating in the study is most likely to be due to parents consulting more frequently with 
younger children, especially infants. 
 
The rate of obtaining urines (75.8%) and leak rate (4.0%) found in the pilot study can be used 
to inform the sample size for the main study. The prevalence of UTI was found to be 4.2% 
(95% CI 1-18%). The confidence interval is very wide due to the small sample size. A larger 
sample size is needed in order to obtain a more accurate prevalence rate.  
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None of the three children found to have a UTI were suspected of UTI by the GP. All three 
had been given alternative diagnoses. The numbers in this pilot study were small. However, 
the finding of UTI in children thought to have an alternative cause of illness has been 
demonstrated in other studies.
48 68 83 85 164
  
 
Telephone interviews were only successfully completed in 61.6%. This was despite 
numerous attempts to contact all parents. Sometimes the telephone numbers were incorrect, 
but more often there were no responses to telephone calls, despite calling at different times of 
day, and often more than five attempts. When I was successful, the parents were happy to 
answer the questions and the interviews were completed quickly. When numerous attempts 
were needed, it was a time consuming part of the study. It was difficult to know whether to 
leave messages or when to stop trying to contact parents. Generally when I left messages 
there was no return call (although on one occasion a parent did return my call). I did not want 
to repeatedly try to contact parents or appear to be putting pressure on them to respond. Also 
as the time since the initial consultation passed, the parents memory of their childs illness 
would be getting worse.   
 
Parents generally reported that obtaining urine samples was straight forward using both 
methods. However, those using the nappy pads reported this as being easier than those using 
the clean catch method. Practice nurses also found that the urine sampling was 
straightforward and easier than they had expected.  
 
Changes to pilot study protocol and study documents 
The experience of conducting the pilot study, and the results and feedback from participating 
nurses, informed the proposed study protocol and documents for the larger study. These are 
summarised in Table 3.4. 
 
The feedback from the surgery which dropped out was useful in determining how to approach 
practices for the larger study.  It was felt that a smaller number of enthusiastic surgeries with 
sufficient nursing capacity would be more effective at recruiting than a larger number of less 
engaged practices or those with lower nursing capacity. It also highlighted the importance of 
emphasising to practices the need to ensure practice nurses completing study procedures had 
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the time and support to do this. Therefore larger practices, with two or more nurses were 
initially approached about the larger study.  
 
Obtaining urine samples from as many of the participants as possible is of paramount 
importance for an accurate prevalence rate. For the pilot study practices were paid £50 for 
every child recruited to the study irrespective of whether a urine sample was obtained or not. 
For the larger study, a reimbursement strategy which reflected the importance and additional 
time required to obtain a sample may improve the urine sample rate, perhaps with separate 
fees for enrolment and completion of the urine sample.  
 
The feedback from the nurses that the CRF was quick to complete, coupled with the low rate 
of completed telephone follow-up interviews led to a significant change in the protocol. Any 
data needed from all participants would be collected on the CRF, and information only 
needed on those with a UTI (or borderline result) would be collected by telephone follow-up. 
This would greatly reduce the workload related to the telephone interviews, would allow 
more in-depth questions relating to a positive UTI to be asked only of those to whom it was 
relevant, and would ensure that data needed on all participants were collected systematically. 
In addition, due to the difficulty some carers were having recalling symptom duration at the 
telephone follow-up, and as the median duration of symptoms was seven days, it was decided 
that the telephone follow-up interview in the larger study should be conducted at two weeks 
rather than three. I also decided that a telephone follow up interview should not be conducted 
more than four weeks after the initial consultation. 
 
The questions on the pilot study CRF asking the parents how sick they felt their child was 
and how concerned they were about the current illness were felt by practice nurses to be 
cumbersome and some reported finding that it was confusing as to how they should be 
completed. Analysis of these scores was also difficult. This was simplified for the larger 
study: a five point score instead of 11; clearly defined boxes to tick rather than a line with 
numbers; and only one question to carers asking how unwell they feel that their child is. One 
of the reasons for including this in the CRF was to see how the parents overall impression 
compared with the GPs overall impression and so the CRF was changed so that the parents 
and GPs both had the same scoring boxes to complete.  
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The pilot study has showed that it is feasible to recruit children and obtain urine samples from 
primary care. Showing this enabled us to secure funding to conduct a large cohort study. The 
experience of conducting the pilot study and feedback from participating practices informed 
the development of the protocol and study documents for the larger study.  
 
Table 3.4: Summary of changes made for the main study following the pilot study 
Pilot study Change for main study 
Assessment of  surgery with low recruitment 
which dropped out (nurse practitioner 
attempting study procedures within acute 
clinic) 
Target surgeries with sufficient nursing capacity to 
have a practice nurse completing study procedures. 
Urine samples obtained in 76% of recruited 
children 
Reimbursement strategy for practices to be linked 
with obtaining a urine sample 
Only 62% telephone follow-up interviews 
completed 
Collect data required from all participants on the 
initial CRF. Target telephone follow-up only to those 
with positive or borderline culture results where more 
detailed early follow-up data is required 
Parents having difficulty remembering 
symptoms at telephone follow-up interview 
Conduct the telephone follow-up interview at two 
weeks rather than three weeks 
Parents having difficulty with the illness 
scores.  
Simplified to one score rather than two. Changed to a 
five point scale rather than 11, with clear boxes to 
tick. 
 
The published article from this pilot study is included in Appendix A.1. 
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Chapter 4: Method 
 
Study design  
 
This was a prospective, observational, cross-sectional point prevalence, and cohort study. The 
main aim of the research was to determine the prevalence of UTI in young children 
presenting in primary care with an acute illness.  
 
In order to determine whether a child had a UTI or not, a urine sample was needed from all 
participants. In a prevalence study, the determination of UTI status needs to be independent 
of whether clinicians suspected UTI or not, therefore urine samples needed to be requested 
from all children. I therefore needed a cohort of acutely ill children recruited with 
systematically collected urine samples to determine the point prevalence of UTI.  
 
I was also interested in the clinical outcomes for those found to have a UTI and wanted to 
compare the outcomes of children with UTI to those with borderline or negative cultures. 
Therefore, follow-up data collection was necessary. 
 
Setting 
Determining the prevalence of UTI among consulting acutely ill children is important to help 
GPs to manage these children appropriately. GPs need to know which ill children should 
have their urine sampled or whether UTI is prevalent enough to justify a universal sampling 
strategy in all children. In order to determine this, we need to know the prevalence of UTI in 
that population. For my study, it was therefore important to recruit children typical of those 
seen every day by primary care clinicians, which meant recruiting children from primary care 
as they consulted with an acute illness.  
 
Funding 
The study was awarded funding by The Welsh Office of Research and Development 
(WORD) with a Welsh Assembly Government /Medical Research Council Health Research 
Partnership Award for £139,897 with up to an additional £72,058 in service support costs 
(Project reference: H07-3-008; see Appendix 4.1). 
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Ethical approval 
The study was approved by the South East Wales Research Ethics Committee Panel C 
(reference number: 08/WSE03/11). Several amendments were approved to extend the 
recruitment period and to use posters in the practices to aid recruitment (Appendix 4.2). 
 
Other approvals 
Cardiff University was sponsor for the study. The study was approved by the R&D offices of 
all the LHBs and Trusts involved in the study. The study was included on the UKCRN 
Clinical studies portfolio. The South East Wales Trials Unit (SEWTU) supported the study 
and provided administrative support. 
 
Study name and logo 
I wanted a study acronym and logo to help practices to remember the study. I called the study 
EURICA: The epidemiology of urinary tract infections in children with acute illness in 
primary care. I discussed logo ideas with Jan Sharp in the Medical Illustration department at 
Cardiff University and she designed the first logo, which was inspired by the blocks of colour 
on urinary dipsticks (see Figure 4.1). When I was designing a poster for practices to aid 
recruitment, I felt that we needed a picture and I discussed ideas with Jan in medical 
illustration again. I asked if she could design a picture of a person as if it had been drawn by a 
child, perhaps juggling the EURICA blocks. She designed the logo Eddie in Figure 4.2. 
 
Figure 4.1: The EURICA study logo 
 
 
Figure 4.2: The second EURICA study logo 
 
 
 
I used both logos on the posters and recruitment updates and letters to practices. 
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Sample size calculation 
I calculated that a sample size of 1100 would give a 95% confidence interval of +/- 1% 
around a prevalence rate of 3%.
148
 In the pilot study (n=99), urine samples were obtained in 
75 (75.8%) but a laboratory result was only available in 71(71.7%). Urine samples leaked or 
were lost in transit in 4 (5.3%). If a laboratory result is only available in 72% of recruited 
children, a sample size of 1528 recruited children would be needed to give a sample size of 
1100 children with urine results. Therefore I aimed to recruit 1600 children. The sample size 
calculation was not adjusted to allow for clustering by practices and there was no calculation 
to determine number of practices which should be recruited.  
 
Recruitment 
Recruitment period 
The WORD grant funding was from 1
st
 April 2008  31
st
 March 2010. However, due to 
recruitment problems, the recruitment period was extended until August 2010; with follow-up 
until February 2011 (approvals to extend the study time were given by WORD and the Ethics 
committee).  
 
Practice selection 
Several key decisions needed to be made before deciding which practices to approach to take 
part in the study: 
 
1) Were urine samples going to be analysed by the local laboratory which usually 
analysed samples for the practice or were all urine samples going to be analysed by a central 
(research) laboratory? 
2) How were urine samples going to be transported to the laboratory? 
3) How were clinicians going to receive laboratory results and act on them? 
 
Laboratory choice 
The advantage of using local laboratories would be that the practices normal transport could 
be used, and results would be returned to clinicians as usual, in a format that they were 
familiar with. The disadvantage would be that different laboratories may have had different 
procedures for analysis and reporting urine samples, which would introduce variation into the 
results. Using one central laboratory would reduce the chance of laboratory variation, 
however transport would be more difficult; practices would have to deal with a procedure 
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which was different from normal; and clinicians would receive results in a format which they 
were not familiar with and may have difficulties with interpretation.  
 
For these reasons, I decided that we should use the local NHS laboratories for the study. 
Initially, the best option seemed to be to recruit practices from one area which used the same 
local laboratory. This strategy would keep research procedures as close to normal practice 
procedure as possible, but would not introduce the problems associated with using different 
laboratories. I decided to target practices in the Cardiff and Vale area. 
 
Unfortunately, only nine practices in Cardiff and the Vale agreed to take part in the study. 
Recruitment of children was slower than expected. Therefore I had to extend recruitment into 
other parts of Wales, despite the potential problem of using different laboratories. 
Laboratories in Rhondda Cynon Taf (RCT), Rhyl and Haverfordwest agreed to take part. 
Once the laboratories had agreed to take part I could approach practices. 
 
Transport of urine samples to laboratory 
Having decided to use the local NHS laboratories meant that the normal surgery transport of 
clinical specimens could be used. In addition to reducing costs and minimising new 
procedures for practices which may have hindered recruitment, I felt that using routine NHS 
processes strengthened the study design. The estimate of UTI prevalence from my study 
would be based on urine sampling and analysis as it occurred in routine general practice and 
my study findings would be directly applicable to current every day general practice.  
   
Urine samples were usually collected by NHS (National Health Service) transport at 
approximately midday. As is normal practice, the transport vehicle may have collected 
samples from other practices too and so transport of samples from the practice to the 
laboratory may have taken a few hours. There was no refrigeration of samples during 
transport.  
 
Receipt of NHS laboratory results by clinicians 
It was essential that the results of any urine samples were seen by the clinicians who were 
responsible for assessing and treating the child. I emphasised to everyone participating in the 
study that the clinical management of the child rested entirely with the treating clinician. The 
researchers would only receive a copy of the urine sample results and would not inform 
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participants of the result or advise on management. Using the normal microbiology forms 
ensured that the result would be made available to practices in the standard way (usually 
electronically).  
 
After discussion with microbiologists, initially at Cardiff and Vale (Dr Howe), but 
subsequently with those at all the laboratories taking part, we agreed that urine samples in the 
study would be processed in the normal way, using standard containers and forms, with 
results sent to practices. A copy of the result would also be sent to me in the research office. 
So that laboratory scientists processing urine samples would know to do this, study samples 
would be labelled with a red EURICA sticker. 
 
Practice selection 
Initially I targeted practices in the Cardiff and Vale area with two or more GP partners or two 
or more practice nurses. Although ideally a random sample of practices would be recruited, 
following my experience with the pilot study, I felt that the study was probably not feasible 
for small practices with fewer resources. Unfortunately there were not enough interested 
practices among this group of practices and so I subsequently invited all the practices in 
Cardiff and Vale to participate, and later other practices in other areas.  
 
Practices were initially sent a letter (Appendix 4.3). This was followed up with a telephone 
call to the practice manager. If practices were interested I visited the practice to explain the 
study in more detail. Often, this initial visit was to a practice meeting, which sometimes 
consisted of all the doctors, nurses and administrative staff, and sometimes just one or two 
nurses and doctors. Not all of the practices which initially expressed an interest or who 
requested a visit, ultimately agreed to participate in the study.  
 
Recruitment of practices 
 
Two changes in the NHS had a significant impact on recruitment of practices: 
 
1) Until April 2009, for each practice which agreed to participate in the research study, a 
site specific information (SSI) form had to be submitted to the Ethics committee so 
that they could approve the practice for the study. Although this required information 
from the practice and a Curriculum Vitae (CV) for the lead GP, it generally only took 
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approximately two weeks for the ethics committee to approve the practice for the 
study once they had received the paperwork.  
 
From April 2009, a new process was initiated called SPARC (Streamlined NHS 
Permissions Approach to Research Cymru). Although this process was set up to 
improve both the quality and efficiency of Research and Development (R&D) 
approval processes, it complicated the process of obtaining approvals for subsequent 
practices for my study. Where SSI approvals had previously taken a couple of weeks, 
the process took many months. As responsibility for the SSI approvals moved from 
the ethics committee to the local health boards, it is difficult to determine to what 
extent the delays encountered were due to SPARC and to what extent they were due 
to the NHS restructuring which occurred in October 2009 (below).  
 
2) In October 2009, there was a major restructuring of the NHS in Wales. Until this 
point there had been 22 Local Health Boards (LHBs; covering primary care) and 
seven Hospital Trusts (secondary care). From October 2009, these merged, with a 
resultant seven LHBs which covered both primary and secondary care services for 
each area, with three overarching NHS Trusts. 
 
SSI approvals had to be obtained from LHBs instead of the ethics committee from 
April 2009 onwards. Unfortunately, LHBs were in a state of re-organisation and 
uncertainty. Table 4.1 shows a summary of procedures before and after the changes of 
April and October 2009. 
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Table 4.1: R&D approval procedures before and after the changes in April and October 
2009 
 
Approvals 
for: 
Old system: before April 
2009 
New system: after April 
2009 but before Oct 2009 
New system: Oct 
2009 
Practices to 
participate 
1) Apply to primary care 
LHB directly to conduct 
research in practices in 
their area (1-3 months) 
 
2) SSI approval for 
individual practices from 
the Ethics committee (1-2 
weeks) 
1) Apply to SPARC for each 
practice and primary care 
LHB
*
  
 
2) Apply to each primary care 
LHB
*
  directly  
 
 
Apply to SPARC 
for each LHB/Trust
*
  
and for practice 
specific approvals 
Laboratories 
to participate 
Apply to hospital NHS 
trust directly (1-3 months) 
1) Apply to SPARC for each 
hospital NHS Trust
*
 
 
2) Apply to hospital NHS 
Trust
*
  directly  
* 
The primary care LHBs and hospital NHS Trusts were replaced in October 2009 with a smaller number of 
LHBs covering both primary and secondary care 
 
Approval for the first surgeries to participate in the study prior to these two changes was 
relatively straight forward. However, after April 2009, approval for further practices to take 
part in the study took 10 months. Two surgeries in Rhyl and five surgeries in Haverfordwest 
had agreed to participate in the study. Unfortunately, all but two of these practices withdrew 
their agreement to participate during this process.  
 
CRC-Cymru 
The Clinical Research Collaboration in Wales (CRC-Cymru; now NISCHR-CRC) agreed to 
support recruitment for my study.
165 166
 CRC-Cymru was funded by the Welsh Office of 
Research and Development (WORD) to support research.  
 
Research officers from CRC-Cymru helped with recruitment of practices, distribution of 
equipment, collection of CRFs and consent forms, occasional practice visits and in some 
practices, recruitment of children and data collection. There were initially two research 
officers involved in my study (based in Cardiff), but later representatives in West and North 
Wales were also involved.  
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Training practices 
Once a practice had been approved to participate in the study, I visited the practice to train 
them in study procedures and to provide study documents and equipment. A research officer 
from CRC-Cymru would accompany me when possible.  
 
The minimum attendance I required from practices for training was from the lead GP and the 
practice nurse who would be taking consent and collecting data. I described the study 
procedures and discussed any questions or queries. I provided a summary of processes for the 
study documents and urine samples (see Appendix 4.4) and a copy of the summary of the 
NICE guideline.
1
  
  
I emphasised: 
· The informed consent procedure. 
· The broad inclusion criteria. 
· The importance of obtaining urine samples on all children. 
· The two methods for obtaining urine samples. 
· The observational nature of the research study. 
· The clinical responsibility for management of the child remaining with the GP.  
· Labelling of urine samples with the red EURICA study label in addition to the childs 
identification label but otherwise using the normal procedures for urine samples. 
· Completion of a recruitment log to include children who were approached or eligible 
for the study but not recruited (Appendix 4.5) 
 
Informed consent 
Parents or carers were provided with an introductory letter (Appendix 4.6) and patient 
information leaflet (Appendix 4.7). They were given time both to read them and ask 
questions, and asked to sign the consent form (Appendix 4.8) if they were happy to 
participate in the study. All the documents were approved by the Ethics committee.  
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Payments 
Practice payments 
Practices were reimbursed for the time taken to complete study procedures and obtain a urine 
sample using service support costs. They were paid £30 for every child recruited with a 
consent form and CRF and an additional £15 for every urine sample obtained.  
 
Laboratory payments 
Laboratories were paid £5 for every urine sample analysed using service support costs. 
 
Inclusion and exclusion criteria 
The inclusion and exclusion criteria were clearly stated on the patient registration form (see 
Appendix 4.9). Children were only included if:  
· They were less than five years old and  
· They had an acute illness with a duration of 28 days or less and 
· They had not already been included in the study (those who had participated in the 
pilot study were eligible for the main study) and 
· The parent or carer provided written, informed consent. 
 
Children were excluded if: 
· They were taking regular long-term antibiotics (daily for the past 28 days or more) or  
· They were currently having chemotherapy or  
· They were currently taking oral prednisolone of 10mg or more daily (or equivalent) 
for the past 2 weeks or longer (taking inhaled steroids was not an exclusion criterion). 
 
In the pilot study, one of the exclusion criteria was radiological evidence of urinary tract 
abnormalities (including antenatal scans). For the main study, I wanted to make the 
recruitment as straight forward as possible, and keep exclusion criteria to a minimum, so that 
practices would recruit the majority of children. Following discussions with my supervisors, 
we felt that there would be relatively small numbers of children who would have known 
urinary tract abnormalities and we felt that it would be informative to collect data for these 
children, and if there were sufficient numbers, to determine if children with antenatal urinary 
tract abnormalities were more at risk of UTI or not. This group of children was therefore not 
excluded from the main study. 
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I discussed the inclusion and exclusion criteria with my supervisors and we felt that children 
taking long-term antibiotics, oral steroids or who were currently receiving chemotherapy 
were likely to have a higher risk of infection and were likely to be treated differently by GPs. 
Therefore these children were excluded from the study. Excluding children on long-term 
antibiotics would also exclude children being treated for recurrent UTI. Children with 
diabetes, or other medical conditions or family history, or who were taking other medication 
were not excluded from the study, but these data were collected on the CRF. 
 
Children were excluded if they had already participated in the study in order to keep the 
analysis straight forward. In some ways this was unfortunate, as children tend to consult 
several times a year with different illness episodes
44
 and I was interested in what proportion 
of acute illness consultations were due to UTIs, and so ideally would have liked to have 
included children each time they consulted. However, this would have made the statistical 
analysis more complicated. The data collected from a child who has already been included in 
the study are not independent from the data collected from the same child during a previous 
episode. Therefore the data from children included more than once would need to be analysed 
differently. It would also mean that a larger sample size would be needed (to allow for intra-
cluster correlation) for the same confidence interval, depending on how many children were 
included more than once.   
 
Data collection 
Case Record Form (CRF) 
 
I designed the CRF in three sections (Appendix 4.9 - 4.11). The CRF was designed using 
Teleform (version 10.4.1). Teleform is a package which allows data from scanned documents 
to be entered directly into a database. 
 
Section 1 was the registration form with contact details (Appendix 4.9). This was printed on 
white paper and a copy of this was faxed by practices via the confidential fax line to the 
research office along with the consent form once the child had been recruited to the study. 
Section 2 was printed on yellow paper and was completed by the practice or research nurses 
(Appendix 4.10). Section 3 was printed on orange paper and completed by the treating 
clinician (Appendix 4.11). Sections 2 and 3 were kept by the practice and collected once per 
month by CRC-Cymru research officers. The CRFs were scanned and checked using 
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Teleform with the help of administrative staff. Administrative staff checked that the software 
had scanned data in correctly and produced a record of queries and discrepancies which I 
then checked against the raw data. Queries and decision rules concerning data cleaning were 
discussed with Professor Hood. The data were then exported into SPSS for further data 
cleaning and analysis.  
 
Symptoms and signs 
The symptoms listed were similar to those used in the CRF for the pilot study (Appendix 
3.2). Following discussions with the nurses involved in the pilot study, I merged the variables 
not playing well with low energy/tired,  and I merged clinginess and needing extra care 
as they felt that these variables were measuring the same symptom. I split constipation into 
constipation now and constipation in the past for clarity, and I added sore throat as this 
was a common symptom which I had missed out on the pilot study CRF. I added blood in 
the urine and poor urine flow as haematuria and dysfunctional voiding were listed as 
possible presenting symptoms of UTI in the NICE guideline.
1
 I grouped symptoms into four 
parts on the CRF to make it easier to read. 
 
A five point score (0-4) was used for parental and GP illness scores, rather than the 11 point 
score which had been used in the pilot study. This was to simplify the scoring, limit the time 
needed to complete the CRF and to simplify the analysis.  
 
Background information and risk factors 
I wanted to collect information on all clinical factors potentially useful for ruling UTI in or 
out (see Table 4.3 below). The difficulty was to balance collecting as much information as 
possible whilst not making the CRF too long and time consuming to complete. 
 
Examination findings 
Nurses were asked to record temperature, pulse rate and respiratory rate in section 2 of the 
CRF. Practices were all provided with an infra-red ear thermometer. GPs were asked to 
record their examination findings in section 3 of the CRF.  
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Tables 4.2-4.5 summarise the symptoms, examination findings, potential risk factors and 
management recorded on CRFs. 
 
Table 4.2: Symptoms recorded on CRF (as Yes/No variables) 
 
Runny or blocked 
nose 
Irritable/grouchy Poor feeding/appetite Bed wetting/clothes wet 
when previously dry Clinginess/needing 
extra care 
Diarrhoea 
Sore throat Constipation now Smelly urine 
Earache/holding ear Low energy/tired/lost 
interest in playing 
Constipation in the past Dark or cloudy urine 
Cough Vomiting Pain/crying on passing urine 
Difficulty breathing Poorer sleep Nausea Blood in urine 
Hot/feverish Muscle aches/pains Abdominal pain Poor urine flow 
Rash Poor weight 
gain/weight loss 
Colic/grimacing Increased urinary 
frequency/no. wet nappies   
  
Table 4.3: Other background information recorded on CRF from parents 
 
Highest temperature  measured prior to GP visit 
How unwell do they feel their child is (0-4)? 
Has the child had paracetamol for this illness? 
Has the child had ibuprofen for this illness? 
Past history of UTI 
Past history of asthma 
Past history of diabetes 
Past history of eczema 
Past history of high blood pressure 
Past history of kidney or bladder disease 
Has the child had illnesses in the past with a high temperature but no obvious cause? 
How many weeks did the pregnancy last? 
Was the child breast fed? 
Were any antibiotics taken during the pregnancy? 
Were there any abnormalities of the childs kidneys, bladder or ureters on antenatal ultrasound? 
(For boys) Has the child been circumcised? 
Family history of UTI during childhood 
Family history of kidney or bladder problems 
 
Table 4.4: Examination findings recorded on CRF 
Temperature Ear examination Rash 
Pulse rate Throat examination Dehydration 
Respiratory rate Chest examination Jaundice 
Urine dipstick results Abdomen examination Spinal lesion 
  Fontanelles 
 
Table 4.5: GP impression and management 
How ill do they feel child is (0-4)? Same day hospital referral 
Working diagnosis Hospital referral but not same day 
Any medication prescribed  
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Once practice nurses had obtained consent and completed Sections 1 and 2 of the CRF, the 
child was seen by the GP who examined and treated the child according to their normal 
clinical practice and then completed Section 3 of the CRF.  
 
Urine sampling 
 
Obtaining a urine sample 
Obtaining the urine sample was the most important aspect of the research study. Once 
consent had been obtained, but usually before the CRF was completed, nurses explained to 
parents how to obtain a urine sample. There were two methods of obtaining a urine sample 
(see section below). If a nappy pad was to be used this was inserted as soon as possible after 
consent, to increase the likelihood of obtaining a urine sample before the child left the 
practice. Potties, with sterile bowls inserted, were provided to practices to help obtain clean 
catch samples in older children. The aim was to obtain the urine sample whilst the child and 
parent were going through the process of study data collection and whilst waiting to see the 
GP. After the child had been seen by the GP, they could be seen again by the practice nurse 
to retrieve the nappy pad or clean catch urine sample.  
 
The urine sample was tested with a urinary dipstick and recorded in Section 2 of the CRF. 
The sample container and microbiology form was labelled with the childs personal details as 
normal, but in addition a red EURICA label was added to the sample container and to the 
microbiology form. It was then taken to the laboratory using the practices usual transport. If 
the urine sample was obtained in the afternoon (after the sample collection time), practices 
were asked to store the urine sample in the fridge overnight as recommended by guidelines.
1
  
 
Children were not recruited after the last sample collection on a Friday due to the long delay 
which would have occurred between obtaining a urine sample on Friday afternoon and 
transport to the laboratory on the following Monday. 
 
Urine sampling method 
NICE have recommended that the clean catch urine collection method is used as first choice, 
but that nappy pads are a suitable alternative if clean catch is not feasible.
1
 In the pilot study, 
parents using both methods of urine sampling (nappy pad and clean catch) had reported that 
they were straightforward and easy to use. The practices were supplied with the equipment 
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needed for both methods. This included a sterile plastic bowl (for clean catch) and the 
Newcastle collection pads.  
 
The Newcastle collection pads came in a packet containing two pads and a syringe. The 
nurses and parents were advised to check the pads every 10 minutes to see if urine was 
present. If the pads were soiled, the child needed to be cleaned and a fresh pad used. The 
syringe was provided to extract the urine from the pad. However, when I discussed the 
method with the nurses following the pilot study they described this as very difficult. Instead, 
they had been squeezing the urine out of the nappy pad. At this time I could not find any 
literature suggesting that this was or was not acceptable. I discussed the matter with one of 
the microbiologists (Dr Howe). I was particularly concerned that fibres from the pads might 
interfere with the analysis but it did not appear to be a problem. Since then, the HPA 
Standards for Microbiology report has been published.
89
 In this, they comment on the use of 
nappy pads and the syringe to extract the urine and state, if difficulty is experienced in 
withdrawing urine, the wet fibres may be inserted into the syringe barrel and the urine 
squeezed directly into the container with the syringe plunger. 
 
I also provided practices with leaflets describing how to collect the urine using each method 
which they could give to parents (Appendix 4.12). These were developed for a previous 
research study and I obtained permission from the authors to use these.
46
  
 
Urine containers 
During the pilot study I had been surprised at the number of urine samples which were 
reported as leaked in transit. If the urine sample leaked into the bag on the way to the 
laboratory, it could not be analysed. In the pilot study, 4% of urine samples leaked. At the 
beginning of the main study, there seemed to be even higher numbers of urine samples 
leaking in transit. I discussed this problem with Dr Howe and he advised me that some urine 
sample containers (white top universal containers) were more prone to leaking than others 
and that the NHS had started to use cheaper containers in recent years which were more 
prone to leaking. He recommended a slightly more expensive white topped universal 
container which I provided to practices to try to reduce the problem. Some laboratories 
required different types of urine collection containers (e.g. red topped boric acid containers) 
which they provided to practices. 
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Laboratory results 
The NHS laboratory results were sent to GPs in the normal way. GPs managed children 
according to their normal clinical practice. Advice for GPs, if they required it, on the 
management of children or interpretation of urine culture results, was available for the 
duration of the study from a consultant paediatric nephrologist, Dr Judith van der Voort.  
 
A copy of the result was sent to me by laboratories using Royal Mail. Results were entered 
into an Access database by Mandy Iles (research administrator). I checked the accuracy of 
data entry for urine results in 10% of cases. Data entry was accurate for the majority of 
results. However, I found that there were some errors and missing information for some of 
those with positive or borderline results and so I double checked the data entry for all cases 
with positive or borderline results.  
 
Follow-up 
For any children with positive or borderline urine results, I aimed to complete a telephone 
follow-up interview at two weeks after the index consultation, and no more than 4 weeks 
following the index consultation. 
 
I entered the data from the telephone follow-up interviews directly into the Access database. 
The data collected are shown in Table 4.6 and Appendix 4.13. 
 
Table 4.6: Data collected at 2 week telephone follow-up 
 
· Has the child completely recovered? 
· How many days did the illness last? 
· Has the child been admitted to hospital? 
· Has the child been admitted to hospital? 
· Has the child seen the GP, nurse, A+E, OOH since the initial consultation? 
· Has there been any contact with NHS Direct, a pharmacist or a specialist? 
· What method was used to obtain a urine sample? 
· How easy (0-5: 0=difficult- 5=easy) was it to obtain a urine sample in this way? 
· How many other children live in the house? 
· Has anyone else in the house had illnesses or antibiotics in the past 3 months? 
· Does anyone living in the house work in a hospital, nursing/residential home, GP surgery, 
school or other medical/child care facility? 
· Does the child attend school, nursery, day care, breakfast club or have a child minder? 
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I made at least three attempts to contact parents at different times of the day. If the telephone 
number did not work or I had the wrong number I contacted practices to see if they had any 
other telephone numbers listed for the child or their parents. 
 
6 month follow-up 
All children from whom a urine sample had been obtained were targeted for the six month 
notes review follow-up. This was a single page form and practices were paid £10 for each 
follow-up form which they completed (Appendix 4.14). Table 4.7 shows the data which were 
collected on these forms. 
 
Table 4.7: Data collected at 6 month notes follow-up 
 
Number of GP re-consultations Any hospital referrals 
Number of acute hospital admissions Any investigations of the urinary tract (or 
referrals for these) 
Number of OOH/A&E contacts Ultrasound scan 
Number of courses of oral antibiotics DMSA scan 
Number of urine samples MCUG scan 
 
 
Outcome measures 
 
Primary outcome measure 
The primary outcome measure was the prevalence of UTI, defined as pure or predominant 
bacterial growth of >10
5
 colony forming units (cfu)/ml of urine on NHS laboratory culture. 
 
Secondary outcome measures  
· Symptoms, examination findings and risk factors at presentation and predictive values  
· GP working diagnosis and management and comparison between UTI and non-UTI 
groups 
· Near-patient urinary dipstick results and predictive values 
· Duration of illness with comparison between UTI and non-UTI groups 
· Re-consultation, hospital admission rates and courses of oral antibiotics for six 
months after recruitment with comparison between UTI and non-UTI groups 
· Hospital referral and imaging of the urinary tract for six months after recruitment with 
comparison between UTI and non-UTI groups.  
 96 
 
Data cleaning 
 
The CRF and six month follow up data from Teleform were combined with the laboratory 
urine results and telephone follow up data from Access. Data were checked, cleaned, 
anonymised and analysed using SPSS version 16.  
 
I kept a log of data cleaning and changes which I made (Appendix 4.15) and decision rules 
which were agreed on with one of my supervisors (Professor Hood; Appendix 4.16).  
 
During the data cleaning process, I checked individual variables for missing data and unusual 
values. I looked at the data range for continuous and date variables, searching for outlying 
values.  
 
Missing information 
For most questions in the CRF, where questions required a Yes or No response, missing 
information was re-categorised as No for the analyses. Responses of not applicable and 
dont know were also analysed as a No response. I was interested to know whether there 
was an association of a Yes response with UTI, for each variable, compared with not having 
a Yes response. For the same reason, abnormal examination findings by the GP were 
compared with those from whom abnormal findings were either not reported on the CRF or if 
this information was missing.  
 
For variables such as highest temperature recorded by the parent/carer or for the illness 
severity scores (parents and GPs), missing information remained as missing information and 
the analysis was only conducted on those in whom it had been completed. In the case of the 
GPs working diagnosis, I considered missing information as a response in its own right, as 
GPs may have left this response out if they were unsure of the diagnosis.  
 
Grouping variables 
I grouped children according to age, with the same age-ranges used in the NICE guidelines.
1
 I 
used a threshold of 38
o
C to create a binary variable for temperature as this is used by most 
previous studies to define fever.
 45 58-62 66 68-70 72 82 99-102 129 130
 For some categorical variables 
(for example: working diagnosis, number of courses of antibiotics at follow up), the groups 
were too small for statistical tests and in these cases I grouped some categories together. For 
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each case where I have done this, I have described which categories I have grouped together 
and provide justification for this in the results chapter. 
 
I only included children who had provided a urine sample within two days of the initial 
recruitment (index) consultation. I calculated this based on the date of consultation and 
consent on the CRF and the date of the urine sample. I wanted to ensure that the urine sample 
result related to the presenting symptoms and signs of the acute illness at the index 
consultation. 
 
Statistical analysis  
 
I calculated the prevalence and associated confidence intervals using Wilsons method, which 
is a method most appropriate for small proportions as advised in Newcombes paper.
148
  
 
For the analysis of binary variables, I used Chi-square (!
2
) tests to look for association of 
variables with UTI. Where the numbers were too small to use !
2 
tests I used Fisher Exact 
tests. For associations between UTI and ordinal variables with more than two categories, Chi-
square tests were used (not Chi-square test for trend).   
 
For the continuous variables (pulse rate, respiratory rate and temperature) I plotted 
histograms to determine whether they were normally distributed. For those which were 
normally distributed I presented mean, standard deviation and used the t-test to compare 
groups. For those which were not normally distributed I calculated median, inter-quartile 
range and used the Mann-Whitney U test to compare groups.  
 
Throughout my thesis, I have presented p-values to two decimal places and all other figures 
to one decimal place. 
 
Multilevel modelling 
I explored the impact of my two level sampling (practices and patients) using the intra-class 
coefficient (ICC). This estimated the proportion of variability in the prevalence which was 
attributable to the sampling of practices rather than variation due to sampling of children 
within practices. This is explained further in the results chapter. The two-level sampling 
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appeared to result in only a small amount of clustering. Therefore, I used single level 
multivariable analysis techniques. 
 
Multivariable analysis   
I used logistic regression to determine which presenting symptoms and signs were most 
associated with UTI. I used the univariable analyses as a screening tool to determine which 
variables to enter into my logistic regression analysis. Symptoms and signs with a p-value of 
<0.1 on univariable analysis were entered into a forward stepwise logistic regression using 
SPSS. Where there was significant association between individual symptoms using chi-
square tests (e.g. dysuria and urinary frequency), I entered these variables in combination as 
well as individually into the model. I assessed the model fit using the model !
2
 and 
Nagelkerke R
2
 statistics.  
 
I calculated the probability of UTI for all combinations of the variables in the model using the 
equation for the logistic regression:  
 
p (Y) = 1/1 + e
- (-b0+biX1i+b2X2i++bnXni)
  
 
Where p(Y) is the probability of Y occurring (in this case UTI); e is the base of natural 
logarithms, and bn is the regression coefficient of the corresponding variable Xn.
167
  
 
I used these probabilities and their associated confidence intervals to propose a urine 
sampling strategy for GPs. I compared urine sampling using my proposed sampling strategy 
with sampling based on GP suspicion and sampling based on NICE guidelines. 
 
If any of the features listed in the table of presenting symptoms and signs in the NICE 
guideline (see Results chapter, Figure 5.9)
1
 were present for that child, I assumed that a urine 
sample should have been taken in that child, unless there was evidence of an alternative site 
of infection. I determined whether there was evidence of an alternative site of infection from 
the GP working diagnosis. If the working diagnosis was listed as upper respiratory tract 
infection (URTI), lower respiratory tract infection (LRTI), tonsillitis, gastroenteritis, 
conjunctivitis or otitis, I considered there to be an alternative site of infection present.  
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GPs were deemed to have suspected UTI if UTI was mentioned at all in the working 
diagnosis question of the CRF.  
 
Sources of bias 
 
During the design of the study, I was aware of the importance of minimising the chance of 
bias, particularly selection bias. The main problem with many of the published studies 
concerning UTI in children was the inclusion of children only if the child had been suspected 
of having UTI by the clinician. The study population would therefore be different from the 
target population, biased towards children who were suspected of having UTI by the 
clinician. This may have resulted in biased associations with presenting symptoms and signs. 
I tried to minimise the risk of this happening in my study by asking surgeries to recruit (all) 
sequentially ill children and obtain urine samples on all of them, irrespective of their 
presenting symptoms and signs or level of UTI suspicion. I also arranged for reimbursement 
for surgeries to be split so that some of the money would not be reimbursed unless a urine 
sample was obtained. This was in part to reflect the added time and effort required to obtain a 
urine sample but also to encourage urine sampling on all children and to hopefully minimise 
selection bias by GPs and nurses.  
 
I was aware that seriously ill children who were admitted acutely to hospital were less likely 
to be recruited, as neither clinicians nor parents would want to delay admission to hospital 
because of study procedures. I tried to address this by encouraging practices to request 
consent for the study but no other study procedures, if possible prior to admission. My main 
outcome measure was UTI prevalence and the CRF only addressed secondary study 
objectives. A urine sample would most likely be obtained at the hospital and I could find out 
the culture result through the hospital if I had consent for the study and follow-up procedures. 
 
I also considered attrition bias in my study design. This was potentially relevant for the 
clinical outcomes measured during follow-up, particularly for the telephone follow-up. I 
asked nurses to check telephone numbers at recruitment. Section 1 of the CRF recorded this 
data. I attempted to contact parents at least three times on different days and different times to 
try to avoid losing them from follow up. 
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Ethical considerations 
 
The main ethical issues affecting my study were informed consent and confidentiality of data. 
Both these aspects of my study were assessed, discussed at the meeting, and approved by the 
Ethics Committee. The Access database which had identifiable data on it was password 
protected, and only accessed by two members of the study team (Amanda Iles (Research 
Administrator) and me). All data were anonymised before transfer to SPSS for analysis. The 
paper CRFs and consent forms were stored in locked filing cabinets in the South East Wales 
Trials Unit (SEWTU).  
 
There was also the potential risk that if more children were identified as having UTI than 
would happen in normal clinical practice, and if some of these results were false positives, 
those children may receive unnecessary antibiotics or unnecessary investigations. I discussed 
this issue with my supervisors and with the ethics committee. According to current 
guidelines, an ill child found to have a positive urine culture would be considered to have a 
UTI and treatment and follow up investigations would be advised. However, we agreed that 
the responsibility for the clinical management of the child would be entirely up to the treating 
clinician. In recognition of this potential difficulty for clinicians, we approached a consultant 
paediatric nephrologist (Dr Judith van der Voort) who agreed to be available to provide 
advice for clinicians for the duration of the study. 
 
I used the STROBE guidelines and checklist to inform my approach for reporting my 
findings (Appendix 4.17).
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Representativeness of sample 
 
I have sought a sample of children which is representative of the larger population of children 
presenting in UK general practice with an acute illness. I will be drawing conclusions about 
all acutely ill children aged less than five years presenting to the GP in the UK with an acute 
illness (target population) based on my findings in the sample of children which was included 
in this study (sample). It is therefore important to be confident that the sample is 
representative of the sampled population, or if not, to be able to describe and understand any 
bias; and that the sampled population is representative of the target population. 
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In this chapter I have described how, during the design of the study and development of the 
study protocol, I tried to ensure the resultant sample would be representative of the target 
population and minimise selection bias. 
 
In the Results chapter, I will describe the sample and compare it to the sampled population 
and I will also describe the sampled population and compare this to the target population. I 
will consider to what extent selection bias may have occurred and what impact the multi-level 
sampling method may have had.  
 
In the Discussion, I will consider to what extent my results can be generalised to the target 
population.  
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Chapter 5: Results 
 
In this chapter I will present results for the main and secondary outcomes (the prevalence of 
UTI; the sensitivity and predictive values of clinical features and point of care dipsticks in 
predicting UTI; and the clinical outcomes for children with UTI). I will also describe the 
development of a clinical decision aid for GPs. However, before I present these findings, I 
will consider the representativeness of my study sample (practices and children). 
 
Sample 
 
Description of sample  
I obtained a sample of children in a two stage sampling procedure: 
1) Sample of GP practices. 
2) Sample of acutely ill children from practices. 
 
In order to determine how representative my sample is of the target population (acutely ill 
children <5 years old in UK general practice; Figure 5.1), I have considered how similar my 
sample of GP practices are to UK GP practices in general; I have described the proportion of 
potentially eligible children recruited by practices; and I have then considered my final 
sample and compared it with those who were potentially eligible but either not recruited or 
recruited but not able to provide a urine sample within 2 days. Figure 5.1 shows a 
representation (not to scale) of my sample and the target population. I have also explored the 
variation in the main outcome (prevalence) across practices and laboratory areas to see if 
these are significant variables to consider when generalising my findings.  
 
Headline: 1003 children were recruited from 13 General Practices. Urine samples were 
obtained from 597 children within 2 days. Participating practices had larger list sizes than 
the average for Wales (9774vs. 6242) and had a slightly higher proportion of registered 
children aged less than five years old (7.1% vs. 5.5%). Recruited children who provided a 
urine sample within 2 days were older than non-recruited children and those not providing 
a urine sample within 2 days (2.3 years vs. 1.6 years and 1.6 years). There was no 
significant difference in UTI prevalence by laboratory area and only 5.6% of the 
prevalence variance was explained by between practice variation.  
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Figure 5.1: Representation of study sample and target population 
 
 
 
A sample of 13 practices in Wales was recruited to take part in the study. In 2008, there were 
499 GP practices in Wales and 10102 in the UK as a whole.
169 My sample of GP practices 
represents 2.6% of the total number of Welsh practices and 0.1% of all UK practices. Figure 
5.2 is a summary box describing my study sample. 
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Figure 5.2: Description of sample 
 
Practices 
Thirteen practices participated in the study, with four associated NHS microbiology 
laboratories. Most practices were in South East Wales, with two practices in the West and 
one in the North of Wales. Practices were represented in both affluent and less affluent areas. 
The National Statistics Area Classification was used to describe surgery areas (Table 5.1).  
 
The Townsend score was used as a measure of deprivation. It was calculated based on the 
postcode for practices. The postcodes were used to determine the ward/LSOA (Lower Super 
Target population: children aged <5 years old presenting with an acute illness (<28 days) in 
primary care in the UK 
 
Sampled population: children aged <5 years old presenting with an acute illness (<28 days) 
from 13 general practices in Wales  
 
Recruited children: 1003 children aged <5 years old presenting with an acute illness (<28 
days) recruited from 13 general practices in Wales  
 
Study sample: 597 children aged <5 years old presenting with an acute illness (<28 days) 
who provided a urine sample within 48 hours recruited from 13 general practices in Wales 
 
1003 eligible children recruited by practices 
  
 294 did not provide a urine sample 
  
 
709 provided urine samples (70.1%) 
 
 23 urine samples leaked in transit 
 89 urine samples received >2 days after consultation 
 
 
597 urine samples analysed within 2 days of consultation (84.2% samples; 59.5% of recruited 
children) 
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Output Area) and the Townsend score relating to this ward was found on the Public Health 
Wales website.
170 171
 
 
Table 5.1 shows the National Statistics Area Classification and Townsend scores. The 
practice name, post code, practice code and ward details have been removed for 
confidentiality. All the practices were given a centre ID number (CID) for the study. 
 
Table 5.1: National Statistics Area Classification and Townsend score 
CID National Statistics Area 
Classification 
Townsend score for 
England and Wales 
Townsend score 
quintiles (1=least 
deprived 
9 Urban commuter -3.41 1 
7 Well off mature 
households 
-2.69 2 
8 Well off mature 
households 
-2.67 2 
6 Affluent urban community -2.33 2 
10 Mature urban households -0.16 3 
19 Small town community 0.05 3 
3 Urban terracing 0.64 4 
2 Urban terracing 0.92 4 
5 Small town communities 1.84 4 
15 Urban terracing 3.03 4 
1 Struggling urban families 4.08 5 
4 Mature city professionals 4.95 5 
18 Resorts and retirements 7.09 5 
 
The table shows that the 13 practices represented a range of areas covering all quintiles with 
Townsend scores ranging from -3.41 (least deprived) to 7.09 (most deprived). The full range 
for Townsend scores is -12 (least deprived) to +12 (most deprived). Seven of the practices in 
my study are in the most deprived two quintiles, with four practices in the least deprived two 
quintiles, suggesting a range of deprivation levels was covered. 
 
Looking at the National Statistics Area Classification, rural areas are under-represented. Most 
of the practices in the study were in urban or city areas. 
 
Practice list size 
Twelve of the thirteen practices provided the number of registered patients and proportion of 
those aged less than five years old. Table 5.2 shows this information. 
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Table 5.2: Practice list information 
 
Practice 
(CID) 
No. patients 
registered 
with 
practice 
No. of children 
<5 registered 
with the practice 
Proportion of 
children on 
practice list 
1 12828 980 7.6% 
2 11497 923 8.0% 
3 12231 793 6.5% 
4 8027 506 6.3% 
5 - - - 
6 4982 246 4.9% 
7 8050 547 6.8% 
8 4548 448 9.9% 
9 6855 401 5.8% 
10 2121 309 14.6% 
15 25251 1744 6.9% 
18 16084 1100 6.8% 
19 11757 922 7.8% 
Total 124231 8919 Mean=7.2% 
 
The smallest practice which gave their list size was CID 10, a single-handed practice with a 
list size of 2121. CID 5 did not give their list size and this was the only other single-handed 
practice in the study. The largest list size was 25251 (CID 15). 
 
The median list size of practices was 9773.5. This is higher than the average for Wales, 
which was found to be 6242 in a report in 2008.
172
  
 
This indicates that the practices included in this study are different in this respect to practices 
in general in the UK. However, the two largest practices (CIDs 15 and 18) recruited only 
small numbers of children, representing less than 5% of all recruited children. Without 
including these two practices, the mean list size is 8038.5, which is still larger than the 
average for Wales.
172
  
 
The larger list sizes for practices may reflect my initial targeting of larger studies; or may be 
due to larger practices being more likely to agree to participate, perhaps due to having more 
resources, flexibility or organisational structure which would make it easier to take part in 
research. This study required significant time to be allocated to recruiting children and 
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obtaining urine samples and smaller practices may not have had nurse time or room to be able 
to do this.  
 
Children registered with practices 
The proportion of registered patients who were less than five years old varied from 4.9-14.6% 
with an overall mean of 7.1%. 
 
This is a slightly higher proportion of registered children less than 5 years old than the 
national average for Wales (5.5%) or England (6.0%).
172
  
 
Recruitment rate of practices 
Practices started recruitment for the study at different times (figure 5.3). Following the pilot 
study,
150
 I felt that the best approach for optimising recruitment and keeping a high urine 
retrieval rate was to have a small number of practices who were very familiar with the study 
and intensively recruiting. It became clear that I would not reach the numbers needed from 
the sample size calculation in the time available if I did not recruit more practices.  
 
Figure 5.3: Recruitment periods of surgeries  
 
Year 2008 2009 2010 
Month J A S O N D J F M A M J J A S O N D J F M A M J J 
CID                                                   
1*                                                   
2                                                   
3                                                   
4*                                                   
5*                                                   
6                                                   
7*                                                   
8                                                   
9*                                                   
10                                                   
15*                                                   
18*                                                   
19                                                   
* practices which had help with recruitment from CRC-Cymru/NISCHR research officers 
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Unfortunately several problems affected recruitment and approval of practices to take part in 
the study. There was a change in the NHS structure in Wales; with the formation of seven 
new LHBs combining the previous primary care LHBs with the secondary care Trusts, and 
three overarching NHS Trusts. There was also a change in the R+D approval process and 
structure in Wales with the formation of SPARC (see Methods, Table 4.1). This resulted in 
long delays in getting practices which had agreed to participate in the study approved to start 
recruitment. This resulted in some practices dropping out completely and several practices 
only had a short time to recruit (CID 15 and 18). 
 
Some practices had help with recruitment from CRC-Cymru/NISCHR-CRC  research 
officers. These are shown with an asterisk on Table 5.3. Recruitment varied between 
practices. Figure 5.4 shows the total number of children recruited per practice and figures are 
given in Table 5.3. 
 
Figure 5.4: Bar chart showing numbers recruited by practice  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
One practice (CID 1) recruited 25% of all children in the study. CID 6 and 9 recruited 27% 
between them and the remaining 48% children were recruited by the other 10 practices.  
There was a wide variation in the time practices gave to recruitment, so recruitment rate was 
calculated per month. This is shown in Table 5.3. Recruitment rate varied between practices 
from 1.5 per month to 11.7 per month, with an overall average (mean) of 5.6 per month.  
The proportion of children recruited with urine samples within 2 days varied from 41%- 86% 
by practice (see Table 5.3 ) with a mean of 60%. The rate of children recruited with a urine 
Practice CID number 
Number recruited 
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sample within 2 days (eligible urine retrieval rate) ranged from 1.1-6.0 per month. The two 
practices with the highest recruitment rates per month (CID 1 and CID 15) had below average 
eligible urine retrieval rates of 57% and 51% respectively. The practice with the lowest 
eligible urine retrieval rate was CID 5 with a rate of 41%. This was a single handed, research-
naive practice in a deprived city area. They also had a reasonably low total recruitment (51) 
and recruitment rate per month (2.8), despite support from CRC-Cymru/NISCHR research 
officers.  
 
The low urine retrieval rates in some practices may indicate that practices were only 
requesting urine samples from some children, perhaps in those whom they most suspected 
UTI, which could result in selection bias. If this was the case, there should be a difference in 
UTI prevalence according to urine retrieval rate with low urine retrieval rates associated with 
high UTI prevalence.  However, UTI prevalence was not higher in the practice with the 
lowest urine retrieval rate (CID 5: UTI prevalence 4.8%). In the four practices with the next 
lowest urine retrieval rates (of less than 55%), the prevalences were 9.5%, 0.0%, 20.0% and 
3.4%. The two practices with the highest urine retrieval rate had prevalences of 3.4% and 
16.7%. Although the numbers with UTI are small, there does not seem to be any association 
between prevalence and urine retrieval rate. 
 
Two practices had eligible urine retrieval rates of more than 80% (CIDs 7 and 18). These 
practices had low total recruitments of 34 (CID 7) and 35 (CID 18). CID 7 also had the 
lowest monthly recruitment rate of 1.5. CID 18 had a monthly recruitment rate of 3.5. 
 
Consultation rate of children 
Seven practices were able to provide the number of consultations in a year with children 
under 5. This is shown in Table 5.4. 
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Table 5.3:  Recruitment numbers and Townsend score by practice 
 
 
 
Table 5.4: Practice list size, consultations with children and recruitment to study for 
seven practices 
CID No. of 
children 
<5 
registered 
No. of 
children 
recruited 
Estimated 
proportion 
of children 
on list 
recruited 
Number of 
face to face 
consultations 
with children 
<5 per year 
Number of 
consultations 
per registered 
child per year 
Recruitment 
rate per 
year 
1 980 251 25.6% 5480 5.6 126 
3 793 43 5.4% 4193 5.3 65 
6 246 106 43.1% 2733 11.1 67 
7 547 34 6.2% 1830 3.3 18 
9 401 165 41.1% 1750 4.4 104 
10 309 96 31.1% 2847 9.2 96 
18 1100 14 1.3% 4315 3.9 42 
Total  4376 709 16.2% 23148 5.3 518 
 
Practice  
(CID) 
Total no. 
recruited 
(% of total) 
Townsend 
score 
Quintile  
(1 is least 
deprived) 
No.  months 
of 
recruitment 
Recruitment 
rate per 
month 
No. 
recruited 
with urine 
samples 
received 
within 48 
hrs  
Rate 
recruited 
per month 
with urine 
samples 
within 48 
hrs 
1 251 (25.0%) 5 24 10.5 143 (57.0%) 5.6 
2 104 (10.4%) 4 17 6.1 60 (57.7%) 3.5 
3 43 (4.3%) 4 8 5.4 25 (58.1%) 3.1 
4 45 (4.5%) 5 18 2.5 35 (77.8%) 1.9 
5 51 (5.1%) 4 20 2.6 21 (41.2%) 1.1 
6 106 (10.6%) 2 19 5.6 80 (75.5%) 4.2 
7 34 (3.4%) 2 23 1.5 29 (85.3%) 1.3 
8 39 (3.9%) 2 13 3.0 21 (53.8%) 1.6 
9 165 (16.5%) 1 19 8.7 87 (52.7%) 4.6 
10 96 (9.6%) 3 12 8.0 56 (58.3%) 4.7 
15 35 (3.5%) 4 3 11.7 18 (51.4%) 6.0 
18 14 (1.4%) 5 4 3.5 12 (85.7%) 3.0 
19 20 (2.0%) 3 9 2.2 10 (50.0%) 1.1 
Total  1003  189 5.6 597 (60.0%)  
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CID 6 and CID 10 have high consultation rates for children and CID 7 had low consultation 
rates.  Overall for the practices which provided this information the average was 5.7 
consultations per registered child per year which is similar to published rates.
38 173 
 
Patients 
A total of 1031 children were recruited. Twenty eight were subsequently excluded because a 
signed consent form was not received or because they did not fit the eligibility criteria, 
leaving 1003 eligible recruited children. 
 
The recruited children in the study represented only a small proportion of all the possible 
consultations with children less than five years old. This is to be expected as practices were 
not recruiting during every surgery, in fact many allocated only one or two sessions per week 
to recruit for the study; not all the nurses and GPs from the surgery were involved in 
recruitment; some practices only recruited when CRC-Cymru/NISCHR research officers 
were present; and many of the consultations would represent re-consultations with children 
already recruited into the study (as children consult on average 5-6 times per year) and some 
consultations would not have been for acute illness, and would therefore not have been 
eligible.  
 
Practices were asked to recruit sequentially attending children (every eligible child) during 
the times of recruitment. The main objective of this method was to limit selection bias by 
practices.  
 
Recruitment logs 
Practices were asked to keep a recruitment log. This is notoriously difficult in general 
practice research, given all the other priorities and pressures in practice. Four practices did 
not complete the recruitment logs. The nine practices which did complete recruitment logs 
listed 122 children who were potentially eligible but not recruited for various reasons. Fifty 
nine (48.4%) of those listed did not meet eligibility criteria.  
 
There were 63 children listed who were eligible and were approached, but who were not 
recruited for various reasons. Table 5.5 shows the proportion of eligible children who were 
recruited as listed on recruitment logs from the nine practices which completed them. Table 
5.6 shows the reasons for non-recruitment. 
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Table 5.5: Proportion of eligible children recruited as listed on recruitment logs 
Practice 
(CID 
number) 
Number of potentially 
eligible children 
approached and not 
recruited 
Total number 
recruited by 
practice 
Percentage of 
potentially eligible 
children who were 
recruited  
1 21 251 92.3% 
2 1 104 99.0% 
4 2 45 95.7% 
5 4 51 92.7% 
6 2 106 98.1% 
7 2 34 94.4% 
8 17 39 69.6% 
9 8 165 95.4% 
15 6 35 85.4% 
Total 63 830 92.9% 
 
One practice (CID 8) had a higher proportion of potentially eligible children who were listed 
on its recruitment log but not recruited (30.4%). All other practices had a low reported 
proportion of children not being recruited if they were eligible. The most common reason 
cited on the logs for non-recruitment was not willing or declined (27.0%), and in 17.5% 
no reason was given. In 11.1% of cases it was stated that the parent specifically did not want 
to provide a urine sample or did not think their child had a UTI. Lack of time was only given 
as the reason in 6.3% of cases (Table 5.6). 
 
Table 5.6: Reasons for non-recruitment  
 
Reason for non-recruitment Number (%) 
Temporary resident/lives out of area 3 (4.8%) 
Too ill 3 (4.8%) 
Not English speaker 5 (7.9%) 
Not enough time 4 (6.3%) 
Parent did not think it was a UTI or did not want to provide a urine 
sample 
7 (11.1%) 
Person bringing child to surgery was not parent so could not give 
consent 
6 (9.5%) 
Not willing/declined 17 (27.0%) 
No reason given 11 (17.5%) 
Other 7 (11.1%) 
Total  63 
 
In 4.8% the reason for non-recruitment was that the child was too ill. This is important as we 
might expect there to be a higher prevalence of UTI among more seriously ill children and if 
a high proportion of non-recruitment had been found for this reason, it may indicate that the 
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sample was biased towards less ill children and may have resulted in a prevalence value 
lower than the true target population prevalence.  
 
The low overall numbers recorded on the recruitment logs suggest that it is unlikely that they 
represent all the potentially eligible children presenting to the surgery. It is more likely that 
they represent children who were approached to take part in the study but who ultimately 
were not recruited. Many surgeries only attempted to recruit children on certain days or 
during certain clinics and recruitment logs would not have been completed for all children 
attending the surgery on other non-study days. Of the 63 children not recruited as indicated 
by recruitment logs, 34 (54.0%) were male. The median age was 1.6 years (IQR 1.0  3.1). 
 
Age and gender 
1003 children were included in the study. 504 (50.2%) were male and 499 were female.  
The median age was 1.9 years (IQR 0.9-3.3) with the youngest only 13 days old and the 
oldest recruited two days before his 5th birthday. 
 
Urine samples 
Urine samples were obtained from 709 (70.7%) children. There was no laboratory analysis in 
23 of these (3.2%). The sample leaked in 22 and there was an accident in the laboratory in 
one case. Nearly half of all urine samples (49.2%) were received on the same day as 
recruitment. Eight samples were received more than 28 days following the index consultation 
and recruitment. Due to the importance of the urine sample result relating to the presenting 
symptoms, only those urine samples received within 2 days (same day, next day or day 2) of 
recruitment were used in the main analyses (n=597).  Figure 5.5 shows when urine samples 
were received following the index consultation. 
 
  
 114 
 
Figure 5.5: Bar chart showing when urine samples were analysed by laboratories 
following index consultation 
 
Number of samples 
 
 
 
Of the 597 received within 2 days, 318 (53%) urine samples were obtained before the child 
left the surgery. Only 294 samples were received by the laboratory on the same day, so 24 
samples were presumably collected in the afternoon and stored overnight and sent the next 
day to the laboratory. It was much less likely that the urine sample was received within 48 
hours of the consultation if the sample was not obtained before the child had left the surgery 
(p<0.01).  
 
Urine sample collection method 
The CRF recorded which of the two collection methods was used or given to parents to 
collect urine samples in 431 (72.2%) recruited children. This information was missing in 166 
(27.8%). Nappy pads were used in all children less than 3 months old, and the majority of 
children less than 3 years old (74.3% aged >3 months-3 years). The clean catch method was 
used in all children 3 years and older. Table 5.7 shows the urine sample method by age and 
gender. 
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Table 5.7: Urine sample collection method by age and gender 
 
 
Age range 
 
Gender 
Urine sampling method 
Clean catch Nappy pad 
<3 months Male 0 13 
Female 0 10 
Total 0 23 
>3 months to <3 
years 
Male 25 95 
Female 36 81 
Total 61 176 
>3 years Male 102 0 
Female 69 0 
Total 171 0 
Total 232 (53.8%) 199 (46.2%) 
 
 
Final sample for full analysis  
Of the 597 included in the full analysis, 313 were male (52.4%) and 284 (47.6%) female.  
The median age was 2.3 years (IQR 1.0-3.5). Most were aged between 3 months and 3 years 
old (n=349; 58.5%) with thirty-two (5.4%) less than 3 months old and 216 (36.2%) aged 3 
years or older. These characteristics and some of the most common presenting symptoms are 
compared between those included in the full analysis and those who were recruited but not 
included in the full analysis. See Table 5.8.  
 
Those not included in the full analysis were younger than those who were included. They 
were on average eight months younger (median age 1.6 years compared with 2.3 years; p-
value <0.01). This may have been due to difficulties obtaining a urine sample in younger 
children. It may indicate that my sample under-represents younger children which may have 
affected the prevalence.  
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Table 5.8: Characteristics of children included in the full analysis compared with those 
not included.  
Characteristic Those included in 
full analysis 
(n=597) 
Those not included in 
full analysis 
(n=406) 
p-value 
(!
2) 
Age Median age 2.3 (IQR 1.0-3.5) 
1.3.3.5)3333.493.4
1.6 (IQR 0.8-3.3) <0.01 
<3 months 32 (5 4%) 28 (6.9%) 
3 months  3years 349 (58.5%) 289 (71.2%) 
>3 years 216 (36.2%) 89 (21.9%) 
Gender Male 313 (52.4%) 191 (47.0%) 0.94 
Female 284 (47.6%) 215 (53.0%) 
GP 
working 
diagnosis 
 
 
URTI 177 (29.6%) 121 (29.8%) 0.35 
Viral illness 90 (15.1%) 55 (13.5%) 
LRTI 48 (8.0%) 43 (10.6%) 
UTI 41 (6.9%) 13 (3.2%) 
Tonsillitis 32 (5.4%) 26 (6.4%) 
Otitis 32 (5.4%) 19 (4.7%) 
Gastroenteritis 26 (4.4%) 18 (4.4%) 
Other 100 (16.8%) 67 (16.5%) 
No diagnosis  36 (6.0%) 32 (7.9%) 
GP suspected UTI 41 (6.9%) 13 (3.2%) 0.01 
 
There was no statistical difference in gender (p=0.94) between the two groups. There was no 
statistical difference between GP working diagnosis when all categories were compared 
(p=0.35). However, when I created a new binary variable based on GP working diagnosis of 
UTI or not, I found that there was a statistically significant difference between those who 
were included in the full analysis and those who were not (p=0.01), with GPs listing UTI as a 
working diagnosis twice as often in those who were ultimately included in the full analysis 
compared with those who were not. This could indicate selection bias. However, selection 
bias in this case would not be because GPs were more likely to recruit children who they 
suspected may have UTI as this comparison is with those ultimately included in the full 
analysis with those who were not, among all those already recruited (n=1003) by GPs. It 
may indicate that GPs may have been more likely to emphasise the need for urine samples in 
this group of children. 
 
For the remainder of this chapter I will be focusing only on those included in the full analysis 
(n=597).  
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Primary outcome:  
Prevalence of UTI 
 
The main outcome was the prevalence of UTI defined as a positive urine culture at the local 
NHS laboratory with a growth of more than 100,000 cfu/ml of a single or predominant 
organism. The prevalence in the sample was 35/597 (5.9%). 
 
As discussed previously, this is the prevalence in the recruited sample who submitted urine 
samples within two days. To use this value to conclude what the actual prevalence is in the 
target population (population proportion), requires the calculation of confidence intervals 
(CI) (Appendix 5.1). This standard method gives 95% CI for the prevalence of 4.3-7.7%. 
However, this standard method is less accurate when used for proportions close to zero. For 
small proportions the lower confidence interval may cross zero, which is not possible. 
Wilsons method advised by Newcombe adjusts for this.
148
 This gives the 95% CI for the 
prevalence to be between 4.3%-8.0%. 
 
Variation in prevalence and potential bias 
Prevalence by practice, by lab area, by Townsend score, multi-level analysis/modelling 
To determine further how representative my sample population is likely to be of the target 
population, I wanted to examine how much of the variability in prevalence could be 
explained by the practice, laboratory area or by deprivation and how much variation was 
introduced by the two-level sampling. 
 
There was no statistically significant variation in prevalence of UTI by deprivation of 
practice area (using Townsend score quintile; p=0.12).  
 
I wanted to see if the variation in prevalence was purely due to chance from sampling 
children or whether the prevalence was likely to vary from practice to practice.  
Prevalence within individual practices varied from 0-20.0% (see Table 5.9 and Figure 5.6). 
The practices with the lowest prevalence (CIDs 3 and 15), recruited only 25 and 18 children 
respectively. With a prevalence of 5.9% you would expect 1.5 cases of UTI out of 25 and 1.1 
cases out of 18. Those practices with the highest prevalence (CID 18 and 19) recruited even 
smaller numbers increasing overall the likelihood of wide variation due to chance. In each 
case, there were only two cases of UTI but due to the overall small numbers a large 
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percentage is produced. In the case of CID 19, where two UTIs were found out of 10 
recruited eligible children, the prevalence of 20% would be reduced to 10% if only one of 
those had not been positive.  
 
Table 5.9: Prevalence of UTI by practice 
 
Practice (CID) Townsend score 
quintile 
No. with UTI Total number 
eligible children 
recruited by practice 
% with UTI 
1 5 7 143 4.9 
2 4 2 60 3.3 
3 4 0 25 0.0 
4 5 2 35 5.7 
5 4 1 21 4.8 
6 2 7 80 8.8 
7 2 1 29 3.4 
8 2 2 21 9.5 
9 1 3 87 3.4 
10 3 6 56 10.7 
15 4 0 18 0.0 
18 5 2 12 16.7 
19 3 2 10 20.0 
Total  35 597 5.9 
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I wanted to see if the variation in prevalence could be explained by differences in practices. 
For example, were different practices recruiting children differently which could have 
resulted in varying prevalences or was there a difference in prevalence of UTI in the different 
practices due to socioeconomic or other differences, or whether it more likely simply to be 
sampling variation. 
  
I was also interested in whether the variation could be due to different laboratory practices. 
Table 5.10 shows the prevalence with associated confidence intervals by laboratory area.  
There were insufficient numbers to statistically test the difference in prevalence between 
practices or laboratory areas. However, looking at the confidence intervals, they are all wide 
and all overlap, suggesting that there would be no statistically significant difference.  
 
Table 5.10: Variation in prevalence by laboratory 
 
Lab area Total no. 
received by 
lab 
No. not cultured due 
to negative 
microscopy 
Prevalence of 
UTI 
95% confidence 
intervals for 
prevalence 
1 501 26 (5.2%) 25 (5.0%) 3.4-7.3% 
2 * 18 12 (66.7%) 0 (0.0%) 0-17.6% 
3 66 2 (3.0%) 8 (12.1%) 6.3-22.1% 
4 12 0 (0.0%) 2 (16.7%) 4.7-44.8% 
Total 597 40 (6.7%) 35 (5.9%) 4.3-8.0% 
* Lab. which had SOP to only culture microscopy positive urine 
 
One laboratory (Lab area 2) had a SOP which clearly stated that microscopy which was 
negative would not be cultured. All other laboratories stated that urine would be cultured if 
microscopy was negative. However, Lab area 1 began to use an automated microscopy 
machine (flow cytometer) part of the way through the study and if no bacteria were found on 
flow cytometry, the urine was not cultured. Lab area 3 did not culture the urine on two 
occasions.  
 
Multilevel modelling 
I then considered an alternative approach to see what  the effect of the two levels of sampling 
(practices then children) may have had and to what extent practice explained the variability in 
prevalence rates rather than the variation expected simply from sampling children 
(independent of practice). 
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I calculated the intraclass coefficient (ICC). This represents the proportion of the total 
variability in the outcome that is attributable to the surgeries. It is a gauge of whether a 
contextual variable has an effect on the outcome. I considered the 13 practices as clusters. 
The ICC was calculated and adjusted to allow for different sizes of clusters.
174
 All my 
calculations are included in Appendix 5.1. 
 
This gave an ICC of 0.056. The ICC can be used as a measure of the degree of similarity of 
individuals within clusters and between clusters. The ICC represents the proportion of the 
total variance that is due to variation between clusters. 
 
If the surgery has a large effect on the children within it, then the variability within the 
surgery will be small (children will behave similarly). Variability in the prevalence within 
surgeries is then minimized and variability in prevalence between surgeries is maximised, 
therefore ICC is large. Conversely if the surgery has little effect on the children then the 
outcome will vary a lot within surgeries, which will make differences between surgeries 
relatively small. Therefore, the ICC will be small.  
 
The ICC is a ratio of the between cluster variance to the total variance and has a value which 
can range from 0 to 1 with 1 indicating that all the variance is explained by the between 
cluster variance to 0 where none of the variance is explained by the between cluster variance. 
So an ICC of 0.056 means that (only) 5.6% of the total variance is explained by the 
between surgery variance.  
 
Considering whether antibiotic prescription prior to urine sampling could have affected 
prevalence 
It is possible that a false negative culture negative result could have occurred if children were 
prescribed antibiotics at the index consultation and took them prior to providing a urine 
sample. I do not know if this could have occurred. Children who provided urine samples 
before leaving the surgery would not have had the opportunity to take any antibiotics. 
Antibiotics were prescribed in 31% (99/318) of children who provided urine samples prior to 
leaving the surgery and in 25% (70/279) of those who did not. Among those who did not 
provide urine samples prior to leaving the surgery, there was no difference in UTI prevalence 
between those who were prescribed antibiotics during the consultation and those who were 
not (p=0.33). This suggests that antibiotics were unlikely to have had a significant effect on 
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UTI prevalence in my study. Perhaps GPs and nurses encouraged parents to obtain a urine 
sample before the child started the antibiotics. 
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Main Findings 
 
Primary Outcome 
 
Headline: The prevalence of UTI was 5.9%. A further 2.8% had a borderline result. The 
prevalence of UTI was higher in younger children. In older children (>3 years) the 
prevalence of UTI was higher in girls than boys. There was no significant difference in the 
prevalence of UTI according to urine collection method. There was no seasonal variation. 
   
I found the estimate of the prevalence of UTI, defined as the growth of one organism of 
greater than 100,000 cfu/ml, in acutely ill children under five years old to be 5.9% (35/597) 
with a 95% confidence interval of 4.3-8.0%.  
 
Culture results 
In addition to the prevalence of UTI defined as the growth of one organism of greater than 
10
5
 cfu/ml (primary outcome: 5.9%), I was also interested in borderline culture results. I 
considered these to be either the growth of a single organism of between 10
4 
and 10
5
 cfu/ml 
(11/597;1.8%) or the growth of two organisms of more than 100,000 cfu/ml (6/597; 1.0%). In 
total, a further 2.8% were considered to have a borderline result (see Table 5.11).  
 
Almost half of the samples (48.4%) had mixed growths, presumed to be contaminants, and 
regarded as negative. The standard definition of UTI (used for this study) requires there to be 
a pure or predominant growth of a single organism. A culture result of mixed growth or 
heavy mixed growth, does not meet the criteria required for a UTI. It is therefore regarded as 
not-UTI. Clinicians may treat choose to repeat the culture on another urine sample or may 
treat it as negative. However, it is possible that contaminating bacteria are hiding a true UTI 
(false negative result) or that the UTI is caused by more than one organism. If either of these 
cases were true, the prevalence of UTI found in my study would be an underestimation of the 
true prevalence.   
 
Heavy mixed growths were more common in nappy pad samples (61.7%) compared with 
clean catch samples (13.2%; p>0.01). Forty (6.7%) urine samples were not cultured as 
microscopy was negative. 
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Table 5.11: Culture results  
 
Culture result Number (%) % (95% CI) 
Positive >105 cfu/ml single organism 35 (5.9) 5.9 (4.3-8.0) 
Borderline 104-105 cfu/ml single organism 11 (1.8) 2.8 (1.8-4.5) 
>10
5
 cfu/ml two organisms 6 (1.0) 
Negative Heavy mixed growth >105 cfu/ml 208 (34.8)  
91.3 (88.8-93.3) Mixed growth 104-105 cfu/ml 81 (13.6) 
No growth or growth <10
4
 cfu/ml 216 (36.2) 
Not cultured as microscopy negative 40 (6.7) 
 
Overall, more than half (54.2%) of the UTIs were caused by E.coli. About a fifth (22.9%) 
were reported as Coliform, and a further fifth as other organisms. Further data regarding 
bacterial species and sensitivity profile is given later in the chapter along with antibiotic 
prescription and outcomes. 
 
Prevalence of UTI by age and gender 
Although age was not statistically significantly associated with UTI at the p=0.05 level, there 
was a trend towards a higher prevalence of UTI in the younger children (p=0.05; Table 5.12). 
The sample size was small and confidence intervals were wide in the youngest children, 
suggesting that the study was underpowered to detect a difference. 
 
There was no significant difference in the prevalence of UTI between girls and boys, with 
19/284 (6.7%) of girls and 16/313 (5.1%) of boys with UTI (p=0.41). Table 5.13 gives a 
breakdown of the association between gender and UTI by age. There was no difference in the 
gender of children with UTI aged less than three years, but UTI was more common in girls 
than boys over the age of three years (p<0.01).  
 
Table 5.12: Prevalence of UTI by age  
  
Age range (NICE) Proportion with UTI % UTI  95% CI  
<3 months 4/32 12.5% 5-28% 
>3 months & <3  years 24/349 6.9% 5-10% 
>3 years 7/216 3.2% 2-7% 
Total  35/597 5.9% 4-8% 
p=0.05 
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Table 5.13 Prevalence of UTI by age and gender combined 
 
Age range (NICE) Gender UTI (%) p-value (Fishers 
exact) 
< 3 mths Male 2/18 (11.1%) 1.00 
Female 2/14 (14.3%) 
>3 mths & <3 yrs Male 14/177 (7.9%) 0.53 
Female 10/172 (5.8%) 
>3 yrs Male 0/118 (0.0%) <0.01 
Female 7/98 (7.1%) 
 
 
Urine sampling method and UTI prevalence 
The method of urine collection was indicated in 431 (72.2%) children. Table 5.14 shows the 
proportion of UTIs with each method. Table 5.15 shows the proportion of UTIs by sample 
method and age.  
 
Overall, there seemed to be a higher proportion of UTIs in those whose urine was collected 
using the nappy pad method, although this difference was not statistically significant (p=0.19; 
Table 5.14). 
 
Table 5.14: urine sampling method and association with UTI 
 
Urine sampling 
method 
n %UTI 
Clean catch 232 3.0% 
Nappy pad 199 5.5% 
   p=0.19 
 
 
Table 5.15: urine sample method and association with UTI by age 
 
Age Urine sample method Proportion with UTI 
> 3 years old Clean catch 3/171 (1.8%) 
Nappy pad 0  
<3 years old * Clean catch 4/61 (6.6%) 
Nappy pad 11/199 (5.5%) 
  * p=0.76 
 
However, when urine sample method was considered only in those less than three years old 
(the age group in whom both methods were used), the proportion of UTIs in the nappy pad 
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group was lower than in the clean catch group, although this difference was not statistically 
significant (p=0.76).  
 
This suggests that the lower proportion of UTIs in clean catch samples overall may be mainly 
due to age rather than sampling method, with older children less likely to have UTI and more 
likely to have urine collected by the clean catch method.  
 
Seasonal variation 
Many common illnesses (e.g. URTI, Flu) are seasonal and I wanted to see whether there was 
a seasonal pattern to UTI.  Table 5.16 shows recruitment and UTI prevalence by month.  
 
Table 5.16: UTI prevalence by month 
 
Month Number recruited Number with UTI (%) 
January 31 2 (6.5%) 
February 45 4 (8.9%) 
March 69 3 (4.3%) 
April 37 5 (13.5%) 
May 43 0 (0.0%) 
June 46 4 (8.7%) 
July 53 3 (5.7%) 
August 58 3 (5.2%) 
September 57 3 (5.3%) 
October 53 1 (1.9%) 
November 60 5 (8.3%) 
December 45 2 (4.4%) 
Total  597 35 (5.9%) 
 
The highest prevalence of UTI occurred in April but the lowest was in May. There did not 
appear to be a consistent pattern suggesting that a seasonal pattern for UTI is unlikely. 
Numbers were too small for statistical testing. 
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The numbers recruited (denominators) each month also do not show a pattern. I would have 
expected to see a peak in recruitment over the winter months reflecting increased presentation 
with other common illnesses. This does not convincingly show this. 
 
Table 5.17: Year of recruitment  
 
Year of recruitment Number recruited Number with UTI (%) 
2008 230 7 (3.0%) 
2009 258 16 (6.2%) 
2010 109 12 (11.0%) 
Total 597 35 (5.9%) 
 
Table 5.17 shows the recruitment and prevalence of UTI by year.  
There was a higher proportion of UTI diagnosed in 2010 than in 2008 or 2009 (p=0.01). In 
2010, there were fewer practices still recruiting with fewer overall numbers recruited and two 
new practices with two new laboratories, which could potentially have influenced this. 
 
Secondary Outcomes 
 
Headline: a multivariable logistic regression model identified age range, pain or crying on 
passing urine and increased urinary frequency as being associated with UTI. A history of 
fever or absence of an alternative site of infection was not significantly associated with 
UTI.  
 
Presenting symptoms 
I wanted to examine whether presenting symptoms were associated with UTI and whether 
they could potentially be used to determine which children were more likely to have UTI or 
to target urine sampling.  
 
As described in Chapter 4, missing data for presenting symptoms were considered not to have 
the symptom.  
  
There were 7-11 children with missing data for runny nose, earache, cough, difficulty 
breathing, feverish, rash, irritable, clingy, low energy, poor sleep, poor feeding, diarrhoea, 
constipation and vomiting. There were more missing data (between 16-47 children) for sore 
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throat, muscle aches/pains, nausea, abdominal pain, colic, bed wetting, smelly urine, dark 
urine, dysuria, haematuria, poor urine flow, urinary frequency and poor weight gain.  
 
Table 5.18 shows the presenting symptoms in those with UTI compared with those without 
UTI. Symptoms with a p-value of <0.1 on univariate analysis are highlighted in bold. 
 
Table 5.18: Presenting symptoms in children with and without UTI  
 
 Symptom  Proportion of those  
with UTI with 
symptom (%) 
Proportion of those 
without UTI with 
symptom (%) 
p-value 
 Irritable/grouchy  28/35 (80.0%)  355/562 (63.2%)  0.04 
 Clingy  25/35 (71.4%)  376/562 (66.9%)  0.58 
 Poor feeding  24/35 (68.6%)  305/562 (54.3%)  0.10 
 Runny nose  23/35 (65.7%) 400/562 (71.2%)  0.49 
 Cough  23/35 (65.7%)  390/562 (69.4%)  0.65 
 Fever  21/35 (60.0%)  334/562 (59.4%)  0.95 
 Tiredness  20/35 (57.1%)  265/562 (47.2%)  0.25 
 Poor sleep  18/35 (51.4%)  297/562 (52.8%)  0.87 
 Sore throat  12/35 (34.3%)  218/562 (38.8%)  0.60 
 Increased urinary frequency   11/35 (31.4%)  75/562 (13.3%) < 0.01 
 Vomiting  11/35 (31.4%)  16/562 (2.8%)  0.72 
 Smelly urine  11/35 (31.4%)  125/562 (22.2%)  0.21 
 Earache  10/35 (28.6%)  170/562 (30.2%)  0.83 
 Difficulty breathing  9/35 (25.7%)  133/562 (23.7%)  0.78 
 Abdominal pain  8/35 (22.9%)  115/562 (20.5%)  0.73 
 Dark urine  8/35 (22.9%)  78/562 (13.9%)  0.14 
 Rash  7/35 (20.0%)  120/562 (21.4%)  0.85 
 Nausea  5/35 (14.3%)  74/562 (13.2%)  0.80 
 Wetting when previously dry  5/35 (14.3%)  32/562 (5.7%)  0.06 
 Pain/crying when passing urine   5/35 (14.3%)  26/562 (4.6%)  0.03 
 Poor urine flow  3/35 (8.6%)  18/562 (3.2%)  0.12 
 Colic  2/35 (5.7%)  27/562 (4.8%)  0.68 
 Poor weight gain  1/35 (2.9%)  27/562 (4.8%)  1.00 
 Haematuria  1/35 (2.9%)  3/562 (0.5%)  0.22 
 Muscle aches or pains  0/35 (0.0%)  55/562 (9.8%)  0.03 
 
Being irritable or grouchy, having an increased frequency of wet nappies or passing urine, 
pain or crying when passing urine and not having muscle aches or pains, were associated with 
UTI with a p-value of <0.05. A history of day or bed wetting when the child had previously 
been dry, was associated with UTI with a p-value of 0.06.  
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Signs  
The signs which were recorded on the CRF included three continuous variables, which were 
temperature, pulse rate and respiratory rate, as well as a range of binary variables for 
examination findings.  
 
For the continuous variables, in order to assess whether parametric (normal) or non-
parametric parameters and tests would be more accurate, I needed to decide whether each 
variable had a normal distribution or not. I plotted histograms for each of these variables 
(Appendix 5.2). I have therefore presented parametric parameters and t-test for temperature 
and heart rate and non-parametric parameters and Mann Whitney U test for respiratory rate. 
  
Table 5.19: Association of continuous variables with UTI. 
 
 Sign n Overall 
mean/median 
S.d./IQR UTI 
Mean/median 
No UTI 
Mean/median 
p-value 
Temperature 
(measured in 
surgery; 
o
C) 
466 36.8 
o
C 0.97 
(s.d.) 
36.8
 o
C 36.9
 o
C 0.71 
Pulse rate 
(beats per 
minute) 
340 112  17.7 
(s.d.) 
109 112 0.46 
Respiratory rate 
(breaths per 
minute) 
304 28  12 (IQR) 27 28 0.67 
 
There was no statistically significant difference in the values of these variables between 
children with and without UTI (Table 5.19). I also created a binary variable for temperature 
of > 38.0
o 
C or <38.0
o
C. There was a greater proportion of children with a temperature > 
38.0
o 
C in the UTI group (42.9%) compared with the non-UTI group (29.0%), with a p-value 
of 0.08. 
 
Clinician examination findings 
Table 5.20 shows the association of UTI with examination findings. There was no 
statistically significant difference in these examination findings between those with and those 
without UTI. Numbers of children who had positive examination findings overall were eight 
(1.3%) children with abnormal abdominal examination, 118 (19.8%) with abnormal throat 
examination, 75 (12.6%) with abnormal chest examination and 62 (10.4%) with abnormal ear 
examination. An abnormal ear examination was found in only 2.9% of children with UTI 
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compared with 10.9% of children without UTI, however this was not statistically significant 
(p=0.16). 
 
Table 5.20: Examination findings and UTI 
  
Risk factors 
Table 5.21 shows the association with other risk factors collected on the CRF with UTI.  
Table 5.21: Association of risk factors with UTI. 
Risk factor Proportion of 
those with UTI 
with risk factor 
(%) 
Proportion of 
those without UTI 
with risk factor 
(%) 
p-value 
Past history 
 
 
 Previous UTI  3/35 (8.6%)  31/562 (5.5%)  0.44 
 Diabetes  0/35 (0.0%)  0/562 (0.0%) - 
Asthma  0/35(0.0%) 55/562 (9.8%) 0.06 
 Eczema  10/35 (28.6%)  104/562 (18.5%)  0.14 
 Hypertension  0/35 (0.0%)  1/562 (0.2%)  1.00 
 Kidney disease  2/35 (5.7%)  5/562 (0.9%)  0.06 
 Circumcised  0/35 (0.0%)  8/562 (1.4%)  1.00 
 Illnesses in past with fever 
but no obvious cause 
 9/35 (25.7%)  122/562 (21.7%)  0.58 
 Any other illnesses  4/35 (11.4%)  73/562 (13.0%)  1.00 
 Birth history  Breast fed  20/35 (57.1%)  254/562 (45.2%)  0.17 
 Abnormalities of renal 
system on A/N USS 
 2/35 (5.7%)  10/562 (1.8%)  0.15 
 Antibiotics during pregnancy  6/35 (17.1%)  82/562 (14.6%)  0.68 
Family history  UTI in childhood of brothers, 
sisters or parents 
 6/35 (17.1%)  114/562 (20.3%)  0.65 
Kidney disease  2/35 (5.7%)  30/562 (5.3%)  0.71 
Examination/signs No. of children with 
UTI positive for the 
finding (%) 
No. of children 
without UTI positive 
for the finding (%) 
p-value 
Abdominal examination abnormal  1/35 (2.9%)  7/562 (1.2%)  0.39 
Throat examination abnormal  7/35 (20.0%)  111/562 (19.8%)  0.97 
Chest examination abnormal   4/35 (11.4%)  71/562 (12.6%)  1.00 
Ear examination abnormal  1/35 (2.9%)  61/562 (10.9%)  0.16 
 130 
 
A past history of kidney disease was associated with UTI with a p-value of 0.06, but numbers 
were very small. A past history of asthma was more common in those without UTI (p=0.06).  
None of the other potential risk factors, including past history of UTI and family history of 
childhood UTI, were significantly associated with UTI.  None of the boys who had UTI had 
been circumcised and only 8/313 (2.6%) of boys overall had been circumcised. 
 
Anti-pyretics prior to consultation 
More than half (55.6%) of parents indicated that their child had been given paracetamol in the 
24 hours prior to the consultation. Both paracetamol and ibuprofen had been given in 15.6%. 
One third (34.6%) of children had not been given either paracetamol or ibuprofen. If it was 
not indicated that anti-pyretics were given on the CRF, I assumed that the child had not been 
given them. I looked at the association of having been given anti-pyretics with age of the 
child, a history of fever and association with UTI (Tables 5.22 and 5.23). 
 
Table 5.22: Association of paracetamol in the 24 hours prior to the index consultation 
with age, history of fever and subsequent diagnosis of UTI 
Variable Paracetamol in prior 24 hours p-value 
YES NO 
Age  <3 months 7/32 (28.0%) 25/32 (72.0%) P<0.01 
>3 months & <3 years 200/349 (57.3%) 149/349 (42.7%) 
> 3 years 125/216 (57.9%) 91/216 (42.1%) 
History of 
fever 
YES 240/355 (67.6%) 115/355 (32.4%) P<0.01 
NO 92/242 (38.0%) 150/242 (62.0%)   
UTI YES 18/35 (51.0%) 17/35 (49.0%) P=0.61 
NO 314/562 (55.9%) 248/562 (44.1%) 
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Table 5.23: Association of ibuprofen in the 24 hours prior to the index consultation with 
age, history of fever and subsequent diagnosis of UTI 
 
Variable Ibuprofen in prior 24 hours p-value 
YES NO 
Age  < 3months 0/32 (0.0%) 32/32 (100.0%) P=0.05 
 >3 months & <3 years  49/349 (14.0%) 300/349 (86.0%) 
> 3 years 35/216 (16.2%) 181/216 (83.8%) 
History of 
fever 
YES 71/355 (20.0%) 284/355 (80.0%) P>0.01 
NO 13/242 (5.4%) 229/242 (94.6%) 
UTI YES 4/35 (11.4%) 31/35(88.6%) P=0.81 
NO 80/562 (14.2% 482/562 (85.8%) 
 
The youngest children (<3 months old) were less likely to have been given paracetamol 
(p<0.01) and ibuprofen (P=0.05). Children were more likely to have been given paracetamol 
and ibuprofen in the preceding 24 hours if they had had a history of fever described by the 
parents (p<0.01 for both paracetamol and ibuprofen). There was no association between 
paracetamol or ibuprofen with subsequent diagnosis of UTI (p=0.61 and p=0.81 
respectively).  
 
Assessment of illness 
Parental and GP assessment of illness severity 
Parents were asked to indicate how unwell they thought their child was using a 5 point scale 
from 0 (not unwell at all) to 4 (severely unwell).  GPs were asked to assess children using a 
similar scale. Neither parents nor GPs graded any child as 4. In order to analyse these 
variables more easily, the scales were re-coded into mild illness (scores of 0 and 1 combined) 
and moderate illness (scores of 2 and 3 combined).  
 
This question was not answered by GPs and parents in 8 cases; missing from GPs in a further 
21 and missing from parents in a further 32 cases. 
 
Table 5.24 shows the comparison of parental and GP illness severity assessment scores. 
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Table 5.24: Association of parental and GP assessment of illness severity  
 
 GP assessment  
0-1 (mild illness) 2-3 (moderate illness) Total 
Parental 
assessment 
0-1 (mild illness) 257(47.9%) 23(4.3%) 280 (52.2%) 
2-3 (moderate illness) 179(33.4%) 77(14.4%) 256 (47.8%) 
 Total 436 (81.3%) 100 (18.7%) 536 
p<0.01; Kappa=0.23 
 
Parents assessed children to be more unwell than GPs (p<0.01) with 256 (47.8%) children 
assessed by parents as having a moderately severe episode compared with only 100 (18.7%) 
GPs. GPs and parents agreed on illness severity in 334 (62.3%) cases. The Kappa statistic 
(0.23) shows that overall there was fairly low agreement between GPs and parents 
assessment of illness severity. 
 
Tables 5.25 and 5.26 show the association of illness severity and UTI. 
 
Both GPs and parents seemed to assess more children in the UTI group as having a greater 
severity of illness, however this was not statistically significant in either case (p=0.11 
parents; p= 0.33 GPs). Considering an illness score of 2-3 by either parent or GP was not 
associated with UTI (p=0.27; Table 5.27) and neither was considering an illness score of 2-3 
by both parent and GP (p=0.17; Table 5.27). 
 
 
Table 5.25: Illness severity according to parent and association with UTI 
 UTI  
YES NO Total 
Illness severity 0-1  12 (38.7%) 281 (53.4%) 293 
2-3 19 (61.3%) 245 (46.6%) 264 
 Total 31 526 557 
p=0.11 
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Table 5.26: Illness severity according to GP and association with UTI 
 UTI  
YES NO Total 
Illness severity 0-1 24 (75.0%) 439 (81.9%) 463 
2-3 8 (25.0%) 97 (18.1%) 105 
 Total 32 536 568 
p=0.33 
 
Table: 5.27: Illness severity by GP and Parent combined and association with UTI 
 UTI p-value 
YES NO 
Illness severity score of 2-3 
by either GP or parent 
YES 18/279 (62.1%) 261/279 (51.2%) P=0.27 
NO 11/257 (37.9%) 246/257 (48.5%) 
Illness severity score of 2-3 
by both GP and parent 
YES 7/77 (9.1%) 70/77 (90.9%) P=0.17 
NO 22/459 (4.8%) 437/459 (95.2%) 
 
 
GP working diagnosis 
Table 5.28 shows the GP working diagnosis and association with UTI. Of those with UTI 
(n=35), 14 (40%) were thought to have a URTI by GPs. UTI was found in 14 (7.9%) of 
children with a working diagnosis of URTI; in two (6.3%) diagnosed with tonsillitis; in seven 
(17.1%) of those thought to have UTI; and in three (8.3%) of those with no working 
diagnosis given. None of those diagnosed with LRTI (n=48) or ear infections (n=32) were 
found to have UTI.  
 
 134 
 
Table 5.28: GP working diagnosis and UTI 
GP working diagnosis UTI (%) No UTI (%) Total 
URTI 14 (7.9%) 163  177  
LRTI 0 (0.0%) 48  48  
Tonsillitis 2 (6.3%) 30  32  
Ear infection 0 (0.0%) 32  32  
Conjunctivitis 1 (6.7%) 14  15  
Gastroenteritis 1 (3.8%) 25  26  
UTI 7 (17.1%) 34  41  
Viral illness 3 (3.3%) 87  90  
Other 4 (4.0%) 96  100  
No working diagnosis given/missing  3 (8.3%) 33  36  
Total 35 562  597  
 
I created two binary variables for statistical testing. One was suspected UTI. GP suspicion 
of UTI was based on the working diagnosis question on the CRF which was completed by 
GPs at the initial consultation and before urine culture results were available. The other 
binary variable I created was alternative source of infection which I coded as positive if 
URTI, LRTI, tonsillitis, ear infection, conjunctivitis or gastroenteritis were given as a 
working diagnosis. If the working diagnosis given was UTI, viral illness, other or if it was 
missing, alternative source of infection was coded as negative.  
 
Table 5.29 shows association of suspected UTI with UTI on culture. A working diagnosis of 
UTI indicated by the GP was significantly associated with UTI on culture with an odds ratio 
of 4.0 (p<0.01). However, 80% of those with UTI on culture were not suspected of having 
UTI by GPs demonstrating that UTI in children is very difficult to diagnose clinically. 
 
Table 5.29: Association of GP suspicion of UTI and UTI on culture 
GP suspicion of UTI UTI found on culture Total Odds  
YES  NO 
YES 7 (20.0%) 34 (6.0%) 41 (6.9%) 0.2 
NO 28 (80.0%) 528 (94.0%) 556 (93.1%) 0.1 
Total  35 (100%) 562 (100%) 597 (100%) Odds ratio = 3.9 
p<0.01 
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Table 5.30 shows the association of the presence of an alternative source of infection with 
UTI. This was not associated with UTI (p=0.64). 
 
Table 5.30: Association of presence of an alternative source of infection and UTI 
Presence of an alternative source 
of infection 
UTI  Total 
YES NO 
YES 18 (51.4%) 312 (55.5%) 330 (55.3%) 
NO 17 (48.6%) 250 (44.5%) 267 (44.7%) 
Total 35 (100%) 562 (100%) 597 (100%) 
p=0.64 
 
Predicting UTI 
 
Multivariable analysis 
Age category and symptoms or signs that were associated with UTI with a p-value of <0.1 on 
univariate analysis were entered into a forward stepwise logistic regression model (Table 
5.31).  
 
Although those with a UTI less commonly had a history of asthma (p=0.06), and more often 
had a history of kidney or bladder disease (p=0.06), past history was not included in the 
logistic regression model as I wanted to make the model as simple as possible, concentrating 
on clinical findings. Neither a history of fever described by parents nor an alternative site of 
infection (URTI, LRTI, tonsillitis, gastroenteritis, conjunctivitis, otitis) diagnosed by 
clinicians were significantly associated with UTI (p=0.95 and p=0.64 respectively) so these 
were not entered into the logistic regression model. No examination findings other than a 
fever of greater than or equal to 38
o
C were associated with UTI. Table 5.31 shows the 
presenting symptoms and signs which were entered into the logistic regression model. 
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Table 5.31: Presenting symptoms and signs in children entered into the logistic 
regression model   
 
Symptom Proportion of those 
with UTI with 
symptom (%) 
Proportion of those 
without UTI with 
symptom (%) 
Odds 
ratio 
p-value on 
univariable 
analysis 
Increased urinary 
frequency  
11/35 (31.4%) 75/562 (13.3%)  3.0 <0.01 
Wetting when 
previously dry 
5/35 (14.3%) 32/562 (5.7%)  2.8 0.06 
Pain/crying when 
passing urine  
5/35 (14.3%) 26/562 (4.6%)  3.4 0.03 
Irritable/grouchy 28/35 (80.0%) 355/562 (63.2%)  2.3 0.04 
Temp measured in 
surgery > 38
o
C 
15/35 (42.9%) 163/562 (29.0%)  1.8 0.08 
Muscle aches or pains 0/35 (0.0%) 55/562 (9.8%)  0.1* 0.03 
Poor feeding/off food 24/35 (68.6%) 305/562 (54.3%)  1.8 0.10 
* Calculated using Yates continuity correction.
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Multivariable analysis identified age range, pain or crying on passing urine and increased 
urinary frequency or frequency of wet nappies as being associated with UTI (Table 5.32).  
 
 
Table 5.32: Multivariable analysis: variables included in the model 
 
Symptom/characteristic B S.E. 95% CI for B Odds 
ratio  
p-value 95% CI 
for odds 
ratio Lower Upper 
Urinary frequency 1.0 0.4 0.2 1.7 2.6 0.02 1.2-5.7 
Pain on passing urine 1.2 0.6 0.2 2.3 3.3 0.03 1.1-9.8 
NICE age range<3/12
* 
1.7 0.7 0.4 3.0 5.5 0.01 1.5-21.0 
NICE age range 3/12-3 
years
* 
0.9 0.5 0.0 1.7 2.4 0.06 1.0-5.8 
Constant -3.8 0.4 -4.6 -2.9  
Model !
2
 p <0.01; Nagelkerke R
2
=0.08  
* age range >3 years used as the reference range 
 
 
Model fit 
The model !
2
 is significantly different from the null model (the baseline model with the 
constant only and no predictors), with a p-value of <0.01, suggesting that UTI prediction is 
improved based on these symptoms and signs. However, the Nagelkerke R
2
 statistic (0.08) 
implies that the model is not a very good fit. 
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Predicted probability of UTI based on the model 
 
Headline: Using the multivariable model, the estimated probability of UTI in children less 
than three years old was >5% irrespective of presenting symptoms and signs. In children 
aged three to five years old, with neither pain on passing urine nor increased urinary 
frequency, the estimated probability of UTI was 2%. A proposed urine sampling strategy 
based on this model would detect 97% of UTIs but would involve a large increase in urine 
sampling from acutely ill children.  
 
I wanted to calculate the probability of UTI for children of different age groups presenting 
with or without the symptoms in the model (summarised in Table 5.32). My calculations are 
shown in Appendix 5.3. I have summarised the probabilities and confidence intervals in 
tables 5.33-5.35. 
 
Table 5.33: Predicted probability of UTI (with 95% confidence intervals) for children 
aged less than 3 months with and without urinary frequency and dysuria. 
 
Age <3 months Pain/crying on passing urine % (95% CI) 
YES NO 
Increased frequency of 
urine/wet nappies 
YES 31.5% (5.4-98.4) 25.3% (1.7-86.4) 
NO 29.4% (4.5-91.5) 10.4% (1.4-52.5) 
 
All of the probabilities have wide confidence intervals. If there is pain/crying on passing 
urine, it is unlikely that the true probability lies below 4.5%, even with the wide confidence 
intervals, irrespective of increased urinary frequency. If there is no pain/crying on passing 
urine, the lower confidence interval drops to 1.4%. 
 
Table 5.34: Predicted probability of UTI (with 95% confidence intervals) for children 
aged 3 months or more but less than 3 years with and without urinary frequency and 
dysuria. 
 
Age > 3 mths & <3 yrs Pain/crying on passing urine (95% CI) 
YES NO 
Increased frequency 
of urine/wet nappies 
YES 32.0% (3.8-94.4%) 15.2% (1.2-63.4%) 
NO 12.5% (3.2-74.7%) 5.1% (1.0-23.2%) 
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All of the probabilities have wide confidence intervals. If there is pain/crying on passing 
urine, it is unlikely that the true probability lies below 3.2%, irrespective of increased urinary 
frequency. If there is no pain/crying on passing urine, the lower confidence interval drops to 
1.0%. 
 
Table 5.35: Predicted probability of UTI (with 95% confidence intervals) for children 
aged 3 years or more with and without urinary frequency and dysuria. 
 
Age > 3yrs Pain/crying on passing urine (95% CI) 
YES NO 
Increased frequency 
of urine/wet nappies 
YES 16.5% (5.4-74.7%) 5.7% (1.7-23.2%) 
NO 6.7% (4.5-34.0%) 2.2% (1.0-5.0%) 
 
All of the probabilities have wide confidence intervals. If there is pain/crying on passing 
urine, it is unlikely that the true probability lies below 4.5% (the lower confidence interval), 
even with the wide confidence intervals, irrespective of increased urinary frequency. If there 
is no pain/crying on passing urine, the lower confidence interval drops to 1.0%. 
 
These probabilities are summarised in Figure 5.7, presented to nearest whole percentage for 
the figure. I have highlighted low probabilities of UTI in yellow, high probabilities in red and 
those with moderate probabilities in orange.  
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Figure 5.7:  Probabilities of UTI based on the multivariable model. 
 
· In children younger than 3 months, the probability of UTI was high, irrespective of 
symptoms, at 12.5% with 95% confidence interval of 5.0%-28.1%.  
· In children 3 months or older but less than 3 years old, the overall prevalence was 
6.9% with a 95% confidence interval of 4.7%-10.0%.  
· Looking more closely at the symptoms based on the model, the highest probability of 
UTI is in children with increased frequency of passing urine (or number of wet 
nappies), particularly if they also have pain or crying when passing urine. Children in 
this age group, with neither pain/crying on passing urine nor increased urinary 
Acutely ill child 
Age <5 years 
Probability of UTI=5.9% 
(35/597; 95%CI=4.3-8.0) 
 
Age < 3 months 
Probability of UTI=12.5% 
(4/32;95% CI=5.0-28.1) 
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irrespective of symptoms 
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years 
Probability of UTI=6.9%  
(24/349;95% CI=4.7-
10.0) 
Increased frequency of 
passing urine/ wet 
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Increased pain or crying 
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No pain or crying when 
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Probability of UTI=15% 
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frequency/wet nappies  
Pain or crying when 
passing urine 
Probability of UTI=12% 
No pain or crying when 
passing urine 
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Age 3 -5 years 
Probability of UTI=3.2% 
(7/216; 95% CI=1.6-6.5) 
Increased urine frequency  
Pain or crying when 
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Probability of UTI=17% 
No pain or crying when 
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Probability of UTI=6% 
No increase in urine 
frequency  
Pain or crying when 
passing urine 
Probability of UTI=7% 
No pain or crying when 
pasing urine  
Probability of UTI=2% 
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frequency, had a probability of UTI of 5% but the 95% confidence intervals are wide 
(1.0%-23.2%).  
· For children aged 3-5 years, the overall probability of UTI was 3.2% with a 95% 
confidence interval of 1.6%-6.5%. The probability was highest if both dysuria and 
frequency were present (17%; 95% CI 5.4%-74.7%), approximately 6%-7% if only 
one of the symptoms were present, but much lower if neither were present, with a 
probability of 2% (95% CI 1.0%-5.0%). 
 
Urine sampling strategies 
 
Several urine sampling strategies are available to GPs. One option is to sample urine only 
when UTI is suspected. Another strategy would be to follow the NICE guideline 
recommendations for urine sampling.
1
 Another sampling strategy would be to sample urine 
from all presenting ill children less than five years old.  Based on the results of this study, I 
propose another possible sampling strategy: 
 
As confidence intervals are wide, caution is needed for making recommendations. However, 
one possible strategy may be to sample urine from all children aged less than three years, and 
in children aged between three and five years who have either urinary frequency or dysuria 
(or both), but not to sample urine from children aged between three and five years with 
neither urinary frequency nor dysuria. 
  
Comparison of various sampling strategies 
In the next section I compare four sampling strategies with culture results to determine the 
sensitivity and specificity of using each method to determine which children should have 
their urine sampled: 
1) Urine sampling based on GP suspicion of UTI 
2) Urine sampling based on the NICE guidelines  
3) Sampling urine from all children less than three years old and in children aged 
between three and five years old with urinary frequency or dysuria (proposed urine 
sampling strategy). 
4) Universal urine sampling from all acutely ill children <5 years old. 
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Urine sampling based on GP suspicion of UTI 
GP suspicion of UTI was based on the working diagnosis question on the CRF which was 
completed by GPs at the initial consultation and before urine culture results were available.  
A working diagnosis of UTI indicated by the GP was significantly associated with UTI on 
culture with an odds ratio of 3.9 (p<0.01; Table 5.29). However, the sensitivity is only 20% 
(Table 5.3). This means that 80% of UTIs found on culture would have been missed if only 
those who were suspected of having UTI had their urine sampled.  
 
Table 5.36: Predictive value of GP suspicion of UTI  
 
Feature Value 
Sensitivity 7/35 20.0% 
Specificity 528/562 94.0% 
 
 
Urine sampling based on the NICE guidelines
1
  
Figures 5.8 and 5.9 show the summary of guidance for diagnosis of UTI copied directly from 
the NICE guideline. 
 
Figure 5.8: Summary of guidance for diagnosis section 1.1: 
 
1.1 Diagnosis  
1.1.1 Symptoms and signs 
- Infants and children presenting with unexplained fever of 38°C or higher should have a 
urine sample tested after 24 hours at the latest.  
- Infants and children with an alternative site of infection should not have a urine sample 
tested. When infants and children with an alternative site of infection remain unwell, 
urine testing should be considered after 24 hours at the latest. 
- Infants and children with symptoms and signs suggestive of urinary tract infection 
(UTI) should have a urine sample tested for infection. Table 1 is a guide to the 
symptoms and signs that infants and children present with. 
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Figure 5.9: Presenting symptoms and signs in infants and children with UTI from NICE 
Age group Symptoms and signs 
Most common                                     Least common                     
Infants younger than 
3 months 
Fever 
Vomiting 
Lethargy 
Irritability 
Poor feeding 
Failure to thrive 
Abdominal pain 
Jaundice 
Haematuria 
Offensive urine 
Infants 
and 
children, 
3 months 
or older 
Preverbal Fever Abdominal pain 
Loin tenderness 
Vomiting 
Poor feeding 
Lethargy 
Irritability 
Haematuria 
Offensive urine 
Failure to thrive 
Verbal Frequency 
Dysuria 
Dysfunctional voiding 
Changes to continence 
Abdominal pain 
Loin tenderness 
Fever  
Malaise 
Vomiting 
Haematuria 
Offensive urine 
Cloudy urine 
 
I used Figures 5.8 and 5.9 to calculate which children would have had a urine sample sent if 
the NICE guidelines had been followed. I assumed that one of any of the symptoms given 
would be sufficient to warrant a urine sample. If there was an alternative site of infection, a 
urine sample was not deemed necessary. 
 
Table 5.37: Urine sampling based on NICE guidelines and UTI  
 
Sample based on NICE 
guidelines 
UTI found on culture Total Odds  
YES  NO 
YES 17 (48.6%) 219 (39.0%) 236 (39.5%) 0.08 
NO 18 (51.4%) 343 (61.0%) 361 (60.5%) 0.05 
Total  35 562 597 Odds ratio=1.5 
Sensitivity = 17/35 = 48.6%; Specificity=343/562=61.0% 
 
Many more children (six fold) would have their urine sampled if the NICE guidelines were 
followed compared with sampling based on GP suspicion (Table 5.37). The sensitivity is 
higher, detecting twice as many UTIs. Urine would be sampled in 40% children using this 
strategy but would still miss 51% of UTIs. 
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Proposed urine sampling strategy 
Table 5.38 summarises the association of culture results with urine sampling using my 
proposed strategy, where urine is sampled from all children less than three years old and only 
in children three years or older if they have urinary frequency or dysuria. 
 
 Table 5.38: Association of culture results with proposed urine sampling strategy 
 
Urine sample based on 
proposed urine sampling 
strategy 
UTI found on culture Total Odds  
YES  NO 
YES 34 (97.1%) 380 (67.6%) 414 (69.3%) 0.09 
NO 1 (2.9%) 182 (32.4%) 183 (30.7%) 0.01 
Total  35 562 597 Odds ratio = 16.3 
Sensitivity = 34/35 = 97.1%; Specificity = 182/562 = 32.4%  
 
Comparing the proposed sampling method with sampling based on NICE guidelines 
Only one (2.9%) of those with UTI would have been missed with the proposed sampling 
method, giving a sensitivity of 97.1%. Urine samples would need to be obtained in 69.3% of 
children (compared with 39.5% with the NICE guidelines). This increase in urine sampling 
(1.8 fold) would result in double the number of UTIs detected (97.1% vs. 48.6%).  
 
Comparing the proposed sampling method with sampling based on GP suspicion 
Comparing the proposed sampling method with sampling based on GP suspicion, 10 times 
more urine samples would be needed but five times more UTI would be detected. 
With this sampling strategy, 12 urine samples need to be sampled and tested to pick up one 
UTI (number needed to test=12). 
 
Comparing the proposed sampling method with universal sampling 
Comparing the proposed sampling method with a universal sampling strategy, 183 less 
samples would be needed (30% less), but one UTI would be missed.  
 
The one child missed using my proposed sampling method and my dataset was a four year 
old girl with no urinary symptoms but with abdominal pain and vomiting and a past history of 
UTI. The GP did not give a working diagnosis. 
 
Table 5.39 compares the proposed sampling strategy with sampling based on GP suspicion, 
NICE guidelines and universal sampling.  
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Table 5.39: Urine sampling outcomes based on GP suspicion, NICE guidelines, 
universal sampling and a proposed sampling strategy based on the model. 
 
Age 
group 
Urine sample GP 
suspicion 
If NICE 
guidelines had 
been applied 
Universal 
sampling (all 
acutely ill 
children <5 
years) 
Proposed 
sampling 
strategy 
<3 
months 
(n=32) 
Number  urine samples 0 9 32 32 
Number UTI diagnosed 0 1 4 4 
Number UTI missed 4 3 0 0 
3 mths-
3 yrs 
(n=349) 
Number  urine samples 19 150 349 349 
Number UTI diagnosed 3 10 24 24 
Number UTI missed 21 14 0 0 
>3 yrs 
(n=216) 
Number  urine samples 22 77 216 33 
Number UTI diagnosed 4 6 7 6 
Number UTI missed 3 1 0 1 
TOTAL  Number  urine samples 41 (6.9%) 236 (39.5%) 597 (100.0%) 414 (69.3%) 
 Number UTI diagnosed 7 (20.0%) 17 (48.6%) 35 (100.0%) 34 (97.1%) 
 Number UTI missed 28 (80.0%) 18 (51.4%) 0 (0.0%) 1 (2.9%) 
 Sensitivity 20.0% 48.6% 100.0% 97.1% 
 Specificity 94.0% 61.0% 0.0% 32.4% 
 
Near patient testing 
 
Urinary dipsticks 
 
Headline: Nitrites and blood on urinary dipstick were associated with UTI. However, 
sensitivity was low (<50% in each case). Specificity was high (97.2%) when both leukocytes 
and nitrites were positive. Dipstick findings varied by urine sampling method. 
 
Predictive symptoms or signs can be used to help to determine which children should have 
their urine sampled, as described above. Once the urine has been obtained, the next decisions 
are: whether the sample should be sent to the laboratory for microscopy and culture or not 
and whether the child should be treated with immediate antibiotics or not. 
 
Urine dipsticks are frequently used in adults, and in practice are probably often used in 
children. However, the reliability of the use of dipsticks in children has been questioned, as 
discussed in chapter 1.
1 112
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The children in my study may be different from previously studied populations of children as 
these children have had their urine systematically sampled for presentations of all acute 
illnesses. Therefore, I wanted to examine the predictive value of the dipsticks in my 
population, despite the fact that my study was not powered to determine these with great 
accuracy. 
 
Of the 597 included in the main analysis, 397 (66.5%) had dipstick results. Table 5.40 shows 
the urinary dipstick tests which were found to be significantly associated with UTI. 
 
Table 5.40: Testing an association between dipsticks and UTI 
Dipstick test Association with UTI: 
p-value  
Leukocytes 0.08 
Nitrites <0.01 
Protein 0.38 
Blood 0.04 
Ketones 0.13 
Glucose 0.12 
 
Leukocytes were not found to be significantly associated with UTI. However, as this is 
commonly used as a predictor for UTI I have included it in Table 5.41. I have also included 
combinations of positive findings of leukocytes and nitrites as these have been combined and 
used in algorithms previously and are advised by NICE for children aged three years or 
older.
1
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Table 5.41: Dipstick results and association with UTI 
Positive on Urine 
dipstick test for: 
UTI (%) No UTI (%) p-value Sensitivity Specificity 
Leukocytes 5/16 (31.3%) 52/359 (14.5%) P=0.08 31.3% 85.5% 
Nitrites 7/16 (43.8%) 21/359 (5.8%) P<0.01 43.8% 94.2% 
Blood 4/16 (25.0%) 28/359 (7.8%) P=0.04 25.0% 92.2% 
Both Leukocytes AND 
Nitrites positive  
4/16 (25.0%) 10/359 (2.8%) P<0.01 25.0% 97.2% 
Either Leukocytes  OR 
Nitrites positive 
8/16 (50.0%) 63/359 (17.5%) P<0.01 50.0% 82.5% 
 
All of the dipstick tests are fairly specific but all have very low sensitivity. So, using them to 
diagnose UTI would result in many cases of UTI being missed. One option may be to use 
them to treat some children with antibiotics whilst waiting for the culture result. With a high 
specificity this would not result in many unnecessary antibiotics, but would mean that most 
UTI would not be treated until the culture result became available.  
 
Dipstick findings: urine sampling method and age 
I wanted to explore dipstick findings with different urine sampling methods as this has not 
been established clearly in previous studies. Table 5.42 compares dipstick findings with the 
two different urine sampling methods. 
 
Table 5.42: Dipstick findings and urine sampling method 
 
Dipstick test  Number (%) of clean catch 
samples which are positive for 
the test 
Number (%) of nappy pad 
samples which are positive 
for the test 
p-value 
Leukocytes 27 (12.4%) 30 (19.4%) 0.05 
Nitrites 8 (3.7%) 20 (12.9%) <0.01 
Protein 55 (25.2%) 18 (11.6%) <0.01 
Blood 22 (10.1%) 10 (6.5%) 0.15 
Ketones 36 (16.5%) 12 (7.7%) 0.01 
Glucose 0 (0.0%) 3 (1.9%) 0.07 
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Protein and ketones were less commonly found in nappy pad samples compared with clean 
catch samples Nitrites were more commonly positive in nappy pad samples. This is 
interesting as the rates of UTI were similar in nappy pad and clean catch samples. 
 
One possible explanation is that the age of the child may be confounding this association. 
Table 5.43 shows the proportion of positive dipstick findings by age. There are higher levels 
of nitrites in younger children and higher levels of protein and ketones in older children. 
 
Table 5.43: Dipstick results and age 
Dipstick  Number (%) of <3 
month olds positive 
for the test 
Number (%) of 
3mths-3yrs positive 
for the test 
Number (%) of >3 yr 
olds positive for the 
test 
p-value 
Leukocytes 5 (25.0%) 34 (17.7%) 18 (11.0%) 0.10 
Nitrites 4 (20.0%) 22 (11.5%) 2 (1.2%) <0.01 
Protein 2 (10.0%) 25 (13.0%) 46 (28.2%) 0.01 
Blood 3 (15.0%) 13 (6.8%) 16 (9.8%) 0.34 
Ketones 1 (5.0%) 18 (9.4%) 29 (17.8%) 0.03 
Glucose 1 (5.0%) 2 (1.0%) 0 (0.0%) * 
* Numbers too small for !
2
 test 
 
Clinical outcomes  
 
Headline: Antibiotics were prescribed at the index consultation in 28.3% of children 
overall and in 37.1% of those with UTI. Children with UTI were more likely to have 
received an appropriate antibiotic at the index consultation if the GPs working diagnosis 
included UTI.  Half of the children with UTI had an illness which lasted more than two 
weeks. There was no difference in the number of re-consultations, admission or hospital 
referrals between those with and without UTI at six month follow-up. Children with a UTI 
received more courses of oral antibiotics in the following six months than children without 
UTI. Adherence to NICE guidelines for imaging following UTI was low (3.6%). 
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Initial management 
 Antibiotic prescription 
Oral antibiotics were prescribed at the initial (index) consultation in 169 (28.3%) children 
(Table 5.44). The majority of antibiotic prescriptions were for respiratory tract infections, 
with lower respiratory tract infections (LRTI) accounting for 24.0% of all antibiotic 
prescriptions and upper respiratory tract infections (URTI) accounting for a further 19.2%. 
Antibiotics were prescribed in 90.6% cases of tonsillitis, in 83.3% of LRTI and in 75.0% of 
ear infections (Table 5.45). Approximately half of those with a working diagnosis of UTI 
were prescribed antibiotics at the index consultation (prior to the diagnosis being confirmed 
with culture results).  
 
 
Table 5.46 shows the association of GP working diagnosis and oral antibiotic prescription at 
index consultation where the GP working diagnoses were amalgamated into fewer categories 
to allow statistical testing. This shows that there was a statistically significant difference in 
oral antibiotic prescription according to GP working diagnosis (p<0.01).  
 1
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GPs were twice as likely to prescribe antibiotics at the index consultation if their working 
diagnosis included UTI (51.2% vs. 26.6%; p<0.01; Table 5.47).  
 
Table 5.47: Comparing antibiotic prescription at index consultation in those with and 
without a working diagnosis of UTI 
Oral antibiotic prescription at  
index consultation 
GP working diagnosis 
includes UTI 
UTI not listed in GP 
working diagnosis  
Total 
Oral antibiotics prescribed 21 (51.2%) 148 (26.6%) 169 (28.3%) 
Oral antibiotics not prescribed 20 (48.8%) 408 (73.4%) 428 (71.7%) 
Total 41 556 597 
p<0.01 
 
A higher GP illness severity score was associated with an increased likelihood of prescription 
of antibiotics (p<0.01; Table 5.48). 
 
Table 5.48: GP assessment of illness severity and association with prescription of 
antibiotics at the index consultation 
 
Oral antibiotics prescribed GP illness severity score 
0-1  2-3 Total 
Yes 107(23.1%) 60 (57.1%) 167 (29.4%) 
No 356 (76.9%) 45 (42.9%) 401 (70.6%) 
Total 463 105 568* 
* missing information in 29 
p<0.01 
 
A child with a temperature of 38
o
C or more measured in the surgery increased the likelihood 
of an antibiotic prescription at the index consultation. However, only 36.0% of those with a 
temperature of 38
o
C or more were prescribed an antibiotic (p<0.01; Table 5.49).  
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Table 5.49: Fever of 38oC or more measured in surgery and association with antibiotic 
prescription 
Oral antibiotics 
prescribed 
Temperature measured in surgery  
Total >38oC <38oC 
Yes 64 (36.0%) 105 (25.1%) 169 (28.3%) 
No 114 (64.0%) 314 (74.9%) 428 (71.7%) 
Total 178 419 597 
p<0.01 
 
Association of antibiotic prescription and subsequent UTI 
Table 5.50 shows that antibiotics were prescribed at the initial (index) consultation in 37.1% 
of those who were subsequently found to have a UTI and in 27.8% of those who were 
subsequently found not to have a UTI, but the difference was not statistically significant 
(p=0.23).  
 
 Table 5.50: Antibiotic prescription at index consultation and association with UTI 
Oral antibiotic prescription at  
index consultation 
Subsequent culture result  
UTI No UTI Total 
Oral antibiotics prescribed 13 (37.1%) 156 (27.8%) 169 (28.3%) 
Oral antibiotics not prescribed 22 (62.9%) 406 (72.2%) 428 (71.7%) 
Total 35 562 597 
p=0.23 
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14 day follow-up 
Illness duration  
Telephone follow up was completed on 28/52 (57%) children with a positive or borderline 
culture result two weeks following index consultation. In 17 cases the urine result was not 
available in time to do the telephone follow up. In seven cases there was no answer despite 
multiple attempts. 
 
Table 5.51 shows the outcomes for the 18 children with UTI and the ten children with 
borderline culture results who had telephone follow up completed. 
  
Table 5.51: 14 day outcomes for children with UTI 
14 day outcome UTI  Borderline culture results 
Telephone follow up completed 18 10 
Child had fully recovered from illness 9 (50.0%) 7 (70.0%) 
Illness lasted >2 weeks 9 (50.0%) 3 (30.0%) 
Child had been assessed or admitted to hospital 0 (0.0%) 0 (0.0%) 
Child had re-consulted with GP 3 (16.7%) 2 (20.0%) 
Child had re-consulted with nurse 1 (5.6%) 0 (0.0%) 
Child had been to A&E 0 (0.0%) 0 (0.0%) 
Child had been seen in OOH 2 (11.1%) 0 (0.0%) 
Advice had been sought from pharmacist 0 (0.0%) 1 (10.0%) 
Advice had been sought from NHS Direct 1 (5.6%) 0 (0.0%) 
Child had been to see a specialist 0 (0.0%) 1 (10.0%) 
 
Of the nine children with UTI who had not fully recovered by two weeks, two (22.2%) had 
been prescribed antibiotics at the initial consultation (one was prescribed trimethoprim and 
one was prescribed amoxicillin). Two of the nine children (22.2%) who had fully recovered 
within two weeks were also prescribed antibiotics at the initial consultation (one had been 
prescribed cefalexin and one was prescribed penicillin V).  
 
Six month follow-up 
Of those included in the main analysis, 515 follow-up forms were sent to practices and 
returned, completed; four were sent and not completed due to the patients leaving the 
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practice. A total of 78 were not sent follow up forms to complete due to urine results not 
being available until later.  
 
The following results relate to those included in the main analysis with completed six month 
follow up forms (n=515). 
 
Table 5.52: Six month outcomes comparing those with UTI and those without 
Variable Frequency in those 
with UTI at index 
consultation 
Frequency in those 
with negative culture 
at index consultation 
p-value 
Number of in surgery face to 
face consultations 
0-1 8 (28.6%) 189 (38.8%) 0.28 
>2 20 (71.4%) 298 (61.2%) 
Number of acute/same day 
hospital admissions 
0 27 (96.4%) 452 (92.8%) 0.40 
>1 1 (3.6%) 35 (7.2%) 
Number of OOH or A+E 
contacts (including 
telephone) 
0 14 (50.0%) 315 (64.7% 0.12 
>1 14 (50.0%) 172 (35.3%) 
Number of courses of oral 
antibiotics 
0 7 (25.0%) 243 (49.9%) 0.02 
1 11 (39.3%) 154 (31.6%) 
>2 10 (35.7%) 90 (18.5%) 
Number of children  referred to the 
hospital for any reason 
6 (21.4%) 50 (10.3%) 0.10 
Number of children referred for or had 
any investigations of the renal tract  
4 (14.3%) 7 (1.4%) <0.01 
Number of children who have had or 
been referred for an USS 
3 (10.7%) 6 (1.2%) 0.01 
Number of children who have had or 
been referred for a DMSA scan 
1 (3.6%) 1 (0.2%) 0.07 
Number of children who have had or 
been referred for a MCUG scan 
0 (0.0%) 0 (0.0%)  
Total 28 487  
 
Table 5.52 shows outcome variables for the 6 months following the index consultation for 
those with UTI compared to those without. There were more referrals for renal tract 
investigations (p<0.01) and ultrasound scans (p=0.01). This is an expected finding as 
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guidelines recommend investigations and ultrasound scans for some children with UTI. Out 
of the 28 children with UTI in whom follow up data are available, three (10.7%) had been 
referred for or had an USS in the following six months, one (3.6%) had had or been referred 
for a DMSA scan and no children had had or been referred for a MCUG scan.  
 
The numbers were small when those with borderline results were considered separately and 
no statistical testing was performed. Eleven (64.7%) had two or more face to face 
consultations during the six month period; one (5.9%) had one or more hospital admissions; 
seven (41.2%) had one or more OOH/A&E contacts; and two (11.8%) had two or more 
courses of oral antibiotics. Two children with borderline results (11.8%) had been referred to 
hospital, and had been referred for or received ultrasound scans of the renal tract. 
 
There was a significant difference in the number of courses of antibiotics in the following six 
months between those with UTI and those without (p=0.02). Twice as many children with a 
UTI received two or more courses of antibiotics in the following six months compared with 
children without a UTI.  
 
Causative organism, antimicrobial sensitivity profile and empirical antibiotics 
Table 5.53 shows the antimicrobial sensitivity profile of the organism causing UTI and the 
antibiotic which was prescribed for children suspected and not suspected of having a UTI. 
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Table 5.53 Causative organism, antimicrobial sensitivity profile and prescribed 
antibiotics for children with UTI 
 
 
 
 
 
 
GP 
suspected 
UTI 
(n=7) 
PID Name of 
organism 
Antibiotics to which the 
organism is resistant 
 Antibiotic 
prescribed at 
index consultation 
Was prescribed 
antibiotic likely to 
treat UTI? 
326 Coliform Not given Trimethoprim Unclear 
1337 E.coli Fully sensitive Cefalexin Yes 
363 Coliform Amoxicillin None No 
1823 E.coli Amoxicillin Trimethoprim Yes 
1055 Coliform Fully sensitive Trimethoprim Yes 
1154 E.coli Amoxicillin Trimethoprim Yes 
1851 E.coli Amoxicillin, Trimethoprim Augmentin Yes 
 
 
 
GP did 
not 
suspect 
UTI 
(n=28) 
463 E.coli Fully sensitive None No 
468 E.coli Amoxicillin, Co-amoxiclav Penicillin V  No 
1938 E.coli Amoxicillin, Co-amoxiclav Amoxicillin  No 
1153 Enterococcus Fully sensitive  None No 
39 Coliform Not given None No 
1085 E.coli Amoxicillin None No 
461 E.coli Amoxicillin, Co-amoxiclav Amoxicillin  No 
472 E.coli Amoxicillin Penicillin V No 
396 E.coli Fully sensitive None No 
1361 E.coli Amoxicillin None No 
1832 Citrobacter 
freundii 
Amoxicillin, Cefalexin None No 
1342 Coag neg staph* Fully sensitive None No 
1368 Enterococcus Fully sensitive None No 
1377 E.coli Amoxicillin Amoxicillin  No 
1383 E.coli Fully sensitive None No 
2019 Enterococcus 
cloacae 
Not given None No 
1029 Coliform Trimethoprim None No 
1077 Coag neg staph* Fully sensitive None No 
156 Coliform Not given None No 
158 Coliform Not given None No 
408 Staphylococcus Not given None No 
1685 Coliform Amoxicillin, Augmentin, 
Nitrofurantoin 
None No 
2016 E.coli Ampicillin, Co-amoxiclav, 
Trimethoprim 
None No 
2063 E.coli Not given Amoxicillin  Unclear 
1382 Coag neg staph* Fully sensitive Co-amoxiclav  Yes 
5002 E.coli Fully sensitive None No 
3003 E.coli Fully sensitive None No 
2057 E.coli Fully sensitive None No 
* Coagulase negative staphylococcus 
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Of the seven who the GP suspected of having a UTI, six were prescribed an antibiotic. In five 
of these cases the bacteria was listed by the laboratory as showing sensitivity to the antibiotic 
prescribed. In one case sensitivities were not given by the laboratory. 
 
Of the 28 not suspected of having a UTI by the GP, antibiotics were prescribed in seven 
cases. However, in most of these cases (five) the antibiotic prescribed was one to which the 
bacteria were resistant (based on the laboratory report). In one case the bacteria were listed as 
being sensitive to the antibiotic prescribed, and in one case sensitivities were not provided. 
For children not suspected of having a UTI by the GP, appropriate antibiotics were prescribed 
empirically at the index consultation in only two (7.1%) children, compared with six (85.7%) 
receiving appropriate empirical antibiotics if they were suspected of having UTI.  
 
Overall, 6/35 (17.1%) children with a UTI had appropriate antibiotics prescribed at the initial 
consultation, a further two (5.7%) probably had appropriate antibiotics (sensitivities not given 
by laboratory), five (14.3%) had antibiotics prescribed to which the bacteria were resistant, 
and 22 (62.9%) were not prescribed antibiotics at the initial consultation.  
 
More than half (54.2%) of the UTIs were caused by E.coli (Table 5.54).  About a fifth 
(22.9%) were reported as Coliform, and a further fifth as other organisms. Among the 19 
E.coli culture results, more than half (11; 57.9%) were resistant to at least one antibiotic. This 
included amoxicillin in every case. About a third of all E.coli cultured were resistant to two 
or more antibiotics (Table 5.54). Among the 16 non-E.coli UTIs, resistance to antibiotics 
seemed to be lower with only a quarter resistant to at least one antibiotic and of these, two 
(12.5% overall) were resistant to more than one antibiotic.  
 
The laboratories were less likely to report antibiotic sensitivities for non-E.coli UTIs, with 
sensitivities not given in 6/16 (37.5%) of non-E.coli UTIs compared with 1/19 (5.3%) of 
E.coli UTIs. 
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Table 5.54: Summary of causative bacterial species and antibiotic sensitivities (n=35) 
Name of 
bacteria  
Number of 
UTI caused  
Antibiotic 
sensitivities 
not given 
Fully 
sensitive to 
antibiotics 
Resistant to 
1 antibiotic 
only 
Resistant 
to >2 
antibiotics 
E.coli 19 (54.3%) 1 (5.3%) 7 (36.8%) 5 (26.3%) 6 (31.6%) 
Coliform 8 (22.9%) 4 (50.0%) 1 (12.5%) 2 (25.0%) 1 (12.5%) 
Enterococcus 3 (8.6%) 1 (33.3%) 2 (66.7%) 0 (0.0%) 0 (0.0%) 
Coag-neg 
staphylococcus 
3 (8.6%) 0 (0.0%) 3 (100%) 0 (0.0%) 0 (0.0%) 
Citrobacter 1 (2.9%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (100%) 
Staphylococcus 1 (2.9%) 1 (100%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 
 
Table 5.55 shows the association of causative organism, antibiotic prescription and clinical 
outcomes for children with UTI. 
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Table 5.55: Association of organism, antibiotic prescription and clinical outcomes at 6 
months    
 PID Name of 
organism 
Was 
prescribed 
antibiotic 
likely to 
treat UTI? 
Surgery 
consultations 
OOH or 
A&E 
contacts 
No. courses 
oral 
antibiotics 
Hospital 
referrals 
Had or 
referred 
for USS 
GP did 
suspect 
UTI 
326 Coliform Unclear 2 1 1 0 0 
1337 E.coli Yes 3 2 4 1 1 
363 Coliform No 1 0 1 0 0 
1823 E.coli Yes 4 1 1 0 0 
1055 Coliform Yes 0 0 0 0 0 
1154 E.coli Yes . . . . . 
1851 E.coli Yes . . . . . 
GP did 
not 
suspect 
UTI 
463 E.coli No 6 0 2 0 0 
468 E.coli No 1 0 1 0 0 
1938 E.coli No 5 0 1 1 0 
1153 Enterococcus No 7 1 3 0 0 
39 Coliform No 6 0 3 0 0 
1085 E.coli No 0 0 0 0 0 
461 E.coli No 7 1 4 1 1 
472 E.coli No 7 3 2 0 0 
396 E.coli No 2 0 1 0 0 
1361 E.coli No 7 4 2 1 1 
1832 Citrobacter 
freundii 
No 4 0 4 1 0 
1342 Coag neg 
staph 
No 3 4 1 0 0 
1368 Enterococcus No 3 2 1 0 0 
1377 E.coli No 5 2 4 1 0 
1383 E.coli No 1 1 1 0 0 
2019 Enterococcus 
cloacae 
No . . . . . 
1029 Coliform No . . . . . 
1077 Coag neg 
staph 
No . . . . . 
156 Coliform No 4 0 2 0 0 
158 Coliform No 2 0 0 0 0 
408 Staph* No 5 0 0 0 0 
1685 Coliform No 6 2 1 0 0 
2016 E.coli No 1 0 0 0 0 
2063 E.coli Unclear 0 1 0 0 0 
1382 Coag neg 
staph 
Yes . . . . . 
5002 E.coli No . . . . . 
3003 E.coli No 1 0 1 0 0 
2057 E.coli No 5 1 0 0 0 
* Staphylococcus 
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There was only one acute hospital admission, one DMSA scan and no MCUG among all the 
children with UTI so these numbers were not presented in this table. I used a Mann-Whitney 
U-test to see whether there was a difference in outcomes between those in whom the GP 
suspected UTI and who generally received an appropriate antibiotic and those in whom the 
GP did not suspect a UTI and who generally did not receive an appropriate antibiotic. There 
was no significant difference in the median number of surgery consultations (P=0.33), 
OOH/A&E contacts (P=1.00); or courses of antibiotics between the two groups. The numbers 
in the follow up categories were small. More research is needed to explore this further. 
 
Imaging of children with UTI and comparison with NICE guidelines 
The NICE guidelines for imaging in children are divided into three age categories, which are 
slightly different from the three age categories used for diagnosis and symptoms. For  
imaging, the groups are aged: less than six months; six months or older but less than three 
years; and three years or older.  
 
Table 5.56 shows the number of children who had been referred for or received ultrasound 
scans (USS), DMSA scans or MCUG scans in the six months following the index 
consultation.  
 
Table 5.56: Imaging and referral during the six months following index consultation for 
children with UTI and a completed follow-up form (n=28) 
Age range Referred to 
hospital 
Had or referred for 
USS 
Had or referred for 
DMSA 
Yes No Yes No 
<6 months Yes 1 0 0 1 
No 0 3 0 3 
>6 months - 
<3 years 
Yes 1 3 0 4 
No 0 14 0 14 
>3 years Yes 1 0 1 0 
No 0 5 0 5 
 Total 3 25 1 27 
 
NICE states: 
· Infants and children with atypical UTI should have ultrasound of the urinary tract 
during the acute infection to identify structural abnormalities of the urinary tract such 
as obstruction. 
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· For infants younger than 6 months with first-time UTI that responds well to 
treatment, ultrasound should be carried out within 6 weeks of the UTI.  
· For infants and children 6 months or older with first-time UTI that responds to 
treatment, routine ultrasound is not recommended unless the infant or child has 
atypical UTI. 
·  Infants and children who have had a lower urinary tract infection should undergo 
ultrasound (within 6 weeks) only if they are younger than 6 months or have had 
recurrent infection.  
·  A DMSA scan 4-6 months following the acute infection should be used to detect 
renal parenchymal defects. 
Figures 5.10  5.13 are copied from the NICE guideline. Figure 5.10 defines atypical and 
recurrent UTI. Figures 5.11-5.13 show the recommendations from the NICE guidelines for 
imaging following UTI. 
 
Figure 5.10: Definitions of atypical and recurrent UTI in NICE guideline 
Atypical UTI includes: 
- Seriously ill  
- Poor urine flow 
- Abdominal or bladder mass 
- Raised creatinine 
- Septicaemia 
- Failure to respond to treatment with suitable antibiotics within 48 hours 
- Infection with non-E.coli organisms 
 
Recurrent UTI: 
1) Two or more episodes of UTI with acute pyelonephritis/upper urinary tract infection or 
2) One episode of UTI with acute pyelonephritis/upper urinary tract infection plus one or 
more episode of UTI with cystitis/lower urinary tract infection or 
3) Three or more episodes of UTI with cystitis/lower urinary tract infection. 
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Figure 5.11: Recommended imaging schedule for infants younger than 6 months in 
NICE guideline 
Test Responds well to treatment 
within 48 hours 
Atypical UTIa Recurrent UTIa 
Ultrasound during the 
acute infection 
No Yes
c 
Yes 
Ultrasound within 6 weeks Yes
b 
No No 
DMSA 4-6 months No Yes Yes 
MCUG No Yes Yes 
a
 see figure 5.10 for definition 
b
 if abnormal consider MCUG 
c
 In an infant or child with a non-E.coli UTI, responding well to antibiotics and with no other features of atypical 
infection, the ultrasound can be requested on a non-urgent basis to take place within 6 weeks.  
 
 
Figure 5.12: Recommended imaging schedule for infants and children 6 months or older 
but younger than 3 years in NICE guideline 
Test Responds well to 
treatment within 48 hours 
Atypical UTIa Recurrent UTIa 
Ultrasound during the 
acute infection 
No Yes
c 
No 
Ultrasound within 6 
weeks 
No No Yes 
DMSA 4-6 months No Yes Yes 
MCUG No No
b 
No
b 
a
 see figure 5.10 for definition 
b
 While MCUG should not be performed routinely it should be considered if the following features are present: 
· Dilatation on ultrasound 
· Poor urine flow 
· Non-E.coli UTI 
· Family history of VUR 
c
 In an infant or child with a non-E.coli UTI, responding well to antibiotics and with no other features of atypical 
infection, the ultrasound can be requested on a non-urgent basis to take place within 6 weeks.  
 
Figure 5.13: Recommended imaging schedule for children 3 years or older in NICE 
guideline 
Test Responds well to treatment 
within 48 hours 
Atypical UTIa Recurrent UTIa 
Ultrasound during the 
acute infection 
No Yes
b c
 No 
Ultrasound within 6 
weeks 
No No Yes
b 
DMSA 4-6 months No No Yes 
MCUG No No No 
a
 see figure 5.10 for definition 
b
 Ultrasound in toilet-trained children should be performed with a full bladder with an estimate of bladder 
volume before and after micturition 
c
 In an infant or child with a non-E.coli UTI, responding well to antibiotics and with no other features of atypical 
infection, the ultrasound can be requested on a non-urgent basis to take place within 6 weeks.  
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NICE recommends that all children under six months old should have an ultrasound within 
six weeks (in some children this should be during the acute infection). Only one of those 
under 6 months old had an USS (25.0%).  
 
Those with atypical or recurrent UTIs are also advised to have a DMSA scan. It is difficult to 
see from the data I collected whether some of the criteria for atypical or recurrent UTI apply, 
so I have examined whether there was infection with non-E.coli organisms and whether there 
was a history of UTI previously. There were only two with a past history of UTI but I could 
not tell how many previous UTIs had occurred or whether it was an upper UTI or not. For 
this purpose I assumed that it was an upper UTI and so justified various imaging. 
 
Table 5.57 shows the number of non-E.coli UTI and previous UTI (making the current 
episode a recurrent one) for different ages. 
 
Table 5.57: Association of age with non-E.coli UTI and recurrence 
 
Age range Number with 
non-E.coli UTI 
Number with 
history of UTI 
previously 
Number who 
had USS 
Number who 
had DMSA 
<6 months 1 0 0/1 0/1 
>6 mths - <3 yrs 9 1 (1 of the 9 non-
E.coli UTI) 
0/9 0/9 
>3 years 2 1 (E.coli UTI) 0/3 0/3 
 
 
Table 5.58: Comparison of imaging completed in study children within 6 months 
following UTI with NICE guideline recommendations 
 
Age range NICE 
guidelines 
recommend 
USS 
Had or 
referred 
for USS 
NICE 
guidelines 
recommend 
DMSA 
Had or 
referred 
for 
DMSA 
NICE 
guidelines 
recommend 
MCUG 
Had or 
referred 
for 
MCUG 
<6 months 4/4 1/4  
 
1 0/1 1 0/1 
>6 mths - <3 
yrs 
9/18 0/9  9 0/9 0 0 
>3 years 3/6 0/3  1 0/1 0 0 
Total 16/28 1/16 11/28 0/11 1/28 0/1 
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An ultrasound scan was indicated for all children less than six months old and half of the 
children in the older two age categories (Table 5.58). Only one (6.3%) of all the children in 
whom an USS was indicated, and none of the 11 in whom a DMSA scan was indicated, 
according to NICE guidelines, were reported as having had one or been referred for one in 
the six months following the index consultation. MCUG was only indicated in one child and 
was not done. This gives an overall guideline adherence for imaging of 1/28 (3.6%). 
 
In the youngest age category, one of the four children in whom an USS was indicated 
received one, and the one child in whom a DMSA scan was indicated did not receive it. 
There was one child in this age category who was referred to hospital during this period and 
so may have had investigations arranged by paediatrics that the surgeries were unaware of, 
but this was the same child who was reported as having an USS by the surgeries and was not 
the child with the non-E.coli UTIs in whom a DMSA scan was indicated. 
 
In the middle age category (6 months  3 years), nine of the 18 children were indicated for 
both USS and DMSA scans according to NICE. None of these children had either 
investigation, although one of the other children (in whom it was not apparently indicated 
according to NICE guidelines*) had an USS. Four children were referred to hospital in this 
age category. One of those referred had a non-E.coli UTI and was one of the nine in whom 
both USS and DMSA scans were indicated. If this child had received an USS and DMSA 
scan via the hospital referral, the surgery may not have known about that. The other three 
who were referred to hospital were not those in whom scanning was indicated. Therefore, for 
those in the middle category, assuming that the one child who was referred to hospital 
received scans, possibly 1/9 (11.1%) in whom both an USS and DMSA scan were indicated 
may have received them. 
 
In the oldest age category, ultrasound and DMSA scans were indicated in three out of the six 
children. None of these children were reported by surgeries as receiving either of these tests, 
although another child in whom it was not apparently indicated* did receive both an USS and 
DMSA scan. This was also the one child in this age category who was also referred to 
hospital. 
 
 
 
* NB these children may have fulfilled some of the other criteria for atypical UTI e.g. septicaemia or 
failure to respond to antibiotics within 48 hours and so investigations may have been indicated.  
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Chapter 6: Discussion  
 
Summary of Methods and Results 
 
Summary of what was done 
I completed a systematic review of the literature relevant to estimating prevalence rates in 
acutely ill children with systematic urine sampling in primary care settings (GP and A+E; 
chapter 2). I found that it was not clear what the prevalence rate of UTI was for unselected ill 
children presenting in UK primary care and concluded that a prospective study was warranted 
to determine prevalence of UTI in the UK. 
 
A pilot study, in four GP practices in South Wales with 99 children, showed that it was 
feasible to recruit and obtain urine samples from acutely ill children in general practices 
(chapter 3).
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I undertook a prospective study of 597 children, with systematic urine sampling, of children 
aged less than five years who presented to their GP with an acute illness of less than 28 days 
duration to provide an estimate of the prevalence of UTI. Thirteen GP practices and five NHS 
laboratories across Wales participated between March 2008 and July 2010. Children were 
excluded if they were on immunosuppressant treatment or long-term antibiotic treatment or 
had previously taken part in the study. I aimed to recruit 1600 children to give a sample size 
of 1100 with urine samples, allowing for some (30%) not providing urine samples. The 
sample size calculation was based on a predicted (estimated) prevalence of 3% with a 95% 
confidence interval of +/- 1%. 
 
Presenting symptoms, signs, risk factors, examination findings, working diagnosis and 
treatment were recorded on the CRF at the index consultation. A urine sample was requested 
from all children and obtained before leaving the surgery where possible. The urine sample 
was tested with a dipstick (where possible) and then sent to the local NHS laboratory using 
routine processes.  
 
A positive culture was defined as pure or predominant bacterial growth of >10
5
 cfu/ml on 
culture. All other results were considered negative for the main analyses. Additional 
sensitivity analyses defined a borderline culture as 10
4
-10
5
 cfu/ml of a single organism (in 
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laboratories which recorded growth at this level) or >10
5
 cfu/ml of two organisms. Urines 
with heavy mixed growths (>10
5
 cfu/ml of more than two organisms) were considered 
contaminated.  
 
A telephone follow-up questionnaire was completed at 14 days after the index consultation, 
for children with a positive or borderline culture result. A six month follow up questionnaire 
was sent to surgeries for all children who had provided a urine sample at the index 
consultation. 
 
Practices were asked to keep recruitment logs for eligible children who consulted, and record 
numbers of children invited and those consenting to participate. A check was made to see 
whether age and gender profiles were consistent with the practice population. 
 
The main analysis was limited to children from whom a urine sample had been provided 
within 48 hours of the index consultation (and where the laboratory had been able to analyse 
the specimen). I described the association of symptoms, signs and risk factors with UTI. I 
used the univariable analyses as a screening tool for inclusion of symptoms and signs (with a 
p-value of <0.1) into a multivariable logistic regression model.  
 
I calculated the probability of UTI for children in my study based on symptoms and signs 
using the model. I used the probabilities from the model to propose a urine sampling strategy 
for use by GPs. I compared my proposed sampling strategy with the sampling strategy 
advised in the NICE guideline and with sampling based on GP suspicion of UTI.
1
  
 
Summary of study population 
A total of 1003 eligible children were recruited from 13 general practices. Recruitment rate 
varied between practices from 1.5 per month to 11.7 per month. Four practices were not able 
to complete recruitment logs. The nine practices that did complete recruitment logs listed 63 
eligible children who were approached but not recruited. Median age of recruited children 
was 2.3 (IQR 1.0-3.5) compared with non-recruited children with a median age of 1.6 years 
(IQR 1.0-3.1). 
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Urine samples were obtained in 709 (70.7%), but leaked in 23 (3.2%) cases. Intact urine 
samples were received by laboratories within 48 hours of the index consultation in 597 cases 
(59.5%) and only these were included in the main analysis.  
 
Urine samples were obtained before the child left the surgery for 318 (53.2%) of the children 
included in the analysis. It was much less likely that the urine sample was received within 48 
hours of the index consultation if the sample was obtained after leaving the surgery (p<0.01). 
Antibiotics were prescribed in 31.1% (99/318) of children who provided urine samples prior 
to leaving the surgery and in 25.1% (70/279) of those who did not.  
 
A comparison of children included in the main analysis with those who did not provide a 
urine sample within 48 hours of the index consultation, found that children not included were 
younger (median age 1.6 years compared with 2.3 years in those included; p<0.01). There 
was a higher proportion suspected of UTI by GPs in those included in the main analysis than 
in those not included.  
 
Summary of main findings  
The prevalence of UTI among 597 systematically sampled acutely ill children less than five 
years old presenting in primary care was 5.9% with 95% confidence intervals of between 
4.3% and 8.0%. The prevalence of UTI was higher in younger children, with children under 
three years old having a prevalence of 7.3% (95% CI 5.1-10.4%) compared with children 
aged three years or older having a prevalence of 3.2% (95% CI 1.6-6.5%; p=0.04). 
 
There was no significant difference in the prevalence of UTI between boys and girls younger 
than three years old, but UTI was more common in girls than boys in children aged three 
years or older, with a prevalence of 7.1% (95% CI 3.5-14%) in girls and 0.0 (95% CI 0-3.2%) 
in boys (p<0.01).  
 
Prevalence did not appear to vary with deprivation, month of the year or GP surgery. There 
was a suggestion of some variation in prevalence depending on which laboratory processed 
the sample, however numbers were too small to determine whether this was significant.  
 
In 431 (72.2%) the method of urine sampling was given. Nappy pads were used in the 
majority of children less than three years old (100.0% in those aged <3 months; 74.3% in 
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those aged > 3 months to <3 years). Clean catch collection was used in all children > 3 years 
old. There was no statistically significant difference in the prevalence of UTI between nappy 
pad and clean catch samples (p=0.19).  
 
The definition of UTI used was a pure or predominant growth of bacteria of >10
5
 cfu/ml on 
culture of urine. In addition to the 5.9% which fitted this criterion,  a further 1.8% had a pure 
or predominant growth of bacteria of between 10
4
 and 10
5
 cfu/ml and 1.0% had predominant 
growths of >10
5
 cfu/ml of two different bacteria. Mixed growths were reported in 48.4% of 
samples. A heavy mixed growth of >10
5
cfu/ml was reported in 34.8%. Some laboratories 
commented that mixed growth was likely to represent contamination. Heavy mixed growths 
were more common in nappy pad samples (61.7%) compared with clean catch samples 
(13.2%; p>0.01).  
 
Urine samples were not cultured in 40 (6.7%) cases.   
 
The most common bacteria cultured were E.coli. These were responsible for 54.2% of UTIs. 
An additional 22.9% were reported as Coliforms. More than half of the E.coli (57.9%) and 
37.5% of the Coliform were resistant to one or more antibiotic. 
 
Antibiotics were prescribed at the index consultation (prior to urine culture results) in 37.1% 
of children subsequently found to have a UTI and in 27.8% of those who did not have UTI. 
Antibiotics were more likely to be prescribed if the GP suspected UTI (p<0.01). Appropriate 
(according to the eventual sensitivities) antibiotics were prescribed at the index consultations 
in 6/7 of those who had UTI and who were suspected of having UTI by the GP. In the 28 
with UTI who were not suspected of UTI, only one had an appropriate antibiotic prescribed at 
the index consultation.  
 
A multivariable logistic regression model identified age range, pain or crying on passing 
urine and increased urinary frequency (or frequency of wet nappies) as being associated with 
UTI. Neither a history of fever nor the absence of an alternative site of infection was 
significantly associated with UTI. 
 
Using the multivariable model, the probability of UTI in children less than three years old, 
irrespective of presenting symptoms and signs, was >5%. In children aged three to five years, 
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with neither pain on passing urine nor increased urinary frequency, the probability of UTI 
was 2%.  
 
Therefore a possible strategy of sampling urine in all children under the age of five years old 
except those three years or older without urinary symptoms was considered. This proposed 
strategy was compared with the urine sampling strategy in the NICE guidelines and with 
urine sampling according to GP suspicion of UTI. I estimated that the proposed strategy 
would identify 97% of UTIs and would only miss 3% of UTIs, compared with 51% which 
would be missed if NICE guidelines were followed and 80% if sampling was based on GP 
suspicion alone. However, this would involve sampling twice as many than is currently 
recommended by NICE guidelines and ten times more than would be sampled based on GP 
suspicion alone.  
 
Of the children diagnosed with UTI and with two week follow-up data (n=18), nine (50%) 
had an illness which lasted more than two weeks. None had been admitted to hospital.  
 
Among the children with six month follow up data (n=28 with UTI; n=487 without UTI), 
there was no difference in the number of re-consultations with GPs, number of acute 
admissions, number of out of hours or A&E contacts or number of hospital referrals between 
those with and those without UTI in the six months following the index consultation. 
Children with UTI were treated with more courses of antibiotics than those without, and were 
nearly twice as likely to have received two or more courses of antibiotics in the subsequent 
six months (p=0.02). 
 
Of the children diagnosed with UTI and with six month follow-up data (n=28), three children 
had been referred for or had an USS and one child had received a DMSA scan. No children 
had been referred for or received a MCUG. Comparing the investigations which children 
received with those advised by the current NICE guidelines, showed that only 1/16 
recommended children received an USS and none of the 13 recommended received a DMSA 
scan. The one child in whom a MCUG was indicated did not receive one. Two children 
received an USS and one child a DMSA scan when this did not seem to be indicated by NICE 
guidelines. The overall guideline adherence for imaging was 1/28 (3.6%). 
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Strengths 
 
Literature review  
A literature review and systematic review of prevalence determined the importance of the 
research question and the need for a large prospective prevalence study, with systematic urine 
sampling, in UK general practice.  
 
Pilot study 
The pilot study showed that it was feasible to recruit young children from general practices 
and obtain urine samples.
150
 It helped to secure funding to conduct the large study. Feedback 
from pilot study participants informed the method and CRF development for the main study. 
  
Prospective study with systematic urine sampling 
This was a prospective study with the estimated prevalence of UTI based on the urine 
samples from nearly 600 children recruited from GP surgeries in Wales, UK. This is the 
largest published study of this kind in UK general practice. It is important that the study was 
conducted in the UK, as the results of studies from other countries may not be generalisable 
to general practice in the UK due to differences in health care systems, consulting behaviour 
and socio-demographics.  
 
The results of related studies conducted in A&E departments (see chapter 2), despite using 
systematic sampling methods, may not be generalisable to acutely ill children presenting in 
general practice.
48 60 63 65-68 70 71 73 83 100-103 151 152 154
 Although it is a primary care service, 
children presenting to A&E departments are likely to be different to those presenting to their 
General Practitioner (GP). This may be partly dependent on the country of origin of the 
study.  Children presenting to A&E may be more seriously ill or they may have been taken to 
A&E due to increased parental concern. GPs interested in the probability that a child 
presenting with an acute illness, in their surgery, has a UTI will be more convinced by the 
prevalence of UTI among children presenting in a similar way to other GP practices, rather 
than data from children who present at A&E. 
 
This was a prospective study. All of the symptoms, signs, risk factors, examination findings, 
working diagnosis and treatments were recorded prior to the determination of UTI status. 
This means that any association of these variables with UTI status could not be explained by 
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the influence of practice or research nurses or doctors knowing the case status and 
introducing biased associations (reporting bias).  
 
Systematic urine sampling was one of the greatest strengths, and an important aspect of the 
design, of this study. The prevalence of UTI could not be determined accurately in a group of 
children in whom it was known that cases are easily missed
43
 without systematically 
sampling urine samples from all acutely ill consulting children. I achieved a 70% urine 
sample retrieval rate, with a resultant 597 urine samples finally available for the analysis. 
Although I had hoped for a higher retrieval rate, and ideally wanted all of the children to 
provide urine samples, obtaining 70% urine retrieval rate in this population and setting is a 
strength of this study. The key aspect of my study was that a sample was requested from all 
children, not just in children in whom the clinician suspected UTI. Although it is still 
possible that clinicians and parents were more or less enthusiastic in encouraging urine 
samples from some children, I tried to limit this in the study. Practice or research nurses 
requested a urine sample in most cases even before the child had been seen by the clinician, 
and everyone participating in the study was aware of the importance of obtaining urine from 
all children irrespective of presenting symptoms or what they thought the likely diagnosis 
was. Surgeries were reimbursed with less money if they recruited a child without a urine 
sample. This method reduces the chance of selection bias which has been present in many of 
the studies reporting UTI prevalence rates, as urine samples in other studies are often only 
requested if the clinician suspects UTI may be present.  
 
My study used usual GP and NHS processes for collection, transport, analysis and reporting 
of urine samples. This means that my results are more applicable to everyday general 
practice. The prevalence rate in my study should reflect the prevalence rates which other GPs 
in the UK will get if they were to systematically send urine samples on their acutely ill 
consulting children to their local NHS laboratory. Therefore the prevalence rate in my study 
should be a good estimate for the probability of UTI in a consulting ill child in their routine 
practice. Even with the inherent problems in the current system (e.g. delay in transport to 
laboratory) and with the diagnosis of UTI (imperfect gold standard), conducting a study in 
this pragmatic way means that it can be immediately incorporated into these systems and will 
be useful in everyday (imperfect) practice.  
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Broad inclusion criteria 
Most published studies use highly selected groups of children. Often children are only 
recruited if they have a high fever, commonly >38
o
C. 
48 60 63 65-68 70 71 73 83 100-103 151 152 154
 Other 
studies have shown that UTI can be present without fever and can still be associated with 
renal scarring.
81
 In addition, there are problems with basing study inclusion on fever as the 
definition of fever is difficult,
80
 there is wide variation in the methods used and the accuracy 
of these, and children may have had anti-pyretics or be at different stages in the illness 
perhaps with different associated temperatures. With the evidence that many UTIs were being 
missed in primary care,
43
 I wanted to be sure that I did not exclude children purely on the 
basis of a presenting symptom or sign. Many published studies also included only children 
with narrow age ranges, with most studies using systematic sampling only in very young 
children. The majority of studies included in the systematic review of Shaikh et al,
145
 and 
those  included in my systematic review in chapter two, are of children less than three months 
old.
48 61 63 65-67 70 71 100-103 151-153
   
 
I wanted to determine the prevalence in a typical ill child presenting in the surgery and also in 
the youngest children where the association with long-term complications is strongest.
12
 
Another exclusion criterion in other studies is of children with an alternative source of fever 
or other diagnosis. However, there is evidence that UTI can occur in children with (or 
thought to have) other diagnoses.
48
 I wanted to include all these children irrespective of the 
working diagnosis of the clinician.  
 
Analysis limited to urine samples processed within 2 days of the index consultation 
I only included urine samples which were received by laboratories within 2 days of the index 
consultation for the main analysis. This was to make sure that the urine sample related to the 
presenting symptoms and signs of the acute illness with which the child consulted. This was 
an arbitrary cut off point on which I decided following discussion with my supervisors. The 
more time which passes between the index consultation and collection of the urine sample, 
the more likely that any UTI present may have been cleared or a new illness developed, or 
antibiotics been taken and the urine sample may not accurately reflect the illness at the index 
consultation.  
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Determination of prevalence and confidence intervals 
I determined the prevalence of UTI in this population with fairly narrow confidence intervals. 
The prevalence was substantially higher than I had expected and is an important finding. The 
lower 95% confidence interval value was 4.3% which is likely to be clinically significant as 
GPs will encounter it commonly in routine practice. We can be confident (at least a 95% 
chance) that the true population prevalence of UTI in children under the age of five 
presenting in UK general practice with an acute illness is at least 4.3%. The clinically 
significant question is: is the prevalence (pre-test probability) high enough to justify urine 
samples in all acutely ill children? With the lowest estimate for the 95% confidence interval  
being 4.3%, it is likely that clinicians will consider changing their urine sampling 
behaviour.
40
 
 
Presenting symptoms & signs for children with UTIs including those previously un-
described 
I have described the presenting symptoms and signs for a group of children with UTI which 
includes children who would not have been detected in previous studies without systematic 
urine sampling. Children with UTI diagnosed in this way from general practice have not been 
described before. It may be that the UTIs in these children are different from the UTIs which 
are diagnosed when urine samples are only sent when UTI is suspected by clinicians. 
Although my study was not powered to accurately determine the predictive value of 
symptoms, signs and risk factors, it provides unique descriptive information about UTI 
diagnosed through attempted systematic sampling.  
 
Data gathered on those not recruited & not included in analysis 
Gathering data on those not recruited and those not analysed has allowed me to assess 
evidence of selection bias. 
 
There was a difference in age between those who were included in the main analysis and 
those who were not, with younger children less likely to provide a urine sample within 48 
hours (p<0.01). Children not included in the main analysis were approximately seven months 
younger than those included (median age 1.6 vs. 2.3). There was no difference in gender 
between these two groups. There was a higher level of GP suspicion of UTI among those 
included in the main analysis compared to those not included (OR 2.2; p=0.01). This could be 
due to GPs encouraging urine samples more in children in whom they suspected UTI or 
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perhaps parents were more inclined to obtain the urine sample if they considered their child 
could have a UTI (perhaps if they had urinary symptoms). It could also relate to the fact that 
younger children were less likely to be  in the main analysis and they are more likely to have 
non-specific symptoms. There was an association between GP suspicion of UTI and actual 
UTI (GPs suspected UTI in 20% of those with UTI compared to 6% in those without; 
p<0.01). If GPs encouraged parents to obtain urine samples more actively when they 
suspected UTI, and given that GP suspicion is associated with an increased likelihood of UTI, 
this may indicate some selection bias leading to a slight overestimation of the prevalence.  
 
Weaknesses 
 
Sample size 
I did not recruit the numbers for which I had aimed following my sample size calculation and 
so the confidence intervals were wider (+/- 2%) around my estimate than I had planned. The 
sample size was also not large enough to accurately determine predictive values for 
presenting symptoms and signs. This resulted in large confidence intervals for the odds ratios 
and probabilities in the multivariable model.  
 
The target of 1100 children with urine samples was ambitious for a modestly funded study in 
general practice involving children. A previous study of febrile children in the UK had 
struggled to recruit (target sample size 747; recruited 156).
160
 The pilot study showed that it 
was feasible to recruit acutely ill children from primary care.
150
 Several factors may have 
hindered recruitment for the main study. There were two structural changes which occurred 
during the approval and recruitment of practices. These were the changes to the R&D and 
ethics approval processes for primary care in April 2009 with the development of SPARC 
(Streamlined NHS Permissions Approach to Research  Cymru), and the restructuring of the 
NHS in Wales moving from 22 local health boards and 7 hospital trusts to just 7 local health 
boards (covering primary and secondary care) in October 2009. These two changes caused 
substantial delays in the approval of new practices to recruit for the study. Many practices 
withdrew agreement to participate and several that had agreed and finally received approval 
were only able to recruit for a short time. 
 
 In addition, the swine flu pandemic of 2009 (affecting UK from April Dec 2009) may have 
affected recruitment as practices were busy dealing with this pressing clinical and public 
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health problem and ill children (and adults) thought to have flu were advised not to come to 
surgeries.  
 
Obtaining urine samples from children in general practice is difficult and presumably some of 
the problems which I encountered with recruitment and urine retrieval were due to this. The 
other problem was that the children I wanted surgeries to recruit were the acutely ill children 
who were often consulting as emergencies, being squeezed in as extras in already busy 
clinics.  
 
Multiple significance testing  
I tested many potential predictive variables and this increased the likelihood that some would 
be statistically significant purely by chance. The p-values and associations found with the 
univariable analyses need to be interpreted in this context, and were conducted as a screening 
test to see which variables to enter in the multivariable logistic regression. 
 
Selection bias 
Practices 
Ideally, I would have taken a random sample of GP practices from Wales. Following my 
experience with the pilot study, I attempted to recruit practices in a systematic way, and sent 
out study information to all practices in the Cardiff and Vale area that had two or more GP 
partners or two or more practice nurses. I felt that the best chance of recruiting sequential 
children would be in practices large enough to have the space and resources to have a nurse 
recruiting for the study with protected time and space to facilitate this. Unfortunately there 
were not enough practices interested among this group and so all the practices in the Cardiff 
and Vale area were invited to participate and practices in other areas were also targeted.   
 
Selection bias could have occurred if the practices which participated in the study were 
systematically different to the practices which did not participate in terms of their prevalence 
of UTI, consulting behaviour of ill children, or recruitment of children into the study. 
 
If a practice had a policy of encouraging ill children not to attend the surgery or assessing 
more children over the telephone this could affect the prevalence of UTI by reducing the 
denominator (acutely ill consulting children). If a practice was in an area with high levels of 
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consulting for minor illness, the denominator may be much larger. This would not result in 
bias if the prevalence of UTI was similar in those consulting and those not consulting.  
 
Practices agreeing to take part in the study were more likely to be bigger practices (bigger 
practices were initially targeted) with some flexible nursing capacity which could be used for 
recruitment. Practices which were already research active and those which had already taken 
part in the pilot study were more likely to agree. Practices agreeing to participate may have 
had GPs or nurses who had an interest in UTI.  
 
 The practices in the study were from a range of affluent and deprived areas. They had larger 
list sizes than the average in Wales (mean 10,353 compared with 6,242) and higher than the 
average number of children under five years old registered (7.1% compared with 5.5%).   
 I did not find evidence of significant variation in prevalence between practices. It is unlikely 
that selection of practices resulted in biased prevalence results.  
 
Children 
Not all the children presenting in practices were recruited and not all recruited children 
provided a urine sample. This could have resulted in bias if there was a systematic non-
recruitment or systematic non-provision of urine samples in children more or less likely to 
have a UTI. I requested that practices recruit all eligible children and ask all children to 
provide a urine sample irrespective of whether they suspected that they may have a UTI. 
Ideally practices would recruit every eligible child, but this is not possible in reality and I 
knew from my experience with the pilot study that they would not do this.  
 
Many practices chose to only recruit on certain days or during certain sessions (e.g. 
mornings). I asked practices not to recruit on a Friday afternoon due to the problems with 
getting urine samples to laboratories. Not recruiting on certain days is unlikely to have 
resulted in bias as time of recruitment is unlikely to be linked to UTI prevalence.  
 
Selection bias would be a problem if nurses or GPs were selecting children for recruitment 
into the study based on suspicion of UTI.  There were several ways in which I tried to limit 
this from happening. Firstly, I emphasised the importance of recruiting all children 
irrespective of suspicion of UTI or not. Secondly, practices were financially reimbursed for 
all children whom they recruited irrespective of UTI status, and were reimbursed a higher 
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amount if a urine sample was obtained. This reduced the possibility of there being some 
systematic selection to the study. Also, the nurses and clinicians recruiting, consenting and 
treating the children were unaware of UTI status as this was a prospective study. Given that 
presenting features and clinician suspicion of UTI are poor predictors of actual UTI it seems 
unlikely that there was substantial selection bias in this way. I also asked practices to keep 
recruitment logs of those approached but not recruited to see if there were any differences 
between recruited and non-recruited children which may suggest selection bias. 
 
It is likely that the more seriously ill children were not recruited into my study. I asked 
practices to recruit children even if they were being admitted to hospital but, in reality, this 
would have been difficult, and probably inappropriate, for practices to obtain informed 
consent for this study, record data and attempt to obtain a urine sample when the child was 
seriously ill. I did ask practices simply to consent children and record personal data and not to 
collect the majority of CRF data or a urine sample (assuming it would be taken in hospital) 
but there were no patients in my study who were admitted on the same day as the index 
consultation. This is likely to have resulted in selection bias and probably an under-estimation 
of the prevalence of UTI. However, in practice, a GP urine sampling strategy is unlikely to 
apply to seriously ill children who are being admitted into hospital in any case.   
 
Although all children were asked to provide a urine sample, and practices were financially 
incentivised to obtain a urine sample in all children, there was only a 70% urine retrieval rate, 
and this dropped to 60% when only those providing urine samples within 48 hours were 
analysed. Even if clinicians were not selectively encouraging urine samples from certain 
children, it is likely that those who provided a urine sample within 48 hours were different 
from those who did not, and this could be associated with UTI prevalence. It seems likely that 
more seriously ill children may have been more difficult to obtain urine samples from, 
perhaps if the child was more dehydrated or agitated or taken to hospital and parents less 
focused on a research study. On the other hand, if a child was more ill the parents, GPs and 
nurses may have shown a greater degree of commitment to obtaining a urine sample. If a 
child was less ill or had no urinary symptoms, an obvious infection elsewhere (e.g. ear 
infection) or recovered from their illness very quickly, parents may not have seen the point or 
tried so hard to obtain a urine sample. Children with UTI may have avoided passing urine due 
to pain, making obtaining the urine sample more difficult. 
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Patients living further away from the surgery may have been less inclined to return the urine 
sample if they were unable to provide the sample in the surgery. This may have resulted in 
fewer samples from more deprived or rural areas.  
 
Overall, I think it is mostly likely that these factors resulted in my sample of children under-
representing the most ill children and may have resulted in a slight under-estimation of the 
prevalence of UTI. 
 
Attrition bias 
Children in main analysis older than those not included, and recruited children older than 
non-recruited 
The recruitment logs showed that children who were recruited were older than children who 
were not (median age 1.9 years vs. 1.6 years). Of the children recruited, children who 
provided urine samples within 48 hours and who were included in the main analysis, were 
older than those who did not (median age 2.3 years vs. 1.6 years). This may reflect the 
difficulties of obtaining urine samples in younger children. I found that younger children had 
a higher prevalence of UTI and as they were less well represented in my analysis, this may 
indicate that my prevalence of 5.9% is an underestimation of the true population prevalence. 
 
Loss to follow up was not a major problem for the main outcome or for the multivariable 
model. However, the outcomes from the 14 day telephone interview and the 6 month 
questionnaire were subject to loss to follow-up which can be a source of (attrition) bias. The 
biggest problem was with the telephone follow up which was only completed on 57% of 
targeted (positive or borderline culture result) children. In 70% of cases where telephone 
follow up was not completed, this was due to the results not being available in time. Due to 
this, and the overall numbers very small, there is limited analysis on the telephone follow up 
data. Six month follow up forms were completed in 99% of those in whom they were 
requested. Follow up forms were not requested in 78 (13%) of those who should have been 
sent them (follow up forms were not requested from children who had not provided a urine 
sample) due to the urine results not being available until after the follow-up data collection 
period.  
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Other sources of bias 
Misallocation 
Misallocation is an important issue. The problem of false positive and false negative results is 
significant and impossible to quantify due to the lack of a reliable gold standard. This 
problem is exacerbated in a primary care study in children where samples are more likely to 
be contaminated and there are likely to be delays in transport to the laboratory. Misallocation 
may also have occurred if the child had asymptomatic bacteriuria and a coincidental acute 
illness.  The issue is whether misallocations are likely to have been random (in which case 
the true associations may simply have been diluted) or associated in some way with UTI or 
risk factors, in which case it would result in bias.  
 
Variation in laboratory procedures may have resulted in misallocation. It would have been 
ideal to have had all the urine samples analysed in one laboratory, with high quality 
procedures and standardised SOPs, but this was not possible for my study. I found that there 
was variation between laboratories in procedures for storage, analysis and reporting of urine 
cultures which may have affected my prevalence estimate.    
 
Contamination 
Contamination was more common in nappy pad urine samples. The nappy pads were used in 
the younger children and the prevalence of UTI was highest in the younger children. There 
was no statistically significant difference in the prevalence of UTI between nappy pad and 
clean catch samples which implies that although contamination (and presumably 
misallocation) was more common in nappy pad samples, this was not associated with the 
prevalence of UTI. However, the numbers may have been too small to detect a statistically 
significant difference (type II error).  
 
Another source of misallocation could be due to antibiotics prescribed at the index 
consultation and taken before the urine sample was provided. Only including urine samples 
obtained within 48 hours of the index consultation reduces the risk of this, and GPs may have 
advised parents not to start antibiotics until the sample had been obtained. However, it is 
possible that some children with UTIs were misallocated as a result of this.  Antibiotics were 
prescribed in 31% of children who provided a urine sample prior to leaving the surgery and in 
25% of children in whom a urine sample was obtained after they left the surgery (but within 
48 hours). Of those who did not provide a urine sample before leaving the surgery, there was 
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no difference in the prevalence of UTI according to whether or not antibiotics were 
prescribed (p=0.33). 
 
Summary of potential sources of bias 
Table 6.1 summarises the potential sources of bias which I have identified and the likely 
effect of these on the prevalence of UTI in my study. 
 
Table 6.1: Summary of potential sources of bias and possible effect on prevalence of 
UTI 
Source of bias  Likely effect on 
UTI prevalence 
Selection bias (practices) None 
Selection bias 
(children) 
Younger children less likely to be included (included children 
older than not included) 
Underestimation  
Seriously ill children less likely to be included (no included 
children admitted to hospital; less likely to participate in 
research if very ill) 
Underestimation  
Dehydrated children less likely to be included (less likely to 
produce urine sample within 48 hours) 
Underestimation  
Parents/clinicians did not think UTI likely (possibly less 
commitment to obtaining urine sample) 
Overestimation  
Children with UTI may have had pain on passing urine and less 
likely to produce a urine sample 
Underestimation  
Parents living further away from the surgery may have been 
less likely to return urine samples 
None 
Misallocation  Contaminated and nappy pad samples are more likely to result 
in misallocation. This could result in false positive results or 
false negative results.  
Unclear  
Antibiotics taken prior to urine sample being provided could 
cause false negative results 
Underestimation 
 
Generalisability of findings 
My study was conducted in GP practices in Wales. The primary care system in Wales is 
similar to the rest of the UK. It may not be the same as other countries in Europe or 
worldwide. All healthcare systems will have a similar problem of acutely ill children 
presenting to doctors, but the underlying prevalence of UTI in the population of acutely ill 
children may vary. The consulting behaviour of ill children may also vary between countries. 
This may mean that the estimate of prevalence of UTI which I have found in my study is not 
directly generalisable to other countries. Other studies have found variation in UTI 
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prevalence by ethnicity and circumcision status and I did not have sufficient numbers to 
explore these associations in my study. 
 
No children were recruited in my study out of normal surgery hours (i.e. in the evening or at 
the weekend). It is possible that children presenting in the evening or at the weekend are 
different from those consulting during normal hours, perhaps with more serious illness, and 
possibly with a different risk of UTI. This will not result in bias in my study, it simply means 
that my findings may not be generalisable to this other group of children. This group of 
children is well represented in other studies conducted in A+E departments.  
 
There is evidence that UTI prevalence may vary with ethnicity.
48 68 76 77 145
 I did not collect 
data on ethnicity in my study. This may need to be taken into consideration when 
extrapolating my findings to areas of differing ethnic makeup. 
 
Other considerations 
The two symptoms included in the multivariable logistic regression model (pain or crying on 
passing urine and increased frequency of passing urine or wet nappies) may have been 
difficult to determine in the youngest group of children and numbers were particularly small 
in this group. However, this may not impact on clinical management as the prevalence in this 
group was high irrespective of symptoms, and a urine sample indicated in all of them.  
 
Statistics 
 
Multi-level sampling 
I assessed the impact of the multilevel (two level) sampling, using the intraclass correlation 
coefficient (ICC). This was a way of measuring the impact of taking a sample of surgeries 
and then a sample of children from the surgeries. I found that the variation between practices 
accounted for only a small amount (5.6%) of the overall variability in prevalence of UTI.  
 
Logistic regression 
Logistic regression assumes independence of errors. This means that cases of data should not 
be related in any way. This is one of the reasons for including children into the study only 
once. Logistic regression also assumes that the different prediction variables are not too 
highly correlated with each other.  I assessed the correlation of the variables which I entered 
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into my model with each other. There was some correlation between dysuria and frequency 
and age. Therefore, I included the interaction terms as well as the separate variables in the 
forward stepwise logistic regression model but they were excluded by the analysis and only 
the individual variables were included in the final model. 
 
Validity 
Internal validity and model fit 
 I used all the available data to develop the model and assessed the performance of the model 
on the same data.  
 
I found that the model was significantly better at predicting UTI than the constant only model 
(p<0.01). However, the model does not explain much of the variation in the data. A 
Nagelkerke R
2
 of .08 indicates that the model predicts only 8% of the variation in the data, 
with 92% unaccounted for. This may be because my sample size was not large enough to 
give enough power to detect associations with enough certainty and I may not have included 
the (truly) correct variables in the model. It may be that it is not possible to highly predict 
UTI in young children from symptoms and signs.  
 
External validity 
External validity is the generalisability of the model to other similar populations. It is 
essential to confirm external validity for any prediction model. I have not been able to assess 
the external validity of my model but hope to be able to assess this, and how my proposed 
sampling strategy performs in another similar dataset as part of future work.
176
 
 
From prediction model to clinical decision making 
The prediction model which I derived was associated with probabilities with very large 
confidence intervals.  
 
When I considered possible sampling strategies in view of the logistic regression model, I 
was acutely aware of the large confidence intervals for probabilities particularly when 
considering the effect of the two symptom variables after the age categorisation. If just the 
age was considered, the lower confidence interval for the probability of UTI for both children 
<3 months and children <3 years was >4%. This means that there is reasonable certainty that 
the probability of UTI in a child less than 3 years old is at least 4% irrespective of presenting 
 182 
 
symptoms.  For children aged 3-5 years, the 95% confidence interval for the probability of 
UTI was from 1.6-6.5%, implying that it may not be as necessary to sample urine in all of 
these children. Looking at the probabilities of UTI with associated confidence intervals for 
the addition of the two symptom variables in the logistic regression model (dysuria and 
frequency) the probability was high if both symptoms were present (17%; 95%CI 5.4-
74.7%); moderately high if either of the symptoms was present (6-7%), but much lower if 
neither were present with fairly narrow confidence intervals (2%; 95% CI 1.0-5.0%). If 
neither dysuria nor frequency are present in a 3-5 year old child, we can be reasonably certain 
that the probability of UTI is <5%.  
 
My proposed sampling strategy (based on the logistic regression model) gives a sensitivity of 
97.1% and specificity of 32.4% for UTI. 
 
A major implication of my proposed sampling strategy is that it would require a large 
increase in urine sampling which is likely to be costly, time consuming and the majority of 
samples will be negative. However, it does require less urine sampling than a strategy of 
sampling urine from all acutely ill children, which is also a potential strategy given that the 
overall prevalence of UTI is probably sufficiently high to consider this.
40
 
 
If my sample size had been larger with more power to detect the predictive value of 
symptoms with greater accuracy (and narrower confidence intervals) I may have been able to 
propose a more specific decision rule.  
 
Choice of predictive values 
I have chosen to present sensitivity and specificity when describing the predictive value of 
symptoms, signs or when describing my model. Other features could have been presented, for 
example positive/negative predictive values and positive/negative likelihood ratios. All of 
these values can be calculated from the data presented. I felt sensitivity was the most 
important feature to present as this is the best measure of how many children with UTI would 
be missed with the various models.
177
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Comparison with existing literature and clinical implications 
 
In this section, each paragraph from the summary of findings (at the beginning of this 
chapter) will be discussed in detail. 
 
Prevalence of UTI 
The prevalence of UTI among 597 systematically sampled acutely ill children less than five 
years old presenting in primary care was 5.9% with 95% confidence intervals of between 
4.3% and 8.0%. The prevalence of UTI was higher in younger children, with children less 
than three years old having a prevalence of 7.3% (95% CI 5.1-10.4%) compared with 
children aged three years or older having a prevalence of 3.2% (95% CI 1.6-6.5%; p=0.04). 
 
The prevalence of UTI was higher than I had expected based on earlier primary care studies.
1 
43 60 68 178
 It is also higher than the prevalence I found in the pilot study (chapter 3).
150
 
 
It is slightly lower than the pooled prevalence of 7% which was found in a systematic review 
and meta-analysis of prevalence of UTI in children.
145
 However, as the studies included in 
this systematic review generally had very narrow inclusion criteria (e.g. aged under 3 months 
old and with a fever >38
o
C) and were not necessarily systematically sampled, I had expected 
the prevalence in my study to be much lower than this. The prevalence I found in the younger 
children (less than three years old; 7.3%) was very similar to this pooled prevalence.  
 
The comparison of the prevalence which I have found should be compared with other studies 
which have systematically sampled urine from children (rather than sampled according to 
clinician suspicion), and with studies which have a presenting population of unselected 
children (i.e. primary care settings including GP surgeries, out of hours and A&E 
departments rather than secondary care settings where children have already been selected for 
admission or follow-up by other clinicians). In chapter 2, I presented a systematic review of 
published studies which described the prevalence of UTI in acutely ill children less than five 
years old, presenting in primary care.   
 
The pooled prevalence of these studies was 7% for those aged less than 3 months old (n=15) 
and 8% for those up to 5 years old (n=6). These studies were all based in primary care and 
had systematically sampled urine. However, most of the studies (19/21) were based in 
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paediatric emergency departments rather than GP surgeries, which may have represented a 
more seriously ill population of children; 17/21 studies were based in the USA; and 19/21 
included children only if they had a fever of at least 38
o
C. In addition, there was a high 
degree of heterogeneity between studies, particularly between the six studies for the older 
children. 
 
There are several possible explanations for the difference in findings between mine and other 
studies. This is the first large study in UK primary care which systematically samples urine 
from acutely ill children and is likely to give a more accurate estimate of the true prevalence 
of UTI in the population of children under the age of five with acute illness than other studies 
which have either had clinician suspicion-led urine sampling or have been conducted 
systematically in secondary care or in only highly selected children.  
 
I did not exclude children if they did not have a fever or if they had alternative sources of 
infection, which could have resulted in my study having a lower UTI prevalence than other 
studies. The UK population has low levels of circumcision and higher proportions of white 
children, compared with the USA where most previous studies have been conducted.
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The circumcision rate among boys in my study was only 2.8% which is similar to the UK 
average whereas it is approximately 80% in USA.
158
 Not being circumcised and being white 
have both been found to be associated with a higher risk of UTI in other studies.
48 63 68 76 77 102 
145
 This may partly explain why my study prevalence is higher than other published studies.  
 
The children who were included in my analysis were older than the children not included 
having not provided a urine sample within 48 hours. Obtaining urine samples from the 
youngest children is difficult. Of the children who were included in my study, the prevalence 
was highest in the youngest children. This has also been found in other studies. This may 
have resulted in the prevalence in my study being lower than the true value due to fewer of 
the youngest children being included in the analysis.  
 
None of the children in my study were admitted to hospital and none of them were scored as 
being seriously ill by parents or GPs on the 5 point illness severity score. Although I found no 
association between illness score (by parents or GPs) and UTI, the under-representation of 
the most ill children in my study may have resulted in an under-estimation of the true 
prevalence of UTI in acutely ill children.  
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Gender and age 
There was no difference in the prevalence of UTI between boys and girls younger than 
three years old, but UTI was more common in girls than boys in children aged three years 
or older, with a prevalence of 7.1% (95% CI 3.5-14%) in girls and 0 (95% CI 0-3.2%) in 
boys (p<0.01).  
 
Other studies have found that the prevalence of UTI is higher in boys in the youngest 
children, until about 3-6 months old; after this, UTI is more common in girls.
1
 I also found 
that UTI was more common in girls in the older children (aged 3 years or older). In children 
under three years old I found there was no difference in UTI prevalence between boys and 
girls. It may be that my numbers were not large enough to detect gender differences in the 
youngest children. It may be that UTI is equally prevalent in young boys and girls but that 
previous studies have disproportionately detected UTI in boys, perhaps if it is associated with 
more severe illness or structural abnormalities. Some studies have found that among children 
with UTI, boys have a higher proportion of pyelonephritis and serious bacteraemic UTI than 
girls.
58 180
  
 
Deprivation and time of year 
Prevalence did not appear to vary with deprivation, month of the year or GP surgery.  
 
NICE identified two studies which found that UTI was more common in the summer 
months.
1 181 182
 I expected UTI prevalence to be greater in the summer months because I was 
measuring the proportion of children with acute illness who had UTI and in the winter 
months I would expect there to be greater numbers of children presenting with URTI and 
other viral illness which would therefore result in proportionately less UTI. The swine flu 
epidemic may have been partially responsible for my lack of seasonal variation. The 
epidemic started earlier in the year than the usual winter flu peak, the advice throughout the 
epidemic period was to stay at home and not to present to the surgery (where possible) and 
surgeries were very busy with the epidemic and contingency plans and study recruitment in 
general was lower than expected.  
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Laboratory variation 
There was a suggestion of some differences in prevalence according to laboratory, however 
numbers were too small to determine whether this was significant.  
 
The UTI prevalence varied between the four laboratories but these were associated with wide 
confidence intervals apart from laboratory 1 which received most (84%) of the urine samples. 
Laboratory 2 had the lowest prevalence (0; 95% CI: 0-17.6%) and this was the laboratory 
with a SOP of not culturing microscopy negative urine samples. Laboratories 3 and 4 had 
higher 95% confidence intervals for prevalence than the other laboratories. There were no 
obvious reasons in their SOPs to explain this. It may be due to chance with low numbers of 
urine samples analysed by these laboratories. When the three other laboratories were 
considered as one group and compared to laboratory 1 the prevalence was higher (10.4%) as 
a group, but the confidence intervals overlapped with laboratory 1 (5.8-18.1% compared to 
3.4-7.3% for laboratory 1).  
 
Urine sampling method 
431 (72%) indicated which method of urine sampling was used. Nappy pads were used in 
the majority of children less than three years old (100% aged <3 months; 74% aged > 3 
months to <3 years). Clean catch collection was used in all children > 3 years old.  
There was no statistically significant difference in the prevalence of UTI between nappy 
pad and clean catch samples (p=0.19) There was no statistically significant difference in 
the prevalence between nappy pad and clean catch samples for children under 3 years old 
(p=0.76).  
 
I was surprised that there was no difference in the prevalence of UTI according to sampling 
method. I expected the prevalence in nappy pad samples to be higher due to the higher 
probability of contamination, and possible false positive results (thus misallocation bias), 
and also because the children using nappy pads were younger. When children under three 
years old (those in whom both nappy pads and clean catch methods were used) were 
considered separately, there was still no statistical difference in the prevalence of UTI, 
although the trend was towards fewer UTIs in those using nappy pads than those using the 
clean catch method. This may indicate that nappy pads, with the higher levels of 
contamination, may have higher levels of false negative results.  
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UTI threshold and borderline results 
The definition of UTI was a pure or predominant growth of bacteria of >10
5
 cfu/ml on 
culture of urine. In addition to the 5.9% which fitted this criterion, a further 1.8% had a 
pure or predominant growth of bacteria of between 10
4
 and 10
5
 cfu/ml and 1.0% had 
predominant growths of >10
5
 cfu/ml of two bacteria.  
 
I discussed the results with microbiologists (Dr Robin Howe and Dr Mandy Wootton) at 
Cardiff and Vale LHB and they felt that the pure or predominant growth of between 10
4
 and 
10
5
 cfu/ml of a single bacterial species and predominant growths of >10
5
 cfu/ml of two 
bacteria, although negative by current definitions of UTI may be interpreted as possible UTI 
depending on clinical findings.  
 
The National Laboratory Standards document for 2012 states, [children] colony counts of > 
10
3
 cfu/ml of a single species may be diagnostic of UTI in voided urine.
89
 Generally a pure 
growth of between 10
4
-10
5
 cfu/ml is indicative of UTI in a carefully taken specimen. This 
document would also classify the growth of 2 bacteria each with a growth of >10
5
 cfu/ml or 
one with a growth of >10
5
 cfu/ml and one with a growth of 10
4
-10
5
 cfu/ml as positive if there 
were WBCs on microscopy or if the child were symptomatic.
89
  
 
Some authors have suggested a lower threshold for the diagnosis of UTI.
16 88 109
 
Kanellopoulos et al (2005) found that UTI could be present despite low bacterial counts and 
that these were more common in young children, often caused by non-E.coli bacteria but 
associated with the same risk of scarring as in higher count infections.
16
 Others have argued 
that the presence of more than one organism should not necessarily rule out UTI and that 
mixed infections may occur.
90 107
 If the borderline urine results from my study were 
considered UTIs, the prevalence of UTI would be 8.7%.  
 
There are not sufficient data from my study to suggest whether the threshold should be 
changed. Further studies investigating the development of renal scarring at different 
diagnostic thresholds, and ideally long term follow-up are needed. The clinical outcomes of 
children with borderline or lower threshold results may inform the discussion. If the 
outcomes for these children were more similar to the outcomes of children with UTI than 
those without, it may suggest the need for a change in the diagnostic threshold. I found no 
significant differences in the outcomes of children with UTI, with borderline results or with 
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negative results with respect to the number of re-consultations, acute admissions, out of hours 
or A+E contacts or hospital referrals in the six months following the index consultations, but 
numbers were small. 
 
Children who had a UTI at the index consultation were more likely to have two or more 
courses of antibiotics in the subsequent six months of follow up than those who did not have 
a UTI (p=0.02), but this was not the case for those with borderline results. Children with 
borderline results did receive investigations of the renal tract more often than those with 
negative results.  
 
Further studies are needed to determine the nature of the clinical illness with both short-term 
and long-term outcomes for children with these borderline results.  
 
Mixed growths and contamination 
Mixed growths were reported in 48.4% samples. A heavy mixed growth of >10
5
cfu/ml was 
reported in 34.8%. Some laboratories commented on reports that mixed growth was likely 
to represent contamination. Heavy mixed growths were more common in nappy pad 
samples (61.7%) compared with clean catch samples (13.2%; p>0.01).  
 
There was no statistically significant difference in the prevalence of UTI between nappy pad 
and clean catch samples both for all children (p=0.19), and for children under 3 years old 
(p=0.76).  
 
Giddens (1998) found a contamination rate of 66% in children under 2 years which is similar 
to my finding of heavy mixed growths among nappy pad samples of 61.7%.
86
  
That there was no difference in UTI prevalence between nappy pad and clean catch samples 
is interesting as it is widely believed that the increased contamination of nappy pad samples 
will result in more false positive results. All the nappy pad samples were from children less 
than 3 years old. I found that there was a higher proportion of heavy mixed growth in nappy 
pad samples as I had expected, but the prevalence of UTI was 5.5% in nappy pad samples 
and 6.6% in clean catch samples in the children less than 3 years old, with no statistical 
difference in the prevalence. This is surprising if the hypothesis that nappy pad samples result 
in more false positive results is true. It seems more likely from my data that nappy pad 
samples, growing more mixed cultures, result in a higher chance of false negatives with true 
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positives hidden by contaminating bacteria. Interestingly, there were also higher levels of 
leukocytes and nitrites in the urine samples collected with nappy pads (p=0.05 and p<0.01 
respectively) but no corresponding higher rates of UTI by culture (p=0.19). Lau 2007 
comments that contamination may cause false negative results in infants.
90
 
 
No culture for microscopy negative samples 
Urine samples were not cultured in 40 (6.7%) cases.   
 
Some of these were due to laboratory 2 (12) whose SOP clearly stated that it did not culture 
urine with negative microscopy. Those not cultured constituted 66.7% of samples received by 
this laboratory. Laboratory 1 did not culture 26 (5.2% of all samples received by this 
laboratory) and laboratory 3 did not culture 2 (3%). This seemed to be a variation from the 
normal SOP in these laboratories where urine was cultured in children irrespective of 
microscopy results. However, laboratory 1 began to use an automated microscopy machine 
(flow cytometer) part of the way through the study and if no bacteria were detected by flow 
cytometry, the urine was not necessarily cultured in children. According to the laboratory 
SOP and the National Laboratory Standards for analysis of urine (2012), children should have 
continued to have urine cultured irrespective of microscopy results.
89
 The National 
Laboratory Standards document states that, urine analysers may be used to screen for 
negatives to allow earlier reporting. Regardless of screening result, culture is still 
recommended for all specimens from children.
89
 
 
There is evidence that microscopic detection of white blood cells (pyuria) is not reliable in 
the detection of UTI in children.
112
 On the one hand, UTI can occur without significant 
pyuria
112
 and on the other hand, white blood cells can be detected in the urine of children 
with fever from other illnesses.
183
 Microscopy to detect bacteriuria is a better predictor of 
UTI than microscopy to detect pyuria but still has low sensitivities.
1 112
 
 
NICE conducted a review of other diagnostic tests including flow cytometry (automated 
microscopy) and concluded that there was insufficient evidence to determine the accuracy of 
this.
1
 I found several reports comparing automated microscopy with culture. Sensitivities 
ranged from 64% - 98% and specificity 55% - 92%
184
  All of these were conducted on adult 
populations. I found one paper which considered the accuracy of automated microscopy in 
urines from children.
185 They included 168 urine samples and reported a sensitivity of 89% 
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and specificity of 85% overall, and a sensitivity of 100% and specificity of 83% in children 
under the age of three years old. But only 14 children were under the age of three years old, 
two of whom had positive culture and they also found that urinary dipsticks had 100% 
sensitivity for this group which has been shown by larger studies not to be an accurate 
method.
112
 Interestingly in this paper, these authors from a UK lab, report that their standard 
practice for paediatric samples is to not culture dipstick negative urine despite pointing out in 
their introduction that the NICE guideline recommended manual microscopy in those under 
3 years of age and urine dipstick in those over 3 years of age.
185
 The NICE guidelines 
recommend microscopy in those under 3 years of age in addition to culture in all children 
irrespective of microscopy results.
1
 
 
Laboratory procedures 
The variation in laboratory procedures and adoption of new techniques which may not be 
validated for all populations is quite striking to me. Out of the four laboratories involved in 
my study, one had a SOP of not culturing microscopy negative urine which seems to be at 
odds with current guidelines; and one laboratory began using a method which does not appear 
to be adequately assessed or validated in children. There is a clear need for standardisation of 
laboratory procedures for the diagnosis of UTI in children and a robust process for assessing 
accuracy and validity of new methods and equipment before they are adopted by laboratories.  
 
Causative organisms 
I found that the most common bacteria cultured were E.coli. These were responsible for 
54.2% of UTIs. An additional 22.9% were reported as Coliform. More than half of the 
E.coli (57.9%) and 37.5% of the Coliform were resistant to 1 or more antibiotic. 
 
Most studies report that most UTIs are caused by E.coli, both in adult and paediatric 
populations.
91
 However, only 54.2% of UTIs in my study were E.coli which is a lower 
proportion than most other studies in the literature, with most studies finding that more than 
70-80% of UTIs in children are due to E.coli.
93-95
 Escherichia is a type of coliform (along 
with Klebsiella, Enterobacter, Citrobacter and others) and although it is usually identified by 
laboratories, it is likely that some of the E.coli UTIs were identified as coliform but no 
further, reflecting further variation in laboratory analysing and reporting procedures. 
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 Most published studies did not involve systematic sampling of urine and included much 
older children (up to 16 years old). My study includes children who would not have been 
identified in previous studies without systematic sampling. One study with systematically 
sampled urines from very young infants found that the most common bacteria causing UTI 
was coagulase negative staphylococcus.
96
 Most of the non-E.coli UTIs in my study were in 
children less than three years old (79.2%). Other studies have found that the younger children 
are more likely to have non-E.coli UTI.
94 96 98
 
 
Coagulase negative staphylococcus is often considered to represent contamination but is a 
recognised uropathogen in children, particularly in very young infants, often associated with 
instrumentation of the urinary tract.
89 96
 The distinction between  uropathogenic and  non-
uropathogenic bacteria is not always clear.
89
 There is not a clear set of uropathogens versus 
non-uropathogens as bacteria which are commonly found as skin or gut commensals (and 
therefore possible contaminants) can sometimes be the cause of UTI. Finding a low growth of 
one of these organisms is likely to be as a result of contamination, but a high, pure growth 
may represent a UTI, particularly if the specimen is known to have a very low likelihood of 
contamination (e.g. from a suprapubic (SPA) specimen), if there is a high degree of suspicion 
of UTI (e.g. suggestive symptoms or high WBC count) or if the child is in a group known to 
have a higher risk of UTI from this sort of organism (e.g. has undergone instrumentation of 
the urinary tract or is a very young infant). Categorising bacteria as uropathogens or not with 
certainty is not possible using currently widely available methods.
89
 
 
More than half the E.coli cultured in my study was resistant to at least one antibiotic. This 
was higher than I expected. The UTIs diagnosed in my study are from systematically sampled 
urines from ill children in primary care. These include children with UTI who may not have 
been identified had their urine not been systematically sampled. Therefore these UTIs would 
probably represent the less severe, perhaps self-limiting cases which would have been 
unrecognised, compared with the UTI usually diagnosed when a clinician suspects UTI or 
who are more severely ill or with recurrent UTI. For this reason, I suspect that the resistance 
rate of bacteria found in my study would be lower than normally found.  
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Empirical antibiotic prescription 
Antibiotics were prescribed at the index consultation (prior to urine culture results) in 
37.1% children subsequently found to have a UTI and in 27.8% of those who did not have 
UTI. Antibiotics were most frequently prescribed for presumed respiratory tract infections.  
Antibiotics were more likely to be prescribed if the GP suspected UTI (p<0.01).  
 
Overall, 28% children were prescribed antibiotics at the index consultation, which is similar 
to other studies of acutely ill children presenting in primary care.
178 186
  
Approximately half of those thought to have UTI by the GP were prescribed antibiotics at the 
index consultation (prior to the result being available). I was surprised that half of those who 
the GP thought may have UTI were not prescribed antibiotics at the index consultation. It 
may reflect an uncertainty with the diagnosis even when it is considered. Perhaps they have 
considered that it is enough of a possibility to request a urine sample but not sufficiently 
likely to justify antibiotics until the culture result becomes available. It may be that GPs were 
more likely to suspect UTI or indicate it as a working diagnosis because they were taking part 
in a research study concerning UTI rather than a reflection of normal practice. 
 
Appropriate antibiotics (i.e. ones which would have treated the infection) were prescribed 
at the index consultations in 6/7 of those who had UTI and who were suspected of having 
UTI by the GP. In the 28 with UTI who were not suspected of UTI, only 1 had an 
appropriate antibiotic prescribed at the index consultation.  
 
It is important to recognise that if GPs did not suspect UTI, only 7% received appropriate 
antibiotics at the index consultation compared with 85.7% if GPs suspected UTI.  
 
Presumably those children with UTI who were not prescribed appropriate antibiotics at the 
time of the index consultation would have received them once the culture results were 
received by practices, but unfortunately I did not collect those data. If antibiotics are 
prescribed at the initial consultation (prior to urine culture results), unless UTI is suspected 
by the prescribing clinician, it is unlikely to be effective in treating a UTI. 
 
An important issue is whether antibiotics started a few days after the index consultation (or 
onset of symptoms), as would have been the case for the majority of children with UTI in my 
study, prevent the development of renal scarring and long term complications. This is not 
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clear, although there is some evidence that a delay in treatment of an acute UTI is more likely 
to result in renal scarring.
24-28
 One systematic review found that a delay of 4-7 days increased 
the risk of renal scarring.
23
 Culture results generally take 2-3 days to reach the GP so if the 
urine is sampled promptly, the result communicated to GPs quickly and the antibiotic 
treatment is initiated immediately following the culture result, then perhaps this will be 
sufficient to reduce renal scarring.  
 
More research is needed both in determining how quickly antibiotics need to be administered 
following onset of symptoms to prevent renal scarring and in reducing the delay in diagnosis 
of UTI. The development of fast, accurate diagnostic testing could improve the situation 
dramatically. In the meantime, working within the current situation, it may be that awareness 
of the need for prompt urine sampling and antibiotic therapy needs to be enhanced among 
clinicians and parents. There is likely to be variation in symptom duration prior to consulting 
and GPs generally encourage parents not to consult with their child for common self limiting 
illnesses. The question is, should we encourage parents to consult earlier so that urine can be 
sampled earlier? Raising awareness of the need for prompt urine sampling and high suspicion 
of UTI (and therefore consulting) may result in large increases in early presentations of 
children.  
 
Symptoms and signs 
A multivariable logistic regression model identified age range, pain or crying on passing 
urine and increased urinary frequency (or frequency of wet nappies) as being associated 
with UTI. A history of fever or absence of an alternative site of infection was not 
significantly associated with UTI. 
 
Urinary symptoms 
I was quite surprised that the predictive symptoms and signs which came out of the 
multivariable logistic regression model were urinary symptoms. Published studies and 
guidelines highlight that symptoms tend to be non-specific in children.
1 48 58 72
 In fact, the 
most common presenting symptoms in children with UTI in my study were also non-specific. 
The three most common presenting symptoms were being irritable or grouchy, being clingy, 
and poor feeding. However, they were also extremely common in children without UTI. Only 
11% of those with UTI had increased urinary frequency and only 14% had pain or crying on 
passing urine.  
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It is likely that these urinary symptoms were difficult to establish in the youngest children 
and the model may be less useful in these children. It is also likely that any clinical decision 
rule which includes urinary symptoms will therefore be difficult for clinicians to use as these 
symptoms will be harder for parents to determine in the younger age groups. It is also 
important to note that my sample probably under-represented the younger children.  
 
As described earlier, the multivariable model was overall a poor fit for my data with much 
variability not explained by the model. Further, much larger studies are needed to determine 
whether any symptoms or signs can be used to predict or rule out UTI in children with any 
accuracy. My results suggest that in order to detect UTI, urine would need to be sampled 
from the majority of children irrespective of their presenting symptoms or examination 
findings.  I have proposed a urine sampling strategy in which urine samples are omitted in 
older children without urinary symptoms but this would need to be externally validated in 
another study. 
 
Fever 
The study was not powered to detect the predictive value of symptoms and signs accurately. 
The univariable analyses need to be interpreted with caution due to the large number of tests. 
However, it is striking that a history of fever was not associated with UTI. Temperature 
measured in surgery as a continuous variable was also not associated with UTI. When fever 
measured in surgery was dichotomised to > 38
o
C and <38
o
C, there was possibly an 
association with UTI (p=0.08) but less than half of the children with UTIs had a temperature 
of 38
o
C or above. This is important because the majority of published studies include only 
children with fever and current guidelines highlight the importance of urine sampling in 
children with fever.
1 48 60 63 65-68 70 71 73 83 100-103 151 152 154
 Other studies have also found that 
fever is not necessarily present with UTI and importantly that fever cannot be used to predict 
renal scarring.
81
  
  
Alternative source of infection 
Current guidelines state that urine sampling is not required if there is evidence of a potential 
alternative source of infection (initially).
1
 An alternative source of infection has been 
defined differently in studies and sometimes not defined at all.
48 60 68 71 103 154
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I found that there was no difference in prevalence of UTI between children with and without 
an alternative site of infection (p=0.64).  
 
Looking only at abnormal examination findings rather than clinician working diagnosis, I 
found that children with UTI were just as likely as those without to have an abnormal chest, 
throat, or abdominal examination (p=1.00; p=0.97;p=0.39 respectively). Statistically, there 
was also no difference between UTI and non-UTI groups for abnormal ear examination 
(p=0.16). However looking at the crude numbers (2.9% in UTI group vs. 10.9% in non-UTI 
group), this may be a type 2 error with the small numbers hiding a true association. A larger 
study is needed to look more closely at this. 
 
The finding that UTI cannot be ruled out on the basis of the presence of an alternative site of 
infection is important. UTI will be missed if urine is not sampled from these children. Other 
studies have also found that the presence of an alternative source of infection cannot reliably 
rule out UTI.
48 68
  
 
Proposed urine sampling strategy 
Using the multivariable model, the probability of UTI in children less than three years old, 
irrespective of presenting symptoms and signs, was >5%. In children aged three-to-five 
years, with neither pain on passing urine nor increased urinary frequency, the probability 
of UTI was 2%.  
 
It is not clear what level of prevalence of UTI should warrant universal urine sampling from 
ill children. The balance of costs and benefits is complex.  
 
A survey of paediatricians found that most considered a prevalence of more than 3% in a 
population of children to be sufficient to justify universal urine sampling in that population.
40
 
However, this study was conducted in 1983 and opinions about UTI in children may have 
changed. In addition, the concerns of paediatricians, and the feasibility of universal urine 
sampling in their setting, may be different to those of GPs, microbiologists, health economists 
or policy makers. However, it is a useful benchmark to consider. 
 
A possible strategy of sampling urine in all children under the age of five years old except 
those three years or older without urinary symptoms was considered. This proposed 
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strategy was compared with the urine sampling strategy in the NICE guidelines and with 
urine sampling according to GP suspicion of UTI. I found that the proposed strategy would 
identify 97% of UTIs and would only miss 3% of UTIs, compared with 51% which would 
be missed if NICE guidelines were followed and 80% if sampling were based on GP 
suspicion alone.  
 
This gives a sensitivity of 20.0% and specificity of 94.0% for UTI with sampling based on 
GP suspicion; a sensitivity of 48.6% and specificity of 61.0% with sampling based on NICE 
guidelines; and a sensitivity of 97.1% and specificity of 32.4% following my proposed 
sampling strategy. The decision (decision rule) on whether to obtain a urine sample from an 
ill child needs to have a high sensitivity, even at the expense of specificity.
177
 At this stage we 
only want to omit a urine sample in children whom we can be reasonably sure do not have a 
UTI. Subsequent testing, perhaps with urinary dipsticks or microscopy or laboratory culture, 
will need a high specificity as well as high sensitivity.  
 
My proposed sampling strategy would involve sampling urine from twice as many children 
than is currently recommended by NICE guidelines and ten times more than would be if 
sampling were based on GP suspicion alone. This clearly has huge implications in terms of 
equipment, processing costs and time costs. These costs occur at two main points, firstly at 
the time of consultation in the GP surgery, and secondly when the urine sample is sent and 
processed by the laboratory.  
 
Given that urinary dipsticks, as the only commonly used near patient test, have questionable 
accuracy in children, currently all urine samples should be sent for laboratory microscopy and 
culture for the diagnosis of UTI in children.
1
 With the development of more accurate near 
patient testing this may not be necessary in the future, and the cost and time associated with 
laboratory culture techniques may be reduced. However, without the initial collection of a 
urine sample, whatever new diagnostic tests there are, UTI will not be diagnosed in most 
children because the presenting symptoms and signs cannot be reliably used to rule out UTI. 
It seems likely that the time and cost associated with obtaining a urine sample in primary care 
is necessary now and in the future if we want to improve the diagnosis of UTI.  
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Feasibility of obtaining urine samples 
In addition to the cost, there is the issue of whether it is actually possible. My proposed 
sampling strategy would require urine samples at initial presentation from 69% of acutely ill 
children under five years old. I only obtained a 70% urine retrieval rate, even when practices 
were being reimbursed for their time and incentivised to obtain the urine sample. It was much 
more difficult to obtain urine samples in the younger children, all of whom would require a 
sample if this sampling strategy was followed.  I also found that it was much less likely that a 
urine sample was received within 2 days if it was not obtained at the surgery (p<0.01) and 
this has implications for GPs in terms of space and access to nurses. 
 
GPs and parents would need to be informed and convinced of the need; appropriate sampling 
equipment would need to be more readily available; time and room at the surgery to obtain 
the sample, and nursing staff availability may also be necessary. Some financial support may 
need to be considered in order to change GP sampling behaviour (investment in training and 
education). A UK survey of GPs found that practical difficulties of urine collection and 
concerns about the costs of investigations were important barriers to detecting UTI.
41
 In 
addition, advising parents to bring their child to the surgery promptly for non-specific 
symptoms in order to obtain urine samples contradicts current advice for common, self-
limiting illnesses and would need to be carefully considered.  
 
Cost to the NHS 
The costs and implications of increased urine sampling and processing of samples needs to be 
considered. There are the costs of the equipment to obtain urine samples, the costs of GP or 
nurse time to support obtaining the sample, the laboratory costs of processing and reporting 
the sample; the costs of further patient contact to discuss results and advise on management; 
the costs of increased antibiotic use (including side effects and contribution to antibiotic 
resistance), and the costs of further investigations. The costs need to be weighed up against 
the potential benefits of diagnosing more UTIs, and providing prompt antibiotic treatment, 
with the possible benefits of reducing long-term complications associated with significant 
morbidity and NHS costs.  
 
Whether it is worth the additional costs to the NHS, given that the association with long-term 
complications is far from clear and that UTI is often a mild and possibly self-limiting acute 
illness, is a matter for debate. Clearly, the authors of the NICE guideline in 2007 felt that it 
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was sufficiently important to recommend increased urine sampling and prompt diagnosis and 
treatment; and significant cost savings may be made if expensive investigations and long-
term complications can be avoided.  
 
Further evaluation of my proposed sampling strategy is needed in another data set for 
external validation and modelling of economic implications. This may be possible with 
another study which I am involved in (the DUTY study) which is a large dataset of acutely 
ill children under five years old also with systematically sampled urine.  
 
The views of GPs and parents should also be sought.  
 
Illness duration 
Of the children diagnosed with UTI and with 2 week follow-up data (n=18), 9 (50%) had 
an illness which lasted more than 2 weeks after the index consultation. None had been 
admitted to hospital.  
 
I was surprised that there were so many with an illness lasting beyond two weeks. This was 
reported by parents and their definition of illness will vary. The question I asked was whether 
their child had completely recovered from their illness and if so for how many days had it 
lasted. The numbers are small and I have not got information on those who did not have UTI 
for comparison. It may be that the delay in waiting for the urine sample result and subsequent 
delay in antibiotic prescription contributed to the length of illness. It would have been useful 
to have further data on which symptoms were ongoing, when antibiotics were started, repeat 
culture results to see when resolution of bacteriuria occurred and how this corresponded to 
symptoms. Further research studies are needed to explore this further. 
 
Outcomes  
Among the children with 6 month follow up data (n=28 with UTI; n=487 without UTI), 
there was no difference in the number of re-consultations with GPs, number of acute 
admissions, number of out of hours or A+E contacts or number of hospital referrals 
between those with and those without UTI in the 6 months following the index 
consultation. Children with UTI were treated with more courses of antibiotics than those 
without, with children who had a UTI nearly twice as likely than those without to have 
received two or more courses of antibiotics in the subsequent 6 months (p=0.02). 
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These findings suggest that increasing the detection of UTIs will not necessarily increase the 
use of NHS services (apart from the antibiotic prescriptions). I had expected that there would 
be a higher consultation rate among children who had been diagnosed with UTI as I thought 
that parents would be more likely to bring their child with any further illness in case it was 
another UTI.  I also found it surprising that the number of hospital referrals was not greater in 
the UTI group as the guidelines recommend specialist imaging in some of those children. It 
may be that the referral rate will increase as awareness of the guidelines increases. The 
numbers of children with UTI followed up is fairly small. Larger studies may detect 
differences in consulting behaviour in children who have had UTI compared with those who 
have not. 
 
Imaging and NICE guidelines 
Of the children diagnosed with UTI with 6 month follow-up data (n=28), 3 children had 
been referred for or had an USS and 1 child had received a DMSA scan. No children had 
been referred for or received an MCUG. Comparing the investigations which children 
received with those advised by the current NICE guidelines, showed that only 1/16 
recommended children received an USS and none of the 13 recommended received a 
DMSA scan. The one child in whom an MCUG was indicated did not receive one.  
 
Only one child (the one who had an USS) was referred to the hospital during the six month 
follow up period. 
 
I was surprised at the lack of adherence to guidelines for follow-up. Perhaps clinicians did not 
believe that the UTI diagnosed in this study represented true UTI. They may have felt that as 
they would not have normally sent a urine sample, for many of the children, and did not 
clinically suspect UTI, that it was unlikely to be a UTI even if the result was positive. They 
may have felt that it was more likely to be a false positive caused by contamination.  
 
It may be that clinicians were unaware of the NICE guidelines. I did provide a summary of 
NICE guidelines for all the practices involved in the study and highlighted these during the 
training of practices, however the guideline is long and quite complicated. I was surprised 
that children were not referred to paediatricians for follow-up investigations even if these 
were not arranged by the GPs.  
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I think part of the problem may be that the guidelines are confusing. In the summary section 
for imaging strategies (p11), it states, children with cystitis/lower urinary tract infection 
should undergo ultrasound (within six weeks) only if they are younger than 6 months or have 
recurrent infection.
1
  
 
However, when looking at box 6.14 (p12): Recommended imaging schedule for infants and 
children 6 months or older but younger than 3 years in the NICE guideline, ultrasound during 
the acute infection is recommended for atypical UTI.
1
 Atypical UTI includes children who 
have infection with non-E.coli organisms as well as more serious illness. This probably needs 
to be emphasised to GPs and also laboratories need to report the type of organism more 
accurately than simply coliform.  
 
Two children received an USS and one child a DMSA scan when this did not seem to be 
indicated by NICE  guidelines. It may be that these tests were indicated in these children but 
that I was unable to identify these criteria. Perhaps they had other features which defined 
them as atypical UTI (for example septicaemia or failure to respond to treatment with 
suitable antibiotics within 48 hours). 
 
Summary of specific points relating to current guidelines  
1. The most common presenting symptoms and signs of UTI in children in primary care are 
non-specific. 
2. Urinary symptoms may be helpful in determining which children should have their urine 
sampled in those over the age of three years but not in younger children. 
3. UTI is not more frequent in those without an obvious source of fever.  
4. UTI is not more frequent in those with a fever than those without among acutely ill 
consulting children. 
5. Current guidelines appear to be poorly adhered to in terms of urinary sampling in primary 
care and imaging of children diagnosed with UTI. This may be partly due to the complex 
nature of these aspects of the guideline. 
6. There is a need for standardisation of laboratory storage, analysis and reporting 
procedures. 
 201 
 
These points should inform the next revision of the NICE guideline for urinary tract infection 
in children due in August 2013. 
 
Dissemination of research 
I have published the main findings of my research in the British Journal of General Practice 
(see Appendix A2).
150
 I have discussed my findings with other General Practitioner 
colleagues and presented the findings to the DUTY study management group. I have also 
presented my research at the conferences of the Society of Academic Primary Care (SAPC) 
and the World Organization of National Colleges, Academies and Academic Associations of 
General Practitioners/Family Physicians (WONCA).  
 
 
Summary of further research needed 
Throughout the discussion I have mentioned areas where further research is needed. In this 
section, I have brought these points together as a summary of future research priorities in this 
field. 
· External validation of the model and proposed sampling strategy (possibly using the 
DUTY dataset).
176
 
· Economic modelling of the sampling strategy. 
· Exploration of the views of parents, GPs, microbiologists and paediatric nephrologists 
about widespread urine sampling in children and prevalence thresholds which warrant 
this; feasibility and barriers to such a strategy; and needs for training and equipment 
provision. 
· Evaluation of adherence to and effectiveness of current (NICE) guidelines, 
particularly with regards to urine sampling in primary care and imaging following 
confirmed UTI. Exploration of the views of clinicians on the guidelines and barriers 
to implementation. 
· Further prospective studies with systematic urine sampling in ill children from A+E 
and OOH departments, including those with an alternative site of infection and a 
temperature of <38
o
C. 
· Larger studies to further explore whether specific symptoms, signs, or risk factors 
may be used in combination to determine the probability of UTI with sufficient 
accuracy to enable more targeted urine sampling. 
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· Larger prospective studies with clinical outcomes to determine the optimal diagnostic 
threshold for UTI in children using current standard culture methods.  
· Further investigation of low growth, mixed growth and contaminated samples with 
assessment of immune function and identification of bacterial species and clinical 
outcomes to determine whether these are hiding true UTI. 
· Further clarification of the definition of terms such as predominant growth, 
uropathogen and contamination by laboratories. 
· Investigation of laboratory variation in the process and reporting of urinary specimens 
and agreement/adherence with national standards. 
· Long term follow up studies of children with UTI, including those previously 
unrecognised but now identified from systematic urine sampling, to determine the risk 
of complications such as adult or recurrent UTI, renal scarring, hypertension, pre-
eclampsia and end-stage renal failure. Exploration of the optimal diagnostic threshold 
for culture for detecting children at risk.  
· Effectiveness of antibiotics at preventing progression to long term complications and 
determination of how soon after onset of symptoms and presentation to the GP these 
need to be taken to be effective. Initial studies could use renal scarring in the short 
term as a marker for long term complications. 
· Further exploration of bacterial species grown on culture using DNA techniques (PCR 
pyrosequencing) and comparison between healthy children, those known to have 
UTIs and those with mixed growth or negative culture results to determine whether 
bacterial species which grow less well with standard culture methods may be 
uropathogenic in children. 
· Investigation of potential urinary biomarkers for UTI (e.g. immune system mediated 
chemicals (cytokines)). There is a need for a quicker and more accurate diagnostic test 
for UTI. 
 
My priorities for future research would be: 
1. External validation of my proposed sampling strategy 
2. A cluster randomised trial with an educational intervention (for GPs, nurses and 
parents) aimed at increasing urine sampling and diagnosis of UTI in primary care 
3. A long-term follow-up study of children with UTI identified through systematic 
sampling to determine which children develop long-term complications. 
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Conclusions 
I have achieved the main aim of my research which was to determine the prevalence of UTI 
in acutely ill presenting children in general practice. I have also increased the understanding 
of UTI in terms of the presenting symptoms and signs, management by GPs and clinical 
outcomes (up to six months) and addressed all of my research objectives (Table 6.2) 
 
Table 6.2: Research objectives 
Research objective 
1 Conduct a systematic review of the literature concerning the prevalence of UTI in 
children in primary care. 
2 Conduct a pilot study to determine the feasibility of recruiting, and obtaining 
samples from, ill children in primary care. 
3 Conduct a study to determine the prevalence of UTI (defined as >10
5
 organisms/ml 
of urine) in children aged before their fifth birthday presenting to primary care with 
an acute illness of less than or equal to 28 days duration. 
4 Determine the predictive value of symptoms, signs, risk factors and point of care 
dipstick tests in predicting positive urine culture (UTI) in urine samples 
systematically obtained from acutely ill children in primary care.  
5 Develop a decision support system and sampling strategy for use in primary care for 
the diagnosis of UTI in children. 
6 Describe hospital referral, hospital investigation, re-consultation in primary care and 
UTI rates at 6 months for children found to have a UTI at initial consultation 
compared with those without UTI. 
 
I have identified some of the problems with current practice and shown that urine sampling 
based on GP suspicion or according to current NICE guidelines is likely to miss the majority 
of UTIs.  
 
I have proposed a urine sampling strategy which would increase the identification of UTIs 
but this would result in large increases in urine sampling and needs external validation and 
economic evaluation.  
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I have found that the NICE guidelines are not followed in terms of follow up for children 
with UTI. More research is needed to understand the reasons for this.  
 
I have shown that there is variation in laboratory methods and a need for standardising 
methods and reporting.  
 
I have explored some of the controversial issues and highlighted the need for further research. 
In particular, how important is it to correctly diagnose UTI; does it really lead to long-term 
complications and in which groups of children; how promptly does it need to be treated to 
prevent renal damage; will increasing urine sampling reduce the long-term complications; 
will this be a cost-effective strategy in the long term; and are current methods correctly 
identifying true UTI? 
  
It is of great importance to understand the association between UTI in childhood and long 
term complications and the ability of treatment to prevent these. The decision to advocate 
widespread urine sampling in children hinges on this. If it were not so important to diagnose 
all the UTIs, perhaps if only those with severe or persistent acute illness were at risk of long 
term complications, then there may be less need to change current practice of clinician led 
urine sampling. Perhaps it would not matter if those with mild or self-limiting illness or in 
whom UTI was not suspected or recognised were not diagnosed. However, if there are long-
term complications which can be prevented by prompt diagnosis and treatment of all (even 
mild or self-limiting) UTIs, then the levels of suspicion and urine sampling need to be raised 
significantly. Perhaps urine needs to be sampled routinely from all consulting ill children. 
Urine screening tests (e.g. dipsticks and automated microscopy) would need to have 
extremely high sensitivities for culture to be omitted and the diagnostic threshold on culture 
may need to be lowered if low-count bacteriuria were also found to be associated with long-
term complications. 
 
Long term follow up studies of children diagnosed with UTI, in primary care by systematic 
sampling, are needed. Further studies are needed to determine whether combinations of 
symptoms and signs can be used to predict which children have UTI or used to target urine 
sampling. In the absence of these studies, based on the available evidence, GPs should 
increase urine sampling in acutely ill children and ensure prompt antibiotic treatment and 
appropriate follow up for any children found to have UTI.  
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Appendix 4.2: Ethics committee amendments and poster  
 
  
§ Is your child under 5 years old? 
§ Has your child been ill for less than 28 days? 
§ Is your child unwell? 
Your child may be eligible for the EURICA  research study  
Please ask at reception for further information  
This study involves answering some questions about your childs 
illness and sending a urine sample to see if there could be a urine 
infection causing their symptoms.  
 
 
Version 1  19/11/08 
This important research study will help us to understand urine 
infections in children and how to detect them as early as possible. 
 
When young children are unwell, sometimes the cause is a water 
(urine) infection, even without any specific symptoms. Urine 
infections can therefore be hard to detect in young children. 
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Appendix 4.3: Letter of invitation to practices 
 
 
                
  
 
Dear    
 
Re:  EURICA: The Epidemiology of Urinary Tract Infection (UTI) in Children with Acute 
Illness in Primary Care 
 
We are writing to ask for your practices help with our research study which aims to answer an 
important research question for primary care clinicians.  
 
We want to find out how common UTI is in ill children presenting in primary care.  
 
This is important because: 
 
1) UTI in young children has been associated with long-term complications including renal scarring, 
renal failure and hypertension. Early recognition and treatment of UTI in children is thought to 
reduce this risk.  
 
2) UTI in children is often missed in primary care because the symptoms are non-specific. One UK 
study found that 50% cases of UTI were missed in children. 
 
3) NICE have recently published a guideline concerning UTI in children. This emphasises prompt 
diagnosis and treatment of UTI in children, and promotes a high level of suspicion, with increased 
urine sampling in young children with non-specific symptoms.  
 
4) We currently do not know how common UTI is in acutely ill children presenting in primary care 
because no other studies have systematically sampled urine from this population. We need to 
know this in order to determine whether UTIs in children really are being missed and to inform 
decisions about sampling, diagnosis and management. 
 
We would like you to recruit children under the age of five who present with an acute illness (< 28 
days); take their consent, complete a brief form (CRF) and collect a urine sample.  Most of this can be 
completed by a nurse or health care assistant.  
 
Children should then be managed in the normal way. This is an observational study. We are not asking 
you to change your clinical management of children; children will not be randomised, will not receive 
additional/experimental medication and there are no blood tests. Consent will allow researchers to 
access to patients medical notes, urine results, and for a follow-up telephone call at 2 weeks.   
 
We will reimburse you for your time in participating in this study.  
 
 
Department of Primary Care & Public Health  
Cardiff University 
School of Medicine 
Neuadd Meirionnydd 
Heath Park 
Cardiff   CF14 4XN 
Tel  +44(0)29 2068 7174 
Fax  +44(0)29 2068 7612 
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If you agree to help us to recruit patients, we will pay you £45 for every child you recruit with a 
completed CRF & urine sample (if you recruit 100 children, this will mean a payment of £4500). We 
will also provide equipment for urine collection, dipsticks, and thermometers. A Consultant Paediatric 
Nephrologist will be available for any clinical advice should you need it during the study. 
 
The study is being funded by the Welsh Assembly Government. It has been approved by the South 
East Wales Local Research Ethics Committee. The study is being supported by the South East Wales 
Trials Unit and in collaboration with CRC-Cymru.  
 
We hope that you will be able to help us with this important research. We will contact you or your 
practice manager by telephone shortly to discuss the study and answer any questions. For further 
information please dont hesitate to contact us. 
 
Thank you for your time.  
Yours sincerely, 
 
 
 
 
 
Dr. Kathy OBrien   Mandy Iles 
Study Manager    Study Administrator 
Primary Care & Public Health Primary Care & Public Health 
Cardiff University   Cardiff University 
Telephone: 029 2068 7174  Telephone: 029 20687191 
Email: obrienka@cf.ac.uk  Email: ilesaj1@cf.ac.uk 
 
Professor Christopher Butler 
Head of Department of Primary Care & Public Health  
Cardiff University  
Telephone: 029 2068 7168 
 
  
Department of Primary Care & Public Health  
Cardiff University 
School of Medicine 
Neuadd Meirionnydd 
Heath Park 
Cardiff   CF14 4XN 
Tel  +44(0)29 2068 7174 
Fax  +44(0)29 2068 7612 
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Appendix 4.4: Summary of study procedures for practices 
 
 
 
 
SUMMARY OF DOCUMENTS & SAMPLES  
 
STUDY DOCUMENTS 
 
1) Complete screening log for all eligible children both recruited and not recruited. This 
should be faxed to Kathy OBrien at Cardiff University 029 2068 7612 each week.  
2) For those consented, give the carbon copy of the signed consent form to the carer to 
keep.  
3) Fax consent form and white section 1  patient registration form to Kathy OBrien at 
Cardiff University 029 2068 7612 
4) Keep original consent form & section 1 in the site file. 
5) Ensure yellow section 2 and orange section 3 have been completed and keep these in 
the site file for copying and collection by CRC-Cymru on a monthly basis.  
 
URINE SAMPLE COLLECTION & LABELLING  
 
1) Try and obtain a urine sample whilst the child is in the surgery. 
2) Urine samples should be collected by clean catch method as first choice or by the use 
of a Newcastle collection pad in the nappy.  
3) Urine should then be transferred into a white topped universal container.  
4) The sample should be labelled with the childs name, address and date of birth AND 
with a red EURICA label with the patient ID number on. PLEASE CHECK THIS 
MATCHES THE CRF & PATIENT DETAILS.   
5) The sample should be tested with a dipstick and results recorded in the yellow section 
2 of the CRF.  
6) A standard microbiology form should be completed as normal with the childs full 
details on AND a red EURICA label on all pages of the form.  
7) The urine sample should be refrigerated until collection.  
 
WHEN A URINE SAMPLE IS NOT OBTAINED IN SURGERY 
 
1) Ensure carers know how to obtain the urine sample and have been given both verbal 
and written instructions. 
2) Ensure carers have been given the necessary equipment, a white topped universal 
collection container labelled with patient details AND a red EURICA label, and a 
microbiology form labelled with patient details AND a red EURICA label on each 
page.  
3) Please emphasise the importance of the urine sample, not just for the research study 
but for diagnosing unrecognised UTI in children.  
4) Record the carers contact details and ring the next morning to remind them to return 
the urine sample.  
  
 2
4
2
 
  A
p
p
en
d
ix
 4
.5
: 
R
ec
ru
it
m
en
t 
lo
g
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
  
  
 
 
 
 
G
P
 S
u
rg
er
y
 N
a
m
e
: 
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
_
C
en
tr
e 
Id
en
ti
fi
er
 (
C
ID
) 
 
  
  
  
  
  
 
F
o
r 
a
ll
 c
h
il
d
re
n
 a
g
ed
 b
e
fo
re
 t
h
ei
r 
5
th
 b
ir
th
d
a
y
 w
h
o
 c
o
n
su
lt
, 
p
le
a
se
 c
h
ec
k
 t
h
ei
r 
el
ig
ib
il
it
y
 f
o
r 
E
U
R
IC
A
. 
  
 
C
o
m
p
le
te
 t
h
is
 t
a
b
le
 e
v
e
ry
 t
im
e 
y
o
u
 c
o
n
si
d
er
 a
 p
a
ti
en
t 
fo
r 
E
U
R
IC
A
. 
 
 D
at
e 
o
f 
co
n
su
lt
at
io
n
 
P
at
ie
n
t
s 
d
at
e 
o
f 
b
ir
th
 
P
at
ie
n
t
s 
g
en
d
er
 M
/F
 
W
as
 p
at
ie
n
t 
re
cr
u
it
ed
?
 
If
 r
ec
ru
it
ed
 p
le
as
e 
g
iv
e 
P
at
ie
n
t
s 
S
tu
d
y
 
N
u
m
b
er
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
If
 r
ec
ru
it
ed
, 
h
as
 
u
ri
n
e 
sa
m
p
le
 b
ee
n
 
co
ll
ec
te
d
? 
If
 n
o
t 
re
cr
u
it
ed
 p
le
as
e 
g
iv
e 
re
as
o
n
 f
o
r 
ex
cl
u
si
o
n
/n
o
t 
co
n
se
n
te
d
/n
o
t 
ap
p
ro
ac
h
ed
? 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
E
U
R
IC
A
 S
C
R
E
E
N
IN
G
 L
O
G
 
 P
le
a
se
 f
a
x
 w
ee
k
ly
 t
o
 
K
a
th
y
 O
B
r
ie
n
 F
a
x
 n
o
: 
0
2
9
 2
0
6
8
 7
6
1
2
 
 
0
 
9
 
 243 
 
 
 
 
    
EURICA: The Epidemiology of Urinary Tract Infection (UTI) in Children  
with Acute illness in Primary Care 
 
Letter to Parent/Carer 
 
I am writing to ask if you will help us with our research.  We are conducting a study 
to find out how common urine infections are in children under the age of five who 
visit their doctor with an illness. This may be any illness, including coughs and colds 
 there may not be any obvious signs of a urine infection. Asking you to help with our 
research does not mean that we think your child has a urine infection. 
 
As young children often do not have any obvious signs of a urine infection, it can be 
hard for doctors to identify which children have urine infections. We will see how 
many ill children actually do have a urine infection by sending a urine sample for all 
children.  We hope to improve understanding and diagnosis of urine infections in 
children.  It is important to identify a urine infection if it is present, as there is 
treatment available to treat this, and early treatment may avoid complications later on.    
 
If you agree to help us with this research, the nurse, GP or health care assistant will 
take some details about your childs illness, check your childs temperature and 
collect a urine sample.  Your child will then be treated as normal by your doctor. All 
information collected about you or your child during the course of the research will 
be kept strictly confidential.  
 
Please find enclosed a patient information sheet explaining the study in more detail. 
Your GP, Nurse or Health Care Assistant will be able to answer any other questions 
you have.  
 
Thank you for your interest.  We hope that you will help us with our research, but if 
you are not able to do so, this will not adversely affect yours or your childs care in 
any way.  
 
Yours sincerely, 
 
 
 
 
Dr. Kathy OBrien 
 
Email:obrienka@cf.ac.uk Telephone: 029 2068 7174 or 029 2068 7191 
 
 
 
1
st
 February 2008 Version 1 
  
Department of Primary Care & Public Health 
Cardiff University 
Centre for Health Sciences Research 
School of Medicine 
Neuadd Meirionnydd 
Heath Park 
Cardiff CF14 4XN 
Tel Ffon +44 (0)2920687174 
Fax Facs +44 (0)2920687612 
 
Adran Gofal Cynradd a Iechyd y Cyhoedd 
Prifysgol Caerdydd 
Canolfan Ymchwil Gwyddoriaeth Iechyd Yr 
Ysgol Feddygol 
Neuadd Meirionnydd 
Parc y Mynydd Bychan 
Caerdydd CF14 4XN 
Department of Primary care & Public Health 
Head of Department Professor Christopher Butler 
 
Adran Gofal Cynradd a Iechyd y Cyhoedd 
Pennaeth Adran Yr Athro Christopher Butler 
 
Appendix 4.6: Letter 
of invitation to 
parents 
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Appendix 4.7: Parent information sheet 
    
 
EURICA: The Epidemiology of Urinary Tract Infection (UTI) in Children with Acute 
illness in Primary Care 
Parent/Carer Information Sheet 
 
We would like to invite you and your child to take part in a research study. Before 
you decide, you need to understand why the research is being done and what it 
would involve for you. Please take time to read the following information carefully. 
Talk to others about the study if you wish. 
 
Part 1 tells you the purpose of this study and what will happen to you if you take part. 
Part 2 gives you more detailed information about the conduct of the study. 
 
Ask us if there is anything that is not clear or if you would like more information. Take 
time to decide whether or not you wish to take part. 
 
Part 1 of the information sheet 
 
Study title 
 
EURICA: The Epidemiology of Urinary Tract Infection (UTI) in Children with Acute 
illness in Primary Care  
 
(Protocol Version 4, 24/07/2009) 
 
What is the purpose of this study? 
 
Bladder or urinary tract infections in children are common. Diagnosing them is 
important because effective treatment can be given.  In some cases these infections 
may lead to long term medical problems which could be prevented by early 
treatment. This may be a particular problem in young children under the age of five. 
 
We do not know how many children, under the age of five, have urinary tract 
infections. We do know that infection is more common in children who are unwell. It 
may be important for GPs (General Practitioners) and nurses to check the urine of all 
children under the age of five who are unwell, even if there seems to be another 
reason for the illness. Sometimes children have urine infections even if they do not 
complain about problems with passing urine. However, unless we know how 
common these infections really are, we will not be able to give proper guidance to 
GPs and nurses about this.  
 
We are interested in finding out how many ill children who come to see their GP or 
nurse actually have a urinary tract infection.  To do this, we need to get urine 
samples from large numbers of ill children. We also want to see whether a test on 
the urine, which can be completed in the GP surgery, is accurate. We also hope to 
identify some symptoms that may help diagnose urinary tract infections, and to try 
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and understand what might cause infections with bacteria that are not killed by the 
usual antibiotics.  
 
Why have we been invited? 
 
We are asking GP surgeries in Wales to help us with this research and we hope to 
include 1600 children in this study. You have been chosen simply because your child 
is unwell and is under the age of five (aged before their fifth birthday). Asking you to 
help with this research does not mean we believe your child has a urine infection. 
We are simply doing a check of the urine and gathering additional information that 
might not otherwise have been done.    
 
Do we have to take part? 
 
It is up to you to decide whether or not you want your child to take part.  We will 
describe the study and go through this information sheet, which we will then give to 
you. We will then ask you to sign a consent form to show you have agreed to take 
part. You are free to withdraw at any time, without giving a reason. A decision to 
withdraw at any time, or a decision not to take part, will not affect the standard of 
care you or your child receives now or in the future. 
 
What will happen to my child if he/she takes part?  
 
Firstly, the nurse or health care assistant or doctor will ask you about the symptoms 
that your child has had and will check your childs temperature, breathing rate and 
heart rate.  You will then be helped to obtain a urine sample from your child.  In most 
cases, you will be given a sterile pot to collect the sample in.  If this is difficult, 
particularly in children under the age of 2, the nurse will give you a pad to put in the 
childs nappy to collect the urine sample, and you will be shown how to do this.  
 
The urine sample will be tested with a test strip in the surgery, and then sent to the 
hospital laboratory. Your child will then be examined by the doctor or nurse, who will 
decide on treatment as normal.   
 
We will try to obtain a urine sample before you leave the surgery, although in some 
instances it may be necessary to get you to drop the sample off later.  
 
Taking part in the study will mean spending a little more time in the surgery for the 
nurse to ask about symptoms and to collect the urine sample. It may involve up to an 
additional 15-30 minutes of your time at the surgery. However in most cases the 
nurse will see you whilst you are waiting to see the doctor.  
 
At the laboratory, routine tests will be performed on your childs urine sample, to see 
if a bacterial infection is present, and if so, which antibiotics would be the best 
treatment for this particular infection.  These routine test results will be sent to your 
GP as normal, who will then decide if your child needs to receive any treatment or 
further investigations.  These test results will also be available to the research team. 
 
In addition, further laboratory tests will be performed on the urine sample.  These 
tests will help us to understand more about the bacteria which cause urinary tract 
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infections, and how the body responds to these infections. Although these tests will 
not directly be of benefit to your child, they will improve our understanding of urinary 
tract infections in children, and help with the diagnosis and treatment of this 
important condition in the future. Your childs urine may be stored for up to five years 
for additional laboratory tests for research purposes, concerning urinary tract 
infection. 
 
Your consent will allow researchers to access your childs notes (up to 6 months 
after your childs initial visit to the doctor) and to look at the results of any tests. This 
may include GP out of hours, Accident & Emergency and hospital notes as well as 
GP notes. It will also allow us to telephone you approximately two weeks later to ask 
some questions about how your child is feeling and what treatment (if any) they have 
received.  We will also ask some questions about illnesses and antibiotic treatments 
of other family members to help work out whether any other factors contribute to 
these infections. However you do not have to answer all of the questions if you do 
not want to. We wont be contacting everyone who takes part by telephone. In 
general we will only telephone those whose urine result showed an infection or in 
those where the result was unclear and the urine sample needed to be repeated.  
 
What if my childs urine sample shows an infection? 
 
In some cases a repeat urine sample may be needed to confirm the result.  If your 
child turns out to have a urine infection, your doctor will inform you of the result and 
arrange any treatment or follow up if this is necessary.   
We will also request two further urine samples from your child, one and two weeks 
later. These will be sent to the laboratory for routine tests to check that the infection 
has cleared, and additional tests will be performed (as before) to help further 
understanding of urinary tract infections in children. The urine may be stored for up 
to five years for additional laboratory tests.  One of the research team will contact 
you by telephone 2 weeks after your initial visit to the doctor as described above.   
 
What if my childs urine sample is negative (no infection)? 
 
No further urine samples will usually be needed, and you will not be contacted by 
telephone. However, we will be asking for a repeat urine sample in a small number 
of children even if the initial result is negative. If your child is still unwell or you are 
worried about your child you should contact your doctor in the normal way.   
 
What are the possible disadvantages and risks of taking part? 
 
Taking part will mean that we take up a little of your time asking certain questions 
about your childs illness, and in taking a urine sample that may not otherwise have 
been taken. Taking a urine sample in this way is safe and does not cause 
discomfort. We will not take any blood as part of this research study.  
 
If your child is found to have an infection in the urine, another urine test may be 
necessary, as might a visit to the hospital for possible further tests. Most children 
found to have infected urine will have an ultrasound scan of their kidneys - this is not 
painful or invasive.  Treatment and further tests will only be performed if your doctor, 
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or a hospital specialist, feels your child needs them. They will not be performed as 
part of this research study.  
 
What are the possible benefits of taking part? 
 
It is possible that there may be no direct benefit to your child taking part, however if 
your child is found to have an infection, treatment can be given. Improving the 
understanding, diagnosis and management of urinary tract infections may benefit 
your own child or other children in the future.   
 
What if there is a problem? 
 
Any complaint about the way you have been dealt with during the study or possible 
harm you might suffer will be addressed. The detailed information on this is given in 
Part 2.  
 
Will my taking part in this study be kept confidential? 
 
Yes. We will follow ethical and legal practice and all information about you and your 
child will be handled in confidence. The details are included in Part 2.  
 
This completes Part 1. 
 
If the information in Part 1 has interested you and you are considering 
participation, please read the additional information in Part 2 before making 
any decision. 
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Part 2 of the information sheet 
 
What if relevant new information becomes available? 
 
Sometimes we get new information about the condition being studied in a research 
study. If this happens, the research team will inform your doctor. Your doctor will tell 
you and discuss with you whether you and your child should continue with the study. 
If you decide not to carry on, this will not affect the care of you or your child in any 
way.  
 
If the study is stopped for any other reason, we will tell you and the care of you and 
your child will continue as normal.  
 
What will happen if I dont want to carry on with the study? 
 
You and your child can withdraw from the study at any time, without giving a reason. 
A decision to withdraw at any time, or a decision not to take part, will not affect the 
standard of care you or your child receives now or in the future. 
If you do decide to withdraw from the study, we will use the data collected up to your 
withdrawal but will collect no further data or samples for research purposes. Any 
urine samples which are not needed for your childs care, and which can still be 
identified as your childs will be destroyed if you wish.  
 
What if there is a problem? 
 
Complaints 
 
If you have a concern about any aspect of this study, you can speak to the 
researchers at Cardiff University who will do their best to answer your questions 
(contact details below).  
 
Contact for further information about the study 
 
Dr Kathy OBrien,  
Department of Primary Care & Public Health 
Cardiff University 
Neuadd Meirionnydd 
Heath Park 
Cardiff   
CF14 4XN 
 
Tel. 029 2068 7174 
or   029 2068 7191 
 
If you remain unhappy and wish to complain formally, you can do this through the 
Research and Commercial Division of Cardiff University (details below). 
 
 
 
Contact for formal complaints procedure at Cardiff University 
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Chris Shaw 
Research Governance Officer 
Cardiff University 
Research And Commercial Division 
30-36 Newport Road 
Cardiff 
CF24 0DE 
 
Tel. 029 2087 9130 
or 029 2087 9277 
 
Harm 
 
In the event that something does go wrong and you or your child are harmed during 
the research and this is due to someones negligence then you may have grounds 
for a legal action for compensation against Cardiff University but you may have to 
pay your legal costs. The normal National Health Service complaints mechanisms 
will still be available to you.  
 
Will my taking part in this study be kept confidential? 
 
Yes. All information which is collected about your child during the course of the 
research will be kept strictly confidential. Study data stored at the University will be 
kept separate from personal information (names and addresses). Only authorised 
persons on the research team will have access to view identifiable data. However, in 
some instances authorised persons from regulatory authorities may need to access 
data for monitoring of the quality of the research. All members of the research team 
and regulatory bodies are trained in data protection issues and bound by the terms 
of the Data Protection Act 1998.  
 
Once the study is complete and it is no longer necessary to keep identifiable 
information or contact details, we will destroy our records of this personal 
information. Fully anonymised data records will be kept securely for 15 years in line 
with Cardiff Universitys policies. 
 
Your childs urine may be stored securely for up to five years for further research 
concerning urine infections. Names and addresses will be removed from all urine 
samples stored for research purposes. Further ethical approval will be sought from 
the Ethics committee for any further research on these urine samples.  
 
 
Involvement of the General Practitioner 
 
As your Doctor is involved in helping us with this research study, he or she will be 
aware of your childs involvement in the study if you decide to help us.  
 
 
What will happen to any samples I give? 
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Urine samples will be obtained from your child (as described in part 1) and sent to 
the routine laboratory to see if there is a urine infection or not. These tests are often 
part of normal clinical practice for ill children, although they are not necessarily 
performed on all ill children. After these routine urine tests have been completed, the 
urine will have further tests for research purposes (as described in part 1). For the 
routine tests, the urine samples need to be clearly labelled with your childs name, 
address and date of birth so that the results can be reported back to your doctor. 
Once these routine tests are completed, names and addresses will be removed from 
the samples prior to the further, research-related tests.  
 
Will any genetic tests by done? 
 
No. We will not be doing any tests on human DNA.  
 
What will happen to the results of the research study? 
 
A report of the research results will be completed and submitted to the Welsh 
Assembly Government who are funding the study. Results will also be published in 
scientific journals and presented at scientific conferences. Your child will not be 
identified in any report, publication or presentation; all results will be completely 
anonymous.                                                    
 
Once the research study is completed, if you would like a report of the research 
findings this will be available by contacting Dr Kathy OBrien (see below). 
 
Who is organising and funding the research? 
 
This study is being organised by the Department of Primary Care and Public Health, 
Cardiff University with the help of your doctors surgery. The research is being 
funded by the Welsh Assembly Government.  
 
Who has reviewed the study? 
 
All research in the NHS is looked at by an independent group of people, called a 
Research Ethics Committee to protect your safety, rights, wellbeing and dignity. This 
study has been reviewed and given favourable opinion by the South East Wales 
Research Ethics Committee.  
 
Contact for Further Information 
 
Dr Kathy OBrien,  
Department of Primary Care & Public Health , Cardiff University,  
Neuadd Meirionnydd, Heath Park, Cardiff. CF14 4XN 
 
Tel. 029 2068 7174 
or 029 2068 7191 
 
THANK YOU FOR CONSIDERING TAKING PART IN THE STUDY. 
 
7th September 2009 Version 3 
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Centre Identification Number:  
Patient Identification Number for this study  
 
CONSENT FORM 
 
Title of Project:  
EURICA: The Epidemiology of Urinary Tract Infection (UTI) in Children  
with Acute illness in Primary Care  
(Protocol Version 4 dated 24/07/09) 
 
Name of Researcher: Dr Kathy OBrien 
                              
Please initial box 
 
1.  I confirm that I have read and understood the information sheet dated 7
th
 
September 2009 (Version 3) for the above study. I have had the opportunity to 
consider the information, ask questions and have had these answered 
satisfactorily. 
 
2.  I understand that my childs participation is voluntary and that I am free to 
withdraw my child at any time, without giving any reason, without mine or my 
childs medical care or legal rights being affected. 
 
3.  I understand that relevant sections of my childs medical notes and data 
collected during the study, may be looked at by the research team from Cardiff 
University, from regulatory authorities or from the NHS Trust, where it is 
relevant to my child taking part in this research. I give permission for these 
individuals to have access to my childs records. 
 
4.  I understand that my childs urine will be tested by the laboratory in the 
normal way and have additional exploratory laboratory tests performed. It may 
be stored for up to five years for research concerning urinary infections. 
 
5.  I agree for my child to take part in the above study.  
 
_______________________  
Name of Child  (please print) 
  
 
__________________________       ________________   ______________________________ 
Name of Parent/Carer        Date              Signature 
(please print) 
 
__________________________      ________________  ______________________________ 
Name of Person taking consent       Date   Signature 
 
When completed, 1 for carer/parent; 1 for researcher site file; 1 (original) to be kept in 
medical notes  
 5
th
 February 2010 Version 3 
Department of Primary Care & Public Health
Cardiff University 
Centre for Health Sciences Research 
School of Medicine 
Neuadd Meirionnydd 
Heath Park 
Cardiff CF14 4XN 
Tel +44 (0)2920687174 
Fax +44 (0)2920687612 
 
Adran Gofal Cynradd a Iechyd y Cyhoedd
Prifysgol Caerdydd 
Canolfan Ymchwil Gwyddoriaeth Iechyd Yr 
Ysgol Feddygol 
Neuadd Meirionnydd 
Parc y Mynydd Bychan 
Caerdydd CF14 4XN 
Appendix 4.8: Consent form 
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Appendix 4.9: CRF section one  
 
Page 1 of 2
EURICA: The Epidemiology of Urinary Tract Infection in Children with Acute Illness in Primary Care
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Currently taking oral or intramuscular
steroids greater than or equal to 10mg of
prednisolone per day (or equivalent) for
greater than or equal to two weeks
Note: Inhaled steroids are NOT an exclusion
criteria.
If the patient satisfies all eligibility and exclusion criteria please continue to the next section
Aged less than 5 years (before fifth birthday)
Please include child if the answer is 'yes' to all of the following:
Acute Illness for less than or equal to 28 days
First time in this study
Written consent from parent or carer to participate
Please exclude if you answer 'Yes' to any of the following:
Taking regular long term antibiotics
(daily for past 28 days or more)
On chemotherapy
Q1
Q2
Q3
Q4
Q5
Q6
Q7
Section 1: Patient Registration Form
Yes No
PIDCID
Inclusion criteria
Exclusion Criteria
Draft
Page 2 of 2
EURICA: The Epidemiology of Urinary Tract Infection in Children with Acute Illness in Primary Care
Carer details
First Name Surname
Relationship  to  child
Mother Father Other
please specify:
Q12 Q13
Q14
House Number/Name & Street Address
City
Postcode
-
Town
Mobile  Number
Contact Telephone Number
Q15
Q16
Q19
Q18
Q17
Q20
Date of consultation / /
Child's details
Gender
Female Male
Date of Birth
/ /
SurnameFirst Name
  D     D          M    M           Y     Y
Q8 Q9
Q10 Q11
  D     D          M    M           Y     Y
Patient Registration Form
PIDCID
Draft
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Appendix 4.10: CRF section two 
 
Page 1 of 5
Section 2: Case Record Form   Nurse/Healthcare Assistant to ask parent/carer
Yes No
Yes No
Sore throat
Difficulty breathing
/ /
Yes No
Yes No
Runny or blocked nose
Hot/feverish
  D     D          M    M           Y     Y
Date of onset of illness
Yes No
Yes No
Yes No
Yes No
Irritable/grouchy
Clinginess/needing extra care
Low energy/tired or lost interest in
playing
Poorer sleep
Yes No
Yes No N/A
Poorer feeding/poorer appetite
Nausea
Yes NoRash
Yes No
Yes No
Yes No
Vomiting
Diarrhoea
Constipation now
Yes NoCough
Yes No N/AMuscle aches or pains
Yes NoEarache or holding ear
Yes No N/A
Yes No N/AAbdominal pain/tummy ache
Colic/grimacing/pulling up legs
Yes No
Yes NoSmelly urine
Dark or cloudy urine
Yes NoPain/crying on passing urine
Bed wetting/clothes wet when
previously dry
Yes No N/A
Yes NoIncreased urinary frequency or
number of wet nappies
Yes NoPoor weight gain/weight loss
Yes NoWere there any other symptoms?
If YES, please list in the space provided.
Q23
Q26
Q22
Q21
Q24
Q25
Q27
Q29
Q28
Q30
Q33
Q32
Q31
Q35
Q36
Q37
Q34
Q38
Q39
Q40
Q47
Q43
Q46
Q45
Q44
Q41
Q42
PIDCID
Patient's Symptoms
Blood in urine
Yes No
Poor urine flow (interrupted or
intermittent)
Yes No
Q48
Constipation in the past Yes No
Q49
Q50
Draft
Page 2 of 5
Section 2: Case Record Form   Nurse/Healthcare Assistant to ask parent/carer
Please ask the parent/carer to tick a box from 0 to 4 of how unwell they feel their child is today. 0 is not unwell
and 4 is severely unwell.
Normal/not unwell Very unwellSlightly unwell Moderately unwell Severely unwell (as bad
as it could be)
Was the child's temperature measured (by the parent/carer)
at any time during this illness, prior to visiting the GP?
If YES, what was the highest temperature recorded by the
parent/carer
Yes No
Has the child had any medications containing paracetamol
(e.g calpol) for this illness?
If YES please give details starting with the most recent dose
Yes No
/ / :Most recentdose
Approximate timeName of medication Date
Has the child ever been diagnosed
with a UTI before
Yes No
If YES please give approximate dates, with most recent first
/ /
/ /
  D     D          M    M           Y     Y
  D     D          M    M           Y     Y
Background Information
These questions relate to other medical problems that the child has or has had in the past.
Q52
  D     D          M    M           Y     Y
Has the child had any medications containing ibuprofen (e.g
nurofen, cuprofen or calprofen) for this illness?
If YES please give details starting with the most recent dose
Yes No
/ / :Most recentdose
Approximate timeName of medication Date
Q51
  D     D          M    M           Y     Y
PIDCID
Asthma
Diabetes
Eczema
Has the child ever been diagnosed with any of the following?
Q53
Q54
Q55
Yes No Don't Know
Yes No Don't Know
Yes No Don't Know
High blood
pressure
Yes No Don't Know
Q56
Q57
Q58
.
oC
Q59
Draft
Page 3 of 5
Section 2: Case Record Form   Nurse/Healthcare Assistant to ask parent/carer
Kidney or bladder disease
If YES please give name of kidney or bladder disease
Was the child ever breast fed? Yes No
Approximately how many weeks did the pregnancy last?
(40 weeks is full term)
If YES please specify
Any other illnesses
If YES, for how long were they fed only human breast
milk?
Were any antibiotics taken by the mother during pregnancy?
If YES please specify:
Name of antibiotic 2
Q60
Q63
Q61
Q62
Name of antibiotic 1
Yes No Don't Know
Yes No Don't KnowWere there any abnormalities of the child's kidneys, bladder or
ureters on antenatal ultrasound scans?
Please specify if known:
PIDCID
Yes No Don't Know
Yes No Don't Know
Please explain to the parent/carer that the next set of questions relate to the child's birth and early life. There are also
some questions concerning the pregnancy of the child.
We are asking these questions because it is thought that these early experiences may influence the chance of
developing a urine infection or may affect the way the body deals with infection later on in childhood.
We recognise that these questions are more personal and they do not need to answer them if they would rather not.
Yes No Don't KnowHas the child had illnesses in the
past with a high temperature but
no obvious cause or diagnosis?
Q64
Q65
Months Days
Q66
Q67
Draft
Page 4 of 5
Section 2: Case Record Form   Nurse/Healthcare Assistant to ask parent/carer
Yes No
Only if the child is a boy please ask:
Has the child been circumcised?
Has  the child's parents, brothers or sisters ever
been diagnosed with a urinary tract infection (UTI)
during childhood (under 16)?
Yes No Don't Know
Relative 1 Relative 2 Relative 3
Relationship to
child
Age of first UTI
Number of
episodes of UTI
Has  the child's parents, brothers or sisters ever been
diagnosed with a kidney or bladder problem?
Yes No Don't Know
Relative 1 Relative 2
Relationship to
child
Nature of problem
if known
Q68
Q70
PIDCID
The next set of questions relate to close family members of the child this includes mother, father and any brothers or
sisters who are blood relatives of the child. We are asking these questions to see whether urine infections run in families.
Family History
Co.
/min
Temperature (using infrared
digital thermometer in ear)
Pulse rate
Respiratory rate
Q72
/min
Examination
Q71
Q73
Q69
Draft
Page 5 of 5
Section 2: Case Record Form   Nurse/Healthcare Assistant to ask parent/carer
Yes No
Clean catch Nappy pad
/ /
  D     D          M    M           Y     Y
:
Was a urine sample collected
before leaving the surgery?
Method of urine sampling used or
given to parents
Date sample collected
Time sample collected
(24 HR clock)
e.g   1     3    :    4      5
 Urine Dipstick
Please indicate with a tick if any of the following are present
Please ensure that the urine sample and both parts of the
microbiology form have all patient details and a EURICA label.
Please also stick one label here when this is done.
Q74
Q75
Q76
Q77
Q78
PIDCID
EURICA Label
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Leukocytes
Nitrites
Blood
Protein
Glucose
Ketones
Urine Collection
Draft
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Appendix 4.11: CRF section three 
 
Page 1 of 2
Abdomen
Chest
Throat
Ears
Examined Not  Examined
Left Ear Right Ear
Normal
Abnormal
Normal
Abnormal
Please tick all that apply Please tick all that apply
Eardrum  red or inflamed
Ear canal  red or inflamed
Discharge or blood  seen
Eardrum  red or inflamed
Ear canal  red or inflamed
Discharge or blood  seen
Please go to Q80
Examined Not  Examined
Normal Red or inflamed Swollen or enlarged tonsils Discharge or pus
If examined please tick all the apply
Please go to Q81
Examined Not  Examined
Normal Wheeze Crackles
Using accessory muscles Intercostal or subcostal recession
If examined please tick all that apply
Please go to Q82
Normal Loin tenderness Enlarged bladder
Q80
Q81
Q82
Examined Not  Examined Please go to Q83
Section 3: Case Record Form   Clinician to complete
Examination
PIDCID
Q79
If examined please tick all that apply
Mass Other, please specify
Draft
Page 2 of 2
Did you prescribe any medication,
including antibiotics?
Please rate your overall impression of the child by ticking a box
Yes No
If yes, please state details
Name of  medication 1
Name of  medication 2
Name of  medication 3
What is your working diagnosis?
Management at this consultation
Yes No
Yes No
Same day hospital referral?
Hospital referral but not same day
Fontanelles
N/A Normal Sunken Bulging
Q85
Q86
Q87
Q88
Q89
Q90
Section 3: Case Record Form
Normal/not unwell Very unwellSlightly unwell Moderately unwell Severely unwell (as bad
as it could be)
Q84
General/Overall
Please specify
Yes No
Yes No
Jaundice
Dehydrated
Yes NoOther
Yes No
Spinal lesion
Yes NoRash
Q83
PIDCID
Draft
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Appendix 4.12: Leaflets describing urine sampling methods 
These leaflets are not included in the electronic form of the thesis. Permission was obtained 
to use them in the study but not explicitly to make them freely available on-line.  
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Appendix 4.15: Data cleaning and management log 
 
EURICA DATA MANAGEMENT 
 
 
Database name including version 
and date 
Description 
EURICA section 2 v0.0 01.06.2010 Raw data imported from EXCEL for CRF section 2. Some 
corrections made in EXCEL prior to export.  
 
EURICA section 2 v0.1 01.06.2010 See paper data processing folder. Changes dated 1/6/10 
made and saved. 
 
 
EURICA section 2 v0.2 04.06.2010 
 
 
See paper data processing folder. Changes dated 4/6/10 
made and saved. 
 
EURICA section 2 v0.3 15.06.2010 
 
See paper data processing folder. Changes dated 15/6/10 
made and saved 
EURICA section 2 v0.4 08.07.2010 
 
See paper data processing folder. Changes dated 8/7/10 
made and saved 
EURICA section 2 v0.5 15.10.2010 
 
See paper data processing folder. 
Changes dated 15/10/10 made and saved. CID 08  
EURICA URINES v.0.1 16 08 2010  Data checking against paper results. Any errors corrected 
from: 
Double data entry checks, 
Positive/borderline results  checks and entry of repeats  
CID 1 
EURICA URINES v.0.2 
24 08 2010 
Data checking against paper results. Any errors corrected 
from: 
Double data entry checks, 
Positive/borderline results  checks and entry of repeats  
CID 2, 3, 4, 5, 6 
EURICA URINES v.0.3 31 08 2010 Data checking against paper results. Any errors corrected 
from positive/borderline results  checks and entries of 
repeats  CID 7, 8, 9, and part of 10. 
EURICA URINES v.0.4 20 09 2010 Data checking against paper results. Any errors corrected 
from positive/borderline results  checks and entries of 
repeats  10 completed. Also Mandys extra file of 
positive/borderline results which came in later. 
EURICA URINES v.0.5 11 10 2010 Data checking against paper results from Mandys extra 
file of late consent forms and lab results. CID 8 PID 378 is 
entered twice so 1 record removed. CID 15 PID 869 
entered twice so 1 record removed. Checked against latest 
Access database & all urine results entered. Mismatch in 
access database between number with urine results on 
patient recruitment table and lab results table. All checked 
against spss and raw data and changes made. 
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EURICA URINES v.0.6 23 11 2010 Data checking and sorting urines into table. Noted missing 
values for culture for 6 records and info was present in 
comments section so entered into culture: 
1 1101 Not cultured                                       
4 188 Not cultured                                       
6 1366 Not cultured                                       
6 1369 Not cultured    
10 1925 No growth                                          
10 1919 Growth        
 
Noted no bacteria for growth>100,000 and in comments 
states E.coli grown so added to bacteria variable.         
10 1919 Escherichia coli    
10 2063     Escherichia coli                                                                                                                
EURICA URINES v.0.7 10 01 2011  Added urine sample result manually. Sent later by practice. 
For CID 07 PID 329 
Clinician version 0.3 10 01 11.xls  
located in Teleform, raw data, 
clinician corrections 
See paper data processing folder. 
Changes for sec 3 CID 01 6-1025 and CID 2 51-94 
Clinician version 0.4 11 01 11.xls  
located in Teleform, raw data, 
clinician corrections 
See paper data processing folder. 
SEC 3 CID 3 102-135 
Clinician Aug 2010 data version 0.1 
11 01 11.xls  located in Teleform, raw 
data, clinician corrections 
See paper data processing folder. 
CID 1 1656-1699, 3002,3003 
Clinician version 0.5 14 01 11.xls  
located in Teleform, raw data, 
clinician corrections 
See paper data processing folder. 
CID 04 156-160, CID 05 202-215 
Clinician Aug 2010 data version 0.2 
14 01 11.xls  located in Teleform, raw 
data, clinician corrections 
NO CHANGES MADE ON 14 01 2011 . CHANGES 
MADE ON 17 01 11 
CID 15 852-883 
CID 18 1800-1832 
 
Clinician version 0.6 17 01 11.xls  
located in Teleform, raw data, 
clinician corrections 
See paper data processing folder 
CID 6 253-271; 1331-1337 
CID 8 352-383 
CID 6 273-289 & 1342-1358 
CID 7 332-346 
CID 5 234-242 
CID 9 401-448 
CID 10 452-488 
DATABASE MERGING  
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\NurseFullSet 310111.sav 
Merged all nurse(sec 2) data 
 
- R:\PCAPH\PCAPH\SEWTU Studies\EURICA\Main 
study\Analysis\MAIN ANALYSIS\SPSS Databases 
Syntax and Outcomes\EURICA section 2 v.0.6 
26.10.2010.sav &  
 
- R:\PCAPH\PCAPH\SEWTU 
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Studies\EURICA\STATS\TELEFORM\RAW 
DATA\RAW ORIGINAL DATA\EURICA CRF sec 2 
Nurse Aug 2010.xls 
 
 
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\ClinicianFullSet 
310111.sav 
Merged all Clinician (sec 3) data 
 
- R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\STATS\TELEFORM\RAW 
DATA\Clinician corrections\Clinician Aug 2010 data 
version 0.2 14 01 11.xls & 
 
- R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\STATS\TELEFORM\RAW 
DATA\Clinician corrections\Clinician version 0.6 17 01 11 
KO.xls 
 
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\NurseFullSet duplicates 
removed 070211.sav 
Duplicates checked 1 removed and remaining one checked 
manually with paper CRF any corrections made to 
R:\PCAPH\PCAPH\SEWTU Studies\EURICA\Main 
study\Analysis\MAIN ANALYSIS\FULL DATASET 
SPSS ANALYSIS\NurseFullSet 310111.sav 
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\ClinicianFullSetDuplicat
es removed 070211.sav 
Duplicates checked 1 removed and remaining one checked 
manually with paper CRF any corrections made to 
R:\PCAPH\PCAPH\SEWTU Studies\EURICA\Main 
study\Analysis\MAIN ANALYSIS\FULL DATASET 
SPSS ANALYSIS\ClinicianFullSet 310111.sav 
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\combined nurse clinical 
urines (Full set) 
Combined datasets:  
R:\PCAPH\PCAPH\SEWTU Studies\EURICA\Main 
study\Analysis\MAIN ANALYSIS\FULL DATASET 
SPSS ANALYSIS\ClinicianFullSet 310111.sav & 
R:\PCAPH\PCAPH\SEWTU Studies\EURICA\Main 
study\Analysis\MAIN ANALYSIS\FULL DATASET 
SPSS ANALYSIS\NurseFullSet 310111.sav & 
EURICA URINES v.0.7 10 01 2011 
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\combined nurse clinical 
urines (Full set) checks 070111 
Checks of 
R:\PCAPH\PCAPH\SEWTU Studies\EURICA\Main 
study\Analysis\MAIN ANALYSIS\FULL DATASET 
SPSS ANALYSIS\combined nurse clinical urines (Full set) 
 and changes made  added CID and PID numbers for 
REC_IDs 
11,3130,3137,6290,8391,8394,8396,9416,9618,9620,1162
2,15000,61347,91987,91988, 92058 
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\combined nurse clinical 
Checks of duplicates and missing ID numbers. See paper 
copy in data management folder + see related doc. 
REC_ID 4214  no PID 214 for CID 4  should be CID 5. 
urine result for CID 5 PID 214 matches result exactly so 
changed to CID 5.   
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urines (Full set) checks 110111  
REC_ID 11: this was accidentally changed from CID 1 
PID 1 to CID 20 PID 1 (ie REC_ID 201) between 
Nursefull set 31 01 11 and Nursefull set duplicates 
removed 07 02 11. so changed back to CID 1 and Sec 2, 3 
and urine results all correctly assigned and checked. 
 
All duplicate PID numbers 2050-2080 checked. All urine 
results correctly assigned.  
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\combined nurse clinical 
urines (Full set) checks 140111 
Check to see if any have urine dips recorded but no urine 
results available. 
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\combined nurse clinical 
urines (Full set) additional urines 17 
02 11 
Manually entered additional urine results from NHS path 
results.  
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\combined nurse clinical 
urines (Full set) additional urines 28 
02 11 
Manually entered additional urine results from NHS path 
results. 
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\combined nurse clinical 
urines (Full set) additional urines 04 
03 11 
Coded duplicates as excluded 
Also further checks on duplicate PID numbers. 
REC_ID9247 should be CID 5 not CID 9  combined with 
5247 and then 9247 deleted. 
REC_ID 15000 should be CID 9 not CID 1 so combined 
with 95000 and 15000 deleted.  
REC_ID 61354 is correct but rest of crf entered as REC_ID 
91354 so combined and 91354 deleted.  
REC_ID 9 and REC_ID 10  no way of identifying (went 
back to Access database and they are entered with only this 
information) so deleted.  
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\combined nurse clinical 
urines (Full set) additional urines 07 
03 11 
After checking with ACCESS and paper CRFs,  
REC_ID 313 changed to 3137. 
REC_ID 6347 changed to 61347. 
REC_ID 11963 changed to 11693. 
 
Then start variable checks. 
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
Merged with sec 1 from access  table of recruitment  
Patient recruitment access export recruitment a 07 03 11 
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ANALYSIS\FULL DATASET SPSS 
ANALYSIS\FULL DATASET 
(including sec 1) 07 03 2011  
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\FULL DATASET 
additional urines 11 03 2011 
Adding additional urine results from Royal Glam and 
Prince Charles 
Urine results added for  
19 2008 
19 2011 
19 2019  
10 495  
10 498  
10 1922  
10 1923 
 
No consent forms so excluded: 
7 323  
9 5030 
10 2006 
5 219 
9 416 
 
940274  no such number. No info in database. No consent 
form found. Deleted.  
 
Added missing gender data 
 
Change date variables to namea 
e.g. dateurineresult becomes dateurineresulta so that I can 
re-merge access dates.  
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\FULL DATASET 14 03 
2011 
DOB and Date consultation checks. Consent form checks 
for those missing this sec 1 info. 
REC_ID 11963 should be 91963. no info in any section so 
deleted.  
Consent forms missing/not signed so excluded: 
1 1000 
9 5028 
9 416 
5 219 
9 611 (DOB also must be incorrect so left as sys missing) 
 
Missing DOB and Dates of consultation + postcode and 
relative for those entered by hand.  
10496 
120 
11024 
6263 
7312 
3126 
9433 
9446 
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11640 
9625 
10467 
9659 
5248 
91990 
95004 
92050 
92052 
61405 
Checked incorrect dates of birth/dates of consultation and 
changed for 
9632 
9419 
11663 
258 
6284 
2 1141 
10 456 
119 
286 
6255 
6299 
8384 
9623 
11620 
91975 
101910 
 
 
Date of birth for 9 5005 deleted so now sys missing as 
cannot be correct as stated as 30.9.2010 which is after date 
of consultation and date of CRF. 
 
Date of birth for 1 1067 deleted so now sys missing as 
cannot be correct as stated as 28.12.2008 which is after 
date of consultation and date of CRF. 
 
Checked DOB/date of consultation for those with age>5 
yrs.  
Changed incorrect DOBs for  
1 1090 
8 392 
 
Exclude 7 334 and 7 347 10 458 as age>5  
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\FULL DATASET 15 03 
Daysurine checks  minus numbers checked date 
consultation and date urine result. 
Errors corrected for 
3 103 
2 53 
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2011 4 195 
1 27 
1 647 
5 1854 
18 1831 
18 1821 
19 2008 
 
Missing lab results found/rang labs to get for: 
9 633 
10 1909 
10 455 
18 1830 
18 1831 
 
No urine result found and nil on UHW path link for 9 634 
and 9 5000 so urine sample info removed. 
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\FULL DATASET 04 04 
2011 
No changes made 
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\FULL DATASET 11 04 
2011 
CID 19 PID 2009  entered as no growth and no organism 
but has got growth of organism so changed.  
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\FULL DATASET 15 04 
2011 
Additional info from lab about count for PID 2009,2016, 
2018 so entered into database. 
2009 Aerococcus 10^4  10^5 
2016 E.coli >10^5 
2018 Citrobacter >10^5  
R:\PCAPH\PCAPH\SEWTU 
Studies\EURICA\Main 
study\Analysis\MAIN 
ANALYSIS\FULL DATASET SPSS 
ANALYSIS\FULL DATASET 19 04 
2011 
Data cleaning from file (Teleform queries) Nurse 6 1340 - 
1409 
Full dataset with follow up data 06 03 
2012 to start. Changes made and 
saved as Full dataset with follow up 
data 01 07 2012  
Tel f/up odd cases listed as PID 720, 
721,747,769,790,791,849,964.  
These arent PID numbers. Checked ACCESS database 
with names. These are all the ID numbers assigned in 
ACCESS. Checked them all and matched ID, name and 
DOB.  
720 = CID 10, PID 1901 
721 = CID 10, PID 1903 
747 = CID 10, PID 1919 
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769 = CID 10, PID 1685 
790 = CID 10, PID 1911 
791 = CID 10, PID 1916 
849 = CID 09, PID 1977 
964 = CID 09, PID 964 
Manually changed. Data for these for tel f/up added to 
correct CID/PID numbers 
 
Added 2 new variables and completed manually  was 
telephone f/up completed and reason it wasnt if it wasnt. 
 
PID 323  6 month follow up data but no CRF or tel f/up 
?wrong PID number. Paper copy checked 
 
Manual data entry 15 850  874 and 18 1800-1832 and 9 
1981-2057 and 1 3000 & 3003 and 9 5003  5029 and 1 
1698 
 
Following initial frequency checks outlying values spotted 
so checked and corrected errors for  
6    256      no errors 
6    1344    no errors 
6    1359    no errors 
6    260      no errors 
4    180      FU2ADM & FU3OOH errors changed. 
4    154      FU1CON 23 CORRECT 
9    633      FU2ADM error changed 
1    1078    FU2ADM error changed 
1    1649    FU2ADM error changed 
1    1004    no errors 
1    27        no errors 
1    38        FU6REF error changed 
10  494      URINE RESULTS ENTERED. 
10  2053    FU2ADM AND FU5UR errors changed  
10  472      FU5UR error changed 
10  461      FU4AB & FU7INV errors changed & 
RESULTS ENTERED. 
1    1064   FU5UR error changed 
1    1089   FU4AB AND FU5UR errors changed 
9    613     FU4AB AND FU5UR errors changed 
6    284    FU5UR error changed & urine results entered. 
6    271    no errors. Urine results entered.  
 
Full dataset with follow up data 01 07 
2012 to start. Changes made and 
saved as Full dataset with follow up 
data 08 06 2012  
4 154,160 171, 180 have urine results in f/up recorded but 
info not given. Need to chase surgery. 
Checking through all FU forms any with results attached 
checked. Any with 6 entered on database checked due to 
several errors found and any with large numbers checked. 
Also all checked for FU6REF & FU7INV if =1 as several 
errors found here. 
267 
 
If boxes not ticked or number entered assumed =0. 
 
CID 1 PID 1 checked. Date of first urine sample was 
entered incorrectly. Changed. 
1   1085  FU4AB error changed. 
1   1073  FU4AB error changed. 
1   1079  FU1CON & FU3OOH errors changed. 
1   1062  FU6REF error changed 
1   1045  not all urine culture info added so this added.  
1   1043  FU1CON & FU5UR errors changed. 
1   1680  FU1CON error changed 
1   1675  FU3OOH error changed 
1   1642  FU4AB error changed 
1   1641  FU6REF & FU7INV errors changed. 
1   1631  FU1CON error changed 
1   1629  FU6REF & FU7INV errors changed. 
1   1627  FU4AB error changed 
1   1626  FU6REF & FU7INV errors changed. 
1   1625  FU1CON error changed. 
1   3003  incorrect date of urine result. Changed.  
2   52   urine and renal uss results added.  
2   53  FU6REF error changed. 
2   55  FU6REF error changed. 
2   76  FU6REF & FU7INV errors changed 
2   78  FU6REF & FU7INV errors changed 
2   89  Results added.  
2   92  FU6REF error changed. 
2   1134  FU6REF & FU7INV errors changed 
2   1153  incomplete info for results entered. Also wrong 
date. Errors changed.  
3   130  FUUSS error changed. 
4   166  FU6REF error changed 
4   171  FU6REF error changed 
6   252  FU6REF, FU7INV, FUUSS and date of 3
rd
 test 
wrong. errors changed. 
6   254  FU6REF & FU7INV errors changed. Wrong date 
for 1
st
 test. 
6   268  FU6REF & FU7INV errors changed. 
6   269  FU6REF & FU7INV errors changed. 
6   270  incorrect date for test. 
6   272  incomplete info for test. Corrected. 
6   273  incomplete info for test. Corrected. 
6   274  incomplete info for test. Corrected. 
6   275  incomplete info for test. Corrected. 
6   276  FU6REF error changed. incomplete info for test. 
Corrected. 
6   277 incomplete info for test. Corrected. 
6   278  incomplete info for test. Corrected. 
6   279  incomplete info for test. Corrected. 
6   280  incomplete info for test. Corrected. 
268 
 
6   282  incomplete info for test. Corrected. 
6   283  incomplete info for test. Corrected. 
6   285  incomplete info for test. Corrected. 
6   286  incomplete info for test. Corrected. 
6   287  incomplete info for test. Corrected. 
6   288  incomplete info for test. Corrected. 
6   290  incomplete info for test. Corrected. 
6   291  incomplete info for test. Corrected. 
6   293  incomplete info for test. Corrected. 
6   294  incomplete info for test. Corrected. 
6   295  incomplete info for test. Corrected. 
6   297  FU6REF & FU7INV errors changed. incomplete 
info for test. Corrected. 
6   298  incomplete info for test. Corrected. 
6   299 incomplete info for test. Corrected. 
6   300 incomplete info for test. Corrected. 
 
Full dataset with follow up data 08 06 
2012to start. Changes made and saved 
as Full dataset with follow up data 11 
06 2012 
6   1331 incomplete info for test. Corrected.  
6   1332 incomplete info for test. Corrected. 
6   1333 incomplete info for test. Corrected. 
6   1334 incomplete info for test. Corrected. 
6   1335 incomplete info for test. Corrected. 
6   1336 incomplete info for test. Corrected. 
6   1337 FU3OOH ERROR. incomplete info for test. 
Corrected. 
6   1338 incomplete info for test. Corrected. 
6   1340 incomplete info for test. Corrected. 
6   1341 FU6REF & FU7INV errors; incomplete info for 
test. Corrected. 
6    1342 incomplete info for test. Corrected.  
6    1343 incomplete info for test. Corrected.  
6    1344 incomplete info for test. Corrected.  
6    1345 incomplete info for test. Corrected.  
6    1347 incomplete info for test. Corrected.  
6    1348  FU6REF & FU7INV errors incomplete info for 
test. Corrected.  
6     1349 incomplete info for test. Corrected.  
6    1350 incomplete info for test. Corrected.  
6     1351 incomplete info for test. Corrected.  
6    1352 incomplete info for test. Corrected.  
6    1353 incomplete info for test. Corrected.  
6     1354 incomplete info for test. Corrected.  
6    1356 incomplete info for test. Corrected.  
6    1357 incomplete info for test. Corrected.  
6    1358 incomplete info for test. Corrected.  
6    1359 incomplete info for test. Corrected.  
6    1360 incomplete info for test. Corrected.  
6    1361 incomplete info for test. Corrected.  
6    1362 incomplete info for test. Corrected.  
6    1363 incomplete info for test. Corrected.  
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6    1365 incomplete info for test. Corrected.  
6    1366 incomplete info for test. Corrected.  
6    1367 incomplete info for test. Corrected.  
6    1368 incomplete info for test. Corrected.  
6    1369  incomplete info for test. Corrected.  
6    1372 incomplete info for test. Corrected.  
6    1374 incomplete info for test. Corrected.  
6    1376 incomplete info for test. Corrected.  
6    1377 incomplete info for test. Corrected.  
6    1379 incomplete info for test. Corrected.  
6    1380 incomplete info for test. Corrected.  
6    1381 incomplete info for test. Corrected.  
6    1383 incomplete info for test. Corrected.  
6    1404 FU6REF & FU7INV errors incomplete info for 
test. Corrected.  
6    1406 FU6REF & FU7INV errors incomplete info for 
test. Corrected.  
6    1409 incomplete info for test. Corrected.  
7   302  incomplete info for test. Corrected.  
7   314  incomplete info for test. Corrected 
7   315  incomplete info for test. Corrected 
7   317  incomplete info for test. Corrected 
7  319  incomplete info for test. Corrected 
7   322  incomplete info for test. Corrected FU5UR 
CORRECTED 
7   324 incomplete info for test. Corrected 
7   326  incomplete info for test. Corrected 
7   333  incomplete info for test. Corrected 
7  334  incomplete info for test. Corrected 
7   343  DATE ERROR ON TEST RESULT. 
CORRECTED 
7   347  incomplete info for test. Corrected 
7   556  ERROR TEST RESULT . CORRECTED 
7   557  incomplete info for test. Corrected 
8   363  FU6REF & FU7INV errors incomplete info for 
test. Corrected 
8   358  errors and incomplete info for test. Corrected 
Full dataset with follow up data 11 06 
2012 to start. Changes made and 
saved as Full dataset with follow up 
data 18 06 2012 
8   377 FU6REF error corrected 
New variables added: 
EXCLUDEFUP and EXCFUPREAS excluded from 6 
month follow up and reason excluded from 6 month follow 
up. Because of 
 8   383  
note on form that patient left practice half way through f/up 
period (08/09)  d/w KH ?multiply up ?exclude 
8   386  FU1CON and FU7INV errors corrected 
8   392  error in test result. Corrected 
8   393 error in test result. Corrected 
8   394 incomplete info for test. Corrected 
8   396  incomplete info for test. Corrected 
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9   418  FU6REF & FU7INV errors 
9   618  NO INFO AT ALL SCANNED/ENTERED.  
9   619  NO INFO AT ALL SCANNED/ENTERED 
9   620  NO INFO AT ALL SCANNED/ENTERED 
9   622  FU6REF & FU7INV errors 
9   623 FU6REF & FU7INV errors 
9   624  FU6REF & FU7INV errors 
9   640  FU6REF & FU7INV errors 
9   641  FU1CON error 
9   646  FU2ADM error 
9   654  FU6REF & FU7INV errors and test result not 
entered. 
9   1954  FU6REF & FU7INV errors 
9   1959  NO INFO AT ALL SCANNED/ENTERED 
9   1964  NO INFO AT ALL SCANNED/ENTERED 
9   1969  NO INFO AT ALL SCANNED/ENTERED 
9   1970  NO INFO AT ALL SCANNED/ENTERED 
9   1976  NO INFO AT ALL SCANNED/ENTERED 
9   1977  NO INFO AT ALL SCANNED/ENTERED 
9   2054  NO INFO AT ALL SCANNED/ENTERED 
10   454  FU6REF & FU7INV errors 
10   458  FU6REF & FU7INV errors & incomplete test 
result. 
10   461  FU6REF & FU7INV errors & incomplete test 
result. 
10   463  FU6REF & FU7INV errors & incomplete test 
result. 
10   464  FU6REF & FU7INV errors & incomplete test 
result. 
10   468  incomplete test result 
10   469  excluded. Moved from surgery 18/6/2009 
10   471 excluded. Moved from surgery 30/07/2009 
10   472  incomplete test result 
10   474   FU1CON error 
10   480  incomplete test result 
10   481 incomplete test result 
10   482 incomplete test result 
10   485 incomplete test result 
10   492  FU6REF & FU7INV errors 
10   1901  incomplete test result. REGDOB, REGDT & 
FU6FUP also missing. 
10   1902 incomplete test result. 
10   1903  FU1CON & FU5UR errors and REGDOB, 
REGDT & FU6FUP also missing. AND incomplete test 
results.  
10   1911 incomplete test results. 
10   1914  incomplete test results. 
10   1915  incomplete test results. 
10   1919  incomplete test results. 
10   1925  FUINV error 
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10   1929  incomplete test results. 
10   1938  incomplete test results. 
10  2058   FU6REF & FU7INV errors 
10   2064   incomplete test results 
10   2065  FU5UR error.  
10   2072  incomplete test results 
 
 
 
 
Full dataset with follow up data 18 06 
2012to start. Changes made and saved 
as Full dataset with follow up data 22 
06 2012  
1   1099  FU4AB error. 
1   1113  FUDAT1 date entered. Only listed 04/2009 so 
01.04.2009 entered (not close to recruitment date). 
7    302  FUDAT1 date entered. 
9   1977  FUDAT1 entered. 
10   1918  FUOOH  
7   326   FU5UR, FU6REF, and FU7INV errors 
6   298   FU2ADM 
1   1102  FU6REF & FU7INV errors 
9   1970  FU1CON error 
7   345  FU5UR error 
7   556  FU2ADM  
3   127  FU5UR error 
18   1828  FU1CON  
9   407  FU1CON 
 
Full dataset with follow up data 22 06 
2012 to start. Changes made and 
saved as Full dataset with follow up 
data 25 06 2012 
Checking date of urine results listed in follow up period 
and checking they are not giving the index urine. If date 
urine result (original urine result) and date of test 1 (FUP) 
is the same or within 1 day assumed it is the index urine 
and recode number of urine samples in f/up period 
accordingly.  
 
- New variable TRUEFUPUR which is YES if there is a 
f/up urine result listed which is truly a separate urine 
sample sent in the 6 mth f/up period and not an index 
urine sample  
NB this still=1 if the f/up urine sample was a requested 
repeat. New variable on how many days after index 
consultation will be created. 
 
DURING CHECKING 
1   39  Date discrepancy between original repeat sample 
date and f/up sample date but result the same. Checked. 
Error on f/up  should be 29/8/08 so changed. 
4   160   error with urine result date. Changed. 
 
Full dataset with follow up data 25 06 
2012 to start. Changes made and 
saved as Full dataset with follow up 
7   340   date f/up urine result checked. Incorrect. 
Corrected. 
6   295   date f/up urine result checked. Incorrect. 
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data 02 07 2012  Corrected. 
4  checked with Clifton practice as incomplete results 
given. 
4   180  incomplete results. Changed. 
4   154  incomplete results. Changed 
4   160   result 29/12/2008 listed but not given. Added. 
4   171  incomplete results. Changed 
 
2 checked with PM at Highlight as incomplete results 
9   654  urine results had no date. Checked and added. 
9   1969  urine results indicated but no result given. 
Checked and added. 
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Appendix 5.1: Calculation of confidence intervals for prevalence and ICC 
 
Calculation of the prevalence in the population (population proportion) using the sample 
proportion and calculation of the ICC (Intraclass coefficient) 
The standard error of the sample proportion needs to be calculated first: 
If p = sample proportion = 35/597 = 0.0586 
And ! = population proportion 
The standard error of p can be calculated with the following equation: 
SE (p) = " !(1- !)/ "n 
Best approximation of ! is p 
"p = 0.2421 
1-p = 0.9414 
"n = 24.434 
Table showing standard deviation of the population and sample.  
 Population Sample 
Proportion ! p 
Standard deviation  " !(1- !) "p(1-p)  = 0.2279 
 Standard error "p(1-p)/"n = 0.0093 
 
I can then calculate the 95% confidence intervals for the population proportion using the 
sample proportion: 
95% CI= p +/- 1.96 x SE (p) 
=p+/- 1.96 " [p (1-p)/n] 
= 0.0586+/- 0.0183 
=0.0403  0.0769 i.e. the 95% CI for p using this method is 0.043-0.077 
 
Calculation of the ICC and adjustment for cluster size 
ICC adjusting for cluster sizes: 
ICC (r) = MSC MSW 
       MSC + (m0-1) MSW  
Where MSC =mean square between groups and MSW = mean square within groups)  
And where  
 m0 = m  - 
2
1 )1(
)(
å
= -
-k
j Mk
mmj
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Where k is number of clusters (13) and M is total number of individuals in sample (597) and 
mj is the number in each of the clusters. m is average cluster size = 
k
M
=597/13 = 45.923  
This makes (k-1) (M) = 12x597=7164 
The table below shows my interim calculations for the final equation 
Practice (CID) Total number 
(mj) 
(Mj- m )2 (Mj- m )2/ 
(k-1)(M) 
1 143 9423.944 1.315458 
2 60 1981.162 0.027661 
3 25 437.772 0.061107 
4 35 119.312 0.016654 
5 21 621.156 0.086705 
6 80 1161.242 0.162094 
7 29 286.388 0.039976 
8 21 621.156 0.086705 
9 87 1687.320 0.235528 
10 56 101.546 0.014174 
15 18 779.694 0.108835 
18 12 1150.770 0.160632 
19 10 1290.462 0.180131 
Total  597  2.49566 
 
M0 = 45.923  2.49566 = 43.42734 
So, to put this all in to the original equation to calculate ICC: 
ICC (r) = MSC MSW 
       MSC + (m0-1) MSW  
 
MSC (mean square between groups) = 68.660 (F=3.555 Sig 0.060)  
MSW (mean square within groups) = 19.315 
r =            68.660-19.315                                 
        68.660 + (43.42734-1) x 19.315 
Giving an ICC = 49.345/888.1440721 = 0.05556 
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Appendix 5.2: Histograms of continuous variables 
Histograms 
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Temperature was normally distributed. Respiratory rate had a skewed distribution. Pulse rate 
did not seem to be normally distributed at first.  However, the distribution looks symmetrical 
and as if it would be a normal distribution if it was not for a large peak at 120-125 beats per 
minute and a much lower frequency of pulses at 115-120. This may be due to the way pulse 
rate is often measured in clinical practice where the beats are measured for 15 seconds and 
then multiplied by 4 to get the pulse rate for a minute. 120 divides perfectly by 4 to 30. Some 
may have rounded up or down to get a number which was easy to multiply by 4. Mean and 
medians were almost identical at 111.47 and 112.0 respectively. It was considered to be 
normally distributed for the statistical tests. 
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Appendix 5.3: Calculations of probabilities of UTI based on the logistic regression 
model 
 
To calculate the confidence intervals for the probabilities of UTI predicted by the model, I 
needed to calculate the 95% confidence intervals for B (not given in the SPSS output).  
95% confidence intervals for B calculated by B +/- 1.96 x S.E: 
Urinary frequency: 
0.966 +/- 1.96 x 0.398 = 0.966 +/- 0.78008 =   0.18592 - 1.74608 
Pain: 
1.194 +/- 1.96 x 0.554 = 1.194 +/- 1.08584 =    0.10816 - 2.27984 
Age <3/12 
1.712 +/- 1.96 x 0.680 = 1.712 +/- 1.33280 = 0.37920 - 3.04480 
Age 3/12  3 yrs  
0.865 +/- 1.96 x 0.451 = 0.865 +/- 0.88396 = -0.01896 - 1.74896 
Constant  
-3.781 +/- 1.96 x 0.427 = -3.781 +/- 0.83692 = -4.61792 - -2.94408 
 
Model: 
Symptom/characteristic B S.E. 95% CI for B Odds 
ratio  
p-value 95% CI 
for odds 
ratio 
Lower Upper 
Urinary frequency 0.966 0.398 0.186 1.746 2.63 0.015 1.20-5.74 
Pain on passing urine 1.194 0.554 0.181 2.280 3.30 0.031 1.12-9.76 
NICE age range<3/12 1.712 0.680 0.379 3.045 5.54 0.012 1.46-21.0 
NICE age range 3/12-3 
years 
0.865 0.451 0.0190 1.749 2.38 0.055 0.98-5.75 
Constant -3.781 0.427 -4.618 -2.944    
P=0.002 
 
To calculate the probability of UTI using the model: 
p (UTI) = 1/1 + e
- (-3.781 + 0.966[freq]+1.194[pain]+1.712[age <3 mths]+0.865[age 3mths-3yrs])
 
Age less than 3 months old 
p (UTI) = 1/1 + e
- (-3.781 + 0.966[freq]+1.194[pain]+1.712)
 
No symptoms: p (UTI) =1/1 + e
- (-3.871+1.712)
 = 10.35% 
Freq and pain: p (UTI) =1/1 + e
- (-3.781 + 0.966[freq]+1.194[pain]+1.712)
 = 31.47% 
Frequency only: p (UTI) =1/1 + e
- (-3.781 + 0.966[freq]+1.194[pain]+1.712)
 = 25.27% 
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Pain only: p (UTI) =1/1 + e
- (-3.781 +1.194[pain]+1.712)
= 29.42% 
 
Age between 3 months and 3 years old 
p(UTI) = 1/1 + e
- (-3.781 + 0.966[freq]+1.194[pain]+0.865)
 
No symptoms: p (UTI) =1/1 + e
- (-3.781 + 0.865)
 = 5.14% 
Freq and pain: p (UTI) =1/1 + e
- (-3.781 + 0.966[freq]+1.194[pain]+0.865)
 =31.95 % 
Freq only: p (UTI) =1/1 + e
- (-3.781 + 0.966+ 0.865)
 = 12.46% 
Pain only: p (UTI) =1/1 + e
- (-3.781 + 1.194+0.865)
 = 15.16% 
 
Age greater than or equal to 3 years old 
p (UTI) = 1/1 + e
- (-3.781 + 0.966[freq]+1.194[pain])
 
No symptoms: p (UTI) =1/1 + e
- (-3.781)
 =2.23 % 
Freq & pain: p (UTI) =1/1 + e
- (-3.781 + 0.966+1.194)
= 16.51% 
Freq only: p (UTI) =1/1 + e
- (-3.781 + 0.966)
 = 5.65% 
Pain only: p (UTI) =1/1 + e
- (-3.781 + 1.194)
 =6.70 % 
 
 
 
95% confidence intervals: lower: 
Symptom/characteristic B S.E. 95% CI for B 
Lower Upper 
Urinary frequency 0.966 0.398 0.186 1.746 
Pain on passing urine 1.194 0.554 0.181 2.280 
NICE age range<3/12 1.712 0.680 0.379 3.045 
NICE age range 3/12-3 
years 
0.865 0.451 0.0190 1.749 
Constant -3.781 0.427 -4.618 -2.944 
 
p(UTI) = 1/1 + e
- (-4.618 + 0.186[freq]+1.181[pain]+0.379[age <3 mths]+0.0190[age 3mths-3yrs])
 
Age less than 3 months old 
p (UTI) = 1/1 + e
- (-4.618 + 0.186[freq]+1.181[pain]+0.379)
 
No symptoms: p (UTI) =1/1 + e
- (-4.618 +0.379)
 = 1.4% 
Freq and pain: p (UTI) =1/1 + e
- (-4.618 + 0.186+1.181+0.379)
 =5.4 % 
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Frequency only: p (UTI) =1/1 + e
- (-4.618 + 0.186+0.379)
 = 1.7% 
Pain only: p (UTI) =1/1 + e
- (-4.618 + 1.181+0.379)
 = 4.5% 
 
Age between 3 months and 3 years old 
p (UTI) = 1/1 + e
- (-4.618 + 0.186[freq]+1.181[pain]+ 0.0190)
 
No symptoms: p (UTI) =1/1 + e
- (-4.618 + 0.0190)
 = 1.0% 
Freq and pain: p (UTI) =1/1 + e
- (-4.618 + 0.186+1.181+ 0.0190)
= 3.8% 
Freq only: p (UTI) =1/1 + e
- (-4.618 + 0.186+ 0.0190)
 = 1.2% 
Pain only: p (UTI) =1/1 + e
- (-4.618 + 1.181+0.0190)
 = 3.2% 
 
Age greater than or equal to 3 years old 
p (UTI) = 1/1 + e
- (-4.618 + 0.186[freq]+1.181[pain]+0.379)
 
No symptoms: p (UTI) =1/1 + e
- (-4.618)
 =1.0 % 
Freq & pain: p (UTI) =1/1 + e
- (-4.618 + 0.186+1.181+0.379)
 =5.4 % 
Freq only: p (UTI) =1/1 + e
- (-4.618 + 0.186+0.379)
 =1.7 % 
Pain only: p (UTI) =1/1 + e
- (-4.618 + 1.181+0.379)
 = 4.5% 
Symptom/characteristic B S.E. 95% CI for B 
Lower Upper 
Urinary frequency 0.966 0.398 0.186 1.746 
Pain on passing urine 1.194 0.554 0.181 2.280 
NICE age range<3/12 1.712 0.680 0.379 3.045 
NICE age range 3/12-3 
years 
0.865 0.451 0.0190 1.749 
Constant -3.781 0.427 -4.618 -2.944 
 
95% CI upper: 
p(UTI) = 1/1 + e
- (-2.944+ 1.746[freq]+2.280[pain]+3.045[age <3 mths]+1.749[age 3mths-3yrs])
 
Age less than 3 months old 
p (UTI) = 1/1 + e
- (-2.944+ 1.746[freq]+2.280[pain]+3.045)
 
No symptoms: p (UTI) =1/1 + e
- (-2.944+ +3.045)
 = 52.5% 
Freq and pain: p (UTI) =1/1 + e
- (-2.944+ 1.746+2.280+3.045)
 =98.4% 
Frequency only: p (UTI) =1/1 + e
- (-2.944+ 1.746+3.045)
 = 86.4% 
Pain only: p (UTI) =1/1 + e
- (-2.944+ 2.280+3.045)
 = 91.5% 
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Age between 3 months and 3 years old 
p (UTI) = 1/1 + e
- (-2.944+ 1.746[freq]+2.280[pain]+1.749)
 
No symptoms: p (UTI) =1/1 + e
- (-2.944+ 1.749)
 = 23.2% 
Freq and pain: p (UTI) =1/1 + e
- (-2.944+ 1.746+2.280+1.749)
 =94.4% 
Freq only: p (UTI) =1/1 + e
-(-2.944+ 1.746+1.749) =63.4% 
Pain only: p (UTI) =1/1 + e
- (-2.944+ 2.280+1.749)
 = 74.7% 
 
Age greater than or equal to 3 years old 
p (UTI) = 1/1 + e
- (-2.944+ 1.746[freq]+2.280[pain])
 
 
No symptoms: p (UTI) =1/1 + e
- (-2.944)
 =5.0 % 
Freq & pain: p (UTI) =1/1 + e
- (-2.944+ 1.746+2.280)
 =74.7 %
 
Freq only: p (UTI) =1/1 + e
- (-2.944+ 1.746)
 = 23.2% 
Pain only: p (UTI) =1/1 + e
- (-2.944+ 2.280)
 = 34.0% 
 
 
